[
  {
    "bcr_patient_uuid": "6d10d4ee-6331-4bba-93bc-a7b64cc0b22a",
    "patient_ID": "TCGA.04.1331",
    "bcr_drug_barcode": "TCGA-04-1331-D23909",
    "bcr_drug_uuid": "8248d776-145a-4301-8d69-09567aedcf3d",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "VELCADE",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 481,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4.4
  },
  {
    "bcr_patient_uuid": "6d10d4ee-6331-4bba-93bc-a7b64cc0b22a",
    "patient_ID": "TCGA.04.1331",
    "bcr_drug_barcode": "TCGA-04-1331-D23908",
    "bcr_drug_uuid": "0debc4f0-665e-47b4-880c-d732d3897ea2",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 455
  },
  {
    "bcr_patient_uuid": "6d10d4ee-6331-4bba-93bc-a7b64cc0b22a",
    "patient_ID": "TCGA.04.1331",
    "bcr_drug_barcode": "TCGA-04-1331-D23907",
    "bcr_drug_uuid": "f4aaacc4-22bc-4b11-9987-42a72560fe95",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23916",
    "bcr_drug_uuid": "9872734c-4308-4239-a327-badc002227f5",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1094,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1155,
    "drug_cycles": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23913",
    "bcr_drug_uuid": "eaa50f60-2e69-4f97-b316-7f7b4d6ad0e7",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 7,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23917",
    "bcr_drug_uuid": "7fb06145-71d2-4719-b919-ce42f9a236b2",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1094,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1155,
    "drug_cycles": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23919",
    "bcr_drug_uuid": "648e9735-7f2e-4d75-b997-4165f16e33f4",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN/CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23912",
    "bcr_drug_uuid": "a5ef9119-338a-4e6c-a55d-9898611a296a",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 7,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23920",
    "bcr_drug_uuid": "a815049a-3d7b-4507-ac73-9c01557671f5",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOL/CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23918",
    "bcr_drug_uuid": "45d7a0a0-7a94-413c-840e-d265aa8e32b3",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1216,
    "drug_cycles": 3,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23915",
    "bcr_drug_uuid": "3cceae8f-8fbc-4d20-bc2d-aff4a747632f",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 971,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1063,
    "drug_cycles": 3,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23914",
    "bcr_drug_uuid": "66a262b2-950e-462d-a399-affebbfd0761",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 971,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1063,
    "drug_cycles": 3,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23922",
    "bcr_drug_uuid": "8ae61fa8-4a16-4bb1-aa64-344b42cfd9aa",
    "form_completion_date": "2010-2-22",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 606,
    "drug_cycles": 6,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b46263ab-c3ca-4fda-a895-74c7e6e6fe22",
    "patient_ID": "TCGA.04.1332",
    "bcr_drug_barcode": "TCGA-04-1332-D23921",
    "bcr_drug_uuid": "9938439e-42e6-45d7-b1c8-df2a25fd6afe",
    "form_completion_date": "2010-2-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 606,
    "drug_cycles": 6,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "538acb2a-c4ca-4656-a91c-841a42dbf15f",
    "patient_ID": "TCGA.04.1336",
    "bcr_drug_barcode": "TCGA-04-1336-D23927",
    "bcr_drug_uuid": "65f9a9bb-2580-4922-9912-38341e2c039d",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "538acb2a-c4ca-4656-a91c-841a42dbf15f",
    "patient_ID": "TCGA.04.1336",
    "bcr_drug_barcode": "TCGA-04-1336-D23929",
    "bcr_drug_uuid": "bb1ccca2-c7cd-4696-954c-4014fc47e1fc",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "538acb2a-c4ca-4656-a91c-841a42dbf15f",
    "patient_ID": "TCGA.04.1336",
    "bcr_drug_barcode": "TCGA-04-1336-D23928",
    "bcr_drug_uuid": "6232e1fe-6d5b-497e-bb28-aee09a3a7df5",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "31872f6a-d225-4f91-b38d-4505d19e406c",
    "patient_ID": "TCGA.04.1338",
    "bcr_drug_barcode": "TCGA-04-1338-D23938",
    "bcr_drug_uuid": "7df91b7d-ebc2-4b72-9e60-d401fb168d18",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 627,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "31872f6a-d225-4f91-b38d-4505d19e406c",
    "patient_ID": "TCGA.04.1338",
    "bcr_drug_barcode": "TCGA-04-1338-D23936",
    "bcr_drug_uuid": "c40ba7f9-061d-493a-b88e-70b482fdb3be",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 415,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 510,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 812
  },
  {
    "bcr_patient_uuid": "31872f6a-d225-4f91-b38d-4505d19e406c",
    "patient_ID": "TCGA.04.1338",
    "bcr_drug_barcode": "TCGA-04-1338-D23937",
    "bcr_drug_uuid": "303cbcd2-da20-448e-9b83-9469a2068fe8",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 627,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "31872f6a-d225-4f91-b38d-4505d19e406c",
    "patient_ID": "TCGA.04.1338",
    "bcr_drug_barcode": "TCGA-04-1338-D23934",
    "bcr_drug_uuid": "3852b927-d887-4d24-a04b-a490d8104764",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_cycles": 8,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "31872f6a-d225-4f91-b38d-4505d19e406c",
    "patient_ID": "TCGA.04.1338",
    "bcr_drug_barcode": "TCGA-04-1338-D23935",
    "bcr_drug_uuid": "99006d2c-78d0-433d-93c0-11361212d049",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_cycles": 8,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8727855e-120a-4216-a803-8cc6cd1159be",
    "patient_ID": "TCGA.04.1342",
    "bcr_drug_barcode": "TCGA-04-1342-D23944",
    "bcr_drug_uuid": "bbc04766-0c66-4944-983f-535608ffe36d",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 478,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8727855e-120a-4216-a803-8cc6cd1159be",
    "patient_ID": "TCGA.04.1342",
    "bcr_drug_barcode": "TCGA-04-1342-D23946",
    "bcr_drug_uuid": "a8f2443d-7a47-40b8-978c-2221d8a39987",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 478,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8727855e-120a-4216-a803-8cc6cd1159be",
    "patient_ID": "TCGA.04.1342",
    "bcr_drug_barcode": "TCGA-04-1342-D23947",
    "bcr_drug_uuid": "5e0e55b4-42eb-4772-8dcc-a984731aacc9",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 478,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8727855e-120a-4216-a803-8cc6cd1159be",
    "patient_ID": "TCGA.04.1342",
    "bcr_drug_barcode": "TCGA-04-1342-D23945",
    "bcr_drug_uuid": "3d1f08e6-6295-4b2f-85b8-c9e4c70d9073",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 478,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8727855e-120a-4216-a803-8cc6cd1159be",
    "patient_ID": "TCGA.04.1342",
    "bcr_drug_barcode": "TCGA-04-1342-D23943",
    "bcr_drug_uuid": "d4959712-ca57-45a4-996c-550163f99420",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23952",
    "bcr_drug_uuid": "3e3aefa8-7cdc-4c16-ae47-9cce76c8de3f",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23950",
    "bcr_drug_uuid": "4ef4a550-feb8-4a47-b61a-30e9bbcd4b3f",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23951",
    "bcr_drug_uuid": "295a9456-0793-4458-acb2-2766e579c1dd",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23956",
    "bcr_drug_uuid": "b259ff22-9552-43f2-a065-fab193830b68",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_cycles": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23955",
    "bcr_drug_uuid": "9334cb5b-be90-441f-b19d-9281c212dea9",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "drug_cycles": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23957",
    "bcr_drug_uuid": "981f0805-35b4-4c8d-9cf6-08473727598d",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 354,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23953",
    "bcr_drug_uuid": "790fc301-5777-4c02-801c-688ce341e629",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b7715ff6-57a6-4513-9447-aa8bc93f16d4",
    "patient_ID": "TCGA.04.1343",
    "bcr_drug_barcode": "TCGA-04-1343-D23954",
    "bcr_drug_uuid": "613cb525-ddfb-4892-ab3c-647aec37b7b9",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 170,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 262,
    "drug_cycles": 2,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f0c353fd-947c-41e2-b643-3ecc0d69796c",
    "patient_ID": "TCGA.04.1347",
    "bcr_drug_barcode": "TCGA-04-1347-D23965",
    "bcr_drug_uuid": "2f680d7c-a16e-4c02-97dc-b8735edfd538",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "f0c353fd-947c-41e2-b643-3ecc0d69796c",
    "patient_ID": "TCGA.04.1347",
    "bcr_drug_barcode": "TCGA-04-1347-D23963",
    "bcr_drug_uuid": "8ee7bc23-3af3-437e-a1c3-82da7ded82ba",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "f0c353fd-947c-41e2-b643-3ecc0d69796c",
    "patient_ID": "TCGA.04.1347",
    "bcr_drug_barcode": "TCGA-04-1347-D23962",
    "bcr_drug_uuid": "064dd296-90e7-493a-a26b-0e9d1aa58b13",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1764
  },
  {
    "bcr_patient_uuid": "f0c353fd-947c-41e2-b643-3ecc0d69796c",
    "patient_ID": "TCGA.04.1347",
    "bcr_drug_barcode": "TCGA-04-1347-D23964",
    "bcr_drug_uuid": "a176cad9-0e04-4138-802e-18d4935f981f",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23973",
    "bcr_drug_uuid": "90f7c316-6484-466c-8ed0-6b2808bbdf32",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1006,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1157,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23969",
    "bcr_drug_uuid": "06f08769-e9a9-463f-9dc2-feddab17d6a0",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23971",
    "bcr_drug_uuid": "d3abae36-f4b5-4d43-b4f8-af47f4ad136e",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 884,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 976,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23975",
    "bcr_drug_uuid": "7e036a8c-1559-4399-885d-8a1e4d32ed53",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1279,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1432,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23968",
    "bcr_drug_uuid": "98897791-90ee-47b0-a526-1c8571b319a8",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23972",
    "bcr_drug_uuid": "396df1c7-00b5-467a-965a-fbd8b603be40",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN/GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1006,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1157,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23974",
    "bcr_drug_uuid": "9ae97b2d-2789-4e9c-97a4-28a084433803",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1218,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1249,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f7752d6e-f9cd-4dc9-ab01-3ab87acb21e4",
    "patient_ID": "TCGA.04.1348",
    "bcr_drug_barcode": "TCGA-04-1348-D23970",
    "bcr_drug_uuid": "bb7bed55-0fc3-4776-9cfe-59bd4adbbe7a",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 672,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 853,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23979",
    "bcr_drug_uuid": "dbb69d58-12bc-4b08-b033-f6445d45d0b2",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 436,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 653,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23980",
    "bcr_drug_uuid": "e6584537-e4b7-40ac-8cd8-6e6329a6a620",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 436,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 653,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23985",
    "bcr_drug_uuid": "657f0e7d-e78a-426c-877e-5ffe76061984",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 373,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23981",
    "bcr_drug_uuid": "19d1b2b2-e7da-44e6-8eff-02c8438a5e16",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 436,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 653,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23984",
    "bcr_drug_uuid": "1d5f70a4-4277-456b-8425-78630a4842fe",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 373,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23982",
    "bcr_drug_uuid": "eb24d9d8-a70b-43e2-af7b-199124d06a41",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 436,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 653,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23978",
    "bcr_drug_uuid": "21e672d6-60ea-4ba5-a90a-3d8d33c0197d",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 436,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 653,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23983",
    "bcr_drug_uuid": "b6b0b86f-0a20-4b17-a137-0d361563e1e3",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 373,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "4b930a10-4b12-4428-84f9-3255b4a3bc4f",
    "patient_ID": "TCGA.04.1349",
    "bcr_drug_barcode": "TCGA-04-1349-D23986",
    "bcr_drug_uuid": "4ed4f655-53b4-4a3c-9f0d-68d03e0be4e4",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23998",
    "bcr_drug_uuid": "3f2319b5-98cf-40ee-ada2-7bd9e041c3e3",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "FULUESTRANT",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1726,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23995",
    "bcr_drug_uuid": "566e0b34-13c1-442d-853d-ec2a4a8b70cd",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23993",
    "bcr_drug_uuid": "ce73824b-a2d9-4f29-9172-453c72baefa6",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23994",
    "bcr_drug_uuid": "25b6f90e-7d0b-493c-8353-1e83e32684ab",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23997",
    "bcr_drug_uuid": "a5e9b1ee-6713-4f06-abd5-4450057f0ca5",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "AROMASIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1622,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23990",
    "bcr_drug_uuid": "823bb81f-7708-4a0f-b91f-02f8f375c263",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 216,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23999",
    "bcr_drug_uuid": "cae5bb23-53c0-40bc-8bfc-d3541ebd7b2d",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "FASLODEX",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1726,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23989",
    "bcr_drug_uuid": "d3bc267a-90d8-490c-ac82-32383c4ca950",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 216,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23991",
    "bcr_drug_uuid": "196d7307-35f0-4476-80ac-ee00c4b5a305",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23992",
    "bcr_drug_uuid": "b7cd073a-7ba3-48ec-8172-0a230b6c0f7a",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 720,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0f4a4ad1-e394-45c4-9aa9-aadf2bff0628",
    "patient_ID": "TCGA.04.1350",
    "bcr_drug_barcode": "TCGA-04-1350-D23996",
    "bcr_drug_uuid": "c6ca377d-35fb-4558-a98e-6a2722f37fa1",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "12b032ed-ff92-4bfe-b980-eb273ae8ae17",
    "patient_ID": "TCGA.04.1351",
    "bcr_drug_barcode": "TCGA-04-1351-D24002",
    "bcr_drug_uuid": "a7c3ad1f-4d37-4b3e-9b47-d4ec008b2874",
    "form_completion_date": "2009-12-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12b032ed-ff92-4bfe-b980-eb273ae8ae17",
    "patient_ID": "TCGA.04.1351",
    "bcr_drug_barcode": "TCGA-04-1351-D24003",
    "bcr_drug_uuid": "b6d20430-8f48-46d9-876a-65ed5004e96e",
    "form_completion_date": "2009-12-23",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8652ddee-98f4-4584-b450-e6f2f5c9d7ec",
    "patient_ID": "TCGA.04.1356",
    "bcr_drug_barcode": "TCGA-04-1356-D24007",
    "bcr_drug_uuid": "6d03f8af-3a97-4801-bded-4dd5c67c3e8d",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 312,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4531.3
  },
  {
    "bcr_patient_uuid": "8652ddee-98f4-4584-b450-e6f2f5c9d7ec",
    "patient_ID": "TCGA.04.1356",
    "bcr_drug_barcode": "TCGA-04-1356-D24006",
    "bcr_drug_uuid": "dcc12929-7c55-426b-83cd-0f693a953cfb",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 312,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1824.5
  },
  {
    "bcr_patient_uuid": "a6aad7f9-8444-4c2f-8e4b-b19fd453544f",
    "patient_ID": "TCGA.04.1361",
    "bcr_drug_barcode": "TCGA-04-1361-D24014",
    "bcr_drug_uuid": "89aeb2a5-7c9d-4496-aec9-1d616616507c",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 844,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6aad7f9-8444-4c2f-8e4b-b19fd453544f",
    "patient_ID": "TCGA.04.1361",
    "bcr_drug_barcode": "TCGA-04-1361-D24016",
    "bcr_drug_uuid": "a5ce32b9-e2c9-4f51-803d-168a80a2a582",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 844,
    "drug_cycles": 12,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a6aad7f9-8444-4c2f-8e4b-b19fd453544f",
    "patient_ID": "TCGA.04.1361",
    "bcr_drug_barcode": "TCGA-04-1361-D24017",
    "bcr_drug_uuid": "259ac9a0-8e2c-4dca-a3cc-21878c2d46e6",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 936,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 989,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a6aad7f9-8444-4c2f-8e4b-b19fd453544f",
    "patient_ID": "TCGA.04.1361",
    "bcr_drug_barcode": "TCGA-04-1361-D24018",
    "bcr_drug_uuid": "91768e3d-6abe-4398-ace4-98c1559151ec",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 936,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 989,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a6aad7f9-8444-4c2f-8e4b-b19fd453544f",
    "patient_ID": "TCGA.04.1361",
    "bcr_drug_barcode": "TCGA-04-1361-D24015",
    "bcr_drug_uuid": "6e726984-aca5-4ae7-9f92-1984000dac83",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 844,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1d192835-524e-429d-bf74-3c4727acb446",
    "patient_ID": "TCGA.04.1362",
    "bcr_drug_barcode": "TCGA-04-1362-D24021",
    "bcr_drug_uuid": "5a583495-0c6e-4fcf-a5cb-c8bf245de3f9",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2593
  },
  {
    "bcr_patient_uuid": "1d192835-524e-429d-bf74-3c4727acb446",
    "patient_ID": "TCGA.04.1362",
    "bcr_drug_barcode": "TCGA-04-1362-D24023",
    "bcr_drug_uuid": "3c1ece80-31b8-4d36-b4f4-d0ab005acc4b",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 13856
  },
  {
    "bcr_patient_uuid": "1d192835-524e-429d-bf74-3c4727acb446",
    "patient_ID": "TCGA.04.1362",
    "bcr_drug_barcode": "TCGA-04-1362-D24022",
    "bcr_drug_uuid": "3337ba21-cbbd-4aa9-a0eb-fbf135127996",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1689
  },
  {
    "bcr_patient_uuid": "1d192835-524e-429d-bf74-3c4727acb446",
    "patient_ID": "TCGA.04.1362",
    "bcr_drug_barcode": "TCGA-04-1362-D24026",
    "bcr_drug_uuid": "0eead925-93f1-4a66-a5cb-434ff454c034",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 658,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "1d192835-524e-429d-bf74-3c4727acb446",
    "patient_ID": "TCGA.04.1362",
    "bcr_drug_barcode": "TCGA-04-1362-D24024",
    "bcr_drug_uuid": "815d5029-02f6-4c96-9417-c5b01dcde4f5",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 658,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "1d192835-524e-429d-bf74-3c4727acb446",
    "patient_ID": "TCGA.04.1362",
    "bcr_drug_barcode": "TCGA-04-1362-D24025",
    "bcr_drug_uuid": "af62b4e7-990c-4aad-a592-6ece7da45fd8",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 658,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24036",
    "bcr_drug_uuid": "a0a50587-aad9-4b1d-8206-694d37745750",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 401,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6400
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24041",
    "bcr_drug_uuid": "a745b383-07f8-4eb1-a64a-7e8f7858561b",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 919,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 949,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24030",
    "bcr_drug_uuid": "6ec6788e-d27f-4b70-8e0d-8a863c19a3f6",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 7,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24033",
    "bcr_drug_uuid": "f0840d96-e4ac-4cb5-bb8c-37f30ae5fbce",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 279,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 310,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 19.8
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24031",
    "bcr_drug_uuid": "82444910-d44e-4470-a279-958e2467a045",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2408
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24032",
    "bcr_drug_uuid": "eb6c4302-3a07-4fcb-8131-2be34065fe88",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 235
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24039",
    "bcr_drug_uuid": "58df2207-1cb7-402e-a01c-df9b30e13cf7",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 827,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1860
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24037",
    "bcr_drug_uuid": "6c9294a5-491a-4587-95ab-ce1f11c1ae91",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 401,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24038",
    "bcr_drug_uuid": "421f933a-52e6-42f5-b837-55b2362f589e",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "5F4 LEUCOVORIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 827,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7000
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24035",
    "bcr_drug_uuid": "ee5c2bae-8c4c-4a1d-bf59-b3c1d4357b7c",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 370,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24042",
    "bcr_drug_uuid": "eebd6dca-fb4f-448b-8c96-5f8f94f48847",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 919,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 949,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24040",
    "bcr_drug_uuid": "ee3416d9-a24f-4ec5-b710-a57166eaebd4",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "RBBX 01",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 857,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 857,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8.5
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24029",
    "bcr_drug_uuid": "abbdcb69-6108-40d7-8c23-69271ce2bda5",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 584,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10500
  },
  {
    "bcr_patient_uuid": "80f85c54-e12f-4afa-8fa5-5f3e083b6f95",
    "patient_ID": "TCGA.04.1364",
    "bcr_drug_barcode": "TCGA-04-1364-D24034",
    "bcr_drug_uuid": "58851b60-22dc-4a9d-85fe-338ed52e93b4",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 279,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 310,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 198
  },
  {
    "bcr_patient_uuid": "0484a929-7a7f-4926-8d25-470ddab082ec",
    "patient_ID": "TCGA.04.1365",
    "bcr_drug_barcode": "TCGA-04-1365-D24050",
    "bcr_drug_uuid": "94df838e-3175-48e9-9671-4922ad649d5f",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2329,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0484a929-7a7f-4926-8d25-470ddab082ec",
    "patient_ID": "TCGA.04.1365",
    "bcr_drug_barcode": "TCGA-04-1365-D24049",
    "bcr_drug_uuid": "c7f23742-9c3b-4bef-ad13-5888915ae592",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2063,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2196,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "0484a929-7a7f-4926-8d25-470ddab082ec",
    "patient_ID": "TCGA.04.1365",
    "bcr_drug_barcode": "TCGA-04-1365-D24046",
    "bcr_drug_uuid": "e830225c-50d9-49db-9d48-4186bbc20fd6",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0484a929-7a7f-4926-8d25-470ddab082ec",
    "patient_ID": "TCGA.04.1365",
    "bcr_drug_barcode": "TCGA-04-1365-D24045",
    "bcr_drug_uuid": "90c97127-c03c-4650-9dce-516d12af44d2",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11760
  },
  {
    "bcr_patient_uuid": "0484a929-7a7f-4926-8d25-470ddab082ec",
    "patient_ID": "TCGA.04.1365",
    "bcr_drug_barcode": "TCGA-04-1365-D24048",
    "bcr_drug_uuid": "dd8b96a9-d738-4494-aec8-a4892eb9ba68",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2063,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2196,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0484a929-7a7f-4926-8d25-470ddab082ec",
    "patient_ID": "TCGA.04.1365",
    "bcr_drug_barcode": "TCGA-04-1365-D24047",
    "bcr_drug_uuid": "1d817f79-6e5a-4729-857d-41100fd09200",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2001,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2117,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "30b8f4cd-9245-4496-a8a8-c3e59093bc0a",
    "patient_ID": "TCGA.04.1367",
    "bcr_drug_barcode": "TCGA-04-1367-D24054",
    "bcr_drug_uuid": "b8e70426-e545-4d98-8d53-6a6b8c355636",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 721
  },
  {
    "bcr_patient_uuid": "30b8f4cd-9245-4496-a8a8-c3e59093bc0a",
    "patient_ID": "TCGA.04.1367",
    "bcr_drug_barcode": "TCGA-04-1367-D24053",
    "bcr_drug_uuid": "d22430b7-f915-4dfb-928c-96aea53a860c",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1925
  },
  {
    "bcr_patient_uuid": "6c43727d-631a-40fb-b1a1-242a12889eaa",
    "patient_ID": "TCGA.04.1369",
    "bcr_drug_barcode": "TCGA-04-1369-D24058",
    "bcr_drug_uuid": "102518d8-179f-447a-96fe-c67cccb6bdf7",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 464,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4539
  },
  {
    "bcr_patient_uuid": "6c43727d-631a-40fb-b1a1-242a12889eaa",
    "patient_ID": "TCGA.04.1369",
    "bcr_drug_barcode": "TCGA-04-1369-D24059",
    "bcr_drug_uuid": "288c7d8e-3290-493e-aff8-83a7df40547a",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 175,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 238,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 275,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "6c43727d-631a-40fb-b1a1-242a12889eaa",
    "patient_ID": "TCGA.04.1369",
    "bcr_drug_barcode": "TCGA-04-1369-D24060",
    "bcr_drug_uuid": "933f5331-cf37-4d58-a9c7-5eaa2a3d234a",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "BA4 43 9006",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 392,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 445,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 30000
  },
  {
    "bcr_patient_uuid": "6c43727d-631a-40fb-b1a1-242a12889eaa",
    "patient_ID": "TCGA.04.1369",
    "bcr_drug_barcode": "TCGA-04-1369-D24057",
    "bcr_drug_uuid": "57014ef4-02a2-4f6f-a4ec-f63d59a47947",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 3140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12560
  },
  {
    "bcr_patient_uuid": "7e6cdbc7-26a7-44f2-96fa-094738cbccae",
    "patient_ID": "TCGA.04.1370",
    "bcr_drug_barcode": "TCGA-04-1370-D24063",
    "bcr_drug_uuid": "83f67477-8b87-4f45-b848-4f793508c589",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 315,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2520
  },
  {
    "bcr_patient_uuid": "7e6cdbc7-26a7-44f2-96fa-094738cbccae",
    "patient_ID": "TCGA.04.1370",
    "bcr_drug_barcode": "TCGA-04-1370-D24064",
    "bcr_drug_uuid": "643a2e01-ac72-408c-b5cb-c8de74fe6c58",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 528,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5320
  },
  {
    "bcr_patient_uuid": "bff84539-7862-45b2-b5fc-e77291fcca8b",
    "patient_ID": "TCGA.04.1371",
    "bcr_drug_barcode": "TCGA-04-1371-D24068",
    "bcr_drug_uuid": "d7136f6a-05fe-45b2-99b6-45ee4fdc1b75",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 13200
  },
  {
    "bcr_patient_uuid": "bff84539-7862-45b2-b5fc-e77291fcca8b",
    "patient_ID": "TCGA.04.1371",
    "bcr_drug_barcode": "TCGA-04-1371-D24067",
    "bcr_drug_uuid": "dc9acb16-b331-4c9a-8486-ceeac1cb85e1",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5120
  },
  {
    "bcr_patient_uuid": "bff84539-7862-45b2-b5fc-e77291fcca8b",
    "patient_ID": "TCGA.04.1371",
    "bcr_drug_barcode": "TCGA-04-1371-D24069",
    "bcr_drug_uuid": "3ab89f04-e991-431d-a5de-de29b6dc3b31",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1160
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24078",
    "bcr_drug_uuid": "2cb5bd71-e88f-4c88-8bfa-7fcecdd82169",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 665
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24085",
    "bcr_drug_uuid": "825eb0a8-3865-4461-a42b-9822af8fabe2",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1676,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7792
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24075",
    "bcr_drug_uuid": "debdaa66-085a-4ee2-a1fb-322bc4779f60",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24080",
    "bcr_drug_uuid": "be57a53e-ba99-469a-87a4-dd76ba5de4f8",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1434,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1495,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 201
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24079",
    "bcr_drug_uuid": "94351318-f494-4b2a-9dd7-b81d8e95c476",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PATUPILONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1372,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1434,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 51
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24084",
    "bcr_drug_uuid": "73a0fc31-688d-4661-a134-2088b85cbe37",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1676,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 292
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24074",
    "bcr_drug_uuid": "d74e569d-d9e0-41af-807e-10728d5b9b7c",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 494
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24073",
    "bcr_drug_uuid": "c3d7e061-f05f-4211-85db-5b591fbe106b",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 617
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24076",
    "bcr_drug_uuid": "4cb85ca0-8248-46f3-8435-d03a54f46c7f",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 333
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24082",
    "bcr_drug_uuid": "86d58252-790f-4acb-9709-e59dc68d05de",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1525,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1587,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 336
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24072",
    "bcr_drug_uuid": "0734b108-d85e-4880-b4f3-5df1a9e97f32",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1112
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24083",
    "bcr_drug_uuid": "73b76fec-4906-4c95-8a9b-c65b2072f5c3",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1464,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1587,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1750
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24077",
    "bcr_drug_uuid": "25acdb52-aea6-43a1-8a86-00831b905e8d",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "e9483296-cb91-497a-b955-39a3c3289dac",
    "patient_ID": "TCGA.04.1514",
    "bcr_drug_barcode": "TCGA-04-1514-D24081",
    "bcr_drug_uuid": "fcab5840-933e-49df-8fef-a82d594a24f2",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1525,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1587,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 33.6
  },
  {
    "bcr_patient_uuid": "1c86e4e5-ecc9-4f6d-a557-77bf396a653b",
    "patient_ID": "TCGA.04.1516",
    "bcr_drug_barcode": "TCGA-04-1516-D24088",
    "bcr_drug_uuid": "1cac7e12-6041-453f-bdcb-36d9023936fc",
    "form_completion_date": "2010-6-25",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1c86e4e5-ecc9-4f6d-a557-77bf396a653b",
    "patient_ID": "TCGA.04.1516",
    "bcr_drug_barcode": "TCGA-04-1516-D24089",
    "bcr_drug_uuid": "ad51a508-de7f-4d22-b4a2-a64aebe8ebb4",
    "form_completion_date": "2010-6-25",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1c86e4e5-ecc9-4f6d-a557-77bf396a653b",
    "patient_ID": "TCGA.04.1516",
    "bcr_drug_barcode": "TCGA-04-1516-D24090",
    "bcr_drug_uuid": "c01ba4e5-6d06-430c-bed8-92b8566a1a2b",
    "form_completion_date": "2010-6-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "35916942-e7aa-45db-ad27-03cba67d4d5b",
    "patient_ID": "TCGA.04.1517",
    "bcr_drug_barcode": "TCGA-04-1517-D24094",
    "bcr_drug_uuid": "c7c8f6df-41a9-4999-8081-49601b1917e2",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "35916942-e7aa-45db-ad27-03cba67d4d5b",
    "patient_ID": "TCGA.04.1517",
    "bcr_drug_barcode": "TCGA-04-1517-D24096",
    "bcr_drug_uuid": "06f97b5a-43e9-4fe2-b385-20b3fff0cd82",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "35916942-e7aa-45db-ad27-03cba67d4d5b",
    "patient_ID": "TCGA.04.1517",
    "bcr_drug_barcode": "TCGA-04-1517-D24093",
    "bcr_drug_uuid": "c2db098e-b4d0-4a08-b35a-3821b685becf",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "35916942-e7aa-45db-ad27-03cba67d4d5b",
    "patient_ID": "TCGA.04.1517",
    "bcr_drug_barcode": "TCGA-04-1517-D24095",
    "bcr_drug_uuid": "4e373c73-a0c8-4c20-adfc-68c098db3867",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2bb96e1e-6992-434d-83e5-2f03713b3911",
    "patient_ID": "TCGA.04.1525",
    "bcr_drug_barcode": "TCGA-04-1525-D24102",
    "bcr_drug_uuid": "45a99f98-e53d-40d6-891d-5787134ff44e",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "IROLFLUVIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 436,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 464,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 31
  },
  {
    "bcr_patient_uuid": "2bb96e1e-6992-434d-83e5-2f03713b3911",
    "patient_ID": "TCGA.04.1525",
    "bcr_drug_barcode": "TCGA-04-1525-D24100",
    "bcr_drug_uuid": "5ff6409a-b31a-4c1d-9be5-cb0e87dcd044",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 888
  },
  {
    "bcr_patient_uuid": "2bb96e1e-6992-434d-83e5-2f03713b3911",
    "patient_ID": "TCGA.04.1525",
    "bcr_drug_barcode": "TCGA-04-1525-D24101",
    "bcr_drug_uuid": "17234cea-5e59-4520-bb0c-3ab4230d7138",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "42b3dfa3-152f-4ab7-ac9f-988c7f473bea",
    "patient_ID": "TCGA.04.1530",
    "bcr_drug_barcode": "TCGA-04-1530-D24105",
    "bcr_drug_uuid": "00ca66ba-5726-4770-97c9-3cdcb1322fe4",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1218
  },
  {
    "bcr_patient_uuid": "42b3dfa3-152f-4ab7-ac9f-988c7f473bea",
    "patient_ID": "TCGA.04.1530",
    "bcr_drug_barcode": "TCGA-04-1530-D24106",
    "bcr_drug_uuid": "b92c8c57-7fe6-4ada-b32c-ec7b254b1c1c",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 678
  },
  {
    "bcr_patient_uuid": "42b3dfa3-152f-4ab7-ac9f-988c7f473bea",
    "patient_ID": "TCGA.04.1530",
    "bcr_drug_barcode": "TCGA-04-1530-D24108",
    "bcr_drug_uuid": "e9327dc6-1775-4aff-bce4-b32ea0f465bd",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 550,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2490
  },
  {
    "bcr_patient_uuid": "42b3dfa3-152f-4ab7-ac9f-988c7f473bea",
    "patient_ID": "TCGA.04.1530",
    "bcr_drug_barcode": "TCGA-04-1530-D24107",
    "bcr_drug_uuid": "e53d3505-76db-4d22-a0e5-968e706f3e0e",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 382,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 550,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "1fe19c6b-71d0-4b07-923b-74ea32210db0",
    "patient_ID": "TCGA.04.1536",
    "bcr_drug_barcode": "TCGA-04-1536-D24111",
    "bcr_drug_uuid": "4c9cdf72-d881-4079-bec6-5453fe89239d",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3360
  },
  {
    "bcr_patient_uuid": "1fe19c6b-71d0-4b07-923b-74ea32210db0",
    "patient_ID": "TCGA.04.1536",
    "bcr_drug_barcode": "TCGA-04-1536-D24116",
    "bcr_drug_uuid": "b895268f-eb7a-4293-9f10-6dbaea5fd999",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 518,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "1fe19c6b-71d0-4b07-923b-74ea32210db0",
    "patient_ID": "TCGA.04.1536",
    "bcr_drug_barcode": "TCGA-04-1536-D24114",
    "bcr_drug_uuid": "feed8215-093e-4fb3-a54c-38013eb6625f",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 518,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "1fe19c6b-71d0-4b07-923b-74ea32210db0",
    "patient_ID": "TCGA.04.1536",
    "bcr_drug_barcode": "TCGA-04-1536-D24113",
    "bcr_drug_uuid": "57161b96-b564-4d9b-89ff-30dc8dee32c8",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 188
  },
  {
    "bcr_patient_uuid": "1fe19c6b-71d0-4b07-923b-74ea32210db0",
    "patient_ID": "TCGA.04.1536",
    "bcr_drug_barcode": "TCGA-04-1536-D24112",
    "bcr_drug_uuid": "049090d1-2734-4c0c-b1f1-d7fe561af4c8",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2125
  },
  {
    "bcr_patient_uuid": "1fe19c6b-71d0-4b07-923b-74ea32210db0",
    "patient_ID": "TCGA.04.1536",
    "bcr_drug_barcode": "TCGA-04-1536-D24115",
    "bcr_drug_uuid": "efdac1c1-cacb-45e9-8da2-5c9209fcda54",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 518,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24124",
    "bcr_drug_uuid": "20d4ef39-b4e4-4099-87b4-3c1ae4e8ede7",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1487,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 122.1
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24133",
    "bcr_drug_uuid": "98ae57ba-9add-4fe6-9fb3-bce9ae6a5669",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2512,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 28756
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24119",
    "bcr_drug_uuid": "ba72049a-201d-41b9-8de5-836bdcfffe5d",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2534
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24134",
    "bcr_drug_uuid": "96845b6d-fb8b-448e-a46d-fddd67417df7",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2512,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2870
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24125",
    "bcr_drug_uuid": "39b4a282-57ca-433c-b064-947aee07c02b",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1529,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 159
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24126",
    "bcr_drug_uuid": "232608ab-c0eb-4ce7-b90f-500736a7b355",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1564,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1781,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 32496
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24122",
    "bcr_drug_uuid": "2bb98c0b-c301-4b4c-a529-767fd0eb9e36",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1051,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1294,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4004
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24130",
    "bcr_drug_uuid": "1b6278b2-3735-4dbc-b72c-c3a0de8b231b",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2176,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4875
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24127",
    "bcr_drug_uuid": "11a6fcf9-f217-42ef-92df-6290ee4740ac",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1564,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1781,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 11299.9
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24128",
    "bcr_drug_uuid": "89467124-049b-4810-abf9-b2d8d9346378",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1993,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2106,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7398
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24121",
    "bcr_drug_uuid": "957ad38f-b0eb-459a-a8d6-fe69e4ceb3ed",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 17378
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24123",
    "bcr_drug_uuid": "f22e4162-0e7a-4685-a9f9-f8c7c4413fb7",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1051,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1294,
    "drug_cycles": 12,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24120",
    "bcr_drug_uuid": "d5500c2d-df88-43c8-bcff-c3a415ef606f",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24132",
    "bcr_drug_uuid": "59897436-39f7-4492-9b3c-b9785fb4da51",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2328,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 343
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24131",
    "bcr_drug_uuid": "ae31010e-271a-4578-8b6b-af308af8c194",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2207,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2268,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0c1a2e7d-e7e4-481e-a012-ef214c444497",
    "patient_ID": "TCGA.04.1542",
    "bcr_drug_barcode": "TCGA-04-1542-D24129",
    "bcr_drug_uuid": "19692f61-2cbc-49a2-b4ec-8dc55dad3507",
    "form_completion_date": "2009-11-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2176,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 124.15
  },
  {
    "bcr_patient_uuid": "c75c915f-ef4b-4c19-8ace-995e6c6015fd",
    "patient_ID": "TCGA.04.1638",
    "bcr_drug_barcode": "TCGA-04-1638-D24142",
    "bcr_drug_uuid": "529c5977-9ad5-40f3-89f3-4b26793a407e",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c75c915f-ef4b-4c19-8ace-995e6c6015fd",
    "patient_ID": "TCGA.04.1638",
    "bcr_drug_barcode": "TCGA-04-1638-D24141",
    "bcr_drug_uuid": "63e4b64e-ff9e-4716-b524-46b22d2fb4de",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c75c915f-ef4b-4c19-8ace-995e6c6015fd",
    "patient_ID": "TCGA.04.1638",
    "bcr_drug_barcode": "TCGA-04-1638-D24139",
    "bcr_drug_uuid": "8b200c15-6dc8-468b-b56f-e0d576fc6f0f",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11400
  },
  {
    "bcr_patient_uuid": "c75c915f-ef4b-4c19-8ace-995e6c6015fd",
    "patient_ID": "TCGA.04.1638",
    "bcr_drug_barcode": "TCGA-04-1638-D24137",
    "bcr_drug_uuid": "07806476-c405-476d-9b26-904d536b25ac",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 968
  },
  {
    "bcr_patient_uuid": "c75c915f-ef4b-4c19-8ace-995e6c6015fd",
    "patient_ID": "TCGA.04.1638",
    "bcr_drug_barcode": "TCGA-04-1638-D24140",
    "bcr_drug_uuid": "486f4a95-24cd-4047-8ae4-2d0d1bf97c21",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c75c915f-ef4b-4c19-8ace-995e6c6015fd",
    "patient_ID": "TCGA.04.1638",
    "bcr_drug_barcode": "TCGA-04-1638-D24138",
    "bcr_drug_uuid": "e2445899-ef2f-48ec-b6cf-24b31caa303c",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2990
  },
  {
    "bcr_patient_uuid": "6f592f17-e00b-4d04-a45b-d9d4cf4c3075",
    "patient_ID": "TCGA.04.1644",
    "bcr_drug_barcode": "TCGA-04-1644-D24148",
    "bcr_drug_uuid": "0b27b41b-630b-4780-8962-d7d2890b1b49",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1208
  },
  {
    "bcr_patient_uuid": "6f592f17-e00b-4d04-a45b-d9d4cf4c3075",
    "patient_ID": "TCGA.04.1644",
    "bcr_drug_barcode": "TCGA-04-1644-D24150",
    "bcr_drug_uuid": "a5117a44-5eff-422c-a7ef-6a64aa046c04",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 661,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6f592f17-e00b-4d04-a45b-d9d4cf4c3075",
    "patient_ID": "TCGA.04.1644",
    "bcr_drug_barcode": "TCGA-04-1644-D24146",
    "bcr_drug_uuid": "e34aab47-56e3-467c-b3d8-57873b04644f",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2704,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12432
  },
  {
    "bcr_patient_uuid": "6f592f17-e00b-4d04-a45b-d9d4cf4c3075",
    "patient_ID": "TCGA.04.1644",
    "bcr_drug_barcode": "TCGA-04-1644-D24147",
    "bcr_drug_uuid": "394ae296-dd59-40da-afdb-8a8fd220616a",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "6f592f17-e00b-4d04-a45b-d9d4cf4c3075",
    "patient_ID": "TCGA.04.1644",
    "bcr_drug_barcode": "TCGA-04-1644-D24149",
    "bcr_drug_uuid": "bea9d9ec-f88f-4bae-9fe3-59b8569c7439",
    "form_completion_date": "2010-8-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 661,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "d38ca631-ed5c-4182-a647-625060726fa7",
    "patient_ID": "TCGA.04.1646",
    "bcr_drug_barcode": "TCGA-04-1646-D24157",
    "bcr_drug_uuid": "6d910b78-da27-4662-a1be-49ce6a177002",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 522,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "OTHER"
  },
  {
    "bcr_patient_uuid": "d38ca631-ed5c-4182-a647-625060726fa7",
    "patient_ID": "TCGA.04.1646",
    "bcr_drug_barcode": "TCGA-04-1646-D24155",
    "bcr_drug_uuid": "9e09e80f-02fb-4097-be1a-c9bfadf68c36",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1504
  },
  {
    "bcr_patient_uuid": "d38ca631-ed5c-4182-a647-625060726fa7",
    "patient_ID": "TCGA.04.1646",
    "bcr_drug_barcode": "TCGA-04-1646-D24153",
    "bcr_drug_uuid": "d6ee5514-3071-4e54-a301-10301dbdb0dd",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8188
  },
  {
    "bcr_patient_uuid": "d38ca631-ed5c-4182-a647-625060726fa7",
    "patient_ID": "TCGA.04.1646",
    "bcr_drug_barcode": "TCGA-04-1646-D24156",
    "bcr_drug_uuid": "609ef3ee-d20e-4681-be55-2fdaa9070a04",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 522,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "OTHER"
  },
  {
    "bcr_patient_uuid": "d38ca631-ed5c-4182-a647-625060726fa7",
    "patient_ID": "TCGA.04.1646",
    "bcr_drug_barcode": "TCGA-04-1646-D24154",
    "bcr_drug_uuid": "74086d54-72be-400c-b01d-a365f36d5674",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4709
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24164",
    "bcr_drug_uuid": "cd9ed497-a263-4fda-99ef-74b1f4916798",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24165",
    "bcr_drug_uuid": "1f937eb0-6773-48b1-925f-54a58b003fbd",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 129
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24166",
    "bcr_drug_uuid": "a9fefaaf-f2d3-453b-82df-f333775b8ca0",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24161",
    "bcr_drug_uuid": "0d18b847-2e08-45dc-a2c3-d387fe57031e",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5140
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24163",
    "bcr_drug_uuid": "d0bd5f53-352e-4300-b4c2-58609d888103",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24160",
    "bcr_drug_uuid": "1a700a0d-2529-42d5-9117-dceea252ad8a",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 23296
  },
  {
    "bcr_patient_uuid": "cddce77f-21e6-4124-9f03-96fb5ca7cefa",
    "patient_ID": "TCGA.04.1648",
    "bcr_drug_barcode": "TCGA-04-1648-D24162",
    "bcr_drug_uuid": "09efef17-deb9-41ff-ab69-d9567c390137",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2544
  },
  {
    "bcr_patient_uuid": "314e446d-3a57-4c91-ac2e-4fc211456ee6",
    "patient_ID": "TCGA.04.1649",
    "bcr_drug_barcode": "TCGA-04-1649-D24170",
    "bcr_drug_uuid": "bef99616-fb63-4a21-bb71-09f9e6a33c99",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1704,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "314e446d-3a57-4c91-ac2e-4fc211456ee6",
    "patient_ID": "TCGA.04.1649",
    "bcr_drug_barcode": "TCGA-04-1649-D24169",
    "bcr_drug_uuid": "976c28f1-f941-4649-a5eb-1f8377e55c18",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1704,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "55153632-1673-487a-85c0-f156377db1fc",
    "patient_ID": "TCGA.04.1651",
    "bcr_drug_barcode": "TCGA-04-1651-D24177",
    "bcr_drug_uuid": "302abefb-98a4-4ae9-b633-f083742d1dcc",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 994,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "55153632-1673-487a-85c0-f156377db1fc",
    "patient_ID": "TCGA.04.1651",
    "bcr_drug_barcode": "TCGA-04-1651-D24173",
    "bcr_drug_uuid": "2d418f76-5289-4b42-bccd-367cc6177bdd",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4416
  },
  {
    "bcr_patient_uuid": "55153632-1673-487a-85c0-f156377db1fc",
    "patient_ID": "TCGA.04.1651",
    "bcr_drug_barcode": "TCGA-04-1651-D24174",
    "bcr_drug_uuid": "a960436a-2466-4c72-8ef7-89b73f8a0114",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3228
  },
  {
    "bcr_patient_uuid": "55153632-1673-487a-85c0-f156377db1fc",
    "patient_ID": "TCGA.04.1651",
    "bcr_drug_barcode": "TCGA-04-1651-D24175",
    "bcr_drug_uuid": "50b984e7-efd8-4d76-9551-883eeda43257",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1869
  },
  {
    "bcr_patient_uuid": "55153632-1673-487a-85c0-f156377db1fc",
    "patient_ID": "TCGA.04.1651",
    "bcr_drug_barcode": "TCGA-04-1651-D24176",
    "bcr_drug_uuid": "49f8c5a0-530d-41d5-93aa-dd3accbc566d",
    "form_completion_date": "2009-11-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 638,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "d86adfac-56be-4a69-9315-5a90b4113e65",
    "patient_ID": "TCGA.04.1652",
    "bcr_drug_barcode": "TCGA-04-1652-D24181",
    "bcr_drug_uuid": "7c7d1c47-ed7b-411b-b974-274f7e527369",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "d86adfac-56be-4a69-9315-5a90b4113e65",
    "patient_ID": "TCGA.04.1652",
    "bcr_drug_barcode": "TCGA-04-1652-D24183",
    "bcr_drug_uuid": "e710f8e4-0ad9-47d6-9682-6bb5c7ec4ca1",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 894,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 955,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "d86adfac-56be-4a69-9315-5a90b4113e65",
    "patient_ID": "TCGA.04.1652",
    "bcr_drug_barcode": "TCGA-04-1652-D24182",
    "bcr_drug_uuid": "bc27edb0-7d82-454f-9fcf-dfaefff83fad",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "GEMICITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "d86adfac-56be-4a69-9315-5a90b4113e65",
    "patient_ID": "TCGA.04.1652",
    "bcr_drug_barcode": "TCGA-04-1652-D24180",
    "bcr_drug_uuid": "6f994167-d0ff-4613-a3f7-193b4dc243f6",
    "form_completion_date": "2009-11-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "ff33db70-91d4-4dbb-a4fc-d81a128d0f32",
    "patient_ID": "TCGA.04.1654",
    "bcr_drug_barcode": "TCGA-04-1654-D24189",
    "bcr_drug_uuid": "1247ef93-1e2d-450c-9cde-a787b06e0ab3",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 877,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ff33db70-91d4-4dbb-a4fc-d81a128d0f32",
    "patient_ID": "TCGA.04.1654",
    "bcr_drug_barcode": "TCGA-04-1654-D24186",
    "bcr_drug_uuid": "b19aeaef-1ab3-44b8-a588-2040992cf2eb",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 877,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ff33db70-91d4-4dbb-a4fc-d81a128d0f32",
    "patient_ID": "TCGA.04.1654",
    "bcr_drug_barcode": "TCGA-04-1654-D24187",
    "bcr_drug_uuid": "328766be-9ea1-4360-b816-10dd79d46bb5",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "ff33db70-91d4-4dbb-a4fc-d81a128d0f32",
    "patient_ID": "TCGA.04.1654",
    "bcr_drug_barcode": "TCGA-04-1654-D24188",
    "bcr_drug_uuid": "31686ad3-5c2c-4d51-aede-07dc220a29ab",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 380
  },
  {
    "bcr_patient_uuid": "f8a5547f-f1bc-4c01-8b68-25b5ee0caeab",
    "patient_ID": "TCGA.04.1655",
    "bcr_drug_barcode": "TCGA-04-1655-D24196",
    "bcr_drug_uuid": "6af7c96d-fd92-4419-89f8-4a3f81291128",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 839,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f8a5547f-f1bc-4c01-8b68-25b5ee0caeab",
    "patient_ID": "TCGA.04.1655",
    "bcr_drug_barcode": "TCGA-04-1655-D24195",
    "bcr_drug_uuid": "31f9f5de-7d10-4be7-922a-486e53358208",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "f8a5547f-f1bc-4c01-8b68-25b5ee0caeab",
    "patient_ID": "TCGA.04.1655",
    "bcr_drug_barcode": "TCGA-04-1655-D24193",
    "bcr_drug_uuid": "6554c537-7883-461c-a2bc-e5d5cff12e2f",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 953
  },
  {
    "bcr_patient_uuid": "f8a5547f-f1bc-4c01-8b68-25b5ee0caeab",
    "patient_ID": "TCGA.04.1655",
    "bcr_drug_barcode": "TCGA-04-1655-D24194",
    "bcr_drug_uuid": "d6ee6177-9651-4002-8886-321a006ddb09",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 574
  },
  {
    "bcr_patient_uuid": "f8a5547f-f1bc-4c01-8b68-25b5ee0caeab",
    "patient_ID": "TCGA.04.1655",
    "bcr_drug_barcode": "TCGA-04-1655-D24192",
    "bcr_drug_uuid": "0fc35dff-0325-4013-8faa-f9338450f776",
    "form_completion_date": "2009-11-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1288
  },
  {
    "bcr_patient_uuid": "6746533a-8d0b-4ebc-87ec-49c8738121a8",
    "patient_ID": "TCGA.09.0364",
    "bcr_drug_barcode": "TCGA-09-0364-D24199",
    "bcr_drug_uuid": "57b55461-64a0-45a0-baef-0650a107f9bf",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6746533a-8d0b-4ebc-87ec-49c8738121a8",
    "patient_ID": "TCGA.09.0364",
    "bcr_drug_barcode": "TCGA-09-0364-D24200",
    "bcr_drug_uuid": "780b9212-5bfd-40ff-acef-8d60cb64bdb2",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 125
  },
  {
    "bcr_patient_uuid": "7621ed77-98bc-4b4e-8011-e18fcd014071",
    "patient_ID": "TCGA.09.0365",
    "bcr_drug_barcode": "TCGA-09-0365-D24205",
    "bcr_drug_uuid": "8c488ff2-8e08-47d4-ab18-b271a8d00717",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "7621ed77-98bc-4b4e-8011-e18fcd014071",
    "patient_ID": "TCGA.09.0365",
    "bcr_drug_barcode": "TCGA-09-0365-D24204",
    "bcr_drug_uuid": "c742fa3b-01b4-42d8-94a9-f5909f22b5d9",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 273
  },
  {
    "bcr_patient_uuid": "23771dab-2aab-4d2b-95e2-9af7092cee6b",
    "patient_ID": "TCGA.09.0366",
    "bcr_drug_barcode": "TCGA-09-0366-D24208",
    "bcr_drug_uuid": "6c5228bf-8c8a-4919-8775-626e30a7370e",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "23771dab-2aab-4d2b-95e2-9af7092cee6b",
    "patient_ID": "TCGA.09.0366",
    "bcr_drug_barcode": "TCGA-09-0366-D24210",
    "bcr_drug_uuid": "b0230f3d-a6f8-4e55-a04e-d6d0d37c99e4",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 288,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1.5
  },
  {
    "bcr_patient_uuid": "23771dab-2aab-4d2b-95e2-9af7092cee6b",
    "patient_ID": "TCGA.09.0366",
    "bcr_drug_barcode": "TCGA-09-0366-D24209",
    "bcr_drug_uuid": "ac21dd09-cdc4-45dd-bf7e-3ae965e1d90b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "9bbc01b4-056c-4ddc-aca4-ff20718646d0",
    "patient_ID": "TCGA.09.0367",
    "bcr_drug_barcode": "TCGA-09-0367-D24214",
    "bcr_drug_uuid": "4e41a6a2-7536-4235-b3e2-307541a2f55e",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "9bbc01b4-056c-4ddc-aca4-ff20718646d0",
    "patient_ID": "TCGA.09.0367",
    "bcr_drug_barcode": "TCGA-09-0367-D24213",
    "bcr_drug_uuid": "5947ae4d-2a9e-4e90-87e6-dca175e44cc6",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9bbc01b4-056c-4ddc-aca4-ff20718646d0",
    "patient_ID": "TCGA.09.0367",
    "bcr_drug_barcode": "TCGA-09-0367-D24215",
    "bcr_drug_uuid": "c830352b-ac14-400e-a5e8-24d933b324ce",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 1145
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24224",
    "bcr_drug_uuid": "a3c40628-cd5c-49dd-98f3-eed3e9460b59",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 310,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 446,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24222",
    "bcr_drug_uuid": "bbdd7a4d-fef2-4c8c-861b-13a0f7078f3b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24220",
    "bcr_drug_uuid": "5e712ef4-3b95-4cfb-913c-1440d7767ee5",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24223",
    "bcr_drug_uuid": "7d37f03d-f6d7-4a69-a9da-8e6830441fa9",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 298,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 298,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24218",
    "bcr_drug_uuid": "aeffde3e-f5d7-46b9-98da-ec10ec9ca0ef",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24221",
    "bcr_drug_uuid": "8f85510a-6960-4611-95c3-22de367928af",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1d9893c8-0de3-4b07-b0ba-a53019b23eb4",
    "patient_ID": "TCGA.09.0369",
    "bcr_drug_barcode": "TCGA-09-0369-D24219",
    "bcr_drug_uuid": "ac05217b-40a7-4a8c-9ff0-2fb4526a9f18",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "644a88a7-dc56-468a-af5c-60278aab7642",
    "patient_ID": "TCGA.09.1659",
    "bcr_drug_barcode": "TCGA-09-1659-D24230",
    "bcr_drug_uuid": "e135fb8b-9cfc-4dd4-b2c5-dea588329278",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "644a88a7-dc56-468a-af5c-60278aab7642",
    "patient_ID": "TCGA.09.1659",
    "bcr_drug_barcode": "TCGA-09-1659-D24229",
    "bcr_drug_uuid": "e95461e2-9e4c-4e78-823c-562005b13fd2",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "644a88a7-dc56-468a-af5c-60278aab7642",
    "patient_ID": "TCGA.09.1659",
    "bcr_drug_barcode": "TCGA-09-1659-D24227",
    "bcr_drug_uuid": "1bf3b092-4fd1-4d22-828b-a0912d5a57cb",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "644a88a7-dc56-468a-af5c-60278aab7642",
    "patient_ID": "TCGA.09.1659",
    "bcr_drug_barcode": "TCGA-09-1659-D24228",
    "bcr_drug_uuid": "89fc6845-3c63-4c2f-ac1a-f3f53d98090f",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "644a88a7-dc56-468a-af5c-60278aab7642",
    "patient_ID": "TCGA.09.1659",
    "bcr_drug_barcode": "TCGA-09-1659-D24231",
    "bcr_drug_uuid": "c8db72a7-72b7-4d98-a402-2e064104a929",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "HEXAMETHYLMELAMINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24237",
    "bcr_drug_uuid": "d01e89cf-f3a7-44d6-b16c-f81b8627cf14",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 641,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 709,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24235",
    "bcr_drug_uuid": "31c1fcf0-7c88-43b9-96db-a52d39cf4245",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 192
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24238",
    "bcr_drug_uuid": "e2248b7d-7614-4bcd-9650-8067047dc92b",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 758,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 766,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24236",
    "bcr_drug_uuid": "7c35797f-19d1-480c-8bce-2040e341c6ae",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24234",
    "bcr_drug_uuid": "6599ea24-89a7-4494-b817-2e31333dbd26",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 213,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 332,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24240",
    "bcr_drug_uuid": "d4c5014f-8791-4723-8b70-cade55f5cbde",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1017,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1052,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24241",
    "bcr_drug_uuid": "360588ef-c280-4c8f-af28-5a16924646e3",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 498,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 641,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "f8e9d538-7291-4fe7-b3f2-d01676a027f9",
    "patient_ID": "TCGA.09.1661",
    "bcr_drug_barcode": "TCGA-09-1661-D24239",
    "bcr_drug_uuid": "2fc710fc-85e0-4df2-af3e-6f41158143a7",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 828,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 940,
    "drug_cycles": 17,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24258",
    "bcr_drug_uuid": "f4b7d2bb-c87b-49eb-a81a-6cbe1bd786a3",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2482,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2602,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24247",
    "bcr_drug_uuid": "dc5a3d32-2094-4917-8a07-9bbfa17045f5",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24254",
    "bcr_drug_uuid": "fb873564-df62-4403-9335-80c56c7b00f9",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1989,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2052,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24259",
    "bcr_drug_uuid": "692318d5-4cc3-48f4-8464-e4debb508e72",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2623,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24255",
    "bcr_drug_uuid": "7bf5f35f-f997-4287-83d2-d5da4cbd556a",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2073,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2399,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24266",
    "bcr_drug_uuid": "4c9e6e33-7a19-48a4-85ca-dcccef13eba1",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2566,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2650,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24260",
    "bcr_drug_uuid": "7631cb67-7111-4c19-8711-ccc70c4fc2c4",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2623,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2650,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24245",
    "bcr_drug_uuid": "e1273eb6-bb20-46c9-9bb2-cc41b942d77c",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 15,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24248",
    "bcr_drug_uuid": "cc5ab7ed-36cd-4a9f-ba48-c87a1b240f45",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1233,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24253",
    "bcr_drug_uuid": "a397d96b-fb24-4610-8181-c118d12f2166",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1947,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1968,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 98
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24251",
    "bcr_drug_uuid": "1f1c006f-2912-44a7-ba4e-034e98c93d89",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1590,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1732,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24257",
    "bcr_drug_uuid": "93e131ee-3380-4200-9ca5-10131c10abd1",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2457,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2461,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24265",
    "bcr_drug_uuid": "de3b0446-d6ae-4fee-ad51-8c322e73ee15",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2503,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2517,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24250",
    "bcr_drug_uuid": "31879e3c-bfe5-4c2f-955d-f4e7af0fbdfb",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1590,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1732,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24262",
    "bcr_drug_uuid": "203a528e-89f3-4e4f-bf39-ef1ad477079b",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2684,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2697,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 47
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24246",
    "bcr_drug_uuid": "678644d3-1d86-43d5-828b-5ff5529a97d5",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 15,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24249",
    "bcr_drug_uuid": "588fd714-20ca-4600-90be-76b54f2c0ef8",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1128,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1233,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24252",
    "bcr_drug_uuid": "c0a0b2df-b4d4-41ae-9463-423066932bf7",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1947,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1968,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24263",
    "bcr_drug_uuid": "1b5d2909-0c97-4346-a6ad-8b64797214eb",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2684,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2697,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 954
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24244",
    "bcr_drug_uuid": "f41683e3-2b52-4a8f-a371-5830f1687c3a",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24261",
    "bcr_drug_uuid": "d6211b06-5b18-4f9e-851d-53c7a86bc37d",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2530,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2537,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24264",
    "bcr_drug_uuid": "c53df0bc-2ac3-472e-9241-c6c1790d02cb",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "ARMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1926,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1
  },
  {
    "bcr_patient_uuid": "867f9563-16c9-45a8-b519-6df61ba1b6b7",
    "patient_ID": "TCGA.09.1662",
    "bcr_drug_barcode": "TCGA-09-1662-D24256",
    "bcr_drug_uuid": "1161bec0-3bbb-49c2-88af-0a7123eb3c6a",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2426,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2650,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "3438c018-9856-4628-ae59-7d365713647f",
    "patient_ID": "TCGA.09.1664",
    "bcr_drug_barcode": "TCGA-09-1664-D24270",
    "bcr_drug_uuid": "5c586019-e92b-4f51-ad6c-5eb9366488d5",
    "form_completion_date": "2009-9-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "3438c018-9856-4628-ae59-7d365713647f",
    "patient_ID": "TCGA.09.1664",
    "bcr_drug_barcode": "TCGA-09-1664-D24269",
    "bcr_drug_uuid": "c82effc8-6fc1-410b-8c82-5aeaf9c1a564",
    "form_completion_date": "2009-9-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d",
    "patient_ID": "TCGA.09.1665",
    "bcr_drug_barcode": "TCGA-09-1665-D24276",
    "bcr_drug_uuid": "b1ed85a0-eac9-4666-ab39-010c1399d205",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 483,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d",
    "patient_ID": "TCGA.09.1665",
    "bcr_drug_barcode": "TCGA-09-1665-D24275",
    "bcr_drug_uuid": "8d2d4b4c-596d-42a2-9e4b-0e7b2fee3958",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 917,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1022,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d",
    "patient_ID": "TCGA.09.1665",
    "bcr_drug_barcode": "TCGA-09-1665-D24274",
    "bcr_drug_uuid": "37f4416a-9d1d-4c7d-877e-7871f2b85168",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "9d25cd0e-0a3e-4ee0-b1a3-58ffab348c9d",
    "patient_ID": "TCGA.09.1665",
    "bcr_drug_barcode": "TCGA-09-1665-D24273",
    "bcr_drug_uuid": "8c2c993d-40cd-4027-9569-1b033b7edd54",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24290",
    "bcr_drug_uuid": "96136ebb-d42e-46e9-8ec0-5add836188f0",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "OCA REX OREGOVOMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 256,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 480,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24280",
    "bcr_drug_uuid": "74931445-f83f-45dc-90a1-aecb7765fa41",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24289",
    "bcr_drug_uuid": "201e8965-9390-427b-8279-89e17038f985",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1604,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1757,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24285",
    "bcr_drug_uuid": "b774aba5-d495-4fcc-a1dd-0f5f06ba1d9e",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 616,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 708,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24284",
    "bcr_drug_uuid": "172437f0-7607-4941-bb7d-a1d174db12fa",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 616,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 708,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24281",
    "bcr_drug_uuid": "357d4b2b-6557-43ba-865b-6991025f5471",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24286",
    "bcr_drug_uuid": "7e32e0c6-f8ab-4cc8-944d-39c716db22fa",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24282",
    "bcr_drug_uuid": "9ad3d880-56fd-4369-a662-6448ded41e23",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24288",
    "bcr_drug_uuid": "3380594f-d6ff-4fec-95a3-f50e8b444dd6",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1507,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1598,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24283",
    "bcr_drug_uuid": "722d9fc6-ae4b-4953-a962-35ffe58712ca",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "4eac2c98-86d2-4ee6-a1d3-157d013c78dc",
    "patient_ID": "TCGA.09.1666",
    "bcr_drug_barcode": "TCGA-09-1666-D24287",
    "bcr_drug_uuid": "51c24d42-2dab-4f27-b2ba-a0bda9af9e95",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "32d4d200-1fdf-44ed-b81f-1954a9c93926",
    "patient_ID": "TCGA.09.1667",
    "bcr_drug_barcode": "TCGA-09-1667-D24296",
    "bcr_drug_uuid": "40335523-102a-49a1-b4d4-7909d043b53f",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 820,
    "days_to_drug_end": 1875,
    "drug_cycles": 20,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "32d4d200-1fdf-44ed-b81f-1954a9c93926",
    "patient_ID": "TCGA.09.1667",
    "bcr_drug_barcode": "TCGA-09-1667-D24294",
    "bcr_drug_uuid": "75fe69a4-be66-4430-83bb-26c8e6fc4e3a",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "32d4d200-1fdf-44ed-b81f-1954a9c93926",
    "patient_ID": "TCGA.09.1667",
    "bcr_drug_barcode": "TCGA-09-1667-D24293",
    "bcr_drug_uuid": "7128aad9-cd3e-493b-bbfd-7280aae2574f",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "32d4d200-1fdf-44ed-b81f-1954a9c93926",
    "patient_ID": "TCGA.09.1667",
    "bcr_drug_barcode": "TCGA-09-1667-D24297",
    "bcr_drug_uuid": "28bcdda1-2d1e-46f9-bc34-8e22d90fe9c1",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1135,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "32d4d200-1fdf-44ed-b81f-1954a9c93926",
    "patient_ID": "TCGA.09.1667",
    "bcr_drug_barcode": "TCGA-09-1667-D24295",
    "bcr_drug_uuid": "44e0c058-2dad-42aa-a59f-80335409f7a2",
    "form_completion_date": "2009-8-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 559,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 685,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0e475b3d-be3c-431a-ab12-5a867ea8f6cd",
    "patient_ID": "TCGA.09.1668",
    "bcr_drug_barcode": "TCGA-09-1668-D24301",
    "bcr_drug_uuid": "d03e27fc-0655-4ff0-b02f-aa7941ea73f5",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "0e475b3d-be3c-431a-ab12-5a867ea8f6cd",
    "patient_ID": "TCGA.09.1668",
    "bcr_drug_barcode": "TCGA-09-1668-D24303",
    "bcr_drug_uuid": "fb1e1df5-88fc-4470-8a14-b8e52cb01d91",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "0e475b3d-be3c-431a-ab12-5a867ea8f6cd",
    "patient_ID": "TCGA.09.1668",
    "bcr_drug_barcode": "TCGA-09-1668-D24302",
    "bcr_drug_uuid": "e5afb655-15ff-4e6d-8a65-2427d238370e",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "b1c90c69-6149-4105-8182-ab9212f196be",
    "patient_ID": "TCGA.09.1669",
    "bcr_drug_barcode": "TCGA-09-1669-D24307",
    "bcr_drug_uuid": "30c1255f-a36c-4d86-8f8e-a064143d8315",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "b1c90c69-6149-4105-8182-ab9212f196be",
    "patient_ID": "TCGA.09.1669",
    "bcr_drug_barcode": "TCGA-09-1669-D24306",
    "bcr_drug_uuid": "50dcc375-fa24-4050-ad1e-92cd42c75e97",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "60014a6e-6a13-4f92-bbfd-eeeee9632f98",
    "patient_ID": "TCGA.09.1670",
    "bcr_drug_barcode": "TCGA-09-1670-D24311",
    "bcr_drug_uuid": "e72190f5-2626-4416-8a8c-e8435831131c",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "60014a6e-6a13-4f92-bbfd-eeeee9632f98",
    "patient_ID": "TCGA.09.1670",
    "bcr_drug_barcode": "TCGA-09-1670-D24312",
    "bcr_drug_uuid": "a9036291-7a11-408c-bf4d-69e72c45fe65",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "60014a6e-6a13-4f92-bbfd-eeeee9632f98",
    "patient_ID": "TCGA.09.1670",
    "bcr_drug_barcode": "TCGA-09-1670-D24310",
    "bcr_drug_uuid": "0425c8ba-5351-4002-8ce5-99d9f36dac5d",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER"
  },
  {
    "bcr_patient_uuid": "66dc6379-a98b-498f-8109-e3a811d043ea",
    "patient_ID": "TCGA.09.1672",
    "bcr_drug_barcode": "TCGA-09-1672-D24316",
    "bcr_drug_uuid": "39aa2254-337c-461d-97c1-1733b934db3d",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "66dc6379-a98b-498f-8109-e3a811d043ea",
    "patient_ID": "TCGA.09.1672",
    "bcr_drug_barcode": "TCGA-09-1672-D24315",
    "bcr_drug_uuid": "0374f5fb-511c-41e7-a7b1-0438a5f9110a",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4e6f88de-7624-4719-8234-4c9e5b2e2988",
    "patient_ID": "TCGA.09.1673",
    "bcr_drug_barcode": "TCGA-09-1673-D24319",
    "bcr_drug_uuid": "930899a5-34a2-46c3-9584-8203d90c4173",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL OR TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4e6f88de-7624-4719-8234-4c9e5b2e2988",
    "patient_ID": "TCGA.09.1673",
    "bcr_drug_barcode": "TCGA-09-1673-D24320",
    "bcr_drug_uuid": "61389628-3aff-4fa0-bc4b-566c03bd0019",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1ede8063-e0e9-466d-891c-ac8916f1b5fa",
    "patient_ID": "TCGA.09.1674",
    "bcr_drug_barcode": "TCGA-09-1674-D24323",
    "bcr_drug_uuid": "c829fcf0-0841-4229-adf3-10798090ed07",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "1ede8063-e0e9-466d-891c-ac8916f1b5fa",
    "patient_ID": "TCGA.09.1674",
    "bcr_drug_barcode": "TCGA-09-1674-D24324",
    "bcr_drug_uuid": "a0689762-9c26-4b5d-abd0-e97287570a20",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0fc8777c-8f12-472f-a0ea-085139b35d1f",
    "patient_ID": "TCGA.09.1675",
    "bcr_drug_barcode": "TCGA-09-1675-D24329",
    "bcr_drug_uuid": "c83250a3-fa1a-4fba-9d68-7656b0ae9ff0",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "0fc8777c-8f12-472f-a0ea-085139b35d1f",
    "patient_ID": "TCGA.09.1675",
    "bcr_drug_barcode": "TCGA-09-1675-D24328",
    "bcr_drug_uuid": "855b5a4b-8752-46eb-ad51-3917f471d8e9",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "0fc8777c-8f12-472f-a0ea-085139b35d1f",
    "patient_ID": "TCGA.09.1675",
    "bcr_drug_barcode": "TCGA-09-1675-D24330",
    "bcr_drug_uuid": "6af7d774-e00a-4411-bb4b-30be83bfa4ad",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 15,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "0fc8777c-8f12-472f-a0ea-085139b35d1f",
    "patient_ID": "TCGA.09.1675",
    "bcr_drug_barcode": "TCGA-09-1675-D24327",
    "bcr_drug_uuid": "b14864f9-e7b2-4987-ac25-a5804bc74634",
    "form_completion_date": "2009-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 15,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e",
    "patient_ID": "TCGA.09.2044",
    "bcr_drug_barcode": "TCGA-09-2044-D24335",
    "bcr_drug_uuid": "47992e98-d20a-4eaa-8d9a-e0098cf2e22a",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e",
    "patient_ID": "TCGA.09.2044",
    "bcr_drug_barcode": "TCGA-09-2044-D24336",
    "bcr_drug_uuid": "21ab3e49-5209-4617-af8c-1c957d3616a7",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24343",
    "bcr_drug_uuid": "bb92bbda-df68-4f6d-a51e-95da220fb45c",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24346",
    "bcr_drug_uuid": "fc471499-6c71-4641-a6a2-46d6521a837d",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 875,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 895,
    "drug_cycles": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24342",
    "bcr_drug_uuid": "7d3b6c00-c2bf-482b-bdf9-a3362a8457a0",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24339",
    "bcr_drug_uuid": "6c79b320-a371-4afe-a40c-af0f28090dc7",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 11,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 810
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24344",
    "bcr_drug_uuid": "0298c721-f7a3-4b0b-836d-a7499fcfd188",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24341",
    "bcr_drug_uuid": "455a8a8b-4170-4478-a4a4-32a2082271d7",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24340",
    "bcr_drug_uuid": "868ce7a4-1bfe-46fb-a1ef-f297525b252a",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 11,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24345",
    "bcr_drug_uuid": "b04e60fd-6a47-4141-b49a-075c34588c7b",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 808,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENT AND PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24349",
    "bcr_drug_uuid": "77d77b01-fb4c-4cf8-8f03-8ecd740b662a",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 933,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 939,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24348",
    "bcr_drug_uuid": "2b57866b-5b39-4bd7-b317-a69e3f2c3143",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 933,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 939,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "3768d34f-1527-40db-b116-cd80cee5ec3a",
    "patient_ID": "TCGA.09.2045",
    "bcr_drug_barcode": "TCGA-09-2045-D24347",
    "bcr_drug_uuid": "ae26f30d-0995-4c38-837c-9dcc29376e15",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 808,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "RECURRENT AND PROGRESSION",
    "drug_total_dose": 0.665
  },
  {
    "bcr_patient_uuid": "184aac07-44c1-47f1-8adf-50acbcc1762c",
    "patient_ID": "TCGA.09.2048",
    "bcr_drug_barcode": "TCGA-09-2048-D24352",
    "bcr_drug_uuid": "36759fad-df49-4c76-9c80-ccbd66d8d40a",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24360",
    "bcr_drug_uuid": "97c98396-8ea6-4581-95af-2fff74d5e182",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 995,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 995,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 322
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24355",
    "bcr_drug_uuid": "d83a8dfc-81b1-45fe-bc71-8e50301f9067",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24358",
    "bcr_drug_uuid": "e5d8d89d-7b09-4fa9-9f96-e01af2ad30e6",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 962,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 981,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 92
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24359",
    "bcr_drug_uuid": "edad049f-fccf-495c-ad9b-e04a09872cf0",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 995,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 995,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 649
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24363",
    "bcr_drug_uuid": "8d9c2b58-92c9-49bc-a943-f506dac97ef4",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "GEMCITIBANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1410,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1431,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24357",
    "bcr_drug_uuid": "8c700aae-89fb-479f-a035-ba766d117f7d",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 962,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 981,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 218
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24361",
    "bcr_drug_uuid": "8b6d5d68-4a96-4b7f-9198-f3decc4e3817",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1017,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24362",
    "bcr_drug_uuid": "bdb2cde3-1c7d-4820-a9c0-a667e68e6daf",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1410,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1431,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24365",
    "bcr_drug_uuid": "be355cf1-4bc6-4561-83f9-c530a6ea6e7a",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1779,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1964,
    "drug_cycles": 20,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 46
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24364",
    "bcr_drug_uuid": "41c6a131-9a0b-4745-ab82-cf90e8d54de4",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1712,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1768,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "05eb8bd5-d31b-4595-921a-366e53ea5a8b",
    "patient_ID": "TCGA.09.2049",
    "bcr_drug_barcode": "TCGA-09-2049-D24356",
    "bcr_drug_uuid": "806b0a19-adfb-4091-99e5-f53f85ab70c3",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "3c037acf-f453-4513-a6dd-129163ddde2a",
    "patient_ID": "TCGA.09.2050",
    "bcr_drug_barcode": "TCGA-09-2050-D24370",
    "bcr_drug_uuid": "e8e55844-54ae-4eaa-870f-879d2fc1fc3c",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "3c037acf-f453-4513-a6dd-129163ddde2a",
    "patient_ID": "TCGA.09.2050",
    "bcr_drug_barcode": "TCGA-09-2050-D24371",
    "bcr_drug_uuid": "1d6971b6-36e2-45af-a856-314033ffc348",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "3c037acf-f453-4513-a6dd-129163ddde2a",
    "patient_ID": "TCGA.09.2050",
    "bcr_drug_barcode": "TCGA-09-2050-D24368",
    "bcr_drug_uuid": "8b49a093-29ac-43b2-afe1-29b764d8040c",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 25,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "3c037acf-f453-4513-a6dd-129163ddde2a",
    "patient_ID": "TCGA.09.2050",
    "bcr_drug_barcode": "TCGA-09-2050-D24369",
    "bcr_drug_uuid": "a5f02758-3d64-4485-9264-696da62d12f0",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 25,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24375",
    "bcr_drug_uuid": "0f1610c9-8ce0-40e3-881e-0ba904f9038b",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24377",
    "bcr_drug_uuid": "077cc169-cf4a-4177-9f9e-8f14fa534c1c",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 913,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 941,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24381",
    "bcr_drug_uuid": "6fb5e7f5-d6cd-4b93-80cb-7f5e114b6847",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1586,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1698,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 376
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24376",
    "bcr_drug_uuid": "aed478ec-3ae2-4c26-9734-8d6a57a957f5",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "OVAREX STUDY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATION THERAPY"
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24382",
    "bcr_drug_uuid": "0d3f88c5-99cb-41b5-b48f-02197c8ac79f",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1586,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1698,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1380
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24374",
    "bcr_drug_uuid": "55db8cf8-429e-4b6e-9511-299e01d1922f",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24380",
    "bcr_drug_uuid": "03b1566e-cda5-4842-a3f2-1fc17dfb6148",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 947,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1024,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24379",
    "bcr_drug_uuid": "7857ae81-1908-47bc-93a9-072a19062d7a",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 947,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1024,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "02594e5e-8751-47c1-9245-90c66984b665",
    "patient_ID": "TCGA.09.2051",
    "bcr_drug_barcode": "TCGA-09-2051-D24378",
    "bcr_drug_uuid": "51dd5cd9-1805-42ac-bb7e-e163028eb07e",
    "form_completion_date": "2009-11-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 913,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 941,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "ea605be2-6578-4e01-8ec3-bbd84c0b7f1d",
    "patient_ID": "TCGA.09.2053",
    "bcr_drug_barcode": "TCGA-09-2053-D24385",
    "bcr_drug_uuid": "d711d5ea-2290-411c-afa5-ab30773d3e11",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "ea605be2-6578-4e01-8ec3-bbd84c0b7f1d",
    "patient_ID": "TCGA.09.2053",
    "bcr_drug_barcode": "TCGA-09-2053-D24386",
    "bcr_drug_uuid": "e2e0c1ed-9af3-414e-b5e4-b993d4ebf97f",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "cbd87697-7708-4b69-9e50-9ee474feabe1",
    "patient_ID": "TCGA.09.2054",
    "bcr_drug_barcode": "TCGA-09-2054-D24393",
    "bcr_drug_uuid": "d7d74c67-9d2c-43ce-8ccf-37ebb18b35fc",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 428,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 513,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cbd87697-7708-4b69-9e50-9ee474feabe1",
    "patient_ID": "TCGA.09.2054",
    "bcr_drug_barcode": "TCGA-09-2054-D24390",
    "bcr_drug_uuid": "d033d1e2-585a-4515-a09c-3bb2ed9373f3",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "cbd87697-7708-4b69-9e50-9ee474feabe1",
    "patient_ID": "TCGA.09.2054",
    "bcr_drug_barcode": "TCGA-09-2054-D24391",
    "bcr_drug_uuid": "88f8d9fd-3a90-4644-abd7-48ee8c850bdf",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "cbd87697-7708-4b69-9e50-9ee474feabe1",
    "patient_ID": "TCGA.09.2054",
    "bcr_drug_barcode": "TCGA-09-2054-D24392",
    "bcr_drug_uuid": "167ef959-4751-4101-9754-2e14e556f5d3",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cbd87697-7708-4b69-9e50-9ee474feabe1",
    "patient_ID": "TCGA.09.2054",
    "bcr_drug_barcode": "TCGA-09-2054-D24389",
    "bcr_drug_uuid": "5acfc9ba-d325-4e43-b8b4-154653154ad0",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "838778c3-0b33-4fc5-97fc-5da163475485",
    "patient_ID": "TCGA.09.2055",
    "bcr_drug_barcode": "TCGA-09-2055-D24396",
    "bcr_drug_uuid": "71b4da94-56ba-47a7-9cbe-e33ec42f2095",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "838778c3-0b33-4fc5-97fc-5da163475485",
    "patient_ID": "TCGA.09.2055",
    "bcr_drug_barcode": "TCGA-09-2055-D24397",
    "bcr_drug_uuid": "49441fe6-198e-43c3-ba65-b1575d1075ab",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "ea6405c4-0fe4-4f37-bef2-275072f91e39",
    "patient_ID": "TCGA.09.2056",
    "bcr_drug_barcode": "TCGA-09-2056-D24401",
    "bcr_drug_uuid": "83a5aabd-3f44-4398-9fd1-09ffac14acde",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ea6405c4-0fe4-4f37-bef2-275072f91e39",
    "patient_ID": "TCGA.09.2056",
    "bcr_drug_barcode": "TCGA-09-2056-D24400",
    "bcr_drug_uuid": "4782449f-9b8d-48f6-80e7-d05021eef896",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24406",
    "bcr_drug_uuid": "10140623-084f-46ad-b207-672f4b228676",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 293,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24409",
    "bcr_drug_uuid": "73fa5659-2aae-4310-9744-237bc5d74ea4",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1496,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 925
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24405",
    "bcr_drug_uuid": "353e255d-4a5f-422b-b3ae-7f92abc7edf0",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24408",
    "bcr_drug_uuid": "f759a3d3-377f-4eab-ab14-84a4d30dba5b",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1308,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1447,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2118
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24404",
    "bcr_drug_uuid": "4411d09e-4315-4204-aef6-ee87de442231",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3380
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24410",
    "bcr_drug_uuid": "399884f4-0245-4df5-bad4-9c599adac869",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1517,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1630,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 326
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24407",
    "bcr_drug_uuid": "5d6b4186-c9d2-419c-93d3-3555fc8058f7",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 593,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1028,
    "drug_cycles": 15,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7500
  },
  {
    "bcr_patient_uuid": "869c9aae-85eb-4faa-8893-b3f487e8981c",
    "patient_ID": "TCGA.10.0925",
    "bcr_drug_barcode": "TCGA-10-0925-D24411",
    "bcr_drug_uuid": "2673b75d-e190-43f5-96f3-440828653be4",
    "form_completion_date": "2010-2-5",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 321,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 593,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9600
  },
  {
    "bcr_patient_uuid": "e641aed9-1dd8-4c30-b231-f12b20a76df0",
    "patient_ID": "TCGA.10.0926",
    "bcr_drug_barcode": "TCGA-10-0926-D24417",
    "bcr_drug_uuid": "a6419a7d-cf48-41ab-ae3c-4e1e5746e9ad",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "INTERLEUKIN-12",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 232,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e641aed9-1dd8-4c30-b231-f12b20a76df0",
    "patient_ID": "TCGA.10.0926",
    "bcr_drug_barcode": "TCGA-10-0926-D24416",
    "bcr_drug_uuid": "2ed5c38f-994f-4aae-ad6f-2be5d242946e",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 290,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 729,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 975
  },
  {
    "bcr_patient_uuid": "e641aed9-1dd8-4c30-b231-f12b20a76df0",
    "patient_ID": "TCGA.10.0926",
    "bcr_drug_barcode": "TCGA-10-0926-D24414",
    "bcr_drug_uuid": "7d7d38a9-711f-480d-a3f2-1c866145b0aa",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 860
  },
  {
    "bcr_patient_uuid": "e641aed9-1dd8-4c30-b231-f12b20a76df0",
    "patient_ID": "TCGA.10.0926",
    "bcr_drug_barcode": "TCGA-10-0926-D24415",
    "bcr_drug_uuid": "8651d712-bb73-4b45-bbcf-1f5054c30742",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "AJUVANT AND PROGRESSION",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24425",
    "bcr_drug_uuid": "3d37f28e-e854-4a31-a7f1-407e7c128dba",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1686,
    "days_to_drug_end": 1910,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION AND RECURRENCE",
    "drug_total_dose": 2320
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24427",
    "bcr_drug_uuid": "3c8fee69-6a99-4182-8581-b545e14c58a2",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2330,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2463,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION AND RECURRENCE",
    "drug_total_dose": 9920
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24424",
    "bcr_drug_uuid": "f5b4eecf-392c-4dc2-b6b4-84147f8d78a8",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "ARIMIDEX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1601,
    "days_to_drug_end": 1686,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION AND RECURRENCE",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24426",
    "bcr_drug_uuid": "5543938e-67eb-414c-a80d-dcb113ce7c6e",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1938,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2302,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION AND RECURRENCE",
    "drug_total_dose": 845
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24421",
    "bcr_drug_uuid": "8a17dc93-4b32-40e2-8134-94b2aa680461",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "days_to_drug_end": 121,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24422",
    "bcr_drug_uuid": "6f9c873b-a61c-4074-abaf-03124c45be22",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2940
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24428",
    "bcr_drug_uuid": "e99dde4c-fd87-4c00-8d67-dcd6cb912a64",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1336,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1640,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION AND RECURRENCE",
    "drug_total_dose": 12000
  },
  {
    "bcr_patient_uuid": "933dbfbd-4697-403e-bd73-c17cb300c94b",
    "patient_ID": "TCGA.10.0927",
    "bcr_drug_barcode": "TCGA-10-0927-D24423",
    "bcr_drug_uuid": "6efe15d8-13aa-4760-8bfb-dadb529205f0",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1017,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1301,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PROGRESSION AND RECURRENCE",
    "drug_total_dose": 5400
  },
  {
    "bcr_patient_uuid": "99f1ae02-86ec-4d93-8cd4-650bf6f02c10",
    "patient_ID": "TCGA.10.0930",
    "bcr_drug_barcode": "TCGA-10-0930-D24435",
    "bcr_drug_uuid": "d0b6b8e2-d04f-4bac-9938-6ce9760f5018",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 694,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 736,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 810
  },
  {
    "bcr_patient_uuid": "99f1ae02-86ec-4d93-8cd4-650bf6f02c10",
    "patient_ID": "TCGA.10.0930",
    "bcr_drug_barcode": "TCGA-10-0930-D24433",
    "bcr_drug_uuid": "5c3e10dc-5d6b-4948-ba8b-4ac663d8e8db",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "99f1ae02-86ec-4d93-8cd4-650bf6f02c10",
    "patient_ID": "TCGA.10.0930",
    "bcr_drug_barcode": "TCGA-10-0930-D24436",
    "bcr_drug_uuid": "9e40afd1-1f30-4db6-9986-40cd5b982b0f",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 694,
    "days_to_drug_end": 736,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "99f1ae02-86ec-4d93-8cd4-650bf6f02c10",
    "patient_ID": "TCGA.10.0930",
    "bcr_drug_barcode": "TCGA-10-0930-D24437",
    "bcr_drug_uuid": "548ef658-969a-490c-9410-cf5e38504c2a",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 782,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 838,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 210
  },
  {
    "bcr_patient_uuid": "99f1ae02-86ec-4d93-8cd4-650bf6f02c10",
    "patient_ID": "TCGA.10.0930",
    "bcr_drug_barcode": "TCGA-10-0930-D24434",
    "bcr_drug_uuid": "bfd5b64b-62d5-4c17-8783-e6dbbf799d03",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2520
  },
  {
    "bcr_patient_uuid": "99f1ae02-86ec-4d93-8cd4-650bf6f02c10",
    "patient_ID": "TCGA.10.0930",
    "bcr_drug_barcode": "TCGA-10-0930-D24438",
    "bcr_drug_uuid": "07366f75-ef12-4507-a120-de282ff35bb7",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24447",
    "bcr_drug_uuid": "6f5f2462-b8d3-41a1-a759-bd6620dbea7a",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 666,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 440
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24443",
    "bcr_drug_uuid": "44b0875b-a102-42e4-a61f-abfce289b500",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "days_to_drug_end": 124,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2268
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24445",
    "bcr_drug_uuid": "9c1c5ddc-68bf-48fb-8cae-507131f94067",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 386,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 509,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3240
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24442",
    "bcr_drug_uuid": "dfdc84f0-c615-4da5-b487-34e7f9691adc",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "days_to_drug_end": 124,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24450",
    "bcr_drug_uuid": "8bd774bd-af1c-42d9-9e7f-5b3af5ba9fab",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 876,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 932,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 231
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24441",
    "bcr_drug_uuid": "9c726295-8f59-46f7-8c2b-82ffb7160c98",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "days_to_drug_end": 124,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2430
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24448",
    "bcr_drug_uuid": "e771584c-41ce-4c1b-a77f-01e3c8fe3d4b",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 538,
    "days_to_drug_end": 666,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 420
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24451",
    "bcr_drug_uuid": "8e89e478-3caf-4f3c-9f7d-6beb6d51b978",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 383,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1880
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24446",
    "bcr_drug_uuid": "392d5262-c107-42a2-b5a5-b33725bc6c95",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 666,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1840
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24452",
    "bcr_drug_uuid": "bffe9f9b-5c33-4340-b4d7-14f05b68f15f",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "IRRESSA",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 792,
    "days_to_drug_end": 848,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24444",
    "bcr_drug_uuid": "fdaa015f-c778-4f16-8461-faa4255fc6c0",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 386,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 509,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1632
  },
  {
    "bcr_patient_uuid": "e07a61e2-bcd2-4a96-80df-97e04aafbd32",
    "patient_ID": "TCGA.10.0931",
    "bcr_drug_barcode": "TCGA-10-0931-D24449",
    "bcr_drug_uuid": "473285f6-556e-4b10-b85c-03b35b3fd7c6",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 792,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 848,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 23.78
  },
  {
    "bcr_patient_uuid": "9446e349-71e6-455a-aa8f-53ec96597146",
    "patient_ID": "TCGA.10.0933",
    "bcr_drug_barcode": "TCGA-10-0933-D24455",
    "bcr_drug_uuid": "40b513c9-3e2c-434c-84bc-b79ca9ae8c0e",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND RECURRENCE",
    "drug_total_dose": 1740
  },
  {
    "bcr_patient_uuid": "9446e349-71e6-455a-aa8f-53ec96597146",
    "patient_ID": "TCGA.10.0933",
    "bcr_drug_barcode": "TCGA-10-0933-D24456",
    "bcr_drug_uuid": "89e0dd01-e64f-44ab-b287-379aa1c62a89",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND RECURRENCE",
    "drug_total_dose": 2160
  },
  {
    "bcr_patient_uuid": "65ddccd2-70a7-48b3-88e1-9d6fd1dcd11b",
    "patient_ID": "TCGA.10.0934",
    "bcr_drug_barcode": "TCGA-10-0934-D24459",
    "bcr_drug_uuid": "369dd738-d6cc-4e91-a5bb-a317fe8f262b",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 525
  },
  {
    "bcr_patient_uuid": "65ddccd2-70a7-48b3-88e1-9d6fd1dcd11b",
    "patient_ID": "TCGA.10.0934",
    "bcr_drug_barcode": "TCGA-10-0934-D24460",
    "bcr_drug_uuid": "8905b636-eb21-4da2-9c21-10097b036851",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "48f8afa8-7712-4428-b0d0-d8c3340504b6",
    "patient_ID": "TCGA.10.0935",
    "bcr_drug_barcode": "TCGA-10-0935-D24463",
    "bcr_drug_uuid": "3b5b164a-2480-499e-94a3-b17eb309ddc5",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "48f8afa8-7712-4428-b0d0-d8c3340504b6",
    "patient_ID": "TCGA.10.0935",
    "bcr_drug_barcode": "TCGA-10-0935-D24464",
    "bcr_drug_uuid": "8871014c-27c2-4cef-aeb0-58c025e2b10e",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 385
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24467",
    "bcr_drug_uuid": "9bd9d92a-4775-495d-9209-1475005505f4",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 62,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1615
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24469",
    "bcr_drug_uuid": "84fd790c-fc01-4d6d-bd3b-c4860f0e78b4",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2280
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24474",
    "bcr_drug_uuid": "38fab685-29ce-4fff-9179-8691a08107d1",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 237,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 615,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24470",
    "bcr_drug_uuid": "ee4d18da-f9a9-41f5-b867-87deff293046",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 621,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 678,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1035
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24473",
    "bcr_drug_uuid": "335550af-0cce-4f0b-bb51-d2a7c0427588",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 939,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1007,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11200
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24468",
    "bcr_drug_uuid": "3886dc45-0ac8-4881-8901-ed14880ac3c6",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24472",
    "bcr_drug_uuid": "f6bca061-1141-4801-8241-cd2004e60d5d",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 810,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 936,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "7016714b-6af8-45dd-8341-1493927e5515",
    "patient_ID": "TCGA.10.0936",
    "bcr_drug_barcode": "TCGA-10-0936-D24471",
    "bcr_drug_uuid": "edcae4f7-3cd7-420f-b9d8-a8a91be49e85",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 678,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 800,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "a5030259-cf9c-4a58-8710-b9da8ee59320",
    "patient_ID": "TCGA.10.0937",
    "bcr_drug_barcode": "TCGA-10-0937-D24478",
    "bcr_drug_uuid": "64cba306-01c8-4412-9e49-95d131594683",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3990
  },
  {
    "bcr_patient_uuid": "a5030259-cf9c-4a58-8710-b9da8ee59320",
    "patient_ID": "TCGA.10.0937",
    "bcr_drug_barcode": "TCGA-10-0937-D24477",
    "bcr_drug_uuid": "db74055c-a84f-449b-82f1-9108f0ff89c0",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1980
  },
  {
    "bcr_patient_uuid": "a5030259-cf9c-4a58-8710-b9da8ee59320",
    "patient_ID": "TCGA.10.0937",
    "bcr_drug_barcode": "TCGA-10-0937-D24480",
    "bcr_drug_uuid": "f638ea11-a654-4755-af37-e67ded7c0ca7",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 21
  },
  {
    "bcr_patient_uuid": "a5030259-cf9c-4a58-8710-b9da8ee59320",
    "patient_ID": "TCGA.10.0937",
    "bcr_drug_barcode": "TCGA-10-0937-D24479",
    "bcr_drug_uuid": "985bd058-ab32-48c3-b123-43ac7e98ac1a",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 296,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "a5030259-cf9c-4a58-8710-b9da8ee59320",
    "patient_ID": "TCGA.10.0937",
    "bcr_drug_barcode": "TCGA-10-0937-D24481",
    "bcr_drug_uuid": "b7a1dace-94aa-4b2e-9b21-8887a767f9b0",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 451,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4176
  },
  {
    "bcr_patient_uuid": "7ca97692-0bf5-4bbd-81ce-10a051d04bd5",
    "patient_ID": "TCGA.10.0938",
    "bcr_drug_barcode": "TCGA-10-0938-D24485",
    "bcr_drug_uuid": "4ec299a4-7ca0-401b-a821-eb152b0bdb5e",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 960
  },
  {
    "bcr_patient_uuid": "7ca97692-0bf5-4bbd-81ce-10a051d04bd5",
    "patient_ID": "TCGA.10.0938",
    "bcr_drug_barcode": "TCGA-10-0938-D24486",
    "bcr_drug_uuid": "10f1ac83-b3d8-4d46-8f20-0375c6e60795",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "LETROZOLE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "7ca97692-0bf5-4bbd-81ce-10a051d04bd5",
    "patient_ID": "TCGA.10.0938",
    "bcr_drug_barcode": "TCGA-10-0938-D24487",
    "bcr_drug_uuid": "c66f69b0-dcca-4e31-a97d-f082c418b72e",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "LUPRON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 3.75
  },
  {
    "bcr_patient_uuid": "7ca97692-0bf5-4bbd-81ce-10a051d04bd5",
    "patient_ID": "TCGA.10.0938",
    "bcr_drug_barcode": "TCGA-10-0938-D24484",
    "bcr_drug_uuid": "23a9ca35-0862-46fa-a079-8d3834f1178c",
    "form_completion_date": "2009-3-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "ADJUVANT AND PROGRESSION",
    "drug_total_dose": 3150
  },
  {
    "bcr_patient_uuid": "1e14f098-17b2-4f54-8e4f-e38088008df7",
    "patient_ID": "TCGA.13.0714",
    "bcr_drug_barcode": "TCGA-13-0714-D24491",
    "bcr_drug_uuid": "9d443d74-433e-4f6f-8591-4a482fc81098",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "1e14f098-17b2-4f54-8e4f-e38088008df7",
    "patient_ID": "TCGA.13.0714",
    "bcr_drug_barcode": "TCGA-13-0714-D24490",
    "bcr_drug_uuid": "8ca3dedd-47ab-4034-aab2-6050c4600c4a",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "1e14f098-17b2-4f54-8e4f-e38088008df7",
    "patient_ID": "TCGA.13.0714",
    "bcr_drug_barcode": "TCGA-13-0714-D24492",
    "bcr_drug_uuid": "e54432b5-99df-4c39-b995-647542102aaf",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3867e193-c82f-4693-9b32-bac76b5f4d06",
    "patient_ID": "TCGA.13.0717",
    "bcr_drug_barcode": "TCGA-13-0717-D24495",
    "bcr_drug_uuid": "01973948-9206-4968-b05a-8b19e465ef65",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "3867e193-c82f-4693-9b32-bac76b5f4d06",
    "patient_ID": "TCGA.13.0717",
    "bcr_drug_barcode": "TCGA-13-0717-D24496",
    "bcr_drug_uuid": "3a6a17e8-3079-4667-be37-f8a1adc186e1",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "0d23fa5b-95f8-4626-a4d2-c72ad3cc553b",
    "patient_ID": "TCGA.13.0720",
    "bcr_drug_barcode": "TCGA-13-0720-D24499",
    "bcr_drug_uuid": "aaffa8ca-1eab-4ffc-89bb-6445124f34b8",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0d23fa5b-95f8-4626-a4d2-c72ad3cc553b",
    "patient_ID": "TCGA.13.0720",
    "bcr_drug_barcode": "TCGA-13-0720-D24500",
    "bcr_drug_uuid": "a2017b37-9590-4aff-83e9-ec7eca6ee91e",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "0d23fa5b-95f8-4626-a4d2-c72ad3cc553b",
    "patient_ID": "TCGA.13.0720",
    "bcr_drug_barcode": "TCGA-13-0720-D24501",
    "bcr_drug_uuid": "aea4d94c-bf50-4440-a9a6-8e32d97645af",
    "form_completion_date": "2009-4-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 239,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 292,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "ff530f28-0ec0-4494-bb54-44bb055bae1c",
    "patient_ID": "TCGA.13.0723",
    "bcr_drug_barcode": "TCGA-13-0723-D24505",
    "bcr_drug_uuid": "2da9827e-d8d0-4341-9c31-da97c92e0d3f",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "ff530f28-0ec0-4494-bb54-44bb055bae1c",
    "patient_ID": "TCGA.13.0723",
    "bcr_drug_barcode": "TCGA-13-0723-D24504",
    "bcr_drug_uuid": "bb7c2bfe-7d7b-485e-a5f7-145a5a680ef7",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a9abe7a7-4126-414b-87d2-a6d25abcf1fa",
    "patient_ID": "TCGA.13.0724",
    "bcr_drug_barcode": "TCGA-13-0724-D24508",
    "bcr_drug_uuid": "821d3091-cd9c-4958-a260-e9ea9cc10b72",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "days_to_drug_end": 75,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "446ce2a3-d328-443c-a419-3344baad0e16",
    "patient_ID": "TCGA.13.0725",
    "bcr_drug_barcode": "TCGA-13-0725-D24513",
    "bcr_drug_uuid": "98617757-5925-4a7b-b333-b843536db376",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 190,
    "days_to_drug_end": 215,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "446ce2a3-d328-443c-a419-3344baad0e16",
    "patient_ID": "TCGA.13.0725",
    "bcr_drug_barcode": "TCGA-13-0725-D24512",
    "bcr_drug_uuid": "24e5e7f8-08b6-4217-8e45-c7a6ce7ceb03",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "446ce2a3-d328-443c-a419-3344baad0e16",
    "patient_ID": "TCGA.13.0725",
    "bcr_drug_barcode": "TCGA-13-0725-D24511",
    "bcr_drug_uuid": "c01c8aa8-2ad3-4add-9c4a-56fa32923507",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "32960bc7-839a-42c5-9460-3917fa578ffc",
    "patient_ID": "TCGA.13.0726",
    "bcr_drug_barcode": "TCGA-13-0726-D24517",
    "bcr_drug_uuid": "9297737f-6669-4c71-858d-095117428338",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "days_to_drug_end": 169,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "32960bc7-839a-42c5-9460-3917fa578ffc",
    "patient_ID": "TCGA.13.0726",
    "bcr_drug_barcode": "TCGA-13-0726-D24516",
    "bcr_drug_uuid": "f8476d0c-e091-4678-a588-e33fdb388ee4",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "days_to_drug_end": 169,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "90f4b65c-cfd4-4066-a5b9-842885c172e2",
    "patient_ID": "TCGA.13.0727",
    "bcr_drug_barcode": "TCGA-13-0727-D24522",
    "bcr_drug_uuid": "85fd0b24-2879-4b9d-af7d-b78feec02170",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 230,
    "days_to_drug_end": 267,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "90f4b65c-cfd4-4066-a5b9-842885c172e2",
    "patient_ID": "TCGA.13.0727",
    "bcr_drug_barcode": "TCGA-13-0727-D24521",
    "bcr_drug_uuid": "c84669f2-ec70-49d1-b206-2db206e0976a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "90f4b65c-cfd4-4066-a5b9-842885c172e2",
    "patient_ID": "TCGA.13.0727",
    "bcr_drug_barcode": "TCGA-13-0727-D24520",
    "bcr_drug_uuid": "48326e26-e676-4b3a-a613-5f8398fa1b3a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15c84da3-16e5-4909-aea9-cb5894b0f8af",
    "patient_ID": "TCGA.13.0751",
    "bcr_drug_barcode": "TCGA-13-0751-D24527",
    "bcr_drug_uuid": "ff901552-345c-4d2f-882f-4f90f4b6cb65",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "15c84da3-16e5-4909-aea9-cb5894b0f8af",
    "patient_ID": "TCGA.13.0751",
    "bcr_drug_barcode": "TCGA-13-0751-D24528",
    "bcr_drug_uuid": "025efed8-6699-48d2-8596-788a6337a354",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 195,
    "days_to_drug_end": 266,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "15c84da3-16e5-4909-aea9-cb5894b0f8af",
    "patient_ID": "TCGA.13.0751",
    "bcr_drug_barcode": "TCGA-13-0751-D24526",
    "bcr_drug_uuid": "06eeae3a-bfc4-461d-8499-af38bf92d8ed",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15c84da3-16e5-4909-aea9-cb5894b0f8af",
    "patient_ID": "TCGA.13.0751",
    "bcr_drug_barcode": "TCGA-13-0751-D24529",
    "bcr_drug_uuid": "1e6a17fb-ccae-4774-885a-87fff00779a2",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 195,
    "days_to_drug_end": 266,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "2956e414-f167-438f-8747-a46fe0723622",
    "patient_ID": "TCGA.13.0755",
    "bcr_drug_barcode": "TCGA-13-0755-D24532",
    "bcr_drug_uuid": "b1fd19c5-0fce-4869-ae4b-9b46b4361b96",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "days_to_drug_end": 41,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 230
  },
  {
    "bcr_patient_uuid": "2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a",
    "patient_ID": "TCGA.13.0757",
    "bcr_drug_barcode": "TCGA-13-0757-D24536",
    "bcr_drug_uuid": "d9c850b0-6889-4a82-94f5-deeab734157d",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a",
    "patient_ID": "TCGA.13.0757",
    "bcr_drug_barcode": "TCGA-13-0757-D24535",
    "bcr_drug_uuid": "694dc262-613f-40fe-b735-58df6a8f7c5c",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "2c69f3a4-c26c-4fbb-a1c0-b1f57554c43a",
    "patient_ID": "TCGA.13.0757",
    "bcr_drug_barcode": "TCGA-13-0757-D24537",
    "bcr_drug_uuid": "e9908539-10a7-4295-b517-eaa029f112b2",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 211,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "514aa64e-a58d-48c2-aff9-498604cc11d6",
    "patient_ID": "TCGA.13.0758",
    "bcr_drug_barcode": "TCGA-13-0758-D24541",
    "bcr_drug_uuid": "34cc047c-282b-4d98-b8d6-e0dcd9ab5ee9",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "514aa64e-a58d-48c2-aff9-498604cc11d6",
    "patient_ID": "TCGA.13.0758",
    "bcr_drug_barcode": "TCGA-13-0758-D24540",
    "bcr_drug_uuid": "052c2082-e91f-4ae5-9471-90fa513e2975",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "00630714-7ab3-44e1-afff-186300edae44",
    "patient_ID": "TCGA.13.0761",
    "bcr_drug_barcode": "TCGA-13-0761-D24546",
    "bcr_drug_uuid": "f9983963-5c1a-496b-8282-939554cd4f52",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "00630714-7ab3-44e1-afff-186300edae44",
    "patient_ID": "TCGA.13.0761",
    "bcr_drug_barcode": "TCGA-13-0761-D24547",
    "bcr_drug_uuid": "bcdda631-62b9-4f30-a4ed-6edd08a6dcd2",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "6485b68f-caa7-45cd-9bc5-78c2add8191d",
    "patient_ID": "TCGA.13.0762",
    "bcr_drug_barcode": "TCGA-13-0762-D24552",
    "bcr_drug_uuid": "93f06508-dccf-4618-83f4-c16fd7ac7e53",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "6485b68f-caa7-45cd-9bc5-78c2add8191d",
    "patient_ID": "TCGA.13.0762",
    "bcr_drug_barcode": "TCGA-13-0762-D24551",
    "bcr_drug_uuid": "83cbff94-94d3-48a7-b33a-4271d6aef3f5",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "6485b68f-caa7-45cd-9bc5-78c2add8191d",
    "patient_ID": "TCGA.13.0762",
    "bcr_drug_barcode": "TCGA-13-0762-D24550",
    "bcr_drug_uuid": "55ae7407-0449-4ebf-bbdb-234a9b82628c",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "034825d0-e8b7-4ac0-be31-25f6038cb04a",
    "patient_ID": "TCGA.13.0764",
    "bcr_drug_barcode": "TCGA-13-0764-D24557",
    "bcr_drug_uuid": "443a788f-f890-4d47-bfbc-c7ff8c756087",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "034825d0-e8b7-4ac0-be31-25f6038cb04a",
    "patient_ID": "TCGA.13.0764",
    "bcr_drug_barcode": "TCGA-13-0764-D24556",
    "bcr_drug_uuid": "a86c31d3-6cf3-4966-8fc6-35ef8a155966",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "034825d0-e8b7-4ac0-be31-25f6038cb04a",
    "patient_ID": "TCGA.13.0764",
    "bcr_drug_barcode": "TCGA-13-0764-D24555",
    "bcr_drug_uuid": "c5a01cb1-41c5-4db6-9fd2-771187c689da",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "774ce281-96b2-467a-9170-079797ee10f7",
    "patient_ID": "TCGA.13.0765",
    "bcr_drug_barcode": "TCGA-13-0765-D24562",
    "bcr_drug_uuid": "e10f7682-e704-4461-99a6-bfb0f4230525",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "774ce281-96b2-467a-9170-079797ee10f7",
    "patient_ID": "TCGA.13.0765",
    "bcr_drug_barcode": "TCGA-13-0765-D24560",
    "bcr_drug_uuid": "071ec052-a24e-4f07-98bc-11b7f907e959",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "774ce281-96b2-467a-9170-079797ee10f7",
    "patient_ID": "TCGA.13.0765",
    "bcr_drug_barcode": "TCGA-13-0765-D24564",
    "bcr_drug_uuid": "77457f7e-2ffc-46d6-839d-6e6edfefaebc",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "774ce281-96b2-467a-9170-079797ee10f7",
    "patient_ID": "TCGA.13.0765",
    "bcr_drug_barcode": "TCGA-13-0765-D24563",
    "bcr_drug_uuid": "58a14e2a-e159-49b3-8dcf-21e5a3d30352",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 589,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 654,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "774ce281-96b2-467a-9170-079797ee10f7",
    "patient_ID": "TCGA.13.0765",
    "bcr_drug_barcode": "TCGA-13-0765-D24561",
    "bcr_drug_uuid": "ddc1fe71-a09c-4c22-8676-91f17fb10e63",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "774ce281-96b2-467a-9170-079797ee10f7",
    "patient_ID": "TCGA.13.0765",
    "bcr_drug_barcode": "TCGA-13-0765-D24565",
    "bcr_drug_uuid": "6d3b20f2-3254-4eda-82dc-bace5d8bf3fd",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 519,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "8fe44099-b313-4bfd-a94a-27e72f2a818c",
    "patient_ID": "TCGA.13.0766",
    "bcr_drug_barcode": "TCGA-13-0766-D24570",
    "bcr_drug_uuid": "e98199f4-62f6-444e-804c-fea51774aa05",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "8fe44099-b313-4bfd-a94a-27e72f2a818c",
    "patient_ID": "TCGA.13.0766",
    "bcr_drug_barcode": "TCGA-13-0766-D24568",
    "bcr_drug_uuid": "3b508635-6136-468c-965e-6c9f011017c6",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8fe44099-b313-4bfd-a94a-27e72f2a818c",
    "patient_ID": "TCGA.13.0766",
    "bcr_drug_barcode": "TCGA-13-0766-D24569",
    "bcr_drug_uuid": "b3b92756-81fc-4d20-8fbe-2be751f193c3",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e732f81c-9b7d-44bd-a905-ff53fbed5009",
    "patient_ID": "TCGA.13.0768",
    "bcr_drug_barcode": "TCGA-13-0768-D24574",
    "bcr_drug_uuid": "419fde28-a4fc-450e-9eea-2e2bfb358bda",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "e732f81c-9b7d-44bd-a905-ff53fbed5009",
    "patient_ID": "TCGA.13.0768",
    "bcr_drug_barcode": "TCGA-13-0768-D24573",
    "bcr_drug_uuid": "57e7d052-fdbb-4d18-85e9-c79ba8256d7b",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "e732f81c-9b7d-44bd-a905-ff53fbed5009",
    "patient_ID": "TCGA.13.0768",
    "bcr_drug_barcode": "TCGA-13-0768-D24577",
    "bcr_drug_uuid": "17b07201-3aff-475c-b83e-6497ed980195",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "e732f81c-9b7d-44bd-a905-ff53fbed5009",
    "patient_ID": "TCGA.13.0768",
    "bcr_drug_barcode": "TCGA-13-0768-D24576",
    "bcr_drug_uuid": "bc1188fa-1bdd-4a7b-9857-005920b5ddf7",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "e732f81c-9b7d-44bd-a905-ff53fbed5009",
    "patient_ID": "TCGA.13.0768",
    "bcr_drug_barcode": "TCGA-13-0768-D24575",
    "bcr_drug_uuid": "7fb6b1aa-f42a-491c-a202-18df8a0d0f5f",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24581",
    "bcr_drug_uuid": "4bbea2bf-9e76-4eb8-943a-c8261c1e3d4b",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24580",
    "bcr_drug_uuid": "710705ec-cf9c-48b3-ba3e-231fd550abdc",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24582",
    "bcr_drug_uuid": "379ea08d-75c7-4d5b-98f6-81fab2e749e8",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 213,
    "days_to_drug_end": 281,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24586",
    "bcr_drug_uuid": "ae155608-caaf-401f-9b84-046e87854d2c",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 794,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 829,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24583",
    "bcr_drug_uuid": "0e93df1a-7811-43d7-ad40-d83f7e680672",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 302,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 449,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 40,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24584",
    "bcr_drug_uuid": "ad968ce1-3353-45e4-a7c6-d061d40f6126",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 479,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 640,
    "drug_cycles": 19,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "90118207-8f11-4784-ac1b-0deec2e7af3a",
    "patient_ID": "TCGA.13.0791",
    "bcr_drug_barcode": "TCGA-13-0791-D24585",
    "bcr_drug_uuid": "75a48310-4c7b-4d7e-aeba-64a599ee42e4",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 654,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 780,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c11cae7e-91cd-4470-a9d8-188a4f6b8fa1",
    "patient_ID": "TCGA.13.0792",
    "bcr_drug_barcode": "TCGA-13-0792-D24589",
    "bcr_drug_uuid": "4c5d66cb-f9d3-4438-944a-a84abe10f840",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c11cae7e-91cd-4470-a9d8-188a4f6b8fa1",
    "patient_ID": "TCGA.13.0792",
    "bcr_drug_barcode": "TCGA-13-0792-D24590",
    "bcr_drug_uuid": "f047d3e4-be77-443e-a63f-a9ed378a2787",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "c11cae7e-91cd-4470-a9d8-188a4f6b8fa1",
    "patient_ID": "TCGA.13.0792",
    "bcr_drug_barcode": "TCGA-13-0792-D24591",
    "bcr_drug_uuid": "c684d9ec-477e-4668-af2d-69f602efaefb",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73",
    "patient_ID": "TCGA.13.0793",
    "bcr_drug_barcode": "TCGA-13-0793-D24595",
    "bcr_drug_uuid": "12f8b3a0-deed-409d-8434-0c0a13501dc7",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73",
    "patient_ID": "TCGA.13.0793",
    "bcr_drug_barcode": "TCGA-13-0793-D24596",
    "bcr_drug_uuid": "3a56ec6c-8b7f-482d-b6b0-4d64e56a91e4",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "ABAGOVOMAB OR PLACEBO",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 200,
    "days_to_drug_end": 362,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "5e90e1ed-cbfd-44ba-a6ff-63ff576b3c73",
    "patient_ID": "TCGA.13.0793",
    "bcr_drug_barcode": "TCGA-13-0793-D24594",
    "bcr_drug_uuid": "75b465bb-15eb-4d7f-8398-3c39d9ada2c0",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b63cad1b-b4c7-4e50-8acb-5cee4e9ce4a9",
    "patient_ID": "TCGA.13.0794",
    "bcr_drug_barcode": "TCGA-13-0794-D24599",
    "bcr_drug_uuid": "281b15dd-f21d-45da-8ba4-98a7232df8d8",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b63cad1b-b4c7-4e50-8acb-5cee4e9ce4a9",
    "patient_ID": "TCGA.13.0794",
    "bcr_drug_barcode": "TCGA-13-0794-D24600",
    "bcr_drug_uuid": "3ae6ca7f-d54e-40bb-9545-a9cbe96a034e",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "b1e11e94-646b-4c44-9d33-1ca67d8356fb",
    "patient_ID": "TCGA.13.0795",
    "bcr_drug_barcode": "TCGA-13-0795-D24604",
    "bcr_drug_uuid": "422f22dc-5eed-420f-a1bb-c308c2a9f817",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "b1e11e94-646b-4c44-9d33-1ca67d8356fb",
    "patient_ID": "TCGA.13.0795",
    "bcr_drug_barcode": "TCGA-13-0795-D24603",
    "bcr_drug_uuid": "a99e93f3-ba26-4014-bbbc-3504115a7f8c",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0de910b1-edaf-47e4-a265-727ee12ac1c3",
    "patient_ID": "TCGA.13.0797",
    "bcr_drug_barcode": "TCGA-13-0797-D24608",
    "bcr_drug_uuid": "d8ca87b3-32a4-4fad-9419-710ff00e2cb0",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "0de910b1-edaf-47e4-a265-727ee12ac1c3",
    "patient_ID": "TCGA.13.0797",
    "bcr_drug_barcode": "TCGA-13-0797-D24607",
    "bcr_drug_uuid": "88409662-1902-43f0-bc49-17443a879455",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 599
  },
  {
    "bcr_patient_uuid": "b9418c6d-94f7-4db4-a1e4-f384b09d54cb",
    "patient_ID": "TCGA.13.0799",
    "bcr_drug_barcode": "TCGA-13-0799-D24612",
    "bcr_drug_uuid": "a3617379-b708-456a-9810-14b2afa80f6d",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "b9418c6d-94f7-4db4-a1e4-f384b09d54cb",
    "patient_ID": "TCGA.13.0799",
    "bcr_drug_barcode": "TCGA-13-0799-D24613",
    "bcr_drug_uuid": "8484fd14-0e7e-45a2-86ce-bcd6b8dfdc48",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "b9418c6d-94f7-4db4-a1e4-f384b09d54cb",
    "patient_ID": "TCGA.13.0799",
    "bcr_drug_barcode": "TCGA-13-0799-D24611",
    "bcr_drug_uuid": "9d2e034d-d90b-4a71-9671-3b061af0102a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "390eed6b-50af-48a9-9fd6-3a68a2bbb7f9",
    "patient_ID": "TCGA.13.0800",
    "bcr_drug_barcode": "TCGA-13-0800-D24618",
    "bcr_drug_uuid": "7686a479-629f-4b7f-9af3-a7179af92576",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "390eed6b-50af-48a9-9fd6-3a68a2bbb7f9",
    "patient_ID": "TCGA.13.0800",
    "bcr_drug_barcode": "TCGA-13-0800-D24617",
    "bcr_drug_uuid": "ff5f69d5-3de1-4738-9a02-dbe76765b393",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "390eed6b-50af-48a9-9fd6-3a68a2bbb7f9",
    "patient_ID": "TCGA.13.0800",
    "bcr_drug_barcode": "TCGA-13-0800-D24616",
    "bcr_drug_uuid": "9a8cf2ea-d928-477e-800a-2201bdeb5b9f",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b8c3d99c-429b-42a3-b486-6fbcb90cc2e0",
    "patient_ID": "TCGA.13.0801",
    "bcr_drug_barcode": "TCGA-13-0801-D24622",
    "bcr_drug_uuid": "48845041-4684-4ce0-afb3-b87310cdec68",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b8c3d99c-429b-42a3-b486-6fbcb90cc2e0",
    "patient_ID": "TCGA.13.0801",
    "bcr_drug_barcode": "TCGA-13-0801-D24623",
    "bcr_drug_uuid": "bb31a332-a1a0-4581-9d52-56985e1e12bc",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b8c3d99c-429b-42a3-b486-6fbcb90cc2e0",
    "patient_ID": "TCGA.13.0801",
    "bcr_drug_barcode": "TCGA-13-0801-D24621",
    "bcr_drug_uuid": "15a73dea-bc43-4bd4-94be-918dc9428c2e",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3c8b5986-f9d5-4e7e-9dd4-3ad301451279",
    "patient_ID": "TCGA.13.0802",
    "bcr_drug_barcode": "TCGA-13-0802-D24627",
    "bcr_drug_uuid": "6327fc62-9594-4666-83cc-db0aed29baed",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3c8b5986-f9d5-4e7e-9dd4-3ad301451279",
    "patient_ID": "TCGA.13.0802",
    "bcr_drug_barcode": "TCGA-13-0802-D24626",
    "bcr_drug_uuid": "98c08254-9631-499e-b215-5c9c32eb8009",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "54cf3bfe-51c0-4cca-9054-bf76b05a9371",
    "patient_ID": "TCGA.13.0803",
    "bcr_drug_barcode": "TCGA-13-0803-D24631",
    "bcr_drug_uuid": "4b3bed15-25df-47c4-8876-bd93ec815e04",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "54cf3bfe-51c0-4cca-9054-bf76b05a9371",
    "patient_ID": "TCGA.13.0803",
    "bcr_drug_barcode": "TCGA-13-0803-D24630",
    "bcr_drug_uuid": "9df60126-cad0-4536-be8b-92e6d5bc5864",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "7e34d3c1-1fab-4326-9a69-4260d2bac558",
    "patient_ID": "TCGA.13.0804",
    "bcr_drug_barcode": "TCGA-13-0804-D24636",
    "bcr_drug_uuid": "53652d84-be01-4719-b091-1e0c5a336931",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "90Y-HU3S193",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 270,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 270,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7e34d3c1-1fab-4326-9a69-4260d2bac558",
    "patient_ID": "TCGA.13.0804",
    "bcr_drug_barcode": "TCGA-13-0804-D24635",
    "bcr_drug_uuid": "9ba0bb7a-0471-4d62-a672-769e560548fd",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7e34d3c1-1fab-4326-9a69-4260d2bac558",
    "patient_ID": "TCGA.13.0804",
    "bcr_drug_barcode": "TCGA-13-0804-D24634",
    "bcr_drug_uuid": "9120000f-695e-4598-948b-393f49a35d72",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2a3a6222-f477-4198-ab9e-cdf527c1a6cf",
    "patient_ID": "TCGA.13.0805",
    "bcr_drug_barcode": "TCGA-13-0805-D24640",
    "bcr_drug_uuid": "77384840-9b33-4f4c-9b08-37d02ec121b7",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2a3a6222-f477-4198-ab9e-cdf527c1a6cf",
    "patient_ID": "TCGA.13.0805",
    "bcr_drug_barcode": "TCGA-13-0805-D24639",
    "bcr_drug_uuid": "bb8c4793-e6e0-4827-ba78-fcd2a9e25910",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "067c5c61-d147-4b08-ab8a-32c30969d564",
    "patient_ID": "TCGA.13.0807",
    "bcr_drug_barcode": "TCGA-13-0807-D24644",
    "bcr_drug_uuid": "1ecc3288-bfd8-444a-9231-b5aae9a6623d",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "067c5c61-d147-4b08-ab8a-32c30969d564",
    "patient_ID": "TCGA.13.0807",
    "bcr_drug_barcode": "TCGA-13-0807-D24643",
    "bcr_drug_uuid": "81a76588-bed5-4afc-b5ec-3a93daac9ead",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c159ab5-8475-4d93-89b8-b6befed4a5b3",
    "patient_ID": "TCGA.13.0883",
    "bcr_drug_barcode": "TCGA-13-0883-D24648",
    "bcr_drug_uuid": "0f78c3d5-a61e-42c2-9a2a-3d649afbcfc4",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "5c159ab5-8475-4d93-89b8-b6befed4a5b3",
    "patient_ID": "TCGA.13.0883",
    "bcr_drug_barcode": "TCGA-13-0883-D24647",
    "bcr_drug_uuid": "d214b9d5-80dd-4328-91a0-0c5f62e7c3c2",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOBPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "5c159ab5-8475-4d93-89b8-b6befed4a5b3",
    "patient_ID": "TCGA.13.0883",
    "bcr_drug_barcode": "TCGA-13-0883-D24649",
    "bcr_drug_uuid": "10e5d0de-68b8-4480-bc66-6fb0d0544380",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 227,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "63a75e0b-9241-4f0e-9236-01a2e2c05b7e",
    "patient_ID": "TCGA.13.0884",
    "bcr_drug_barcode": "TCGA-13-0884-D24656",
    "bcr_drug_uuid": "f696b7ed-1114-49b6-a2a4-8d394fdcfa43",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 74
  },
  {
    "bcr_patient_uuid": "63a75e0b-9241-4f0e-9236-01a2e2c05b7e",
    "patient_ID": "TCGA.13.0884",
    "bcr_drug_barcode": "TCGA-13-0884-D24654",
    "bcr_drug_uuid": "3eeaa9ad-d6c1-4843-8a53-d76c3243380c",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "GEMICITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "63a75e0b-9241-4f0e-9236-01a2e2c05b7e",
    "patient_ID": "TCGA.13.0884",
    "bcr_drug_barcode": "TCGA-13-0884-D24653",
    "bcr_drug_uuid": "7cffdd63-0cfb-4c4c-98e9-ac1d35615574",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "63a75e0b-9241-4f0e-9236-01a2e2c05b7e",
    "patient_ID": "TCGA.13.0884",
    "bcr_drug_barcode": "TCGA-13-0884-D24652",
    "bcr_drug_uuid": "fc570206-ca8e-42f3-a1f2-a46aea37a65e",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "63a75e0b-9241-4f0e-9236-01a2e2c05b7e",
    "patient_ID": "TCGA.13.0884",
    "bcr_drug_barcode": "TCGA-13-0884-D24655",
    "bcr_drug_uuid": "29c3e4e5-9940-499e-94ec-de4979d77ff0",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 240,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 133
  },
  {
    "bcr_patient_uuid": "2a924999-1fbf-470a-97bd-fd2276a9a366",
    "patient_ID": "TCGA.13.0885",
    "bcr_drug_barcode": "TCGA-13-0885-D24659",
    "bcr_drug_uuid": "1b109abf-497f-455d-b2cd-afb4f953f287",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "2a924999-1fbf-470a-97bd-fd2276a9a366",
    "patient_ID": "TCGA.13.0885",
    "bcr_drug_barcode": "TCGA-13-0885-D24661",
    "bcr_drug_uuid": "30bfb060-bc43-4205-a472-4139381c0c69",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 3,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2a924999-1fbf-470a-97bd-fd2276a9a366",
    "patient_ID": "TCGA.13.0885",
    "bcr_drug_barcode": "TCGA-13-0885-D24660",
    "bcr_drug_uuid": "2786c1cb-0952-4c59-b515-77c3a5c35742",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "91de8a74-a1e6-46b6-a06e-70aedf2c3eaf",
    "patient_ID": "TCGA.13.0886",
    "bcr_drug_barcode": "TCGA-13-0886-D24664",
    "bcr_drug_uuid": "806d8340-5dbd-4b37-be0e-0a24f1819e6e",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91de8a74-a1e6-46b6-a06e-70aedf2c3eaf",
    "patient_ID": "TCGA.13.0886",
    "bcr_drug_barcode": "TCGA-13-0886-D24666",
    "bcr_drug_uuid": "189a2c96-a9c3-4a56-bbdb-12b6fd50f3fa",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 263,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91de8a74-a1e6-46b6-a06e-70aedf2c3eaf",
    "patient_ID": "TCGA.13.0886",
    "bcr_drug_barcode": "TCGA-13-0886-D24665",
    "bcr_drug_uuid": "965956e2-03a9-4029-9a70-1be682b08540",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "14c58def-60ee-48e0-a74b-da4eb77ef344",
    "patient_ID": "TCGA.13.0887",
    "bcr_drug_barcode": "TCGA-13-0887-D24670",
    "bcr_drug_uuid": "c463c28f-e65d-4bb2-a88a-9550f415cdd9",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "14c58def-60ee-48e0-a74b-da4eb77ef344",
    "patient_ID": "TCGA.13.0887",
    "bcr_drug_barcode": "TCGA-13-0887-D24669",
    "bcr_drug_uuid": "36a82010-4db9-46e7-9ff5-8fb49a5d51ff",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "14c58def-60ee-48e0-a74b-da4eb77ef344",
    "patient_ID": "TCGA.13.0887",
    "bcr_drug_barcode": "TCGA-13-0887-D24671",
    "bcr_drug_uuid": "f8042e57-3947-4ac3-ac85-7c47074317e3",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 268,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf",
    "patient_ID": "TCGA.13.0888",
    "bcr_drug_barcode": "TCGA-13-0888-D24674",
    "bcr_drug_uuid": "6ff16be4-ef53-4e2d-b800-e9fe11910306",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf",
    "patient_ID": "TCGA.13.0888",
    "bcr_drug_barcode": "TCGA-13-0888-D24675",
    "bcr_drug_uuid": "31c8aef7-cb07-4117-983a-0544b208f1d7",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6cf9f872-2e59-45cf-bb5e-ebd7fa1b3caf",
    "patient_ID": "TCGA.13.0888",
    "bcr_drug_barcode": "TCGA-13-0888-D24676",
    "bcr_drug_uuid": "e70b84ff-49ff-42fb-ae5c-18c3c1a22aa4",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e3712e5a-4575-440f-89d1-8db9498baa88",
    "patient_ID": "TCGA.13.0889",
    "bcr_drug_barcode": "TCGA-13-0889-D24680",
    "bcr_drug_uuid": "bdee55fd-304d-4731-a737-d755e3b0bb00",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e3712e5a-4575-440f-89d1-8db9498baa88",
    "patient_ID": "TCGA.13.0889",
    "bcr_drug_barcode": "TCGA-13-0889-D24679",
    "bcr_drug_uuid": "464ba663-795e-42ab-b946-a067761a2965",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ee0a4a13-613e-4c5d-96c3-8083a013702d",
    "patient_ID": "TCGA.13.0890",
    "bcr_drug_barcode": "TCGA-13-0890-D24684",
    "bcr_drug_uuid": "70389c25-6516-4dbe-96a8-657ae7a0c003",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ee0a4a13-613e-4c5d-96c3-8083a013702d",
    "patient_ID": "TCGA.13.0890",
    "bcr_drug_barcode": "TCGA-13-0890-D24683",
    "bcr_drug_uuid": "2116b411-beb7-44ff-a1b5-1a4a51c0c452",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "0740321b-f8a5-4e1d-b390-ca6187598fac",
    "patient_ID": "TCGA.13.0891",
    "bcr_drug_barcode": "TCGA-13-0891-D24688",
    "bcr_drug_uuid": "6b1c33ed-7ea9-49aa-b1ad-eaadf84463b8",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "0740321b-f8a5-4e1d-b390-ca6187598fac",
    "patient_ID": "TCGA.13.0891",
    "bcr_drug_barcode": "TCGA-13-0891-D24687",
    "bcr_drug_uuid": "c72e692b-29dd-4292-add3-4b3889f27442",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15170c7f-5880-4fb6-82ce-68d3df0dfb68",
    "patient_ID": "TCGA.13.0893",
    "bcr_drug_barcode": "TCGA-13-0893-D24692",
    "bcr_drug_uuid": "a48fb2d1-82b6-4f3b-b211-2319a0b329a7",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 284,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "15170c7f-5880-4fb6-82ce-68d3df0dfb68",
    "patient_ID": "TCGA.13.0893",
    "bcr_drug_barcode": "TCGA-13-0893-D24691",
    "bcr_drug_uuid": "79d5303d-f605-4215-ae23-86f9e3f1e193",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 284,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "15170c7f-5880-4fb6-82ce-68d3df0dfb68",
    "patient_ID": "TCGA.13.0893",
    "bcr_drug_barcode": "TCGA-13-0893-D24693",
    "bcr_drug_uuid": "5bdb21b9-a7f1-41eb-9eb0-ac3208afa81b",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 340,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 566,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "e8372916-7ac7-4535-ae97-0248208224f5",
    "patient_ID": "TCGA.13.0894",
    "bcr_drug_barcode": "TCGA-13-0894-D24696",
    "bcr_drug_uuid": "cadb50a3-648a-458a-a426-dcc49348f377",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "e8372916-7ac7-4535-ae97-0248208224f5",
    "patient_ID": "TCGA.13.0894",
    "bcr_drug_barcode": "TCGA-13-0894-D24697",
    "bcr_drug_uuid": "517b624b-f0c2-425b-a217-8e665840df42",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "e8372916-7ac7-4535-ae97-0248208224f5",
    "patient_ID": "TCGA.13.0894",
    "bcr_drug_barcode": "TCGA-13-0894-D24698",
    "bcr_drug_uuid": "ec90a0ce-59ed-478e-9502-8bce222e6276",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 307,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 330,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "79e6e31c-22a1-481c-903b-ab5499cbd450",
    "patient_ID": "TCGA.13.0897",
    "bcr_drug_barcode": "TCGA-13-0897-D24702",
    "bcr_drug_uuid": "ca45bc16-c21b-49db-bf56-ee1313f059ee",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "79e6e31c-22a1-481c-903b-ab5499cbd450",
    "patient_ID": "TCGA.13.0897",
    "bcr_drug_barcode": "TCGA-13-0897-D24701",
    "bcr_drug_uuid": "cc1f5f91-e9e0-43f6-9e1f-688daa23a656",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c6f3cd4-19c5-418d-b1be-d3fbf63e99db",
    "patient_ID": "TCGA.13.0899",
    "bcr_drug_barcode": "TCGA-13-0899-D24705",
    "bcr_drug_uuid": "24164473-0e73-4062-bf9b-dc624f95510a",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c6f3cd4-19c5-418d-b1be-d3fbf63e99db",
    "patient_ID": "TCGA.13.0899",
    "bcr_drug_barcode": "TCGA-13-0899-D24706",
    "bcr_drug_uuid": "f1500cb6-1acc-4eba-a03d-bdf3b9327360",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "9e48a4b1-6917-4625-9d78-e4832eb816a5",
    "patient_ID": "TCGA.13.0900",
    "bcr_drug_barcode": "TCGA-13-0900-D24710",
    "bcr_drug_uuid": "e939513a-a319-4a7f-b724-3d9a24dbb312",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e48a4b1-6917-4625-9d78-e4832eb816a5",
    "patient_ID": "TCGA.13.0900",
    "bcr_drug_barcode": "TCGA-13-0900-D24709",
    "bcr_drug_uuid": "3dd1d8e2-9bf1-47fb-8fb4-41360012da50",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "27920e1e-b9ab-4587-970a-0cba7025becb",
    "patient_ID": "TCGA.13.0901",
    "bcr_drug_barcode": "TCGA-13-0901-D24714",
    "bcr_drug_uuid": "6d3211ce-35d2-455e-975e-81723a31ec32",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "27920e1e-b9ab-4587-970a-0cba7025becb",
    "patient_ID": "TCGA.13.0901",
    "bcr_drug_barcode": "TCGA-13-0901-D24713",
    "bcr_drug_uuid": "efb4d63b-68d6-452f-9457-fb4fe0c251df",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "27920e1e-b9ab-4587-970a-0cba7025becb",
    "patient_ID": "TCGA.13.0901",
    "bcr_drug_barcode": "TCGA-13-0901-D24715",
    "bcr_drug_uuid": "87333d18-17bb-4cd5-b969-f6fdcf69dd36",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "8783e4b0-2b62-45d5-8cd9-f5a71cc0138e",
    "patient_ID": "TCGA.13.0903",
    "bcr_drug_barcode": "TCGA-13-0903-D24719",
    "bcr_drug_uuid": "d7ddd098-94ed-4968-8ad0-9a6990826131",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "8783e4b0-2b62-45d5-8cd9-f5a71cc0138e",
    "patient_ID": "TCGA.13.0903",
    "bcr_drug_barcode": "TCGA-13-0903-D24718",
    "bcr_drug_uuid": "d0670488-e31a-49a9-a4ed-1015c0b39e32",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8783e4b0-2b62-45d5-8cd9-f5a71cc0138e",
    "patient_ID": "TCGA.13.0903",
    "bcr_drug_barcode": "TCGA-13-0903-D24720",
    "bcr_drug_uuid": "7f98152d-4925-437d-a83a-3b9561499e78",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "8783e4b0-2b62-45d5-8cd9-f5a71cc0138e",
    "patient_ID": "TCGA.13.0903",
    "bcr_drug_barcode": "TCGA-13-0903-D24721",
    "bcr_drug_uuid": "8a819232-2e9f-4703-9afd-2238a6314430",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 335,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "0b519c08-9f23-4ceb-9a13-e16509ca55d7",
    "patient_ID": "TCGA.13.0904",
    "bcr_drug_barcode": "TCGA-13-0904-D24725",
    "bcr_drug_uuid": "0dfb4665-f7e4-48fa-a171-2ca620eb578c",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "0b519c08-9f23-4ceb-9a13-e16509ca55d7",
    "patient_ID": "TCGA.13.0904",
    "bcr_drug_barcode": "TCGA-13-0904-D24724",
    "bcr_drug_uuid": "19a07949-eb4b-4ca2-a6e4-dbcaa275a295",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0b519c08-9f23-4ceb-9a13-e16509ca55d7",
    "patient_ID": "TCGA.13.0904",
    "bcr_drug_barcode": "TCGA-13-0904-D24727",
    "bcr_drug_uuid": "a552a880-bcd5-438e-9595-7eea9cc4ab4b",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 251,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0b519c08-9f23-4ceb-9a13-e16509ca55d7",
    "patient_ID": "TCGA.13.0904",
    "bcr_drug_barcode": "TCGA-13-0904-D24726",
    "bcr_drug_uuid": "df387235-8141-4dd9-bcf3-500fb9ffaece",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "days_to_drug_end": 251,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2038fd65-d8f1-4b16-af90-b1c8f9a379a7",
    "patient_ID": "TCGA.13.0905",
    "bcr_drug_barcode": "TCGA-13-0905-D24730",
    "bcr_drug_uuid": "feedb04f-785c-4c0c-a091-d00618dea595",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "2038fd65-d8f1-4b16-af90-b1c8f9a379a7",
    "patient_ID": "TCGA.13.0905",
    "bcr_drug_barcode": "TCGA-13-0905-D24732",
    "bcr_drug_uuid": "00d12b24-ecbd-4ee0-b3c9-86d1f2051ea3",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "2038fd65-d8f1-4b16-af90-b1c8f9a379a7",
    "patient_ID": "TCGA.13.0905",
    "bcr_drug_barcode": "TCGA-13-0905-D24731",
    "bcr_drug_uuid": "d16052dd-7975-441f-919e-4fcf9463a163",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "e43d3769-e25f-4fb7-9080-ea26defaf094",
    "patient_ID": "TCGA.13.0906",
    "bcr_drug_barcode": "TCGA-13-0906-D24736",
    "bcr_drug_uuid": "30150f9a-7ff8-4c97-96a5-9450f584dd84",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "e43d3769-e25f-4fb7-9080-ea26defaf094",
    "patient_ID": "TCGA.13.0906",
    "bcr_drug_barcode": "TCGA-13-0906-D24735",
    "bcr_drug_uuid": "0f8f7b7a-2605-4d92-89cd-029df70ea38f",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "e43d3769-e25f-4fb7-9080-ea26defaf094",
    "patient_ID": "TCGA.13.0906",
    "bcr_drug_barcode": "TCGA-13-0906-D24737",
    "bcr_drug_uuid": "4648be54-8c2c-4fef-8fb0-fcb9d8ee65d2",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "0ba7b6cc-e5f5-47d7-859a-24e31aa336ab",
    "patient_ID": "TCGA.13.0908",
    "bcr_drug_barcode": "TCGA-13-0908-D24740",
    "bcr_drug_uuid": "411e47eb-8e4a-4db8-90e6-dab616f52f95",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0ba7b6cc-e5f5-47d7-859a-24e31aa336ab",
    "patient_ID": "TCGA.13.0908",
    "bcr_drug_barcode": "TCGA-13-0908-D24741",
    "bcr_drug_uuid": "e0ae3a10-31dd-43b6-b2f1-bebf0fc5128b",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "0ba7b6cc-e5f5-47d7-859a-24e31aa336ab",
    "patient_ID": "TCGA.13.0908",
    "bcr_drug_barcode": "TCGA-13-0908-D24742",
    "bcr_drug_uuid": "a715aa27-039d-4fc8-b247-fc6db02155cf",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "b783f33b-734a-4801-bf39-b559a2035c6f",
    "patient_ID": "TCGA.13.0910",
    "bcr_drug_barcode": "TCGA-13-0910-D24747",
    "bcr_drug_uuid": "b87c89fa-619d-4ba5-899d-e78c89e963c1",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 238,
    "days_to_drug_end": 289,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "b783f33b-734a-4801-bf39-b559a2035c6f",
    "patient_ID": "TCGA.13.0910",
    "bcr_drug_barcode": "TCGA-13-0910-D24746",
    "bcr_drug_uuid": "f8475db6-26ee-485e-ad19-8ec781617a10",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "b783f33b-734a-4801-bf39-b559a2035c6f",
    "patient_ID": "TCGA.13.0910",
    "bcr_drug_barcode": "TCGA-13-0910-D24745",
    "bcr_drug_uuid": "4c9aed17-53a5-4788-8dbe-f3b825e6785e",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8cad4217-5699-4735-9be3-fc0015a8d262",
    "patient_ID": "TCGA.13.0911",
    "bcr_drug_barcode": "TCGA-13-0911-D24751",
    "bcr_drug_uuid": "e179932c-db69-4bfd-bb18-71681cf970e4",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "8cad4217-5699-4735-9be3-fc0015a8d262",
    "patient_ID": "TCGA.13.0911",
    "bcr_drug_barcode": "TCGA-13-0911-D24750",
    "bcr_drug_uuid": "8823c209-2882-4f55-ab70-ec250593c4dc",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "58d34254-4f5b-40a4-9e9f-7160062fb2a4",
    "patient_ID": "TCGA.13.0912",
    "bcr_drug_barcode": "TCGA-13-0912-D24755",
    "bcr_drug_uuid": "60f29631-b790-49a0-92f3-2834f89bfbc7",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "58d34254-4f5b-40a4-9e9f-7160062fb2a4",
    "patient_ID": "TCGA.13.0912",
    "bcr_drug_barcode": "TCGA-13-0912-D24756",
    "bcr_drug_uuid": "f039ec8f-f07a-4b69-9b57-674eb3fe8816",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "58d34254-4f5b-40a4-9e9f-7160062fb2a4",
    "patient_ID": "TCGA.13.0912",
    "bcr_drug_barcode": "TCGA-13-0912-D24754",
    "bcr_drug_uuid": "12cfb557-540b-425c-a068-9897165c526a",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "3e8a51bf-7e1f-4eab-af83-3c60d04db1bf",
    "patient_ID": "TCGA.13.0913",
    "bcr_drug_barcode": "TCGA-13-0913-D24759",
    "bcr_drug_uuid": "0d3b6f19-f63f-41e7-9130-380e82642bb3",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "3e8a51bf-7e1f-4eab-af83-3c60d04db1bf",
    "patient_ID": "TCGA.13.0913",
    "bcr_drug_barcode": "TCGA-13-0913-D24761",
    "bcr_drug_uuid": "e6c2ede1-ccee-463d-b028-c4eb8a176960",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "3e8a51bf-7e1f-4eab-af83-3c60d04db1bf",
    "patient_ID": "TCGA.13.0913",
    "bcr_drug_barcode": "TCGA-13-0913-D24760",
    "bcr_drug_uuid": "fd329f71-cbc1-4149-9e26-3483110f7c08",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "3e8a51bf-7e1f-4eab-af83-3c60d04db1bf",
    "patient_ID": "TCGA.13.0913",
    "bcr_drug_barcode": "TCGA-13-0913-D24763",
    "bcr_drug_uuid": "31cc917f-186a-4e24-bd6a-6344b86f756a",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 962,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1071,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "3e8a51bf-7e1f-4eab-af83-3c60d04db1bf",
    "patient_ID": "TCGA.13.0913",
    "bcr_drug_barcode": "TCGA-13-0913-D24762",
    "bcr_drug_uuid": "895b449e-1a4b-4abe-b8d2-5f86b7aba4f0",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 962,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1071,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4",
    "patient_ID": "TCGA.13.0916",
    "bcr_drug_barcode": "TCGA-13-0916-D24768",
    "bcr_drug_uuid": "d5f8a386-7074-40a4-9d62-699ba2571deb",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4",
    "patient_ID": "TCGA.13.0916",
    "bcr_drug_barcode": "TCGA-13-0916-D24766",
    "bcr_drug_uuid": "e035fe81-878f-4509-ad6e-98266495e5bd",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4",
    "patient_ID": "TCGA.13.0916",
    "bcr_drug_barcode": "TCGA-13-0916-D24767",
    "bcr_drug_uuid": "d53e97a9-93d9-46ad-9bd1-1851d1cff4a4",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "5f60bc2d-738f-43fc-a3fb-61ec6e80e3d4",
    "patient_ID": "TCGA.13.0916",
    "bcr_drug_barcode": "TCGA-13-0916-D24769",
    "bcr_drug_uuid": "a5460512-89a7-41f5-9ea2-63e47680924a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 70,
    "days_to_drug_end": 182,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "45957be6-e4df-4245-acf8-39dfc118ee19",
    "patient_ID": "TCGA.13.0919",
    "bcr_drug_barcode": "TCGA-13-0919-D24772",
    "bcr_drug_uuid": "943463ed-59a4-44d1-a1fe-cd706824fe1f",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "45957be6-e4df-4245-acf8-39dfc118ee19",
    "patient_ID": "TCGA.13.0919",
    "bcr_drug_barcode": "TCGA-13-0919-D24773",
    "bcr_drug_uuid": "53980a2d-3250-4d22-951c-af3ecf5572e7",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "85a85a11-7200-4e96-97af-6ba26d680d59",
    "patient_ID": "TCGA.13.0920",
    "bcr_drug_barcode": "TCGA-13-0920-D24776",
    "bcr_drug_uuid": "7886c638-9120-43dc-a93d-657bae62d49d",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_end": 151,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "31b997dd-aaea-4003-a64d-11d3e19b0bbc",
    "patient_ID": "TCGA.13.0921",
    "bcr_drug_barcode": "TCGA-13-0921-D24779",
    "bcr_drug_uuid": "63fc0d14-1978-464b-b001-b72b7cc526f7",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "31b997dd-aaea-4003-a64d-11d3e19b0bbc",
    "patient_ID": "TCGA.13.0921",
    "bcr_drug_barcode": "TCGA-13-0921-D24780",
    "bcr_drug_uuid": "fa9ca8bd-dc3a-44e7-8853-e0d8147cb914",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "378f7ea2-86b4-4072-80b8-e12d67193106",
    "patient_ID": "TCGA.13.0923",
    "bcr_drug_barcode": "TCGA-13-0923-D24785",
    "bcr_drug_uuid": "b303f13f-01de-4e5a-8fe1-c7ef1b52fe06",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "378f7ea2-86b4-4072-80b8-e12d67193106",
    "patient_ID": "TCGA.13.0923",
    "bcr_drug_barcode": "TCGA-13-0923-D24783",
    "bcr_drug_uuid": "942a1a6d-f1f2-4550-bab2-8cdbe1bcdea0",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "378f7ea2-86b4-4072-80b8-e12d67193106",
    "patient_ID": "TCGA.13.0923",
    "bcr_drug_barcode": "TCGA-13-0923-D24784",
    "bcr_drug_uuid": "26beddad-f96d-4695-b753-f76cf0f72aeb",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "fbb45305-de8d-4baf-8bd0-047b29c2e9d9",
    "patient_ID": "TCGA.13.0924",
    "bcr_drug_barcode": "TCGA-13-0924-D24790",
    "bcr_drug_uuid": "1d2653d7-cad8-4cba-805f-3b87337a64ed",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB OR PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 60,
    "days_to_drug_end": 143,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 920
  },
  {
    "bcr_patient_uuid": "fbb45305-de8d-4baf-8bd0-047b29c2e9d9",
    "patient_ID": "TCGA.13.0924",
    "bcr_drug_barcode": "TCGA-13-0924-D24788",
    "bcr_drug_uuid": "2b11dd9d-5b35-4573-8f46-fb5d477ef580",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fbb45305-de8d-4baf-8bd0-047b29c2e9d9",
    "patient_ID": "TCGA.13.0924",
    "bcr_drug_barcode": "TCGA-13-0924-D24791",
    "bcr_drug_uuid": "b2c02e5d-3faf-4541-9a7b-a92e1694a52e",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB OR PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 164,
    "days_to_drug_end": 213,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "fbb45305-de8d-4baf-8bd0-047b29c2e9d9",
    "patient_ID": "TCGA.13.0924",
    "bcr_drug_barcode": "TCGA-13-0924-D24789",
    "bcr_drug_uuid": "93dd4066-d984-4869-acfe-682e0aa79846",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8",
    "patient_ID": "TCGA.13.1403",
    "bcr_drug_barcode": "TCGA-13-1403-D24794",
    "bcr_drug_uuid": "f08d91eb-9a00-43ad-89ce-b0780a1d9bf4",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8",
    "patient_ID": "TCGA.13.1403",
    "bcr_drug_barcode": "TCGA-13-1403-D24795",
    "bcr_drug_uuid": "904c042a-d9f6-41fa-a753-91928f69b54d",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "0d5e232d-5aa2-4f6f-be58-ffd5f15ee0b8",
    "patient_ID": "TCGA.13.1403",
    "bcr_drug_barcode": "TCGA-13-1403-D24796",
    "bcr_drug_uuid": "5e06e147-2f73-44ea-b089-fd40985fc5f4",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "8e107f4b-1912-4d3e-814a-b863e2d65ed7",
    "patient_ID": "TCGA.13.1404",
    "bcr_drug_barcode": "TCGA-13-1404-D24800",
    "bcr_drug_uuid": "62d968f7-b34f-48cd-a123-77d8acab6661",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "8e107f4b-1912-4d3e-814a-b863e2d65ed7",
    "patient_ID": "TCGA.13.1404",
    "bcr_drug_barcode": "TCGA-13-1404-D24799",
    "bcr_drug_uuid": "8596919f-9468-4131-9aa4-a6f21e70cebf",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "8e107f4b-1912-4d3e-814a-b863e2d65ed7",
    "patient_ID": "TCGA.13.1404",
    "bcr_drug_barcode": "TCGA-13-1404-D24801",
    "bcr_drug_uuid": "2e7b6ee1-77d0-40f3-b598-8959537575bb",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "29dccd25-4c4a-463b-a353-38a193337f38",
    "patient_ID": "TCGA.13.1405",
    "bcr_drug_barcode": "TCGA-13-1405-D24805",
    "bcr_drug_uuid": "036b3384-1b94-4426-af17-f314a1c6fe38",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "29dccd25-4c4a-463b-a353-38a193337f38",
    "patient_ID": "TCGA.13.1405",
    "bcr_drug_barcode": "TCGA-13-1405-D24804",
    "bcr_drug_uuid": "e2a55a7f-4bfd-43db-bd46-3d41ad1008e8",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 599
  },
  {
    "bcr_patient_uuid": "f2dcf4cc-609d-4532-a90d-6ae2bbb53365",
    "patient_ID": "TCGA.13.1407",
    "bcr_drug_barcode": "TCGA-13-1407-D24808",
    "bcr_drug_uuid": "4cd8eaeb-42d7-43f3-b626-83394aa6a3f9",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "f2dcf4cc-609d-4532-a90d-6ae2bbb53365",
    "patient_ID": "TCGA.13.1407",
    "bcr_drug_barcode": "TCGA-13-1407-D24809",
    "bcr_drug_uuid": "8ada4cc3-f455-4065-9def-1341957f353d",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "8fac8e40-beac-4059-9d54-7ee530598cfd",
    "patient_ID": "TCGA.13.1408",
    "bcr_drug_barcode": "TCGA-13-1408-D24812",
    "bcr_drug_uuid": "11c746b9-b132-422a-b4c5-f6389fe6c53b",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "8fac8e40-beac-4059-9d54-7ee530598cfd",
    "patient_ID": "TCGA.13.1408",
    "bcr_drug_barcode": "TCGA-13-1408-D24813",
    "bcr_drug_uuid": "0bc7de2d-ef5a-46ab-b7cb-174b698af786",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "8fac8e40-beac-4059-9d54-7ee530598cfd",
    "patient_ID": "TCGA.13.1408",
    "bcr_drug_barcode": "TCGA-13-1408-D24814",
    "bcr_drug_uuid": "4503cd88-2a47-4ced-af56-16b2b3a96bd3",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8fac8e40-beac-4059-9d54-7ee530598cfd",
    "patient_ID": "TCGA.13.1408",
    "bcr_drug_barcode": "TCGA-13-1408-D24816",
    "bcr_drug_uuid": "91bf1c84-4812-4b16-a1f7-c1cf1042de3e",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8fac8e40-beac-4059-9d54-7ee530598cfd",
    "patient_ID": "TCGA.13.1408",
    "bcr_drug_barcode": "TCGA-13-1408-D24815",
    "bcr_drug_uuid": "e315b96b-2868-4ae0-9096-6c62a57da9f1",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 201,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "18e0e996-8f23-4f53-94a5-dde38b550863",
    "patient_ID": "TCGA.13.1409",
    "bcr_drug_barcode": "TCGA-13-1409-D24819",
    "bcr_drug_uuid": "fdbbf073-c52a-4972-b714-ec92cf255e88",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "18e0e996-8f23-4f53-94a5-dde38b550863",
    "patient_ID": "TCGA.13.1409",
    "bcr_drug_barcode": "TCGA-13-1409-D24820",
    "bcr_drug_uuid": "532deb83-2d9a-4d0c-a56a-1eeec028d682",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c3f9ee36-d34f-472b-ac7f-801a0d400aa4",
    "patient_ID": "TCGA.13.1410",
    "bcr_drug_barcode": "TCGA-13-1410-D24823",
    "bcr_drug_uuid": "93edac67-ef10-41aa-afd0-fb99734e5700",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "c3f9ee36-d34f-472b-ac7f-801a0d400aa4",
    "patient_ID": "TCGA.13.1410",
    "bcr_drug_barcode": "TCGA-13-1410-D24826",
    "bcr_drug_uuid": "5ce755e2-cf11-4bd2-a179-6f9305bb2378",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "c3f9ee36-d34f-472b-ac7f-801a0d400aa4",
    "patient_ID": "TCGA.13.1410",
    "bcr_drug_barcode": "TCGA-13-1410-D24824",
    "bcr_drug_uuid": "d0ba7a4c-cd7a-491e-b632-d4ddef4a09e8",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c3f9ee36-d34f-472b-ac7f-801a0d400aa4",
    "patient_ID": "TCGA.13.1410",
    "bcr_drug_barcode": "TCGA-13-1410-D24825",
    "bcr_drug_uuid": "14439b25-7a92-4ff8-a783-68936013e4bc",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "a9d3a7b0-faf8-4e56-8600-d9e6882a4f23",
    "patient_ID": "TCGA.13.1411",
    "bcr_drug_barcode": "TCGA-13-1411-D24829",
    "bcr_drug_uuid": "97303643-4e4a-41e8-b679-e3bfef06de2e",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "a9d3a7b0-faf8-4e56-8600-d9e6882a4f23",
    "patient_ID": "TCGA.13.1411",
    "bcr_drug_barcode": "TCGA-13-1411-D24830",
    "bcr_drug_uuid": "b3cf475f-ff22-4efe-a7a9-8909dff55877",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "44493c23-82e9-4d9f-8e3c-7b3f9ae44970",
    "patient_ID": "TCGA.13.1412",
    "bcr_drug_barcode": "TCGA-13-1412-D24833",
    "bcr_drug_uuid": "0a3e9870-60d6-4529-9570-b86361452929",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "44493c23-82e9-4d9f-8e3c-7b3f9ae44970",
    "patient_ID": "TCGA.13.1412",
    "bcr_drug_barcode": "TCGA-13-1412-D24834",
    "bcr_drug_uuid": "8b14d588-2044-4f90-9a23-edda2259f27a",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "44493c23-82e9-4d9f-8e3c-7b3f9ae44970",
    "patient_ID": "TCGA.13.1412",
    "bcr_drug_barcode": "TCGA-13-1412-D24836",
    "bcr_drug_uuid": "2f960c5b-fc96-4100-91d5-62689dac2d2b",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "44493c23-82e9-4d9f-8e3c-7b3f9ae44970",
    "patient_ID": "TCGA.13.1412",
    "bcr_drug_barcode": "TCGA-13-1412-D24835",
    "bcr_drug_uuid": "65181bc8-d203-458a-9869-e6c89c79a77b",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "44493c23-82e9-4d9f-8e3c-7b3f9ae44970",
    "patient_ID": "TCGA.13.1412",
    "bcr_drug_barcode": "TCGA-13-1412-D24837",
    "bcr_drug_uuid": "e8f007f4-1cc1-4eea-8b14-300ff06a3b8a",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13f5814c-1f99-4ffa-84a4-3bbd8979faae",
    "patient_ID": "TCGA.13.1477",
    "bcr_drug_barcode": "TCGA-13-1477-D24841",
    "bcr_drug_uuid": "9c33a2aa-bca5-4b74-9eae-754de2f3b26b",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "13f5814c-1f99-4ffa-84a4-3bbd8979faae",
    "patient_ID": "TCGA.13.1477",
    "bcr_drug_barcode": "TCGA-13-1477-D24840",
    "bcr_drug_uuid": "c4ae4f9d-4ec7-47d4-92bd-82121c761ed6",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c5355491-e1e8-46a4-a05e-bafcaf2e7459",
    "patient_ID": "TCGA.13.1481",
    "bcr_drug_barcode": "TCGA-13-1481-D24846",
    "bcr_drug_uuid": "f88e48af-f598-4236-bf59-a343851c2d7c",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 3,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c5355491-e1e8-46a4-a05e-bafcaf2e7459",
    "patient_ID": "TCGA.13.1481",
    "bcr_drug_barcode": "TCGA-13-1481-D24844",
    "bcr_drug_uuid": "82353d99-0371-47d6-90a3-c012f8fad803",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c5355491-e1e8-46a4-a05e-bafcaf2e7459",
    "patient_ID": "TCGA.13.1481",
    "bcr_drug_barcode": "TCGA-13-1481-D24845",
    "bcr_drug_uuid": "799031c3-47c1-4f36-a30d-e518b4c11298",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "f3af727e-b592-4828-94f5-22008666cf8c",
    "patient_ID": "TCGA.13.1482",
    "bcr_drug_barcode": "TCGA-13-1482-D24849",
    "bcr_drug_uuid": "15515ea8-488a-4962-8719-11b9d4bda728",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "f3af727e-b592-4828-94f5-22008666cf8c",
    "patient_ID": "TCGA.13.1482",
    "bcr_drug_barcode": "TCGA-13-1482-D24850",
    "bcr_drug_uuid": "0b9deb4b-3ed0-4350-bfc1-daadb62afa14",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "611600a6-43ec-4029-9682-cd6d6a3312ec",
    "patient_ID": "TCGA.13.1483",
    "bcr_drug_barcode": "TCGA-13-1483-D24853",
    "bcr_drug_uuid": "2832940e-1830-4d9e-9f3e-33a1d5a213b3",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "611600a6-43ec-4029-9682-cd6d6a3312ec",
    "patient_ID": "TCGA.13.1483",
    "bcr_drug_barcode": "TCGA-13-1483-D24855",
    "bcr_drug_uuid": "8cb04ad5-b5e6-4d55-b79c-351194c3821d",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 219,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 239,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "611600a6-43ec-4029-9682-cd6d6a3312ec",
    "patient_ID": "TCGA.13.1483",
    "bcr_drug_barcode": "TCGA-13-1483-D24854",
    "bcr_drug_uuid": "cb6d0c9b-51f7-4bc1-9355-880ec0fa012a",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 174
  },
  {
    "bcr_patient_uuid": "ead71c90-cc5e-42ce-8754-c3cf15a41134",
    "patient_ID": "TCGA.13.1484",
    "bcr_drug_barcode": "TCGA-13-1484-D24859",
    "bcr_drug_uuid": "28c061b0-19ec-4c30-b351-4b54731b4d8a",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ead71c90-cc5e-42ce-8754-c3cf15a41134",
    "patient_ID": "TCGA.13.1484",
    "bcr_drug_barcode": "TCGA-13-1484-D24858",
    "bcr_drug_uuid": "63c40a83-cb68-4b71-9d6a-b78c6e0f4bf5",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "49bfd0fe-48ce-49db-9f76-ce2310410950",
    "patient_ID": "TCGA.13.1485",
    "bcr_drug_barcode": "TCGA-13-1485-D24862",
    "bcr_drug_uuid": "0c370900-9664-4345-ae5e-9ff4c8de205e",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "49bfd0fe-48ce-49db-9f76-ce2310410950",
    "patient_ID": "TCGA.13.1485",
    "bcr_drug_barcode": "TCGA-13-1485-D24863",
    "bcr_drug_uuid": "9ca66b5d-b2d7-4ed3-91d7-e0a0cc34922a",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c9e28934-8379-4511-817c-d787f2c4ca3a",
    "patient_ID": "TCGA.13.1487",
    "bcr_drug_barcode": "TCGA-13-1487-D24869",
    "bcr_drug_uuid": "178b0653-c6f6-4a46-ac22-de69d34385c9",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "c9e28934-8379-4511-817c-d787f2c4ca3a",
    "patient_ID": "TCGA.13.1487",
    "bcr_drug_barcode": "TCGA-13-1487-D24868",
    "bcr_drug_uuid": "9e538e9a-48e2-4dfc-8da2-35cc24c05393",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 208,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c9e28934-8379-4511-817c-d787f2c4ca3a",
    "patient_ID": "TCGA.13.1487",
    "bcr_drug_barcode": "TCGA-13-1487-D24867",
    "bcr_drug_uuid": "9247a4c9-3d8f-4842-9356-c21ae0c3bfd0",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "c9e28934-8379-4511-817c-d787f2c4ca3a",
    "patient_ID": "TCGA.13.1487",
    "bcr_drug_barcode": "TCGA-13-1487-D24866",
    "bcr_drug_uuid": "d30e9978-634d-4cb5-8263-c7e78d3a0bb7",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61",
    "patient_ID": "TCGA.13.1488",
    "bcr_drug_barcode": "TCGA-13-1488-D24872",
    "bcr_drug_uuid": "72712026-5c3c-4b6c-9520-11796bee3a34",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "a85f6f9c-1e1d-44fc-85eb-3b2d96cfbc61",
    "patient_ID": "TCGA.13.1488",
    "bcr_drug_barcode": "TCGA-13-1488-D24873",
    "bcr_drug_uuid": "8b1f61bc-dd0d-42e7-818b-d437b5b7c0a6",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24877",
    "bcr_drug_uuid": "fc5425f7-3273-4bb3-838a-03543f181941",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24876",
    "bcr_drug_uuid": "b0a011bd-04dc-4e24-b280-6c67dd5f3534",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 272,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 272,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24878",
    "bcr_drug_uuid": "4eb06fd9-31b2-459d-96a0-7315217783c1",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24882",
    "bcr_drug_uuid": "9acb3c04-7c91-484b-834b-639ead34a695",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1012,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24879",
    "bcr_drug_uuid": "4bdd6d3b-c2f3-458e-91ea-4e0678cc20db",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24880",
    "bcr_drug_uuid": "9bc5219c-8085-4ded-b99a-8444532624f6",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7248cd60-be22-44bc-bc58-f644db0940a2",
    "patient_ID": "TCGA.13.1489",
    "bcr_drug_barcode": "TCGA-13-1489-D24881",
    "bcr_drug_uuid": "ee222450-84ac-4896-87a4-a7c4498c0772",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1012,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "c8febeef-8e7e-459e-88cb-8086692dc559",
    "patient_ID": "TCGA.13.1491",
    "bcr_drug_barcode": "TCGA-13-1491-D24887",
    "bcr_drug_uuid": "3068ce31-34ef-41d5-98e5-2a49dde8ea1d",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 245,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 401,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "c8febeef-8e7e-459e-88cb-8086692dc559",
    "patient_ID": "TCGA.13.1491",
    "bcr_drug_barcode": "TCGA-13-1491-D24886",
    "bcr_drug_uuid": "375f90a7-f4e6-4437-95a7-823503ea757c",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c8febeef-8e7e-459e-88cb-8086692dc559",
    "patient_ID": "TCGA.13.1491",
    "bcr_drug_barcode": "TCGA-13-1491-D24885",
    "bcr_drug_uuid": "c98fcc34-f54b-4813-97a9-80b88b3a26a1",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "63c6a89b-b28c-434a-a632-5de6545db731",
    "patient_ID": "TCGA.13.1492",
    "bcr_drug_barcode": "TCGA-13-1492-D24890",
    "bcr_drug_uuid": "6f3448eb-dbbd-49e5-9a02-7d5951b8c588",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "63c6a89b-b28c-434a-a632-5de6545db731",
    "patient_ID": "TCGA.13.1492",
    "bcr_drug_barcode": "TCGA-13-1492-D24891",
    "bcr_drug_uuid": "c73b40ca-5b10-47a1-ac49-e4dd24db1e05",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "f50ee039-1da9-43d9-ac01-657ec77a7f32",
    "patient_ID": "TCGA.13.1494",
    "bcr_drug_barcode": "TCGA-13-1494-D24894",
    "bcr_drug_uuid": "cd1fa5ad-5986-444a-ad95-2f307d5700c4",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f50ee039-1da9-43d9-ac01-657ec77a7f32",
    "patient_ID": "TCGA.13.1494",
    "bcr_drug_barcode": "TCGA-13-1494-D24895",
    "bcr_drug_uuid": "4e2bfc0a-008f-4a5d-b555-4fa7ecb07882",
    "form_completion_date": "2009-6-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7",
    "patient_ID": "TCGA.13.1495",
    "bcr_drug_barcode": "TCGA-13-1495-D24902",
    "bcr_drug_uuid": "ef97d8d6-aea8-42de-9b62-054e1106d2ae",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7",
    "patient_ID": "TCGA.13.1495",
    "bcr_drug_barcode": "TCGA-13-1495-D24900",
    "bcr_drug_uuid": "5b1848c8-8f23-471a-9171-95fd53eac209",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 548,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7",
    "patient_ID": "TCGA.13.1495",
    "bcr_drug_barcode": "TCGA-13-1495-D24898",
    "bcr_drug_uuid": "878063e7-b796-4aa4-aecb-55060d6028ab",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7",
    "patient_ID": "TCGA.13.1495",
    "bcr_drug_barcode": "TCGA-13-1495-D24901",
    "bcr_drug_uuid": "cbd8492b-b71f-43ef-aaa8-7902407ef2a8",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "74dcdfb4-a637-4111-9a22-4b4bc7bbc8f7",
    "patient_ID": "TCGA.13.1495",
    "bcr_drug_barcode": "TCGA-13-1495-D24899",
    "bcr_drug_uuid": "19c672b1-5c6a-4562-80fb-a01df80b0337",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "e5a329ec-e50e-4786-901d-b58474f8ea65",
    "patient_ID": "TCGA.13.1496",
    "bcr_drug_barcode": "TCGA-13-1496-D24905",
    "bcr_drug_uuid": "42c8232f-dc83-4025-a957-1c121f960780",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 33,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "e5a329ec-e50e-4786-901d-b58474f8ea65",
    "patient_ID": "TCGA.13.1496",
    "bcr_drug_barcode": "TCGA-13-1496-D24906",
    "bcr_drug_uuid": "b3f86e9e-52c6-40f6-88cf-521bae342105",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 33,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "bc4bc342-20bf-40c3-af26-2c6f942da93d",
    "patient_ID": "TCGA.13.1497",
    "bcr_drug_barcode": "TCGA-13-1497-D24910",
    "bcr_drug_uuid": "61d36d63-ca80-4df2-8f45-5b89934ca979",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "bc4bc342-20bf-40c3-af26-2c6f942da93d",
    "patient_ID": "TCGA.13.1497",
    "bcr_drug_barcode": "TCGA-13-1497-D24911",
    "bcr_drug_uuid": "2bd40f8d-6333-4afe-a21c-f54e28cd9a14",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 185,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "bc4bc342-20bf-40c3-af26-2c6f942da93d",
    "patient_ID": "TCGA.13.1497",
    "bcr_drug_barcode": "TCGA-13-1497-D24909",
    "bcr_drug_uuid": "05f16e3d-5c91-4368-8769-2b40f285d9ff",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "bc4bc342-20bf-40c3-af26-2c6f942da93d",
    "patient_ID": "TCGA.13.1497",
    "bcr_drug_barcode": "TCGA-13-1497-D24912",
    "bcr_drug_uuid": "96fed8b4-c5f5-4ca0-95c4-183c1c2de11b",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "56a30462-2819-4c18-95be-8e73880a4921",
    "patient_ID": "TCGA.13.1498",
    "bcr_drug_barcode": "TCGA-13-1498-D24916",
    "bcr_drug_uuid": "e3d7554b-1876-4b8c-b4e8-d94f161120b4",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 10,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "56a30462-2819-4c18-95be-8e73880a4921",
    "patient_ID": "TCGA.13.1498",
    "bcr_drug_barcode": "TCGA-13-1498-D24915",
    "bcr_drug_uuid": "c1a4c33c-8d2f-461f-ae07-8b782306e443",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 216,
    "drug_cycles": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "56a30462-2819-4c18-95be-8e73880a4921",
    "patient_ID": "TCGA.13.1498",
    "bcr_drug_barcode": "TCGA-13-1498-D24917",
    "bcr_drug_uuid": "5ec3392e-4e4f-462e-9925-77d964be0ddf",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 250,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 632,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2.5
  },
  {
    "bcr_patient_uuid": "b25570ed-baca-4e3f-87c6-2ef18119ba49",
    "patient_ID": "TCGA.13.1499",
    "bcr_drug_barcode": "TCGA-13-1499-D24920",
    "bcr_drug_uuid": "9b87ff6d-772b-4abc-ad28-e0def040c38f",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "b25570ed-baca-4e3f-87c6-2ef18119ba49",
    "patient_ID": "TCGA.13.1499",
    "bcr_drug_barcode": "TCGA-13-1499-D24921",
    "bcr_drug_uuid": "b836dca7-cd27-4236-9bb7-f652bd595c60",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "b25570ed-baca-4e3f-87c6-2ef18119ba49",
    "patient_ID": "TCGA.13.1499",
    "bcr_drug_barcode": "TCGA-13-1499-D24922",
    "bcr_drug_uuid": "54dea9e5-ade7-4b1f-abfc-f3b1d49dde54",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b25570ed-baca-4e3f-87c6-2ef18119ba49",
    "patient_ID": "TCGA.13.1499",
    "bcr_drug_barcode": "TCGA-13-1499-D24923",
    "bcr_drug_uuid": "8c6e1a45-35e8-4195-b1e6-3ffe359242d3",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "b25570ed-baca-4e3f-87c6-2ef18119ba49",
    "patient_ID": "TCGA.13.1499",
    "bcr_drug_barcode": "TCGA-13-1499-D24924",
    "bcr_drug_uuid": "765962d6-30d0-4181-a602-50b728f75df8",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "a285786d-120e-4c88-b48b-8111f4413988",
    "patient_ID": "TCGA.13.1500",
    "bcr_drug_barcode": "TCGA-13-1500-D24928",
    "bcr_drug_uuid": "15ffe254-2600-4046-bf65-1dd44c66bad5",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a285786d-120e-4c88-b48b-8111f4413988",
    "patient_ID": "TCGA.13.1500",
    "bcr_drug_barcode": "TCGA-13-1500-D24929",
    "bcr_drug_uuid": "f7997b39-d17f-4df6-b167-9f763ba44acb",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 225,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "a285786d-120e-4c88-b48b-8111f4413988",
    "patient_ID": "TCGA.13.1500",
    "bcr_drug_barcode": "TCGA-13-1500-D24927",
    "bcr_drug_uuid": "f6462173-d369-423a-b1fc-560c5243c71d",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "561968ce-da9a-4d69-8bc2-bc87b9550f93",
    "patient_ID": "TCGA.13.1501",
    "bcr_drug_barcode": "TCGA-13-1501-D24932",
    "bcr_drug_uuid": "dfd6e676-24dc-4684-8f20-ad1b24c3189c",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "561968ce-da9a-4d69-8bc2-bc87b9550f93",
    "patient_ID": "TCGA.13.1501",
    "bcr_drug_barcode": "TCGA-13-1501-D24933",
    "bcr_drug_uuid": "168cc04a-b942-44dc-906f-12795c06a1c4",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "cd49126a-ec15-43fa-9e43-3f7460d43f2b",
    "patient_ID": "TCGA.13.1504",
    "bcr_drug_barcode": "TCGA-13-1504-D24937",
    "bcr_drug_uuid": "3bc4b2ec-79d0-491f-81ea-9d7c5eb58a96",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 283,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cd49126a-ec15-43fa-9e43-3f7460d43f2b",
    "patient_ID": "TCGA.13.1504",
    "bcr_drug_barcode": "TCGA-13-1504-D24936",
    "bcr_drug_uuid": "92d2f0c8-9875-41f1-8429-6a929ec4166f",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 283,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "914f84bf-578b-4f4d-93cb-378228ea58f6",
    "patient_ID": "TCGA.13.1505",
    "bcr_drug_barcode": "TCGA-13-1505-D24940",
    "bcr_drug_uuid": "ca2b331b-320f-43b9-a347-0998e1b4469f",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "914f84bf-578b-4f4d-93cb-378228ea58f6",
    "patient_ID": "TCGA.13.1505",
    "bcr_drug_barcode": "TCGA-13-1505-D24941",
    "bcr_drug_uuid": "6e83f0a3-d305-449d-82f6-7ded7579a9e0",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "914f84bf-578b-4f4d-93cb-378228ea58f6",
    "patient_ID": "TCGA.13.1505",
    "bcr_drug_barcode": "TCGA-13-1505-D24942",
    "bcr_drug_uuid": "94940689-a0b6-4a75-8b62-bf52715197cd",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1cc02c64-a34e-46ae-9bc7-5d50f2fefb31",
    "patient_ID": "TCGA.13.1506",
    "bcr_drug_barcode": "TCGA-13-1506-D24945",
    "bcr_drug_uuid": "eed33a2f-1991-431e-aed9-a80e2fff5f9a",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "1cc02c64-a34e-46ae-9bc7-5d50f2fefb31",
    "patient_ID": "TCGA.13.1506",
    "bcr_drug_barcode": "TCGA-13-1506-D24948",
    "bcr_drug_uuid": "3f0348d6-1607-4e20-9dad-1c18f02ca8e6",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "1cc02c64-a34e-46ae-9bc7-5d50f2fefb31",
    "patient_ID": "TCGA.13.1506",
    "bcr_drug_barcode": "TCGA-13-1506-D24946",
    "bcr_drug_uuid": "db2514fa-f3d7-4744-aeb2-3ea6191e9513",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 50,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 65
  },
  {
    "bcr_patient_uuid": "1cc02c64-a34e-46ae-9bc7-5d50f2fefb31",
    "patient_ID": "TCGA.13.1506",
    "bcr_drug_barcode": "TCGA-13-1506-D24947",
    "bcr_drug_uuid": "d8424615-0858-44a6-a544-4f86f99b6742",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "1cc02c64-a34e-46ae-9bc7-5d50f2fefb31",
    "patient_ID": "TCGA.13.1506",
    "bcr_drug_barcode": "TCGA-13-1506-D24950",
    "bcr_drug_uuid": "334b7af7-5669-4098-b07a-2e3d85e88871",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1cc02c64-a34e-46ae-9bc7-5d50f2fefb31",
    "patient_ID": "TCGA.13.1506",
    "bcr_drug_barcode": "TCGA-13-1506-D24949",
    "bcr_drug_uuid": "58d4d7d7-f9d6-4800-a354-11dc5d9a086e",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "502e8d02-2953-4514-a2e1-6179dd94da73",
    "patient_ID": "TCGA.13.1507",
    "bcr_drug_barcode": "TCGA-13-1507-D24954",
    "bcr_drug_uuid": "36abb233-04b6-4ffa-be2f-1a6da2577bcf",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "502e8d02-2953-4514-a2e1-6179dd94da73",
    "patient_ID": "TCGA.13.1507",
    "bcr_drug_barcode": "TCGA-13-1507-D24953",
    "bcr_drug_uuid": "e69faabb-e060-4871-b192-ff4af589b249",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 37.5,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "502e8d02-2953-4514-a2e1-6179dd94da73",
    "patient_ID": "TCGA.13.1507",
    "bcr_drug_barcode": "TCGA-13-1507-D24955",
    "bcr_drug_uuid": "e313f9e5-f3b1-48ae-a9e2-eb3ff4559fb1",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 60,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fe402983-70da-44db-b7b1-c32702ddde26",
    "patient_ID": "TCGA.13.1509",
    "bcr_drug_barcode": "TCGA-13-1509-D24959",
    "bcr_drug_uuid": "f341bfee-7f12-4172-be59-3f8386e19360",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "fe402983-70da-44db-b7b1-c32702ddde26",
    "patient_ID": "TCGA.13.1509",
    "bcr_drug_barcode": "TCGA-13-1509-D24958",
    "bcr_drug_uuid": "64ec67ad-a633-4554-afc3-8584cf9cf42c",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "dac96910-0cb2-44ea-b108-2d6d51b07112",
    "patient_ID": "TCGA.13.1510",
    "bcr_drug_barcode": "TCGA-13-1510-D24963",
    "bcr_drug_uuid": "762831bf-cafb-4024-af33-72efdf3f5222",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 325,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dac96910-0cb2-44ea-b108-2d6d51b07112",
    "patient_ID": "TCGA.13.1510",
    "bcr_drug_barcode": "TCGA-13-1510-D24962",
    "bcr_drug_uuid": "20863438-765d-4a56-a8a5-dcf76e119ac3",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "756f6768-e69a-4fe9-aa41-7c58aabe4577",
    "patient_ID": "TCGA.13.1511",
    "bcr_drug_barcode": "TCGA-13-1511-D24966",
    "bcr_drug_uuid": "4247d127-1642-4e0e-b9e0-63c1f16c4436",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 46,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "756f6768-e69a-4fe9-aa41-7c58aabe4577",
    "patient_ID": "TCGA.13.1511",
    "bcr_drug_barcode": "TCGA-13-1511-D24967",
    "bcr_drug_uuid": "311d0b25-b216-4f8d-a58a-b484fff48914",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "756f6768-e69a-4fe9-aa41-7c58aabe4577",
    "patient_ID": "TCGA.13.1511",
    "bcr_drug_barcode": "TCGA-13-1511-D24968",
    "bcr_drug_uuid": "8c238471-c7de-4922-875e-68b8c9ee6f25",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 186,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "82093ed9-a3c8-4e34-931f-4ec7ae745711",
    "patient_ID": "TCGA.13.1512",
    "bcr_drug_barcode": "TCGA-13-1512-D24972",
    "bcr_drug_uuid": "ff3734cb-1218-44b6-9238-000101ea4d25",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "82093ed9-a3c8-4e34-931f-4ec7ae745711",
    "patient_ID": "TCGA.13.1512",
    "bcr_drug_barcode": "TCGA-13-1512-D24971",
    "bcr_drug_uuid": "7bfa8188-46df-46ec-8f64-73d2c54f71b4",
    "form_completion_date": "2009-6-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "8ae56ffc-960c-46c2-bd6c-1dcff33875d0",
    "patient_ID": "TCGA.13.1817",
    "bcr_drug_barcode": "TCGA-13-1817-D24977",
    "bcr_drug_uuid": "5f052b46-08ee-4244-9beb-91a6f49b3fe1",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 318,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 75,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8ae56ffc-960c-46c2-bd6c-1dcff33875d0",
    "patient_ID": "TCGA.13.1817",
    "bcr_drug_barcode": "TCGA-13-1817-D24975",
    "bcr_drug_uuid": "46c68ad3-9918-4b43-af34-dcf1dc8b88bd",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "8ae56ffc-960c-46c2-bd6c-1dcff33875d0",
    "patient_ID": "TCGA.13.1817",
    "bcr_drug_barcode": "TCGA-13-1817-D24976",
    "bcr_drug_uuid": "24256629-d9d5-4c58-9dc1-ca8ccdf4f19f",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 176,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8ae56ffc-960c-46c2-bd6c-1dcff33875d0",
    "patient_ID": "TCGA.13.1817",
    "bcr_drug_barcode": "TCGA-13-1817-D24978",
    "bcr_drug_uuid": "5a5172bf-f07f-4e34-980d-1413e248b8dc",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 552,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 594,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 365,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8ae56ffc-960c-46c2-bd6c-1dcff33875d0",
    "patient_ID": "TCGA.13.1817",
    "bcr_drug_barcode": "TCGA-13-1817-D24979",
    "bcr_drug_uuid": "3166878d-db0c-4d9b-a45a-9701c30fe271",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 552,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 594,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 176,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8ae56ffc-960c-46c2-bd6c-1dcff33875d0",
    "patient_ID": "TCGA.13.1817",
    "bcr_drug_barcode": "TCGA-13-1817-D24980",
    "bcr_drug_uuid": "e8666c06-5d87-4aef-a92d-637aa94392bb",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 706,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 902,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 39,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "82e96c6c-a88c-4e52-be56-7f24f6c7b835",
    "patient_ID": "TCGA.13.1819",
    "bcr_drug_barcode": "TCGA-13-1819-D24983",
    "bcr_drug_uuid": "6c86d95a-46b8-4081-b2ed-bd6dd58012e6",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "82e96c6c-a88c-4e52-be56-7f24f6c7b835",
    "patient_ID": "TCGA.13.1819",
    "bcr_drug_barcode": "TCGA-13-1819-D24984",
    "bcr_drug_uuid": "6c54ce7d-b124-476e-8341-548977e62fd6",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "82e96c6c-a88c-4e52-be56-7f24f6c7b835",
    "patient_ID": "TCGA.13.1819",
    "bcr_drug_barcode": "TCGA-13-1819-D24985",
    "bcr_drug_uuid": "3100c47f-1118-4567-ab6c-dae3e00e0af2",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 518,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 518,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "82e96c6c-a88c-4e52-be56-7f24f6c7b835",
    "patient_ID": "TCGA.13.1819",
    "bcr_drug_barcode": "TCGA-13-1819-D24986",
    "bcr_drug_uuid": "9a7fac23-e0cf-4cfa-8f3a-9acb4fb940d9",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 646,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "82e96c6c-a88c-4e52-be56-7f24f6c7b835",
    "patient_ID": "TCGA.13.1819",
    "bcr_drug_barcode": "TCGA-13-1819-D24987",
    "bcr_drug_uuid": "d0e3c1c6-6f7f-4d26-80dc-677236827dcb",
    "form_completion_date": "2010-3-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 646,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 175,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "56c4bd48-ab15-4b49-ae2f-968653052b50",
    "patient_ID": "TCGA.13.2057",
    "bcr_drug_barcode": "TCGA-13-2057-D24990",
    "bcr_drug_uuid": "413048b1-1b7c-4cb7-a8f3-47cc291c18a9",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "56c4bd48-ab15-4b49-ae2f-968653052b50",
    "patient_ID": "TCGA.13.2057",
    "bcr_drug_barcode": "TCGA-13-2057-D24991",
    "bcr_drug_uuid": "37eff60b-6903-445a-b8ed-588e9df2f112",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f4b56568-a74a-4a2e-89d9-11722ecf5948",
    "patient_ID": "TCGA.13.2059",
    "bcr_drug_barcode": "TCGA-13-2059-D24996",
    "bcr_drug_uuid": "47648d65-c903-46b2-9f45-69f99c62c6d9",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f4b56568-a74a-4a2e-89d9-11722ecf5948",
    "patient_ID": "TCGA.13.2059",
    "bcr_drug_barcode": "TCGA-13-2059-D24995",
    "bcr_drug_uuid": "fcc5cdef-45eb-40d8-85c2-1b6517424003",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f4b56568-a74a-4a2e-89d9-11722ecf5948",
    "patient_ID": "TCGA.13.2059",
    "bcr_drug_barcode": "TCGA-13-2059-D24994",
    "bcr_drug_uuid": "ba631612-075c-4b0c-8da3-15387999edbf",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "196f4600-b6c9-4652-9f77-65c92883f8c1",
    "patient_ID": "TCGA.13.2060",
    "bcr_drug_barcode": "TCGA-13-2060-D25000",
    "bcr_drug_uuid": "f813388d-644d-46c4-b29c-f935cfaf6bc4",
    "form_completion_date": "2009-12-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "196f4600-b6c9-4652-9f77-65c92883f8c1",
    "patient_ID": "TCGA.13.2060",
    "bcr_drug_barcode": "TCGA-13-2060-D24999",
    "bcr_drug_uuid": "1f942379-637b-4d34-9ebe-08a3e2d9152a",
    "form_completion_date": "2009-12-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "196f4600-b6c9-4652-9f77-65c92883f8c1",
    "patient_ID": "TCGA.13.2060",
    "bcr_drug_barcode": "TCGA-13-2060-D25001",
    "bcr_drug_uuid": "f6f38882-1d0e-426f-af54-275027957055",
    "form_completion_date": "2009-12-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25006",
    "bcr_drug_uuid": "728138db-9e40-4995-af75-4b90bfd5d6a7",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25008",
    "bcr_drug_uuid": "12097149-87dd-4fa1-8f0d-5088a4c8062a",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25005",
    "bcr_drug_uuid": "df08b0fe-5176-4c16-80b1-2f2f54bbfe8e",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25011",
    "bcr_drug_uuid": "ba1d69c2-a882-4e82-b282-25f168fbcdf9",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25009",
    "bcr_drug_uuid": "24744559-e344-4016-8695-c4b55f3cd1cb",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25007",
    "bcr_drug_uuid": "ee41741e-220a-4998-a17d-e0b871f7eb88",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 1,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25004",
    "bcr_drug_uuid": "99777074-d6b2-4ece-ae49-81c07c9a25aa",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a22c1451-7841-4fa3-b2f2-5d5cd8aa67d3",
    "patient_ID": "TCGA.13.2061",
    "bcr_drug_barcode": "TCGA-13-2061-D25010",
    "bcr_drug_uuid": "929e7c01-97cc-47d1-bcf0-6b3f02535241",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 147,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 168,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8d1dcf21-efd3-4fbe-ad44-f43a19239383",
    "patient_ID": "TCGA.13.2065",
    "bcr_drug_barcode": "TCGA-13-2065-D25015",
    "bcr_drug_uuid": "9d325c18-026c-4f04-80c4-bf1ce79b67ad",
    "form_completion_date": "2010-2-2",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8d1dcf21-efd3-4fbe-ad44-f43a19239383",
    "patient_ID": "TCGA.13.2065",
    "bcr_drug_barcode": "TCGA-13-2065-D25016",
    "bcr_drug_uuid": "4cd10442-1ec3-49c9-8ec3-a564919e8276",
    "form_completion_date": "2010-2-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "8d1dcf21-efd3-4fbe-ad44-f43a19239383",
    "patient_ID": "TCGA.13.2065",
    "bcr_drug_barcode": "TCGA-13-2065-D25014",
    "bcr_drug_uuid": "ec1c37f5-42f6-4a57-b90c-b4ffad895817",
    "form_completion_date": "2010-2-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "bcb87812-94e3-4dc0-867e-d049b44a2690",
    "patient_ID": "TCGA.13.2066",
    "bcr_drug_barcode": "TCGA-13-2066-D25019",
    "bcr_drug_uuid": "1fd48297-038d-468d-a6e2-b749ef1fa449",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "bcb87812-94e3-4dc0-867e-d049b44a2690",
    "patient_ID": "TCGA.13.2066",
    "bcr_drug_barcode": "TCGA-13-2066-D25020",
    "bcr_drug_uuid": "81c7a339-e58c-460a-82de-70cc361da73e",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0d15e5aa-2483-4f81-973a-ff469296c911",
    "patient_ID": "TCGA.13.2071",
    "bcr_drug_barcode": "TCGA-13-2071-D25024",
    "bcr_drug_uuid": "de33c7f9-63e7-415d-9648-7c5dc597446e",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0d15e5aa-2483-4f81-973a-ff469296c911",
    "patient_ID": "TCGA.13.2071",
    "bcr_drug_barcode": "TCGA-13-2071-D25023",
    "bcr_drug_uuid": "35bbcd97-398d-453a-a49d-0e9a5d097a8b",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "F3618472-32DC-4C90-A407-90050F68BE85",
    "patient_ID": "TCGA.13.A5FT",
    "bcr_drug_barcode": "TCGA-13-A5FT-D43570",
    "bcr_drug_uuid": "36283F3D-1E06-4D7C-A64E-DF9B07460DD9",
    "form_completion_date": "2013-5-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 111,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F3618472-32DC-4C90-A407-90050F68BE85",
    "patient_ID": "TCGA.13.A5FT",
    "bcr_drug_barcode": "TCGA-13-A5FT-D43571",
    "bcr_drug_uuid": "F6311109-F942-40EE-BBC7-BC3334388892",
    "form_completion_date": "2013-5-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0F7AC6CA-7806-4B2A-9D37-94FF74FCD010",
    "patient_ID": "TCGA.13.A5FU",
    "bcr_drug_barcode": "TCGA-13-A5FU-D43573",
    "bcr_drug_uuid": "84B42869-00D9-41FA-BB29-C17DB74E66C9",
    "form_completion_date": "2013-5-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0F7AC6CA-7806-4B2A-9D37-94FF74FCD010",
    "patient_ID": "TCGA.13.A5FU",
    "bcr_drug_barcode": "TCGA-13-A5FU-D43574",
    "bcr_drug_uuid": "A3157A7F-920B-484C-A9B4-BF6C78BC2CFE",
    "form_completion_date": "2013-5-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "34f285ab-6c31-4865-a0a7-a57af3567df0",
    "patient_ID": "TCGA.20.0987",
    "bcr_drug_barcode": "TCGA-20-0987-D25519",
    "bcr_drug_uuid": "94d41e3c-23fc-4a1e-9848-caf6ce4d52bd",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "34f285ab-6c31-4865-a0a7-a57af3567df0",
    "patient_ID": "TCGA.20.0987",
    "bcr_drug_barcode": "TCGA-20-0987-D25521",
    "bcr_drug_uuid": "9df9ba91-1ad5-4fbb-870b-28792a4a90c0",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 427,
    "days_to_drug_end": 442,
    "drug_cycles": 3,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "34f285ab-6c31-4865-a0a7-a57af3567df0",
    "patient_ID": "TCGA.20.0987",
    "bcr_drug_barcode": "TCGA-20-0987-D25520",
    "bcr_drug_uuid": "fff65b98-a78b-436b-bef7-4a4ad0448bcd",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9524775-6b50-4793-8858-24b6a6d3e4e6",
    "patient_ID": "TCGA.20.0990",
    "bcr_drug_barcode": "TCGA-20-0990-D25526",
    "bcr_drug_uuid": "b8c952b4-928b-4ceb-b655-5db68e4da13c",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 901,
    "days_to_drug_end": 999,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1240
  },
  {
    "bcr_patient_uuid": "c9524775-6b50-4793-8858-24b6a6d3e4e6",
    "patient_ID": "TCGA.20.0990",
    "bcr_drug_barcode": "TCGA-20-0990-D25525",
    "bcr_drug_uuid": "00c73916-b074-4f01-8663-a17d24d71686",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "days_to_drug_end": 236,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "c9524775-6b50-4793-8858-24b6a6d3e4e6",
    "patient_ID": "TCGA.20.0990",
    "bcr_drug_barcode": "TCGA-20-0990-D25528",
    "bcr_drug_uuid": "15ac365e-4f23-4eaf-aa92-f6b2dfaec21d",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1034,
    "days_to_drug_end": 1174,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 47
  },
  {
    "bcr_patient_uuid": "c9524775-6b50-4793-8858-24b6a6d3e4e6",
    "patient_ID": "TCGA.20.0990",
    "bcr_drug_barcode": "TCGA-20-0990-D25527",
    "bcr_drug_uuid": "122c2ea5-7803-4149-88c4-b8601e1a2511",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1034,
    "days_to_drug_end": 1174,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "c9524775-6b50-4793-8858-24b6a6d3e4e6",
    "patient_ID": "TCGA.20.0990",
    "bcr_drug_barcode": "TCGA-20-0990-D25524",
    "bcr_drug_uuid": "e4109126-8bb8-4994-b2c0-26b5599e62ca",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 116,
    "days_to_drug_end": 236,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "36595b52-2b5f-4e87-80eb-37c29109e92a",
    "patient_ID": "TCGA.20.0991",
    "bcr_drug_barcode": "TCGA-20-0991-D25531",
    "bcr_drug_uuid": "8a48bcf0-7943-48da-89c6-1831cbe9da03",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 71,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 425
  },
  {
    "bcr_patient_uuid": "d7f82e34-5b34-4e8c-a0cf-d7561bcea43c",
    "patient_ID": "TCGA.20.0996",
    "bcr_drug_barcode": "TCGA-20-0996-D25534",
    "bcr_drug_uuid": "8250f16b-1184-4fd2-8fee-602539eab355",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "days_to_drug_end": 224,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d7f82e34-5b34-4e8c-a0cf-d7561bcea43c",
    "patient_ID": "TCGA.20.0996",
    "bcr_drug_barcode": "TCGA-20-0996-D25537",
    "bcr_drug_uuid": "dc9650af-ba57-4533-a6e1-a7f3c8462f01",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 616,
    "days_to_drug_end": 1078,
    "drug_cycles": 13,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "d7f82e34-5b34-4e8c-a0cf-d7561bcea43c",
    "patient_ID": "TCGA.20.0996",
    "bcr_drug_barcode": "TCGA-20-0996-D25538",
    "bcr_drug_uuid": "6f44cefa-f2d9-45fb-914f-f4ce34d4ec60",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1106,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "d7f82e34-5b34-4e8c-a0cf-d7561bcea43c",
    "patient_ID": "TCGA.20.0996",
    "bcr_drug_barcode": "TCGA-20-0996-D25535",
    "bcr_drug_uuid": "0101cf7f-8bad-467b-a24b-7f0843a67403",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "days_to_drug_end": 224,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "d7f82e34-5b34-4e8c-a0cf-d7561bcea43c",
    "patient_ID": "TCGA.20.0996",
    "bcr_drug_barcode": "TCGA-20-0996-D25536",
    "bcr_drug_uuid": "e552a4cc-5113-447c-b57b-c5b1e8e7d6e3",
    "form_completion_date": "2009-3-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 443,
    "days_to_drug_end": 590,
    "drug_cycles": 15,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "94bd4c68-4bfc-4db3-9365-97c867747133",
    "patient_ID": "TCGA.20.1682",
    "bcr_drug_barcode": "TCGA-20-1682-D25541",
    "bcr_drug_uuid": "f9a9b49a-eefa-4274-b8b0-542674f06e3e",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "94bd4c68-4bfc-4db3-9365-97c867747133",
    "patient_ID": "TCGA.20.1682",
    "bcr_drug_barcode": "TCGA-20-1682-D25542",
    "bcr_drug_uuid": "6817b450-bd86-4a72-a6f2-d2ebbc268095",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "ac2e88ff-8b1e-4691-9a96-5a581f98d827",
    "patient_ID": "TCGA.20.1683",
    "bcr_drug_barcode": "TCGA-20-1683-D25547",
    "bcr_drug_uuid": "350300e1-643d-4b95-90bb-307cc8934f29",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 618,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "ac2e88ff-8b1e-4691-9a96-5a581f98d827",
    "patient_ID": "TCGA.20.1683",
    "bcr_drug_barcode": "TCGA-20-1683-D25545",
    "bcr_drug_uuid": "224f8ff6-5ded-405b-b206-521b0ae15315",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "ac2e88ff-8b1e-4691-9a96-5a581f98d827",
    "patient_ID": "TCGA.20.1683",
    "bcr_drug_barcode": "TCGA-20-1683-D25546",
    "bcr_drug_uuid": "7175a7a2-ccb7-4926-88d0-fac1af5a4ba7",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "94030805-8beb-441a-af73-11a80768edb5",
    "patient_ID": "TCGA.20.1684",
    "bcr_drug_barcode": "TCGA-20-1684-D25551",
    "bcr_drug_uuid": "a6105f0f-4f35-45eb-9a4c-25692167301e",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "94030805-8beb-441a-af73-11a80768edb5",
    "patient_ID": "TCGA.20.1684",
    "bcr_drug_barcode": "TCGA-20-1684-D25550",
    "bcr_drug_uuid": "fd8ac1c7-65cb-4bca-bfa6-fab399cf7e57",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "94030805-8beb-441a-af73-11a80768edb5",
    "patient_ID": "TCGA.20.1684",
    "bcr_drug_barcode": "TCGA-20-1684-D25552",
    "bcr_drug_uuid": "67c20b40-f5e3-4937-a3fc-41ae888dc1a7",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 4,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "cbc5b936-ead5-4858-ab90-e639402789b0",
    "patient_ID": "TCGA.20.1685",
    "bcr_drug_barcode": "TCGA-20-1685-D25556",
    "bcr_drug_uuid": "61e2a648-eede-4da8-98d8-b59dd2b3d85a",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "cbc5b936-ead5-4858-ab90-e639402789b0",
    "patient_ID": "TCGA.20.1685",
    "bcr_drug_barcode": "TCGA-20-1685-D25555",
    "bcr_drug_uuid": "480d3ba4-151c-424e-ac1c-bbfeb855e517",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "cbc5b936-ead5-4858-ab90-e639402789b0",
    "patient_ID": "TCGA.20.1685",
    "bcr_drug_barcode": "TCGA-20-1685-D25557",
    "bcr_drug_uuid": "431a1b7d-0bb3-4262-bf04-9b427b1764d9",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "f007fa7a-7da9-4cb0-8aea-623af1a122c5",
    "patient_ID": "TCGA.20.1686",
    "bcr_drug_barcode": "TCGA-20-1686-D25561",
    "bcr_drug_uuid": "d4a19506-867a-4ff5-914f-9656355a77dc",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "f007fa7a-7da9-4cb0-8aea-623af1a122c5",
    "patient_ID": "TCGA.20.1686",
    "bcr_drug_barcode": "TCGA-20-1686-D25560",
    "bcr_drug_uuid": "a175f848-af9d-492d-8e22-cb3522f495a7",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "9bf16a89-2fc7-4c08-93bc-3105eec5c3cc",
    "patient_ID": "TCGA.20.1687",
    "bcr_drug_barcode": "TCGA-20-1687-D25564",
    "bcr_drug_uuid": "c94c5c61-aaa1-4029-bcb9-34b31ebc25d2",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9bf16a89-2fc7-4c08-93bc-3105eec5c3cc",
    "patient_ID": "TCGA.20.1687",
    "bcr_drug_barcode": "TCGA-20-1687-D25565",
    "bcr_drug_uuid": "345ae7fa-8baa-4247-bcbb-f86a0ab0aa37",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25571",
    "bcr_drug_uuid": "9ade7aa5-18d8-4919-ae99-2a73732ba30e",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 722,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 861,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25574",
    "bcr_drug_uuid": "9c425509-cbf7-43a5-8830-f4f4f75459f7",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1408,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1408,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25568",
    "bcr_drug_uuid": "ade37eb4-02de-42c7-8d26-fad6a3398a00",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2880
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25573",
    "bcr_drug_uuid": "3fd43153-5bdf-45ff-8eef-1bdc764b40ba",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1352,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1380,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25570",
    "bcr_drug_uuid": "f3d78a9b-08ea-4aa8-9cb5-677b67207783",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 526,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 693,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENCE",
    "drug_total_dose": 6061
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25572",
    "bcr_drug_uuid": "c20a16f7-cfb8-421e-8951-fbc938aaa1b2",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1226,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1331,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2540
  },
  {
    "bcr_patient_uuid": "b923ac70-70ea-4a82-8466-46350c5803bf",
    "patient_ID": "TCGA.23.1021",
    "bcr_drug_barcode": "TCGA-23-1021-D25569",
    "bcr_drug_uuid": "ba314cd4-e2a6-4f5a-9104-137cd1e29ba7",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25577",
    "bcr_drug_uuid": "74e65174-6f54-47f9-bf5b-d0f1391cb0dc",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25584",
    "bcr_drug_uuid": "b1b96f3b-7fe8-4b7b-838b-327f628319fb",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1357,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8120
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25581",
    "bcr_drug_uuid": "abf39c56-803d-4f80-a5df-e3b2694ada67",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 762,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 818,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 27.5
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25578",
    "bcr_drug_uuid": "331fc9fd-da0f-4cac-99d7-e00038d4bd7c",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2170
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25580",
    "bcr_drug_uuid": "f1fa07d1-a044-41de-8df7-59d7e43dd7d0",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 741,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 820
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25583",
    "bcr_drug_uuid": "02f03126-9559-4f48-b898-b7f5637a68b3",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1056,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1252,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2500
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25585",
    "bcr_drug_uuid": "d09f3ba6-475f-44a0-a551-0ce2cf7fc770",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1378,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1378,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25582",
    "bcr_drug_uuid": "0a90f6a3-ec5d-4d6a-9b2f-7faa331d8147",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 853,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 937,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "d0673efd-3315-4dd5-8ab6-912bfa07dceb",
    "patient_ID": "TCGA.23.1022",
    "bcr_drug_barcode": "TCGA-23-1022-D25579",
    "bcr_drug_uuid": "fb478bd8-7b3a-4ac6-8819-9d01950ecfe0",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 741,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 17200
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25590",
    "bcr_drug_uuid": "adcca623-3353-4ce2-9458-70cf557d250f",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1272,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1364,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25588",
    "bcr_drug_uuid": "719d9c8c-f6ea-48b1-8f10-6c8c8931e44d",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1455,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25589",
    "bcr_drug_uuid": "de887de7-b839-47a9-8ed7-e5edd06adf99",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1582,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1603,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 198
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25591",
    "bcr_drug_uuid": "4c3c5329-14f8-452b-a67e-9fee4792426e",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1386,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1407,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25598",
    "bcr_drug_uuid": "5caf6ccc-58cf-4133-8594-9687bcbe0cac",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 509,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 509,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 195
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25600",
    "bcr_drug_uuid": "45e660fe-4782-4a00-b0f5-2ff47a27a7b2",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25594",
    "bcr_drug_uuid": "401feab7-c57d-45b1-97e3-c8c0809643b4",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1455,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25599",
    "bcr_drug_uuid": "1038377c-956a-4017-bf37-e559748251c8",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4860
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25601",
    "bcr_drug_uuid": "b43cacae-9796-4b39-aa27-28671ff77f47",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "OVAREX/PLACEBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 468,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25602",
    "bcr_drug_uuid": "011de666-fcd8-42fc-9990-b3f6da3c087f",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1616,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1665,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTANT",
    "drug_total_dose": 23.6
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25596",
    "bcr_drug_uuid": "1245e6b4-623f-4373-837a-30b186dd53e6",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 557,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 609,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 369
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25592",
    "bcr_drug_uuid": "2ff9ec4a-25a5-4e13-855b-28beb08405c6",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2021
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25597",
    "bcr_drug_uuid": "5005f67e-ca1d-4c05-baf1-36cff1fd4a1d",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 509,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 509,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25593",
    "bcr_drug_uuid": "5f56f9d2-2a3c-4f5e-a512-7e633a7f29e7",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1492
  },
  {
    "bcr_patient_uuid": "9e18238f-ae85-4b75-ae87-d92da9731a40",
    "patient_ID": "TCGA.23.1023",
    "bcr_drug_barcode": "TCGA-23-1023-D25595",
    "bcr_drug_uuid": "324ff779-6c57-4e1f-adf7-34b7d3bd72e8",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 557,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 609,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7800
  },
  {
    "bcr_patient_uuid": "8ac6ce06-ab50-4ab4-a469-9f8bf01be963",
    "patient_ID": "TCGA.23.1024",
    "bcr_drug_barcode": "TCGA-23-1024-D25608",
    "bcr_drug_uuid": "4aa79340-215b-4e20-98be-676cd4c8f2e8",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 304,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 541
  },
  {
    "bcr_patient_uuid": "8ac6ce06-ab50-4ab4-a469-9f8bf01be963",
    "patient_ID": "TCGA.23.1024",
    "bcr_drug_barcode": "TCGA-23-1024-D25607",
    "bcr_drug_uuid": "39c2c36e-c470-48f1-82a2-9f358d3e5957",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 304,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 776
  },
  {
    "bcr_patient_uuid": "8ac6ce06-ab50-4ab4-a469-9f8bf01be963",
    "patient_ID": "TCGA.23.1024",
    "bcr_drug_barcode": "TCGA-23-1024-D25606",
    "bcr_drug_uuid": "0a45720d-954b-4382-b052-f73401d543ce",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 304,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1608
  },
  {
    "bcr_patient_uuid": "8ac6ce06-ab50-4ab4-a469-9f8bf01be963",
    "patient_ID": "TCGA.23.1024",
    "bcr_drug_barcode": "TCGA-23-1024-D25605",
    "bcr_drug_uuid": "ad2ca791-17ad-4489-b546-ffff653fff09",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 224,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 529,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATION",
    "drug_total_dose": 2556
  },
  {
    "bcr_patient_uuid": "c6ede8ae-881c-47a0-a0ef-745ed4b7764a",
    "patient_ID": "TCGA.23.1026",
    "bcr_drug_barcode": "TCGA-23-1026-D25613",
    "bcr_drug_uuid": "98eca7c8-8f45-43b4-806f-193aba7901b6",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 866,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 936,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5648
  },
  {
    "bcr_patient_uuid": "c6ede8ae-881c-47a0-a0ef-745ed4b7764a",
    "patient_ID": "TCGA.23.1026",
    "bcr_drug_barcode": "TCGA-23-1026-D25614",
    "bcr_drug_uuid": "3b5456ab-a33b-4cbf-b0e9-6958219b0063",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 866,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 936,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "c6ede8ae-881c-47a0-a0ef-745ed4b7764a",
    "patient_ID": "TCGA.23.1026",
    "bcr_drug_barcode": "TCGA-23-1026-D25612",
    "bcr_drug_uuid": "8eb2970b-6005-448d-b3aa-a1ebcc49df1f",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "c6ede8ae-881c-47a0-a0ef-745ed4b7764a",
    "patient_ID": "TCGA.23.1026",
    "bcr_drug_barcode": "TCGA-23-1026-D25611",
    "bcr_drug_uuid": "5e32312e-6a0d-4e28-a91e-b186be5f1c1c",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3420
  },
  {
    "bcr_patient_uuid": "c9e58844-9d61-44a2-aee6-1760bc19711b",
    "patient_ID": "TCGA.23.1027",
    "bcr_drug_barcode": "TCGA-23-1027-D25619",
    "bcr_drug_uuid": "9aacdc7c-5ecf-49a8-9521-4decc19f0433",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 748
  },
  {
    "bcr_patient_uuid": "c9e58844-9d61-44a2-aee6-1760bc19711b",
    "patient_ID": "TCGA.23.1027",
    "bcr_drug_barcode": "TCGA-23-1027-D25622",
    "bcr_drug_uuid": "4c2c89ca-d46c-4f42-9b08-c66459b8189d",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 769,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 867,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "c9e58844-9d61-44a2-aee6-1760bc19711b",
    "patient_ID": "TCGA.23.1027",
    "bcr_drug_barcode": "TCGA-23-1027-D25621",
    "bcr_drug_uuid": "bae3a196-ad8b-4c6e-baf3-cc6c49029a2f",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 769,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 867,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10932
  },
  {
    "bcr_patient_uuid": "c9e58844-9d61-44a2-aee6-1760bc19711b",
    "patient_ID": "TCGA.23.1027",
    "bcr_drug_barcode": "TCGA-23-1027-D25618",
    "bcr_drug_uuid": "979a32c9-ef1b-4990-9f45-caaa8d702ca3",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1281
  },
  {
    "bcr_patient_uuid": "c9e58844-9d61-44a2-aee6-1760bc19711b",
    "patient_ID": "TCGA.23.1027",
    "bcr_drug_barcode": "TCGA-23-1027-D25620",
    "bcr_drug_uuid": "a3e4c26f-59b6-4dfb-858b-dae3a7810a29",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "c9e58844-9d61-44a2-aee6-1760bc19711b",
    "patient_ID": "TCGA.23.1027",
    "bcr_drug_barcode": "TCGA-23-1027-D25617",
    "bcr_drug_uuid": "541ac876-abe8-4dfb-9330-f95da504b531",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2088
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25635",
    "bcr_drug_uuid": "f26754f2-8f61-4593-9928-59d785330f4e",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1461,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1461,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 525
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25626",
    "bcr_drug_uuid": "7891f1ae-b0a9-448d-b9c0-c4f15de2e582",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2900
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25636",
    "bcr_drug_uuid": "be0eed66-9759-46f5-861d-85d2b3c7dcd4",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1468,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1489,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3100
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25634",
    "bcr_drug_uuid": "02d68082-acf3-4467-b42a-da9e8cd5c130",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1461,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1461,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1552
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25637",
    "bcr_drug_uuid": "7f691d4d-5047-4632-9a47-8b0354586a4e",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1468,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1489,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25627",
    "bcr_drug_uuid": "850beb81-2d13-437e-ae2a-8d4377df3ef9",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 173,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 229,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 201
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25625",
    "bcr_drug_uuid": "dc8137b1-aa0c-46f3-b4bb-fb1b22ed2913",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25629",
    "bcr_drug_uuid": "b09d45b1-238e-42ff-be29-a0aa4024010a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 749,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 859,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 846
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25633",
    "bcr_drug_uuid": "9d1e5abe-9d8b-4399-930e-7a32f508b7ff",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1461,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2667
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25628",
    "bcr_drug_uuid": "04a1186c-fbac-46cc-9511-f3410889dfca",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 749,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 859,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2802
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25631",
    "bcr_drug_uuid": "987f46e8-6c27-4d5a-b765-c5125640486e",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1335,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 417.5
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25630",
    "bcr_drug_uuid": "266bdf06-86e9-4dde-a5f7-5f96cc3c6eca",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 908,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1006,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40.89
  },
  {
    "bcr_patient_uuid": "df53c3c0-3605-4d2b-bdc7-96d9beab27ea",
    "patient_ID": "TCGA.23.1028",
    "bcr_drug_barcode": "TCGA-23-1028-D25632",
    "bcr_drug_uuid": "b5320a45-929d-4b52-b0d4-d3a67e2a6e60",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1153,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10.3
  },
  {
    "bcr_patient_uuid": "4d71dd15-cd01-4dae-ad70-6dc325140207",
    "patient_ID": "TCGA.23.1029",
    "bcr_drug_barcode": "TCGA-23-1029-D25640",
    "bcr_drug_uuid": "eb833ce3-8f8b-4694-b538-a8d573f473d0",
    "form_completion_date": "2009-8-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 375
  },
  {
    "bcr_patient_uuid": "4d71dd15-cd01-4dae-ad70-6dc325140207",
    "patient_ID": "TCGA.23.1029",
    "bcr_drug_barcode": "TCGA-23-1029-D25641",
    "bcr_drug_uuid": "5f098756-c714-43d6-b097-9d2dae9f2152",
    "form_completion_date": "2009-8-12",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 78,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1212
  },
  {
    "bcr_patient_uuid": "cbcf6922-a3c0-43a1-826e-642918b0a635",
    "patient_ID": "TCGA.23.1030",
    "bcr_drug_barcode": "TCGA-23-1030-D25645",
    "bcr_drug_uuid": "d696489a-0cbd-49c2-a070-3d4161baecc2",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5010
  },
  {
    "bcr_patient_uuid": "cbcf6922-a3c0-43a1-826e-642918b0a635",
    "patient_ID": "TCGA.23.1030",
    "bcr_drug_barcode": "TCGA-23-1030-D25644",
    "bcr_drug_uuid": "0545b759-fc20-4f2e-bdc1-95a8e3b09d84",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 622,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 767,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "cbcf6922-a3c0-43a1-826e-642918b0a635",
    "patient_ID": "TCGA.23.1030",
    "bcr_drug_barcode": "TCGA-23-1030-D25646",
    "bcr_drug_uuid": "790576ff-0101-4585-a311-1b60c28a5ea8",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2130
  },
  {
    "bcr_patient_uuid": "cbcf6922-a3c0-43a1-826e-642918b0a635",
    "patient_ID": "TCGA.23.1030",
    "bcr_drug_barcode": "TCGA-23-1030-D25647",
    "bcr_drug_uuid": "a30cd254-7973-4765-883d-f4a89c773a88",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "XYOTAX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 438,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATION",
    "drug_total_dose": 2160
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25651",
    "bcr_drug_uuid": "9be966b3-0747-412f-a979-39238e9d9e22",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2305
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25654",
    "bcr_drug_uuid": "285fafde-48f2-415b-bf55-b7e7ef4e6253",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 446,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 715
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25657",
    "bcr_drug_uuid": "a876fbfc-b6f9-425c-9f99-8581d9c760ab",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 541,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 555,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11.4
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25650",
    "bcr_drug_uuid": "6c520881-7f90-4327-848b-639e34dda8b9",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25655",
    "bcr_drug_uuid": "57796331-d5b0-4b3d-9544-405b027f6373",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 460,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 485,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25653",
    "bcr_drug_uuid": "d9844a5a-51b3-43da-b153-53e40564a073",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 446,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16500
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25656",
    "bcr_drug_uuid": "7ac6d001-2bdb-4e6a-863d-a72c506dfd1c",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 460,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 477,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "c7c3fe4a-327a-4b7e-a259-989b72971209",
    "patient_ID": "TCGA.23.1031",
    "bcr_drug_barcode": "TCGA-23-1031-D25652",
    "bcr_drug_uuid": "ae37b6fb-a4cb-4003-b9e4-6cbc3d5ef1b2",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 265,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 225
  },
  {
    "bcr_patient_uuid": "9fb1ba57-2007-4477-b000-2d36f163efd2",
    "patient_ID": "TCGA.23.1110",
    "bcr_drug_barcode": "TCGA-23-1110-D25669",
    "bcr_drug_uuid": "58fe9851-57be-4df2-bd75-5e5dcbc2a094",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "9fb1ba57-2007-4477-b000-2d36f163efd2",
    "patient_ID": "TCGA.23.1110",
    "bcr_drug_barcode": "TCGA-23-1110-D25667",
    "bcr_drug_uuid": "05f0a85e-8428-42e9-b8c6-79bf2d0eceed",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 333,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 375,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 16800
  },
  {
    "bcr_patient_uuid": "9fb1ba57-2007-4477-b000-2d36f163efd2",
    "patient_ID": "TCGA.23.1110",
    "bcr_drug_barcode": "TCGA-23-1110-D25668",
    "bcr_drug_uuid": "b7078743-ae46-40f4-87e4-3e5d1e8873c7",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "9fb1ba57-2007-4477-b000-2d36f163efd2",
    "patient_ID": "TCGA.23.1110",
    "bcr_drug_barcode": "TCGA-23-1110-D25670",
    "bcr_drug_uuid": "b9882c4e-8bcd-42a7-baa4-a91102a3853a",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "OVAREX/IND",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 179,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "6b2a9f9a-fe96-4311-a330-925c4ad36fe7",
    "patient_ID": "TCGA.23.1111",
    "bcr_drug_barcode": "TCGA-23-1111-D25675",
    "bcr_drug_uuid": "5b8a8e00-e4be-4a14-a676-a1e13668a596",
    "form_completion_date": "2009-8-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3389
  },
  {
    "bcr_patient_uuid": "6b2a9f9a-fe96-4311-a330-925c4ad36fe7",
    "patient_ID": "TCGA.23.1111",
    "bcr_drug_barcode": "TCGA-23-1111-D25673",
    "bcr_drug_uuid": "47ac4877-04ba-4b1e-8cd0-abbe3e23f2e2",
    "form_completion_date": "2009-8-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1860
  },
  {
    "bcr_patient_uuid": "6b2a9f9a-fe96-4311-a330-925c4ad36fe7",
    "patient_ID": "TCGA.23.1111",
    "bcr_drug_barcode": "TCGA-23-1111-D25674",
    "bcr_drug_uuid": "23d2be25-9d1f-4e0d-a2cd-ce35c16e2cd9",
    "form_completion_date": "2009-8-12",
    "pharmaceutical_therapy_drug_name": "INVESTIGAL DRUG AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5850
  },
  {
    "bcr_patient_uuid": "6209e80d-a115-4f8e-bf0d-18461401a1c6",
    "patient_ID": "TCGA.23.1113",
    "bcr_drug_barcode": "TCGA-23-1113-D25678",
    "bcr_drug_uuid": "a3b52bce-08d8-456b-8f1e-d68fb5b21ef7",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "6209e80d-a115-4f8e-bf0d-18461401a1c6",
    "patient_ID": "TCGA.23.1113",
    "bcr_drug_barcode": "TCGA-23-1113-D25679",
    "bcr_drug_uuid": "ad1b6d9d-88c5-4a21-a3d5-485738b49d45",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 870
  },
  {
    "bcr_patient_uuid": "6209e80d-a115-4f8e-bf0d-18461401a1c6",
    "patient_ID": "TCGA.23.1113",
    "bcr_drug_barcode": "TCGA-23-1113-D25680",
    "bcr_drug_uuid": "26c1331d-7f91-47a7-996d-d19bdc7a1244",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11282
  },
  {
    "bcr_patient_uuid": "6209e80d-a115-4f8e-bf0d-18461401a1c6",
    "patient_ID": "TCGA.23.1113",
    "bcr_drug_barcode": "TCGA-23-1113-D25682",
    "bcr_drug_uuid": "d6010400-23c3-4365-a990-0aa37395b0fa",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 225,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 816
  },
  {
    "bcr_patient_uuid": "6209e80d-a115-4f8e-bf0d-18461401a1c6",
    "patient_ID": "TCGA.23.1113",
    "bcr_drug_barcode": "TCGA-23-1113-D25681",
    "bcr_drug_uuid": "8c3b8e3e-b95c-467c-acdf-7734757cc2e3",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 528
  },
  {
    "bcr_patient_uuid": "6209e80d-a115-4f8e-bf0d-18461401a1c6",
    "patient_ID": "TCGA.23.1113",
    "bcr_drug_barcode": "TCGA-23-1113-D25683",
    "bcr_drug_uuid": "0e6ed55a-1671-4de0-92bb-1f511b80c3d6",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 873,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 910
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25688",
    "bcr_drug_uuid": "e6c36e8f-5244-49fd-b850-7b811204f0e4",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1222,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 520
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25686",
    "bcr_drug_uuid": "28862da8-6071-4b65-a284-73b03b98866e",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25689",
    "bcr_drug_uuid": "5369784c-c259-4b05-979b-d85b3da36f4d",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1324,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1350,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 5500
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25696",
    "bcr_drug_uuid": "665be94d-c439-4e5c-9f31-6d83d62a544a",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 663,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 747,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25687",
    "bcr_drug_uuid": "2594811e-287f-418e-bf86-1e968be8111e",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25693",
    "bcr_drug_uuid": "380c38b7-6850-4e82-8f9f-71a6f23b2d41",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1741,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1918,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 475
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25691",
    "bcr_drug_uuid": "2a752af9-ba01-4375-96ee-7f936b87f0be",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1357,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1425,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 1190
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25694",
    "bcr_drug_uuid": "a1d5312d-e9dc-4357-a3a8-a122efc3e0a4",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1985,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2026,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20.4
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25697",
    "bcr_drug_uuid": "2875ceab-afed-41fe-bc04-f6b7729cd8c1",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 865,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 907,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATION",
    "drug_total_dose": 1305
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25692",
    "bcr_drug_uuid": "93752a4e-b8b2-48e8-a5d1-519882e4cd05",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1348,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1425,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 9625
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25690",
    "bcr_drug_uuid": "073ba0a0-4d7b-42fa-807f-7bac715d4b88",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1324,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1350,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "c0c3caab-9277-4a31-a96c-c607e38d5ccc",
    "patient_ID": "TCGA.23.1114",
    "bcr_drug_barcode": "TCGA-23-1114-D25695",
    "bcr_drug_uuid": "114cca0b-8220-4673-b571-a6a051f4e930",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 663,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 747,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "70fe08bd-a0b4-4a88-b82e-813b176f8e40",
    "patient_ID": "TCGA.23.1116",
    "bcr_drug_barcode": "TCGA-23-1116-D25749",
    "bcr_drug_uuid": "fdcbd10e-6a29-44af-a6d3-0ae779462f28",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "days_to_drug_end": 187,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1746
  },
  {
    "bcr_patient_uuid": "70fe08bd-a0b4-4a88-b82e-813b176f8e40",
    "patient_ID": "TCGA.23.1116",
    "bcr_drug_barcode": "TCGA-23-1116-D25748",
    "bcr_drug_uuid": "cebb3b12-fd0f-4d3d-836e-9a2f550a8a89",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "days_to_drug_end": 187,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "70fe08bd-a0b4-4a88-b82e-813b176f8e40",
    "patient_ID": "TCGA.23.1116",
    "bcr_drug_barcode": "TCGA-23-1116-D25750",
    "bcr_drug_uuid": "ca70e5a7-b898-44a8-a40a-56f5788f613d",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 306,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 418,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1530
  },
  {
    "bcr_patient_uuid": "70fe08bd-a0b4-4a88-b82e-813b176f8e40",
    "patient_ID": "TCGA.23.1116",
    "bcr_drug_barcode": "TCGA-23-1116-D25751",
    "bcr_drug_uuid": "aadd8f4f-1254-476b-ae3f-6c120a36477e",
    "form_completion_date": "2009-12-14",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 306,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 418,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 11028
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25700",
    "bcr_drug_uuid": "ae227383-099e-44a2-8398-ba4aa5c804eb",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6470
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25702",
    "bcr_drug_uuid": "bffb1d3e-6bc8-472c-b3b6-2b072e107ea2",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 712,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 757,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3450
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25703",
    "bcr_drug_uuid": "647f8f33-378a-47c3-8cda-37dbc04a7c54",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 781,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 863,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25701",
    "bcr_drug_uuid": "df44bbcd-995d-4b79-9bee-e364bb571dcd",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 624,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 92
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25704",
    "bcr_drug_uuid": "d5b2da86-8889-4e99-b890-64d403e5e8d3",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 890,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 928,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25705",
    "bcr_drug_uuid": "53b2ce95-0ac5-4e1b-af64-9a769cdc3df6",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 951,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 993,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "a88b7e66-5f12-4023-a7e2-fcfbd1f25977",
    "patient_ID": "TCGA.23.1117",
    "bcr_drug_barcode": "TCGA-23-1117-D25706",
    "bcr_drug_uuid": "044d289f-4ad5-4e9f-9e5a-373407bd5892",
    "form_completion_date": "2010-1-11",
    "pharmaceutical_therapy_drug_name": "HERCEPTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 890,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 928,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "700e91bb-d675-41b2-bbbd-935767c7b447",
    "patient_ID": "TCGA.23.1118",
    "bcr_drug_barcode": "TCGA-23-1118-D25709",
    "bcr_drug_uuid": "553ae8b5-bba0-4760-bc39-007b45663eba",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "2dfd8a0e-e642-49b3-abd7-f0334927eebb",
    "patient_ID": "TCGA.23.1119",
    "bcr_drug_barcode": "TCGA-23-1119-D25712",
    "bcr_drug_uuid": "f137b469-6105-4631-9476-7318dfa0df61",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3389,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3494,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2230
  },
  {
    "bcr_patient_uuid": "2dfd8a0e-e642-49b3-abd7-f0334927eebb",
    "patient_ID": "TCGA.23.1119",
    "bcr_drug_barcode": "TCGA-23-1119-D25713",
    "bcr_drug_uuid": "d66ab420-e93b-4d8a-9414-c8439da9c270",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2700
  },
  {
    "bcr_patient_uuid": "fdf83fdf-dfbb-4306-9a1b-b4487d18b402",
    "patient_ID": "TCGA.23.1120",
    "bcr_drug_barcode": "TCGA-23-1120-D25716",
    "bcr_drug_uuid": "706a2a1b-ec67-4c1e-9588-9ad9b8a629ef",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "days_to_drug_end": 146,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "fdf83fdf-dfbb-4306-9a1b-b4487d18b402",
    "patient_ID": "TCGA.23.1120",
    "bcr_drug_barcode": "TCGA-23-1120-D25717",
    "bcr_drug_uuid": "14e5fa9c-6598-4755-8dcf-a2ad8f0253c2",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "days_to_drug_end": 146,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2090
  },
  {
    "bcr_patient_uuid": "81005bae-686a-4598-8994-49d90ebac56f",
    "patient_ID": "TCGA.23.1121",
    "bcr_drug_barcode": "TCGA-23-1121-D25721",
    "bcr_drug_uuid": "a4055b6b-966f-49eb-b54e-58851bea490d",
    "form_completion_date": "2009-7-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1362
  },
  {
    "bcr_patient_uuid": "81005bae-686a-4598-8994-49d90ebac56f",
    "patient_ID": "TCGA.23.1121",
    "bcr_drug_barcode": "TCGA-23-1121-D25722",
    "bcr_drug_uuid": "41650c19-fb75-4a26-81cf-84c3d503fbf8",
    "form_completion_date": "2009-7-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "81005bae-686a-4598-8994-49d90ebac56f",
    "patient_ID": "TCGA.23.1121",
    "bcr_drug_barcode": "TCGA-23-1121-D25720",
    "bcr_drug_uuid": "6533e40b-a0cb-48bf-96f6-65d01afb4d7f",
    "form_completion_date": "2009-7-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 194,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3135
  },
  {
    "bcr_patient_uuid": "d2c0d320-d1c5-4eed-af4f-15540e60db0b",
    "patient_ID": "TCGA.23.1122",
    "bcr_drug_barcode": "TCGA-23-1122-D25726",
    "bcr_drug_uuid": "9be1fb51-4bb5-4ad9-8bdd-d26152e731aa",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 501,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 686,
    "drug_cycles": 20,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 15900
  },
  {
    "bcr_patient_uuid": "d2c0d320-d1c5-4eed-af4f-15540e60db0b",
    "patient_ID": "TCGA.23.1122",
    "bcr_drug_barcode": "TCGA-23-1122-D25729",
    "bcr_drug_uuid": "75bcf34f-515a-4ada-aca8-b0e8548a4a67",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 921,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1031,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENCE",
    "drug_total_dose": 72
  },
  {
    "bcr_patient_uuid": "d2c0d320-d1c5-4eed-af4f-15540e60db0b",
    "patient_ID": "TCGA.23.1122",
    "bcr_drug_barcode": "TCGA-23-1122-D25730",
    "bcr_drug_uuid": "5b6a82d6-b750-44e9-b52f-c8ce5cd84a75",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1054,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1089,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENCE",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "d2c0d320-d1c5-4eed-af4f-15540e60db0b",
    "patient_ID": "TCGA.23.1122",
    "bcr_drug_barcode": "TCGA-23-1122-D25728",
    "bcr_drug_uuid": "d4bbd55b-fc97-42f6-bb91-518b51ae30d0",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 775,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 859,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENCE",
    "drug_total_dose": 5900
  },
  {
    "bcr_patient_uuid": "d2c0d320-d1c5-4eed-af4f-15540e60db0b",
    "patient_ID": "TCGA.23.1122",
    "bcr_drug_barcode": "TCGA-23-1122-D25727",
    "bcr_drug_uuid": "5490f2a7-3eb4-4529-b556-001c0b298aaf",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 707,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 754,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3500
  },
  {
    "bcr_patient_uuid": "d2c0d320-d1c5-4eed-af4f-15540e60db0b",
    "patient_ID": "TCGA.23.1122",
    "bcr_drug_barcode": "TCGA-23-1122-D25725",
    "bcr_drug_uuid": "948c7d43-3dbd-4e69-b81b-ba635e818523",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "60cce7ac-d27d-44a6-9873-ecf91da5e906",
    "patient_ID": "TCGA.23.1123",
    "bcr_drug_barcode": "TCGA-23-1123-D25735",
    "bcr_drug_uuid": "ca5ac43f-2f1e-4180-9c04-2d70675ebbda",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "60cce7ac-d27d-44a6-9873-ecf91da5e906",
    "patient_ID": "TCGA.23.1123",
    "bcr_drug_barcode": "TCGA-23-1123-D25736",
    "bcr_drug_uuid": "3348bc4e-bbef-480d-81d3-aa751f366dd9",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 452,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 599,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENCE",
    "drug_total_dose": 456
  },
  {
    "bcr_patient_uuid": "60cce7ac-d27d-44a6-9873-ecf91da5e906",
    "patient_ID": "TCGA.23.1123",
    "bcr_drug_barcode": "TCGA-23-1123-D25737",
    "bcr_drug_uuid": "800b81f9-0925-43c9-b017-0e9c8fa28a33",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 812,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 894,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENCE",
    "drug_total_dose": 39.9
  },
  {
    "bcr_patient_uuid": "60cce7ac-d27d-44a6-9873-ecf91da5e906",
    "patient_ID": "TCGA.23.1123",
    "bcr_drug_barcode": "TCGA-23-1123-D25734",
    "bcr_drug_uuid": "d80cf2a4-4284-404d-a4d6-72fc39b01dff",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 250,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "8a6d2ce3-cc57-451b-9b07-8263782aa23f",
    "patient_ID": "TCGA.23.1124",
    "bcr_drug_barcode": "TCGA-23-1124-D25744",
    "bcr_drug_uuid": "ac2cb5f8-306a-4e7e-b2cf-e9e8e84ea8fd",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1510,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "8a6d2ce3-cc57-451b-9b07-8263782aa23f",
    "patient_ID": "TCGA.23.1124",
    "bcr_drug_barcode": "TCGA-23-1124-D25741",
    "bcr_drug_uuid": "df58a615-2cd0-4768-855e-d920caff4cbe",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 676,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 872,
    "drug_cycles": 18,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 18000
  },
  {
    "bcr_patient_uuid": "8a6d2ce3-cc57-451b-9b07-8263782aa23f",
    "patient_ID": "TCGA.23.1124",
    "bcr_drug_barcode": "TCGA-23-1124-D25740",
    "bcr_drug_uuid": "4285dc70-1dda-45e9-b520-d7704bfb61ba",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 197,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4950
  },
  {
    "bcr_patient_uuid": "8a6d2ce3-cc57-451b-9b07-8263782aa23f",
    "patient_ID": "TCGA.23.1124",
    "bcr_drug_barcode": "TCGA-23-1124-D25743",
    "bcr_drug_uuid": "4575fc46-e77a-4c7e-b1bc-351538c08b00",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1307,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1342,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "8a6d2ce3-cc57-451b-9b07-8263782aa23f",
    "patient_ID": "TCGA.23.1124",
    "bcr_drug_barcode": "TCGA-23-1124-D25742",
    "bcr_drug_uuid": "d72e12a2-1524-4f1e-ab4e-108fffef106a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1070,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1286,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3080
  },
  {
    "bcr_patient_uuid": "8a6d2ce3-cc57-451b-9b07-8263782aa23f",
    "patient_ID": "TCGA.23.1124",
    "bcr_drug_barcode": "TCGA-23-1124-D25745",
    "bcr_drug_uuid": "d94c08b1-d8f5-480f-bae4-b7239957cdf4",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1566,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "bc3e0b74-ea09-46a5-9f61-16bd15ffd883",
    "patient_ID": "TCGA.23.1809",
    "bcr_drug_barcode": "TCGA-23-1809-D25755",
    "bcr_drug_uuid": "6dab45bd-9189-4f7a-a844-85635ed7cbf7",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1898
  },
  {
    "bcr_patient_uuid": "bc3e0b74-ea09-46a5-9f61-16bd15ffd883",
    "patient_ID": "TCGA.23.1809",
    "bcr_drug_barcode": "TCGA-23-1809-D25754",
    "bcr_drug_uuid": "548a5293-e55f-4f0d-aea8-880f79908766",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1495
  },
  {
    "bcr_patient_uuid": "1592af8e-8d11-4325-8a2b-e0c690b15b58",
    "patient_ID": "TCGA.23.2072",
    "bcr_drug_barcode": "TCGA-23-2072-D25758",
    "bcr_drug_uuid": "0eb5afce-60e8-4797-9672-a84ced84dbdb",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3325
  },
  {
    "bcr_patient_uuid": "1592af8e-8d11-4325-8a2b-e0c690b15b58",
    "patient_ID": "TCGA.23.2072",
    "bcr_drug_barcode": "TCGA-23-2072-D25760",
    "bcr_drug_uuid": "f58539f9-5158-4d42-8b4c-701c651a0c41",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 579,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 620,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6280
  },
  {
    "bcr_patient_uuid": "1592af8e-8d11-4325-8a2b-e0c690b15b58",
    "patient_ID": "TCGA.23.2072",
    "bcr_drug_barcode": "TCGA-23-2072-D25759",
    "bcr_drug_uuid": "7fde5afb-c211-4558-a45f-0bfc5aeb3791",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1890
  },
  {
    "bcr_patient_uuid": "1592af8e-8d11-4325-8a2b-e0c690b15b58",
    "patient_ID": "TCGA.23.2072",
    "bcr_drug_barcode": "TCGA-23-2072-D25761",
    "bcr_drug_uuid": "ac71f616-6349-4cdd-aee1-9e7df89acd4a",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 571,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 64
  },
  {
    "bcr_patient_uuid": "ef57bc45-858f-4d4e-8407-b7eadfa43be5",
    "patient_ID": "TCGA.23.2077",
    "bcr_drug_barcode": "TCGA-23-2077-D25766",
    "bcr_drug_uuid": "5521e637-59d8-4ddf-87cb-146a5266b295",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1622,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1622,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "ef57bc45-858f-4d4e-8407-b7eadfa43be5",
    "patient_ID": "TCGA.23.2077",
    "bcr_drug_barcode": "TCGA-23-2077-D25769",
    "bcr_drug_uuid": "1fa345ea-b957-4961-9564-ba4fc0bbc1fc",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1653,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1758,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "ef57bc45-858f-4d4e-8407-b7eadfa43be5",
    "patient_ID": "TCGA.23.2077",
    "bcr_drug_barcode": "TCGA-23-2077-D25764",
    "bcr_drug_uuid": "5880f08c-91d2-4a3a-b546-c5f38ad84b21",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3300
  },
  {
    "bcr_patient_uuid": "ef57bc45-858f-4d4e-8407-b7eadfa43be5",
    "patient_ID": "TCGA.23.2077",
    "bcr_drug_barcode": "TCGA-23-2077-D25765",
    "bcr_drug_uuid": "55580b30-aed7-4821-a5e6-3c6723d59d3b",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 751
  },
  {
    "bcr_patient_uuid": "ef57bc45-858f-4d4e-8407-b7eadfa43be5",
    "patient_ID": "TCGA.23.2077",
    "bcr_drug_barcode": "TCGA-23-2077-D25767",
    "bcr_drug_uuid": "0963b087-b1d1-46a8-ac6f-a9fca75b64a8",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1622,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1622,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 275
  },
  {
    "bcr_patient_uuid": "ef57bc45-858f-4d4e-8407-b7eadfa43be5",
    "patient_ID": "TCGA.23.2077",
    "bcr_drug_barcode": "TCGA-23-2077-D25768",
    "bcr_drug_uuid": "9c985cb2-5676-4ad4-ae8f-cfd416c28bbb",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1653,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1758,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2206
  },
  {
    "bcr_patient_uuid": "ebe677e6-94b6-45be-a58d-eaae4cf63d12",
    "patient_ID": "TCGA.23.2078",
    "bcr_drug_barcode": "TCGA-23-2078-D25773",
    "bcr_drug_uuid": "3bbb5d6b-af79-42f3-a412-3ae01a8b6bb0",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1980
  },
  {
    "bcr_patient_uuid": "ebe677e6-94b6-45be-a58d-eaae4cf63d12",
    "patient_ID": "TCGA.23.2078",
    "bcr_drug_barcode": "TCGA-23-2078-D25772",
    "bcr_drug_uuid": "e275dc2a-fe10-41d0-9a98-fe92de858ab9",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3240
  },
  {
    "bcr_patient_uuid": "e3ea5137-76b8-4afc-9b80-ed74714e7172",
    "patient_ID": "TCGA.23.2079",
    "bcr_drug_barcode": "TCGA-23-2079-D25778",
    "bcr_drug_uuid": "366f4c76-78f8-4c6e-afa5-375494d96d7e",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 296,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 663
  },
  {
    "bcr_patient_uuid": "e3ea5137-76b8-4afc-9b80-ed74714e7172",
    "patient_ID": "TCGA.23.2079",
    "bcr_drug_barcode": "TCGA-23-2079-D25777",
    "bcr_drug_uuid": "04a0cf5a-70ec-4199-bbaa-75569a40bec1",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3420
  },
  {
    "bcr_patient_uuid": "e3ea5137-76b8-4afc-9b80-ed74714e7172",
    "patient_ID": "TCGA.23.2079",
    "bcr_drug_barcode": "TCGA-23-2079-D25779",
    "bcr_drug_uuid": "fb19a65d-7489-4347-8ea4-b6d265cdcaf6",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2102,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2147,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1651
  },
  {
    "bcr_patient_uuid": "e3ea5137-76b8-4afc-9b80-ed74714e7172",
    "patient_ID": "TCGA.23.2079",
    "bcr_drug_barcode": "TCGA-23-2079-D25776",
    "bcr_drug_uuid": "8b9712e1-d798-4f32-b9a7-1087b0a93e16",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25783",
    "bcr_drug_uuid": "c9566413-8e08-47c1-8a4f-527b3da46ef9",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25782",
    "bcr_drug_uuid": "9ac0d608-4f98-4a24-a71d-73e2428d160c",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT",
    "drug_total_dose": 1750
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25787",
    "bcr_drug_uuid": "498bccb4-7600-48cd-b1dd-3c8c80fb6b6b",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 939,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 960,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 290
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25793",
    "bcr_drug_uuid": "903e47f3-51cb-44cf-8d4b-104edf2dd63e",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "AMG 706",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2070,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2173,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1325
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25788",
    "bcr_drug_uuid": "3274a846-11f3-4a57-a950-f5115fa188a2",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 939,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 960,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25785",
    "bcr_drug_uuid": "6b335083-5754-47d9-8591-2910cb2ad861",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25786",
    "bcr_drug_uuid": "0c4ca03d-0418-47da-bbaf-216d3a8d39cb",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 331,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 418,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25789",
    "bcr_drug_uuid": "87be1e88-31e9-48b0-aa2f-4159d6917c71",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 988,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25790",
    "bcr_drug_uuid": "98483a68-d8fc-4b86-a0e5-51e3715b1bcf",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 988,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 20400
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25792",
    "bcr_drug_uuid": "03beed10-8066-4b0d-9003-4ba326eb7011",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1790,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1948,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25784",
    "bcr_drug_uuid": "a9f3cb5e-4bf8-4810-9a1e-f310588bff21",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2480
  },
  {
    "bcr_patient_uuid": "41178cbc-db73-4007-b5d8-febebf7f578d",
    "patient_ID": "TCGA.23.2081",
    "bcr_drug_barcode": "TCGA-23-2081-D25791",
    "bcr_drug_uuid": "fe9683d7-e2d6-4136-92ea-1d6d51fd5023",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1790,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1948,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 13200
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25798",
    "bcr_drug_uuid": "18d6f8ad-a8f1-49e1-bb97-9234ae71d25e",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 631,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 701,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25802",
    "bcr_drug_uuid": "11a3ce02-a4a6-4448-bc5b-d75b5e18eea8",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1261,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1302,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25808",
    "bcr_drug_uuid": "63edb1bd-5389-42c8-9cb6-56f0558c4a86",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE (VP16)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1457,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1485,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25805",
    "bcr_drug_uuid": "0cb1799a-62c8-4961-a97c-6a3042a78457",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1381,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1401,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 920
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25803",
    "bcr_drug_uuid": "938c58a6-fd84-45a0-b087-8f3fb48c7b86",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1324,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1359,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 14
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25804",
    "bcr_drug_uuid": "78eeb3f1-4910-4452-adf8-b5bb45819a16",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1381,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1401,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1615
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25807",
    "bcr_drug_uuid": "087ed361-e202-4f43-ad80-7548e4afddcc",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1425,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1425,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25800",
    "bcr_drug_uuid": "a695bdf7-521c-40a8-bfdb-7b26c2f2b383",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "RHUMAB/IND",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1169,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1680
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25797",
    "bcr_drug_uuid": "eb6393b4-8b07-467d-9140-7edec56177f7",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2200
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25806",
    "bcr_drug_uuid": "7bd3a692-65be-4684-9346-157cc286a6aa",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1425,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1425,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 730
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25796",
    "bcr_drug_uuid": "3e7107e7-5d80-4ac1-9a79-d3bcc79ef6dc",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4240
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25799",
    "bcr_drug_uuid": "6e3564f4-d965-41f4-8f26-06c247e46d23",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 631,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 701,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 12600
  },
  {
    "bcr_patient_uuid": "2cb82948-7cbe-4b6c-8414-c02f662de2d0",
    "patient_ID": "TCGA.23.2084",
    "bcr_drug_barcode": "TCGA-23-2084-D25801",
    "bcr_drug_uuid": "cf73ecb9-0c9c-4f5a-a6ef-a0c18c63995e",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1240,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 195
  },
  {
    "bcr_patient_uuid": "5554a003-da6f-4ddf-9f05-6785987ac46c",
    "patient_ID": "TCGA.23.2643",
    "bcr_drug_barcode": "TCGA-23-2643-D25816",
    "bcr_drug_uuid": "b22c0d76-80d5-40aa-bb10-9ddc9571a9fa",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 24,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 373
  },
  {
    "bcr_patient_uuid": "5554a003-da6f-4ddf-9f05-6785987ac46c",
    "patient_ID": "TCGA.23.2643",
    "bcr_drug_barcode": "TCGA-23-2643-D25814",
    "bcr_drug_uuid": "25aaccf8-7a6f-441b-9938-b771bec4e3e8",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 610
  },
  {
    "bcr_patient_uuid": "5554a003-da6f-4ddf-9f05-6785987ac46c",
    "patient_ID": "TCGA.23.2643",
    "bcr_drug_barcode": "TCGA-23-2643-D25815",
    "bcr_drug_uuid": "37da2899-93db-4757-9940-479746754dac",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 24,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 294
  },
  {
    "bcr_patient_uuid": "5554a003-da6f-4ddf-9f05-6785987ac46c",
    "patient_ID": "TCGA.23.2643",
    "bcr_drug_barcode": "TCGA-23-2643-D25813",
    "bcr_drug_uuid": "25e8bdc4-321f-4b54-993e-cb26be058f73",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1295
  },
  {
    "bcr_patient_uuid": "fef1696c-a8f4-4db6-8615-e486522baaaa",
    "patient_ID": "TCGA.24.0966",
    "bcr_drug_barcode": "TCGA-24-0966-D25877",
    "bcr_drug_uuid": "d59ae257-aaed-4b32-b2ee-4819c0c1f330",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "days_to_drug_end": 120,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2456
  },
  {
    "bcr_patient_uuid": "fef1696c-a8f4-4db6-8615-e486522baaaa",
    "patient_ID": "TCGA.24.0966",
    "bcr_drug_barcode": "TCGA-24-0966-D25876",
    "bcr_drug_uuid": "6e46e95c-59bd-4b05-aa53-4d4ab9726c05",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "days_to_drug_end": 120,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1390
  },
  {
    "bcr_patient_uuid": "fef1696c-a8f4-4db6-8615-e486522baaaa",
    "patient_ID": "TCGA.24.0966",
    "bcr_drug_barcode": "TCGA-24-0966-D25878",
    "bcr_drug_uuid": "b56ccf47-30cb-49bc-a45b-5d2c2d1617f1",
    "form_completion_date": "2009-3-30",
    "pharmaceutical_therapy_drug_name": "AVASTIN/BEVACIZUMAB/PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 71,
    "days_to_drug_end": 120,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2457
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25884",
    "bcr_drug_uuid": "e3ed5ab9-5714-4914-8344-71cafcd55745",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSITANT DISEASE; GIVEN WITH GEMZAR"
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25888",
    "bcr_drug_uuid": "44789b67-0fe7-4ee7-9461-8adc8b68a710",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25886",
    "bcr_drug_uuid": "98a1282c-fc9a-4ae4-a806-3cd66d04a656",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25883",
    "bcr_drug_uuid": "46c69a64-5995-4736-b17c-f77e8e340301",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSITANT DISEASE; GIVEN WITH GEMZAR"
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25881",
    "bcr_drug_uuid": "33f57318-3e28-48d4-b198-23a2ab37b5ea",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2790
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25882",
    "bcr_drug_uuid": "80e7d102-6aab-4e2b-a2f5-5e98667313d4",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1378
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25887",
    "bcr_drug_uuid": "3b897a94-6154-4608-9a7b-720eb376d971",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25885",
    "bcr_drug_uuid": "4bd719b9-d64e-4581-85e3-5806c52eecc0",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSITANT DISEASE; GIVEN 1X WITH DOXIL"
  },
  {
    "bcr_patient_uuid": "619b14f3-b8cc-4c0a-8304-6719853d592a",
    "patient_ID": "TCGA.24.0968",
    "bcr_drug_barcode": "TCGA-24-0968-D25889",
    "bcr_drug_uuid": "c04896d2-d54b-40dc-a0dd-6dae1fccadd8",
    "form_completion_date": "2010-2-25",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTANT DISEASE; GIVEN 1X WITH CISPLATIN"
  },
  {
    "bcr_patient_uuid": "95e58015-a7c0-4bdc-bf64-7617d24d0784",
    "patient_ID": "TCGA.24.0970",
    "bcr_drug_barcode": "TCGA-24-0970-D25873",
    "bcr_drug_uuid": "426b35b9-eeab-4015-898d-f5a50d3c5f6e",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "days_to_drug_end": 314,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 152
  },
  {
    "bcr_patient_uuid": "95e58015-a7c0-4bdc-bf64-7617d24d0784",
    "patient_ID": "TCGA.24.0970",
    "bcr_drug_barcode": "TCGA-24-0970-D25871",
    "bcr_drug_uuid": "e1f3db9f-1bfe-4fca-8fb6-d17d4ae824fa",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1980
  },
  {
    "bcr_patient_uuid": "95e58015-a7c0-4bdc-bf64-7617d24d0784",
    "patient_ID": "TCGA.24.0970",
    "bcr_drug_barcode": "TCGA-24-0970-D25872",
    "bcr_drug_uuid": "3d5f98c0-fb1e-4647-aa0f-4e9ab61b6d8b",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "days_to_drug_end": 314,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3840
  },
  {
    "bcr_patient_uuid": "6a57948c-0dc5-4ea2-8043-380f26763752",
    "patient_ID": "TCGA.24.0975",
    "bcr_drug_barcode": "TCGA-24-0975-D25864",
    "bcr_drug_uuid": "441ae864-4ce1-43eb-8f2c-3783269ca89b",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6a57948c-0dc5-4ea2-8043-380f26763752",
    "patient_ID": "TCGA.24.0975",
    "bcr_drug_barcode": "TCGA-24-0975-D25867",
    "bcr_drug_uuid": "e255c05a-03e0-47a8-a3bc-064fe0d4449b",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 611,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6a57948c-0dc5-4ea2-8043-380f26763752",
    "patient_ID": "TCGA.24.0975",
    "bcr_drug_barcode": "TCGA-24-0975-D25862",
    "bcr_drug_uuid": "b6206599-e812-43db-8625-fdd6a2142a9c",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6a57948c-0dc5-4ea2-8043-380f26763752",
    "patient_ID": "TCGA.24.0975",
    "bcr_drug_barcode": "TCGA-24-0975-D25865",
    "bcr_drug_uuid": "fbde8509-b99c-4069-86ea-638a3eff0d8d",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6a57948c-0dc5-4ea2-8043-380f26763752",
    "patient_ID": "TCGA.24.0975",
    "bcr_drug_barcode": "TCGA-24-0975-D25866",
    "bcr_drug_uuid": "afafd8b8-0b8c-4e45-944e-df82466920bf",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 611,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6a57948c-0dc5-4ea2-8043-380f26763752",
    "patient_ID": "TCGA.24.0975",
    "bcr_drug_barcode": "TCGA-24-0975-D25863",
    "bcr_drug_uuid": "f67062fb-a896-4c7b-adab-2bfedbaf34cf",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9a30dee8-962a-49db-a85a-c39515c91b68",
    "patient_ID": "TCGA.24.0979",
    "bcr_drug_barcode": "TCGA-24-0979-D25893",
    "bcr_drug_uuid": "8942e664-0aaa-4893-ab7d-027ca7215144",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9a30dee8-962a-49db-a85a-c39515c91b68",
    "patient_ID": "TCGA.24.0979",
    "bcr_drug_barcode": "TCGA-24-0979-D25892",
    "bcr_drug_uuid": "95fa449a-d622-4c36-a4d4-fe256899666f",
    "form_completion_date": "2009-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d1eeaca3-52c0-4a0c-916a-fd64cec911d9",
    "patient_ID": "TCGA.24.0980",
    "bcr_drug_barcode": "TCGA-24-0980-D25897",
    "bcr_drug_uuid": "15cde1b3-b643-4d88-b4e5-6a05bfb9ab64",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "days_to_drug_end": 178,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1265.5
  },
  {
    "bcr_patient_uuid": "d1eeaca3-52c0-4a0c-916a-fd64cec911d9",
    "patient_ID": "TCGA.24.0980",
    "bcr_drug_barcode": "TCGA-24-0980-D25898",
    "bcr_drug_uuid": "2f798bfb-2136-4d59-81f1-297bc7fbf831",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "days_to_drug_end": 178,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2012
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25901",
    "bcr_drug_uuid": "09307e85-1a95-410e-96db-c9761556f6fb",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4090
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25903",
    "bcr_drug_uuid": "ef503cec-e161-41bd-85a3-8bb01f6b1328",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 39
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25902",
    "bcr_drug_uuid": "86c8e150-07cf-4e9e-83d9-e57f33818e05",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1966
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25906",
    "bcr_drug_uuid": "52092e56-744b-43f4-8bda-609e63790207",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 474,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 388
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25905",
    "bcr_drug_uuid": "912d8e00-f08e-482d-bb62-634b415019cc",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 474,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 24798
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25904",
    "bcr_drug_uuid": "8070fa1e-6749-46b8-af00-245149e18154",
    "form_completion_date": "2009-3-10",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25907",
    "bcr_drug_uuid": "ce37916d-d891-424a-bc45-12e3cb0755f6",
    "form_completion_date": "2010-1-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 615,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2276
  },
  {
    "bcr_patient_uuid": "206ce0ed-36a4-47ab-ac8e-f6fca6ac5c18",
    "patient_ID": "TCGA.24.0982",
    "bcr_drug_barcode": "TCGA-24-0982-D25908",
    "bcr_drug_uuid": "8e3d7162-d3b2-4f32-b3a8-948be3ee41ab",
    "form_completion_date": "2010-1-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 488,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 615,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3800
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25825",
    "bcr_drug_uuid": "f44476cf-cc04-42d3-bb41-71b9b94dd313",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1920
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25826",
    "bcr_drug_uuid": "5c3acf57-141b-4ce6-91fe-581490c243ba",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 694,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 910,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 43.2
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25828",
    "bcr_drug_uuid": "31b255dd-31d7-4ed8-933f-d460bb56c52e",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1016,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 756
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25827",
    "bcr_drug_uuid": "22f59aba-f17a-4a62-99f6-f823663235f8",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 694,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 910,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 816
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25829",
    "bcr_drug_uuid": "ded5f911-f2be-4407-8843-973d988ec6b2",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2210
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25831",
    "bcr_drug_uuid": "ba9a1f08-8120-426b-8d9e-75de1729a6ff",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1625,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 130
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25830",
    "bcr_drug_uuid": "23789e95-afa2-45e4-863c-265228e4944c",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1016,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2322
  },
  {
    "bcr_patient_uuid": "f34aa3b6-e966-49c6-bc55-130545772c53",
    "patient_ID": "TCGA.24.1103",
    "bcr_drug_barcode": "TCGA-24-1103-D25832",
    "bcr_drug_uuid": "e6d71b0b-52f3-46bb-9928-e8313c172b61",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1625,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 347
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25835",
    "bcr_drug_uuid": "49a7aa0b-ee9a-451f-bbc4-1b6de517ec0e",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1518
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25836",
    "bcr_drug_uuid": "e9de231f-ab26-4ed6-af61-fa3e6e1173f7",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1526,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1589,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 190
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25837",
    "bcr_drug_uuid": "b446a898-1eae-4f20-88d0-55fafab04fa8",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25838",
    "bcr_drug_uuid": "d48553ab-2f2b-4708-8d43-fdd995fa330c",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2007
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25839",
    "bcr_drug_uuid": "3bcc4b9b-c529-4706-845d-5c82f0e81e9a",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1001,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1113,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25841",
    "bcr_drug_uuid": "8d708e6e-b456-4878-9446-dad3734222aa",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1858,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1876,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 438
  },
  {
    "bcr_patient_uuid": "f9f44f86-10c7-4473-b156-5afbfa9a2ad0",
    "patient_ID": "TCGA.24.1104",
    "bcr_drug_barcode": "TCGA-24-1104-D25840",
    "bcr_drug_uuid": "3a12c164-e3cd-4312-ba87-6320222e0dbc",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1001,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1113,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 402
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25846",
    "bcr_drug_uuid": "ecff3707-6213-40e7-bfba-a2b87b1ac780",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25850",
    "bcr_drug_uuid": "19208898-549c-4bec-9587-862255401569",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1004,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1116,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 258
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25849",
    "bcr_drug_uuid": "b0de8465-4152-4b3c-88e6-fc2adbdc54ed",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1004,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1116,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 19320
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25852",
    "bcr_drug_uuid": "666da692-65f8-4bad-ab2d-32179231bdbf",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1375,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 92
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25847",
    "bcr_drug_uuid": "f2b55619-c372-4f75-83ac-52dd647bcbf0",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 724,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 860,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 48.2
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25851",
    "bcr_drug_uuid": "ddb1bcf5-8150-4936-9f35-65b161732d58",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1228,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1298,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25858",
    "bcr_drug_uuid": "42d6f1c9-fe2e-40a1-8017-3c7fcbb35bb9",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1228,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1298,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2001
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25845",
    "bcr_drug_uuid": "a5c72ec2-4288-4610-a12d-5a88be4834ee",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3410
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25848",
    "bcr_drug_uuid": "6b4fe1cc-975c-40fb-8ba2-24ceed6eb1f4",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 724,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 860,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 486
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25853",
    "bcr_drug_uuid": "b73fda29-b8ca-47ae-9cb2-74fcbfeaa2b7",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1130,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1200,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2275
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25855",
    "bcr_drug_uuid": "df0b4051-0453-488c-abe4-2edaeb0ec8c0",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1375,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1826
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25854",
    "bcr_drug_uuid": "1e77ffe6-2c69-45a6-8102-044a2aa42a6f",
    "form_completion_date": "2010-2-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1313,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1340,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 975
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25857",
    "bcr_drug_uuid": "46f8c3f9-d453-4187-9a47-96a473ca8e76",
    "form_completion_date": "2010-3-10",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 486,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 584,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1725
  },
  {
    "bcr_patient_uuid": "7e01f23a-0b0e-46a2-9f30-c3a9d2c779d2",
    "patient_ID": "TCGA.24.1105",
    "bcr_drug_barcode": "TCGA-24-1105-D25856",
    "bcr_drug_uuid": "b73f86c1-9dc1-4f86-b095-649ed53d41e2",
    "form_completion_date": "2010-3-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 486,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 584,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3360
  },
  {
    "bcr_patient_uuid": "3fc8f799-5bd3-4f48-baf0-c458ce86ab7e",
    "patient_ID": "TCGA.24.1413",
    "bcr_drug_barcode": "TCGA-24-1413-D25911",
    "bcr_drug_uuid": "2c6dac55-044c-46d6-a296-897bda1add73",
    "form_completion_date": "2009-3-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1340
  },
  {
    "bcr_patient_uuid": "3fc8f799-5bd3-4f48-baf0-c458ce86ab7e",
    "patient_ID": "TCGA.24.1413",
    "bcr_drug_barcode": "TCGA-24-1413-D25912",
    "bcr_drug_uuid": "86d3680c-7af1-4bcf-9466-ac5d0d032144",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3864
  },
  {
    "bcr_patient_uuid": "f9793a4b-c0e7-4475-bf80-69543b7ee2f6",
    "patient_ID": "TCGA.24.1416",
    "bcr_drug_barcode": "TCGA-24-1416-D25916",
    "bcr_drug_uuid": "97a17aa1-374b-4024-b74c-8329f9811fc9",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 946
  },
  {
    "bcr_patient_uuid": "f9793a4b-c0e7-4475-bf80-69543b7ee2f6",
    "patient_ID": "TCGA.24.1416",
    "bcr_drug_barcode": "TCGA-24-1416-D25917",
    "bcr_drug_uuid": "d5c511d8-151f-4705-9bc4-f38116984562",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 647
  },
  {
    "bcr_patient_uuid": "f9793a4b-c0e7-4475-bf80-69543b7ee2f6",
    "patient_ID": "TCGA.24.1416",
    "bcr_drug_barcode": "TCGA-24-1416-D25915",
    "bcr_drug_uuid": "c1f341c3-2bb0-4ba5-be48-5a13a54fc492",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 934
  },
  {
    "bcr_patient_uuid": "f9793a4b-c0e7-4475-bf80-69543b7ee2f6",
    "patient_ID": "TCGA.24.1416",
    "bcr_drug_barcode": "TCGA-24-1416-D25918",
    "bcr_drug_uuid": "9b15719a-2356-4fa2-9a7f-42274bbac4a7",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 422
  },
  {
    "bcr_patient_uuid": "48f831b0-5d91-44ae-bc4e-db57ca84fe46",
    "patient_ID": "TCGA.24.1417",
    "bcr_drug_barcode": "TCGA-24-1417-D25921",
    "bcr_drug_uuid": "df82d543-c4f6-4f73-8dfa-b8a5c33a8cce",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2538
  },
  {
    "bcr_patient_uuid": "48f831b0-5d91-44ae-bc4e-db57ca84fe46",
    "patient_ID": "TCGA.24.1417",
    "bcr_drug_barcode": "TCGA-24-1417-D25922",
    "bcr_drug_uuid": "f6dfbc3c-363e-4bc3-8873-82cbcf734bfa",
    "form_completion_date": "2009-4-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5500
  },
  {
    "bcr_patient_uuid": "195ecf43-06bd-4ffe-8d8b-a766f3f7179b",
    "patient_ID": "TCGA.24.1418",
    "bcr_drug_barcode": "TCGA-24-1418-D25927",
    "bcr_drug_uuid": "2e35c3fb-6a4e-42c0-bb5d-928456c65618",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZAMAB/PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8459
  },
  {
    "bcr_patient_uuid": "195ecf43-06bd-4ffe-8d8b-a766f3f7179b",
    "patient_ID": "TCGA.24.1418",
    "bcr_drug_barcode": "TCGA-24-1418-D25925",
    "bcr_drug_uuid": "cbfa21bd-902b-45ff-9d92-67b836fa99b9",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1510
  },
  {
    "bcr_patient_uuid": "195ecf43-06bd-4ffe-8d8b-a766f3f7179b",
    "patient_ID": "TCGA.24.1418",
    "bcr_drug_barcode": "TCGA-24-1418-D25926",
    "bcr_drug_uuid": "9911f81a-48c0-47f9-aa6e-343694b85003",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2554
  },
  {
    "bcr_patient_uuid": "5e18b17d-4626-4b6d-8ac6-e560cee0376c",
    "patient_ID": "TCGA.24.1419",
    "bcr_drug_barcode": "TCGA-24-1419-D25930",
    "bcr_drug_uuid": "91f667fe-afb5-471d-af76-66b09ed65858",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3882
  },
  {
    "bcr_patient_uuid": "5e18b17d-4626-4b6d-8ac6-e560cee0376c",
    "patient_ID": "TCGA.24.1419",
    "bcr_drug_barcode": "TCGA-24-1419-D25931",
    "bcr_drug_uuid": "fb686b35-70cb-45e0-991c-0169f28f0115",
    "form_completion_date": "2009-4-15",
    "pharmaceutical_therapy_drug_name": "PACITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "CONSOLIDATION CHEMOTHERAPY",
    "drug_total_dose": 478
  },
  {
    "bcr_patient_uuid": "5e18b17d-4626-4b6d-8ac6-e560cee0376c",
    "patient_ID": "TCGA.24.1419",
    "bcr_drug_barcode": "TCGA-24-1419-D25932",
    "bcr_drug_uuid": "248762ea-e200-4742-b0f3-bcd821f96cf3",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 806
  },
  {
    "bcr_patient_uuid": "f64ebc7f-0e5a-42b4-af57-6cdb90d24f90",
    "patient_ID": "TCGA.24.1423",
    "bcr_drug_barcode": "TCGA-24-1423-D25939",
    "bcr_drug_uuid": "69287a5a-8ebe-4dbd-b3aa-2c81832c098b",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1703
  },
  {
    "bcr_patient_uuid": "f64ebc7f-0e5a-42b4-af57-6cdb90d24f90",
    "patient_ID": "TCGA.24.1423",
    "bcr_drug_barcode": "TCGA-24-1423-D25938",
    "bcr_drug_uuid": "cf137e40-7f33-415e-834a-da9dfb583a3c",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 532
  },
  {
    "bcr_patient_uuid": "f64ebc7f-0e5a-42b4-af57-6cdb90d24f90",
    "patient_ID": "TCGA.24.1423",
    "bcr_drug_barcode": "TCGA-24-1423-D25937",
    "bcr_drug_uuid": "dfa0c377-ef42-4909-977c-58d6c1d64fe9",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 477
  },
  {
    "bcr_patient_uuid": "c3e443b9-5dc5-4793-91e3-534f21485268",
    "patient_ID": "TCGA.24.1424",
    "bcr_drug_barcode": "TCGA-24-1424-D25942",
    "bcr_drug_uuid": "763af0d0-0624-41b1-bd45-20ace6a3e7c8",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1441
  },
  {
    "bcr_patient_uuid": "c3e443b9-5dc5-4793-91e3-534f21485268",
    "patient_ID": "TCGA.24.1424",
    "bcr_drug_barcode": "TCGA-24-1424-D25944",
    "bcr_drug_uuid": "2d84d139-9b11-4149-96e4-346b15bfdf3e",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 429
  },
  {
    "bcr_patient_uuid": "c3e443b9-5dc5-4793-91e3-534f21485268",
    "patient_ID": "TCGA.24.1424",
    "bcr_drug_barcode": "TCGA-24-1424-D25943",
    "bcr_drug_uuid": "528aaae9-7fb0-4b0e-a7c6-1492c1d7808f",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 972
  },
  {
    "bcr_patient_uuid": "b120b701-c194-43d7-a491-3206fac38ec1",
    "patient_ID": "TCGA.24.1425",
    "bcr_drug_barcode": "TCGA-24-1425-D25948",
    "bcr_drug_uuid": "4e000e93-7c9c-430e-803d-b235fa58d076",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5065
  },
  {
    "bcr_patient_uuid": "b120b701-c194-43d7-a491-3206fac38ec1",
    "patient_ID": "TCGA.24.1425",
    "bcr_drug_barcode": "TCGA-24-1425-D25949",
    "bcr_drug_uuid": "96ca010b-3b93-4206-8972-2599cf9895cd",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 553
  },
  {
    "bcr_patient_uuid": "b120b701-c194-43d7-a491-3206fac38ec1",
    "patient_ID": "TCGA.24.1425",
    "bcr_drug_barcode": "TCGA-24-1425-D25947",
    "bcr_drug_uuid": "def339b3-1e0a-4329-aaae-7a397dcd76a1",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 832
  },
  {
    "bcr_patient_uuid": "c8acee1b-6854-409b-86ab-bf69dbe22ab6",
    "patient_ID": "TCGA.24.1426",
    "bcr_drug_barcode": "TCGA-24-1426-D25954",
    "bcr_drug_uuid": "b9d51cf6-9d92-4497-97a8-30a39aea0f11",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "c8acee1b-6854-409b-86ab-bf69dbe22ab6",
    "patient_ID": "TCGA.24.1426",
    "bcr_drug_barcode": "TCGA-24-1426-D25952",
    "bcr_drug_uuid": "15275f97-b04f-43e1-822e-15c46ca9b9b8",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "c8acee1b-6854-409b-86ab-bf69dbe22ab6",
    "patient_ID": "TCGA.24.1426",
    "bcr_drug_barcode": "TCGA-24-1426-D25953",
    "bcr_drug_uuid": "ccad2740-e09b-4453-8196-ca0bba953c68",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": -8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "02d9aa2e-b16a-48ea-a420-5daed9fd51a6",
    "patient_ID": "TCGA.24.1427",
    "bcr_drug_barcode": "TCGA-24-1427-D25958",
    "bcr_drug_uuid": "f0961ad4-f0c1-406c-ae2d-9d44d6118237",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3848
  },
  {
    "bcr_patient_uuid": "02d9aa2e-b16a-48ea-a420-5daed9fd51a6",
    "patient_ID": "TCGA.24.1427",
    "bcr_drug_barcode": "TCGA-24-1427-D25957",
    "bcr_drug_uuid": "c30b8039-7ef8-495e-954e-b0985c302c10",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1996
  },
  {
    "bcr_patient_uuid": "9c744ff8-1cde-4176-b6d7-0ab62bf42620",
    "patient_ID": "TCGA.24.1428",
    "bcr_drug_barcode": "TCGA-24-1428-D25961",
    "bcr_drug_uuid": "d43e79be-c0cc-4f9b-9631-fbaebe20de3a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "9c744ff8-1cde-4176-b6d7-0ab62bf42620",
    "patient_ID": "TCGA.24.1428",
    "bcr_drug_barcode": "TCGA-24-1428-D25962",
    "bcr_drug_uuid": "b79259a9-f490-4eb8-b109-250dc9b3e2bb",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "9c744ff8-1cde-4176-b6d7-0ab62bf42620",
    "patient_ID": "TCGA.24.1428",
    "bcr_drug_barcode": "TCGA-24-1428-D25963",
    "bcr_drug_uuid": "5548e7d7-b1dd-43fa-8ccc-db41342a5281",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 130,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "9c744ff8-1cde-4176-b6d7-0ab62bf42620",
    "patient_ID": "TCGA.24.1428",
    "bcr_drug_barcode": "TCGA-24-1428-D25964",
    "bcr_drug_uuid": "acd19c02-f634-4947-b1d5-33ce6ddcd4f5",
    "form_completion_date": "2010-6-11",
    "pharmaceutical_therapy_drug_name": "CARBPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 508,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1519
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25968",
    "bcr_drug_uuid": "4630dd23-dba3-4101-8d84-62b9fd51dfa3",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1252
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25971",
    "bcr_drug_uuid": "bafc8e9f-3310-409a-9129-50f29f23b38d",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 568,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 624,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 177
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25973",
    "bcr_drug_uuid": "26fd89d8-c384-4c27-8f76-e8fa42667511",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 652,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 769,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1960
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25969",
    "bcr_drug_uuid": "ada775a9-b4ec-43c5-bf11-7533cd8667cd",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "AMITOSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5301
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25972",
    "bcr_drug_uuid": "3194f6fd-af01-4f55-ba85-50eb0bd7af8e",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 652,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 769,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 128
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25967",
    "bcr_drug_uuid": "574ea0f6-0c98-43ed-a8c7-3bf90f81ae70",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 539
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25975",
    "bcr_drug_uuid": "2a8e83d3-0e03-4a92-ac3d-9db1c4104de4",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "GOMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 804,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 841,
    "drug_cycles": 1.5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5150
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25974",
    "bcr_drug_uuid": "a3db39b6-eb97-47a8-8e64-cb0d8de8ffab",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 804,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 841,
    "drug_cycles": 1.5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 81
  },
  {
    "bcr_patient_uuid": "3018efe7-13a1-47ae-a726-8fc967c73841",
    "patient_ID": "TCGA.24.1430",
    "bcr_drug_barcode": "TCGA-24-1430-D25970",
    "bcr_drug_uuid": "cbaf76a6-ae77-42d5-8ff7-fdc31b7a31bb",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 463,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 547,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 44.88
  },
  {
    "bcr_patient_uuid": "384170fc-e8be-426a-a54e-bf1ca61f2986",
    "patient_ID": "TCGA.24.1431",
    "bcr_drug_barcode": "TCGA-24-1431-D25982",
    "bcr_drug_uuid": "db569566-3e65-423b-89ee-f96f8dd2ae9d",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "384170fc-e8be-426a-a54e-bf1ca61f2986",
    "patient_ID": "TCGA.24.1431",
    "bcr_drug_barcode": "TCGA-24-1431-D25978",
    "bcr_drug_uuid": "f75d63b3-e5e9-4e08-a119-43aa095dec60",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "384170fc-e8be-426a-a54e-bf1ca61f2986",
    "patient_ID": "TCGA.24.1431",
    "bcr_drug_barcode": "TCGA-24-1431-D25979",
    "bcr_drug_uuid": "e647deaf-bd3a-46ee-929f-aec2930b59d4",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "384170fc-e8be-426a-a54e-bf1ca61f2986",
    "patient_ID": "TCGA.24.1431",
    "bcr_drug_barcode": "TCGA-24-1431-D25980",
    "bcr_drug_uuid": "bb8a8867-a1b4-46fb-8c6d-fb1b8f31fcfe",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 262,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 308,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "384170fc-e8be-426a-a54e-bf1ca61f2986",
    "patient_ID": "TCGA.24.1431",
    "bcr_drug_barcode": "TCGA-24-1431-D25981",
    "bcr_drug_uuid": "e6f0b81a-42c2-40cb-b3a4-e2fa19737f34",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25985",
    "bcr_drug_uuid": "e6cc7a45-81ef-4091-9c90-12614add799c",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 284
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25988",
    "bcr_drug_uuid": "dd5e3e6f-08f9-4449-8085-6d08ee8f8737",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 281,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 314,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 24
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25986",
    "bcr_drug_uuid": "7daf51fd-b9e9-40ab-8923-3827104240b3",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1890
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25987",
    "bcr_drug_uuid": "6114e4ae-ce79-42ec-a860-ff6e8be5c913",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "GEMZET",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 228,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 16000
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25991",
    "bcr_drug_uuid": "d5d87b8c-f2a7-4933-952a-d6d64697e9b0",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 535,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 756
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25990",
    "bcr_drug_uuid": "5335c47b-38e3-47d8-ba92-73a859a8d43b",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 395,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 426,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "5503b3a1-7d03-41b2-9ec8-e478c5414d67",
    "patient_ID": "TCGA.24.1434",
    "bcr_drug_barcode": "TCGA-24-1434-D25989",
    "bcr_drug_uuid": "d46e3ac3-da2a-4655-b0e8-04190ea91652",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 371,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D26000",
    "bcr_drug_uuid": "2833bed6-7480-43d9-b6d1-4528bb4bc1ac",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "GEMAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1189,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6952
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D25995",
    "bcr_drug_uuid": "a4a2e768-8d66-4eef-9a7e-e24397ed1287",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 511,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 771,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 135.9
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D25999",
    "bcr_drug_uuid": "ceab1fa5-5738-4e60-9100-6e0a1b677193",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1140,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1189,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 263
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D26001",
    "bcr_drug_uuid": "11036e12-450c-404f-99fd-492656d8bc80",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1259,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1266,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9.63
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D25996",
    "bcr_drug_uuid": "6094c2cf-43ec-43b8-a9ec-8e21041440e4",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 814,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 912,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2350
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D25998",
    "bcr_drug_uuid": "cf7b733e-4265-4eab-9822-3974d73a0a34",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1058,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1126,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4500
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D25994",
    "bcr_drug_uuid": "b65aacb1-c5bb-431b-b422-9d3a5053f383",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3590
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D25997",
    "bcr_drug_uuid": "ceaae508-8082-4f39-b5d5-356e4dba9b75",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 944,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1028,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 286
  },
  {
    "bcr_patient_uuid": "49d2c0cf-a3f3-4519-a755-0a5f769df2ea",
    "patient_ID": "TCGA.24.1435",
    "bcr_drug_barcode": "TCGA-24-1435-D26002",
    "bcr_drug_uuid": "4308a2a0-1e10-4c84-bc45-6ecfc1e7729b",
    "form_completion_date": "2009-5-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1848
  },
  {
    "bcr_patient_uuid": "6e84e89d-4f35-43b8-b47d-b1343b8c1ab9",
    "patient_ID": "TCGA.24.1436",
    "bcr_drug_barcode": "TCGA-24-1436-D26006",
    "bcr_drug_uuid": "af7ffeda-3c58-4d51-a79b-eb8aac840cf2",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1282
  },
  {
    "bcr_patient_uuid": "6e84e89d-4f35-43b8-b47d-b1343b8c1ab9",
    "patient_ID": "TCGA.24.1436",
    "bcr_drug_barcode": "TCGA-24-1436-D26007",
    "bcr_drug_uuid": "82fcfea2-5e77-496f-9bc7-3f26570982f2",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 28.25
  },
  {
    "bcr_patient_uuid": "6e84e89d-4f35-43b8-b47d-b1343b8c1ab9",
    "patient_ID": "TCGA.24.1436",
    "bcr_drug_barcode": "TCGA-24-1436-D26005",
    "bcr_drug_uuid": "075db38d-494a-43d6-87ac-701eef1c15bb",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26020",
    "bcr_drug_uuid": "ed822373-fdf3-4ff0-b016-89d6d3a79706",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1742,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1791,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 168
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26019",
    "bcr_drug_uuid": "f8497cc1-74f7-4707-81d7-cd60360edb9b",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1600,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1733,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2275
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26012",
    "bcr_drug_uuid": "c98d3bb2-e60e-4279-b057-73e950818533",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 976,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1084,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1660
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26015",
    "bcr_drug_uuid": "3b745d08-afcc-48eb-8a61-35314bdb9ee8",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1270,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1383,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 49.4
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26014",
    "bcr_drug_uuid": "a858e299-ace2-4e04-928c-9a5938100d07",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 976,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1084,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 172
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26017",
    "bcr_drug_uuid": "6510eb77-3a5d-419f-980b-ca3687eb0f83",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1465,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1558,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20684
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26018",
    "bcr_drug_uuid": "1d34f8bd-3209-421a-a381-503783bec76d",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1465,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1558,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 277
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26011",
    "bcr_drug_uuid": "e6da954d-4e2e-4695-8f5e-e641e746c8e5",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1712
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26010",
    "bcr_drug_uuid": "cfa3c675-5453-420f-81dd-b11485a4d8de",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3310
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26013",
    "bcr_drug_uuid": "9a2292f5-c1c1-4c34-baa7-75659a6b31a0",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 976,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1084,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1895
  },
  {
    "bcr_patient_uuid": "171f7917-69eb-4a3f-9cc0-0e1dffd412c1",
    "patient_ID": "TCGA.24.1463",
    "bcr_drug_barcode": "TCGA-24-1463-D26016",
    "bcr_drug_uuid": "094334ef-5942-45f8-ab0a-d1b1ef328303",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1270,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1383,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 508
  },
  {
    "bcr_patient_uuid": "4160e048-f0b0-40f5-805b-e277a5893a3b",
    "patient_ID": "TCGA.24.1464",
    "bcr_drug_barcode": "TCGA-24-1464-D26023",
    "bcr_drug_uuid": "00cf7ce9-c07f-4dad-9bb6-c753b989cc0a",
    "form_completion_date": "2009-4-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1937
  },
  {
    "bcr_patient_uuid": "4160e048-f0b0-40f5-805b-e277a5893a3b",
    "patient_ID": "TCGA.24.1464",
    "bcr_drug_barcode": "TCGA-24-1464-D26024",
    "bcr_drug_uuid": "b1703138-84c6-4bae-8a50-718ca2ebde6f",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5555
  },
  {
    "bcr_patient_uuid": "4160e048-f0b0-40f5-805b-e277a5893a3b",
    "patient_ID": "TCGA.24.1464",
    "bcr_drug_barcode": "TCGA-24-1464-D26025",
    "bcr_drug_uuid": "5610bcd5-4bfb-40ee-bdd7-15c71555094a",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 342,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 343,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8.44
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26033",
    "bcr_drug_uuid": "f173fa84-796d-4b1c-a328-63bc667ded63",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 880,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1020,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3110
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26037",
    "bcr_drug_uuid": "60fd442d-0cea-4420-beb7-74230f801921",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1227,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26030",
    "bcr_drug_uuid": "c6e44e2b-090b-4e55-bdde-6b44e3a1f501",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1715
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26032",
    "bcr_drug_uuid": "95c8c713-2e46-4b1f-ba01-0327f5df424f",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 483,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 680,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3820
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26035",
    "bcr_drug_uuid": "7a193f01-5589-49f8-affe-87258ba73206",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TOPETECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1081,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1216,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 57.6
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26036",
    "bcr_drug_uuid": "d560fa78-e2e9-4912-a9de-fefea60898f4",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 670,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 852,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26031",
    "bcr_drug_uuid": "565fb3ee-a4c7-4150-a80f-4b2abfcc9bc0",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 483,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 680,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1904
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26029",
    "bcr_drug_uuid": "e6de86e0-4434-4398-93ab-507903ddf2e5",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3502
  },
  {
    "bcr_patient_uuid": "098acb76-0bf5-44e5-bcae-f919cf5fa5e5",
    "patient_ID": "TCGA.24.1466",
    "bcr_drug_barcode": "TCGA-24-1466-D26034",
    "bcr_drug_uuid": "da59a6a9-6e33-407b-aaca-6d930603d936",
    "form_completion_date": "2009-4-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 880,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1020,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1564
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26046",
    "bcr_drug_uuid": "b48c9b58-4f39-41a9-9475-781a87ef06c1",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1804,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1909,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26049",
    "bcr_drug_uuid": "27368d0d-fbd6-44f4-b65c-ac5ae2b8380a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2476,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2531,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26057",
    "bcr_drug_uuid": "7e70652e-a5d0-4f50-9fc4-8343dabac54a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2819,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2889,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3610
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26041",
    "bcr_drug_uuid": "79b8d114-bedd-4c6e-b9af-333a85dc5a85",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 110,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4565
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26050",
    "bcr_drug_uuid": "4599a840-cb0a-43d2-9461-c29b7c3f9a0b",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOXETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2561,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2737,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1350
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26042",
    "bcr_drug_uuid": "fb26dbaa-2ce9-4a77-94dd-c1e3a03fd281",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1277,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1391,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1780
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26044",
    "bcr_drug_uuid": "46af543c-9421-4864-823d-c9ad5d81850d",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1277,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1391,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26048",
    "bcr_drug_uuid": "2789fe54-3b24-476b-bbaa-b6003d617c4d",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2170,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2296,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26045",
    "bcr_drug_uuid": "825e30c9-5a77-4cd9-8b02-62cb9cb2000f",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1804,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1909,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1620
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26052",
    "bcr_drug_uuid": "0deb02e0-1be4-4b66-9b33-f2ab838a750e",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CYTOXEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2819,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2889,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26054",
    "bcr_drug_uuid": "a4acf824-ec0d-4ff6-a1e2-2e4dbe449d6a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3073,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 3101,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 21
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26055",
    "bcr_drug_uuid": "7f1be972-6b5d-41cc-8707-73ef55706f5a",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2363,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2458,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26043",
    "bcr_drug_uuid": "ed7b02b2-b81a-44b4-a476-72c61e8c5558",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1277,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1391,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1275
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26051",
    "bcr_drug_uuid": "f10bb298-cef0-480a-a2aa-c2cfba674c88",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2561,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2737,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 115
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26058",
    "bcr_drug_uuid": "faac15d8-07b9-42b6-908d-b0fbc92e4927",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2989,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3059,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8871
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26053",
    "bcr_drug_uuid": "ec830e30-41a6-4b9d-bcf9-ab281700ff79",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2989,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 3059,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26056",
    "bcr_drug_uuid": "d9d6017a-251c-4150-b37a-91c584273b99",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 2758,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26040",
    "bcr_drug_uuid": "03fc29d1-6abc-40fe-ace3-74f6a4214538",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2650
  },
  {
    "bcr_patient_uuid": "34f545ab-d420-4dd2-8db4-3159896efd23",
    "patient_ID": "TCGA.24.1467",
    "bcr_drug_barcode": "TCGA-24-1467-D26047",
    "bcr_drug_uuid": "2b31a6de-3753-4ca2-91a0-03eb6c130d67",
    "form_completion_date": "2009-4-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2170,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2296,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56",
    "patient_ID": "TCGA.24.1469",
    "bcr_drug_barcode": "TCGA-24-1469-D26061",
    "bcr_drug_uuid": "0669881e-ea31-48f5-a8fb-5f91b62e6e9c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cd6e5d3d-1c86-40dd-9cb3-b2e2075dec56",
    "patient_ID": "TCGA.24.1469",
    "bcr_drug_barcode": "TCGA-24-1469-D26062",
    "bcr_drug_uuid": "8b7e3c93-43ce-4a4c-88e0-eebfe8e5373a",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a3898640-0d85-441d-a000-b5b8ff857399",
    "patient_ID": "TCGA.24.1470",
    "bcr_drug_barcode": "TCGA-24-1470-D26066",
    "bcr_drug_uuid": "c67a8709-2f8f-4d07-b3d0-548234c86b68",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 593
  },
  {
    "bcr_patient_uuid": "a3898640-0d85-441d-a000-b5b8ff857399",
    "patient_ID": "TCGA.24.1470",
    "bcr_drug_barcode": "TCGA-24-1470-D26065",
    "bcr_drug_uuid": "521e955c-b121-4399-9a5b-4e665a6d8c53",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 475
  },
  {
    "bcr_patient_uuid": "a3898640-0d85-441d-a000-b5b8ff857399",
    "patient_ID": "TCGA.24.1470",
    "bcr_drug_barcode": "TCGA-24-1470-D26067",
    "bcr_drug_uuid": "3285d027-0f38-45a6-807c-92ef0d27504d",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "ceb19678-b453-4529-b6cb-d02f9cb101b4",
    "patient_ID": "TCGA.24.1471",
    "bcr_drug_barcode": "TCGA-24-1471-D26070",
    "bcr_drug_uuid": "9214c29b-a67f-4762-9ca0-9297a0bad8ac",
    "form_completion_date": "2010-5-24",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ceb19678-b453-4529-b6cb-d02f9cb101b4",
    "patient_ID": "TCGA.24.1471",
    "bcr_drug_barcode": "TCGA-24-1471-D26071",
    "bcr_drug_uuid": "789f5290-ddbc-4a16-8398-ab5cb498b563",
    "form_completion_date": "2010-5-24",
    "pharmaceutical_therapy_drug_name": "GOG 218",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d7b3156d-672a-4a55-868d-9ca6a09fcb0f",
    "patient_ID": "TCGA.24.1474",
    "bcr_drug_barcode": "TCGA-24-1474-D26075",
    "bcr_drug_uuid": "bfeee902-a018-4e6e-bb1d-38e6dfa8586a",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1962
  },
  {
    "bcr_patient_uuid": "d7b3156d-672a-4a55-868d-9ca6a09fcb0f",
    "patient_ID": "TCGA.24.1474",
    "bcr_drug_barcode": "TCGA-24-1474-D26077",
    "bcr_drug_uuid": "2a00f718-f1e2-4eff-bc7f-5b77b5f35bc2",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 635,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2365
  },
  {
    "bcr_patient_uuid": "d7b3156d-672a-4a55-868d-9ca6a09fcb0f",
    "patient_ID": "TCGA.24.1474",
    "bcr_drug_barcode": "TCGA-24-1474-D26074",
    "bcr_drug_uuid": "df02a6f7-9b82-42f2-acf8-938d8e6af6f3",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4050
  },
  {
    "bcr_patient_uuid": "d7b3156d-672a-4a55-868d-9ca6a09fcb0f",
    "patient_ID": "TCGA.24.1474",
    "bcr_drug_barcode": "TCGA-24-1474-D26078",
    "bcr_drug_uuid": "a604ab2b-1244-4582-aeb7-42765d3a9923",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 635,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 302
  },
  {
    "bcr_patient_uuid": "d7b3156d-672a-4a55-868d-9ca6a09fcb0f",
    "patient_ID": "TCGA.24.1474",
    "bcr_drug_barcode": "TCGA-24-1474-D26076",
    "bcr_drug_uuid": "eecac960-1b19-4854-beb4-ab67384cee3a",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 350,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 431,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 57
  },
  {
    "bcr_patient_uuid": "21f6bf91-dfc6-4a59-8b76-88a0f95c7b47",
    "patient_ID": "TCGA.24.1544",
    "bcr_drug_barcode": "TCGA-24-1544-D26085",
    "bcr_drug_uuid": "b0f731bc-150c-4aa5-a5e0-66f092fb26cd",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 533,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2500
  },
  {
    "bcr_patient_uuid": "21f6bf91-dfc6-4a59-8b76-88a0f95c7b47",
    "patient_ID": "TCGA.24.1544",
    "bcr_drug_barcode": "TCGA-24-1544-D26086",
    "bcr_drug_uuid": "0270a543-8f1d-42a0-a604-ddd1749bb8cd",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 777,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 799,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 595
  },
  {
    "bcr_patient_uuid": "21f6bf91-dfc6-4a59-8b76-88a0f95c7b47",
    "patient_ID": "TCGA.24.1544",
    "bcr_drug_barcode": "TCGA-24-1544-D26083",
    "bcr_drug_uuid": "accbdf55-0909-4132-b4d5-18989608b05f",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1356
  },
  {
    "bcr_patient_uuid": "21f6bf91-dfc6-4a59-8b76-88a0f95c7b47",
    "patient_ID": "TCGA.24.1544",
    "bcr_drug_barcode": "TCGA-24-1544-D26081",
    "bcr_drug_uuid": "6cf2832e-8a89-462e-8fea-dd6919a4d1a1",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3080
  },
  {
    "bcr_patient_uuid": "21f6bf91-dfc6-4a59-8b76-88a0f95c7b47",
    "patient_ID": "TCGA.24.1544",
    "bcr_drug_barcode": "TCGA-24-1544-D26084",
    "bcr_drug_uuid": "20b56992-e730-4408-b8ea-3e27d43407b5",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 470,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT STABEL DISEASE",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "21f6bf91-dfc6-4a59-8b76-88a0f95c7b47",
    "patient_ID": "TCGA.24.1544",
    "bcr_drug_barcode": "TCGA-24-1544-D26082",
    "bcr_drug_uuid": "10643fbe-cd7a-449d-97de-e788fcb322c4",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12.6
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26092",
    "bcr_drug_uuid": "47004f32-ba26-4d9c-be14-611ebf3f5dd9",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 973,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1028,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 165
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26095",
    "bcr_drug_uuid": "f2c12ae2-10b5-4066-b8c4-2538743a8fff",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1203,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1238,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 215
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26091",
    "bcr_drug_uuid": "bca3bc2d-ed36-41e0-afc3-d899ba451903",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 867,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 951,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 42
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26094",
    "bcr_drug_uuid": "7eae83cf-f8b8-4002-aaa2-c10132f7fdf4",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1056,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1169,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3068
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26089",
    "bcr_drug_uuid": "55f6d8ae-116b-4664-9b7c-dbdb2cccac10",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2520
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26093",
    "bcr_drug_uuid": "e4f6dcef-e36c-4d69-973e-66292bb6d9c3",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1056,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1169,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1476
  },
  {
    "bcr_patient_uuid": "f2ec64f5-a414-4c34-99c7-d59bc4e831e0",
    "patient_ID": "TCGA.24.1545",
    "bcr_drug_barcode": "TCGA-24-1545-D26090",
    "bcr_drug_uuid": "63fb1c9b-e07e-4a55-a88e-be3534fd87fc",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 285,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5750
  },
  {
    "bcr_patient_uuid": "9e7d3dea-5d81-4f10-819c-1c2a68ddd150",
    "patient_ID": "TCGA.24.1546",
    "bcr_drug_barcode": "TCGA-24-1546-D26099",
    "bcr_drug_uuid": "2c1b2afb-5dba-4ecc-b390-b8169b0edfdb",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9e7d3dea-5d81-4f10-819c-1c2a68ddd150",
    "patient_ID": "TCGA.24.1546",
    "bcr_drug_barcode": "TCGA-24-1546-D26098",
    "bcr_drug_uuid": "16c5f27e-162a-4104-9911-29d227cfd46c",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26105",
    "bcr_drug_uuid": "b8403ea4-d3d0-4ac1-982d-8b6fc8f73f25",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26102",
    "bcr_drug_uuid": "82b896d7-b3b2-420c-b7aa-bb20459cf97c",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1750
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26106",
    "bcr_drug_uuid": "6839976c-7816-4663-8ed7-41c9acf7ae7a",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 272,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 327,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 197
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26104",
    "bcr_drug_uuid": "73e950cc-b96f-4ae2-8983-c7c368a066b6",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 221,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26103",
    "bcr_drug_uuid": "aeccb39c-034f-423f-ae71-332c7ac802aa",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4790
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26108",
    "bcr_drug_uuid": "f51b5aad-7380-4d3e-894d-a8addb1a7404",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26107",
    "bcr_drug_uuid": "89cd8691-38f2-4991-86dd-3e97bde5b0a1",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 443,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26109",
    "bcr_drug_uuid": "4530176e-75d6-434b-8d76-b4de9496cde5",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 475,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 488,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26110",
    "bcr_drug_uuid": "e6eb5a6a-9561-4c32-9425-50299638e15e",
    "form_completion_date": "2009-7-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1750
  },
  {
    "bcr_patient_uuid": "66c92b9e-de3c-4d1a-bb69-46ffbc6caf33",
    "patient_ID": "TCGA.24.1548",
    "bcr_drug_barcode": "TCGA-24-1548-D26111",
    "bcr_drug_uuid": "1d635a63-88f6-4118-aede-37e239476d22",
    "form_completion_date": "2009-7-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4790
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26122",
    "bcr_drug_uuid": "48e4085b-04cf-45c7-aa48-96f5b687e896",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "VP16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26127",
    "bcr_drug_uuid": "eb07e660-7282-4a69-af97-edc6838f09b4",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26115",
    "bcr_drug_uuid": "9b813b03-b91a-4d45-a2b3-3fb971350e7c",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26119",
    "bcr_drug_uuid": "58e05d89-9a97-460f-ad0e-e15e4bfc2277",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26120",
    "bcr_drug_uuid": "f0686f43-a6af-4c6c-8a21-ba3f086ff822",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "GEMZAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26126",
    "bcr_drug_uuid": "1896232b-3242-4294-a28e-cb7b347ad760",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26114",
    "bcr_drug_uuid": "678cf3de-c647-4e78-b3d1-7540322bb15b",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26118",
    "bcr_drug_uuid": "d80cf401-7c03-46d9-811a-35f6ca35de19",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26121",
    "bcr_drug_uuid": "91dafd17-6ac1-41ec-a1fa-16d7af1f1a24",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26124",
    "bcr_drug_uuid": "b98c19e8-a11c-4161-9d42-53caa322ca87",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26125",
    "bcr_drug_uuid": "dd2a3437-2db9-4766-a79d-c31bbbc85e04",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1518,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26117",
    "bcr_drug_uuid": "e6e97277-54e1-4889-9cfd-2defde4c7f2f",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26123",
    "bcr_drug_uuid": "50c23ce7-dc88-463e-b3d3-46f14ecb21d9",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26128",
    "bcr_drug_uuid": "c6fa6de4-b848-4745-9dd7-3f0fdad55379",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3b81ec7c-0934-4649-9231-9919dd26dd15",
    "patient_ID": "TCGA.24.1549",
    "bcr_drug_barcode": "TCGA-24-1549-D26116",
    "bcr_drug_uuid": "924adb2e-a095-4a4f-8783-fc6f490f2f3c",
    "form_completion_date": "2009-5-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26134",
    "bcr_drug_uuid": "57b1a47e-8ee1-430f-947c-2aa9308fe0a5",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 986,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1107,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26131",
    "bcr_drug_uuid": "216cba1d-50e3-40b2-83a8-1c94cf9b2c59",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2070
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26136",
    "bcr_drug_uuid": "4a1b352e-113a-4b57-8c5d-a68cd3a08e2e",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1211,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1950
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26133",
    "bcr_drug_uuid": "816567f8-959f-4ac6-881e-af02c374aea7",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 902,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 965,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 405
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26132",
    "bcr_drug_uuid": "4ab59025-4c19-46a1-8a2f-10774327df1b",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 165
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26135",
    "bcr_drug_uuid": "06c0b8ce-5bc9-4141-b182-d5e9235ad517",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1211,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 837
  },
  {
    "bcr_patient_uuid": "1858b58f-fdf4-413c-9c29-96ae85b88a74",
    "patient_ID": "TCGA.24.1550",
    "bcr_drug_barcode": "TCGA-24-1550-D26137",
    "bcr_drug_uuid": "c32b99a6-9f34-4281-9364-de59a8a6f66c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1233,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 64
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26140",
    "bcr_drug_uuid": "b10b8c3a-9710-41f3-bd63-884d87cc52a3",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4140
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26143",
    "bcr_drug_uuid": "9df28b30-f8dc-426a-865e-15ce20302858",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 842,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 975,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26146",
    "bcr_drug_uuid": "a38abeb3-1386-434d-b0b9-71f5beff97c4",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1549,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1549,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26142",
    "bcr_drug_uuid": "ec427308-ea67-43e0-9b4e-a4c9e2db1d3e",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 790,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 790,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 12.5
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26145",
    "bcr_drug_uuid": "7960a8b0-06e3-44a3-886f-bfae511a0a3d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1437,
    "drug_cycles": 19,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3020
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26144",
    "bcr_drug_uuid": "cb2ba36d-6d1b-4a6a-b054-158386921e0c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1227,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1254,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 160
  },
  {
    "bcr_patient_uuid": "499a9b57-ee1a-4012-bbab-c6ad955b5e0a",
    "patient_ID": "TCGA.24.1551",
    "bcr_drug_barcode": "TCGA-24-1551-D26141",
    "bcr_drug_uuid": "76c2ecc7-ea48-46b9-8b1f-e4f6186921fc",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2080
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26150",
    "bcr_drug_uuid": "ecf05a0e-1a8f-4c2b-9370-808c3f91f4ba",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26152",
    "bcr_drug_uuid": "2c4df149-3420-49af-ac83-0c6141b6cb6e",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 728,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 851,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26155",
    "bcr_drug_uuid": "8712ebf0-ac5c-4247-9ef9-0182dfcbe756",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1044,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1170,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1925
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26151",
    "bcr_drug_uuid": "c1aee209-7e03-4455-8b8d-d94c99b25758",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 479,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 587,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26149",
    "bcr_drug_uuid": "98b74f89-c75a-4ca7-93bf-6870cf515821",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26154",
    "bcr_drug_uuid": "f3e0bfc1-9550-4386-a99e-ea615344961c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "AMITOSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 876,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1030,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4325
  },
  {
    "bcr_patient_uuid": "62379be5-13f0-474b-94d3-6f944ec4ee96",
    "patient_ID": "TCGA.24.1552",
    "bcr_drug_barcode": "TCGA-24-1552-D26153",
    "bcr_drug_uuid": "b0251e28-66c8-4d66-8438-ae12f29c7ff0",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 876,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1030,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 822
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26161",
    "bcr_drug_uuid": "802977b2-5136-4d4c-b3fe-39420081c9ba",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 566,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 735,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1740
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26169",
    "bcr_drug_uuid": "4ab24572-b866-4291-91b9-130da20b76d5",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1293,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26166",
    "bcr_drug_uuid": "97353178-8b14-4304-83e8-5d36dbcc9d0d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1623,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3800
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26164",
    "bcr_drug_uuid": "3aadf80a-15eb-4f7c-a794-8d20c2571504",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 944,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1224,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 29746
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26159",
    "bcr_drug_uuid": "f6cf4869-e5f8-4d25-80ea-1d2edb7be439",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1732
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26158",
    "bcr_drug_uuid": "2022d5b4-4eb4-4828-a336-9b0339315ee4",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2715
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26167",
    "bcr_drug_uuid": "0786542b-f7dd-4a39-96a6-561bf1c5f560",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1659,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1691,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6000
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26162",
    "bcr_drug_uuid": "e9f1ebec-2d11-4a31-9f6b-8611497ee60d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 864,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1283,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 70.2
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26165",
    "bcr_drug_uuid": "bad48395-48e1-49eb-ae95-8f224ae67640",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1309,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1623,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3360
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26160",
    "bcr_drug_uuid": "2c52a49d-a429-4fc4-b3a6-b0a71736b176",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 566,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 735,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3360
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26163",
    "bcr_drug_uuid": "5c874880-be44-4e11-b790-426708bd6e46",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 944,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1224,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 448
  },
  {
    "bcr_patient_uuid": "08c64000-d320-4e4d-974b-da503d48890c",
    "patient_ID": "TCGA.24.1553",
    "bcr_drug_barcode": "TCGA-24-1553-D26168",
    "bcr_drug_uuid": "ab504577-5032-4dd4-a101-1013de5f8513",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1735,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1735,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 63
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26175",
    "bcr_drug_uuid": "5cae58de-79d6-40a8-84e3-4d5435b373f1",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1959,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2050,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26180",
    "bcr_drug_uuid": "91c2f17b-0c3a-45d7-b649-490b80802943",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2506,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2628,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26182",
    "bcr_drug_uuid": "117ed049-353f-465d-82bb-1ff4b61c6dec",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2635,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26173",
    "bcr_drug_uuid": "63def26d-2198-4012-9d2a-e17538649b95",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26178",
    "bcr_drug_uuid": "79c1118b-b324-4d35-bca4-9e7825ae7d64",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2262,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2415,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26174",
    "bcr_drug_uuid": "5bbe4103-b205-4f8a-88e4-ff87713c9481",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1563,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1928,
    "drug_cycles": 16,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26177",
    "bcr_drug_uuid": "9ad7092e-7bb7-47d4-87d0-49c8ac554e44",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2262,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2415,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26172",
    "bcr_drug_uuid": "b0e7bfa1-aa6f-4875-a333-1d37969df73a",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26176",
    "bcr_drug_uuid": "bc8f5f9c-8a23-44d0-a253-3a6cc0100be1",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1959,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2050,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26179",
    "bcr_drug_uuid": "ffd29f9d-1824-4e15-b2b2-aea9b65e04e0",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2506,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2628,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d36676e-4140-44b5-aa0e-b2af092b7dc0",
    "patient_ID": "TCGA.24.1555",
    "bcr_drug_barcode": "TCGA-24-1555-D26181",
    "bcr_drug_uuid": "50740da7-ca0d-45d3-b7ca-7fe04e0bfc2d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2635,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26185",
    "bcr_drug_uuid": "7e3fdad5-f18b-4551-8eac-a51ba6bf4320",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26190",
    "bcr_drug_uuid": "d5ae144a-c41e-497b-9f77-a10744c020b8",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1724,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1832,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26186",
    "bcr_drug_uuid": "5525035e-275d-4663-86b4-e8498b97943e",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26189",
    "bcr_drug_uuid": "9c0ce3f1-7ff4-48b3-81d4-8462c10b43b4",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26187",
    "bcr_drug_uuid": "ce8d232a-8763-494e-a177-a4bc0bd01733",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26191",
    "bcr_drug_uuid": "3384e1f5-7a6b-474c-bcbb-ea510df68def",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1724,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1832,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "7592a659-7175-486f-a16e-24a4b4365a36",
    "patient_ID": "TCGA.24.1556",
    "bcr_drug_barcode": "TCGA-24-1556-D26188",
    "bcr_drug_uuid": "b8d6bbad-95c7-45ab-a561-b962d3d39d4f",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 539,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 628,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26197",
    "bcr_drug_uuid": "c496b3e4-ce90-4e94-9a46-55bb27442fe7",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14.7
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26195",
    "bcr_drug_uuid": "386a4c8c-a9a8-45a8-b364-458ce1968c66",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3392
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26202",
    "bcr_drug_uuid": "df63e12d-81ee-4689-a57a-d0e15aac56bc",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 623,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5350
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26205",
    "bcr_drug_uuid": "c9831383-8169-4c19-a7ad-fc3cc27c0a65",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 875,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1008,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 670
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26199",
    "bcr_drug_uuid": "52dafb0c-43cf-4792-8ac6-5c637bc5b87d",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 445,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10980
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26200",
    "bcr_drug_uuid": "e57199e1-666f-4ecf-bb4b-4ea3ddd7b2f1",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 445,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26203",
    "bcr_drug_uuid": "baf86572-a1d7-42d3-aeaf-8d2fa5a4b4ee",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 644,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 727,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1300
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26206",
    "bcr_drug_uuid": "7dbeeb29-0d9a-4b2f-91ea-d8d37e26e1f0",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 875,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1008,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12240
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26198",
    "bcr_drug_uuid": "debe84cc-e3d6-4000-a882-d98d3c8a6ba4",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 300,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 347,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 32.4
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26207",
    "bcr_drug_uuid": "ba3ef76c-2125-4d51-9389-53fbe45038ce",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1027,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1069,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 424
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26210",
    "bcr_drug_uuid": "a3727227-4be8-4f2a-af72-e123a4b9fa28",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 765,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 873,
    "therapy_regimen": "PALLIATIVE"
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26196",
    "bcr_drug_uuid": "64f69477-8db0-43cf-9bac-2ae1b6f59698",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6250
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26208",
    "bcr_drug_uuid": "1cc3aa32-4736-449f-ac47-a04687665f87",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1090,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1300
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26201",
    "bcr_drug_uuid": "9b12afd7-4c83-4a87-acfa-6bdb3ac8bc09",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 462,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 623,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2600
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26204",
    "bcr_drug_uuid": "522480c7-725f-40d4-86d9-911d47a79860",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 754,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 798,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 45.5
  },
  {
    "bcr_patient_uuid": "7dcc809b-e33a-4453-b92a-c00786f48cb0",
    "patient_ID": "TCGA.24.1557",
    "bcr_drug_barcode": "TCGA-24-1557-D26209",
    "bcr_drug_uuid": "6680f2b7-6970-4e51-a357-8755f0d0e451",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1090,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1154,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2315
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26218",
    "bcr_drug_uuid": "63155ebc-160a-4045-a54a-e81db14d275a",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 515,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 588,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11810
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26219",
    "bcr_drug_uuid": "7e540806-6473-46d6-a1ed-008e4c59cd9e",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 403,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 487,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 277
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26217",
    "bcr_drug_uuid": "4c049036-fc07-4cb7-aefb-4b246a630259",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 316,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 382,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT DISEASE TREAMENT",
    "drug_total_dose": 524
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26214",
    "bcr_drug_uuid": "e59ea4e0-2e2c-4f4a-942b-7efb1c0870fe",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 43.75
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26215",
    "bcr_drug_uuid": "ec054464-9e15-41b0-94b1-a7143163f896",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26213",
    "bcr_drug_uuid": "e3d7f2e6-d2ae-4801-b607-03c8f2c13303",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 247,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14.4
  },
  {
    "bcr_patient_uuid": "ba68f2cf-9271-41fd-9655-1fac7681f588",
    "patient_ID": "TCGA.24.1558",
    "bcr_drug_barcode": "TCGA-24-1558-D26216",
    "bcr_drug_uuid": "265b7191-2211-4f94-b21e-ae81322cb380",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 316,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 382,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "PERSISTENT DISEASE TREATMENT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26229",
    "bcr_drug_uuid": "f16bdc03-c3a6-4145-b549-b96b1f1ed982",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 635,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 726,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 15000
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26235",
    "bcr_drug_uuid": "c351ac0b-9b82-4bb8-805d-fa9600249741",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1216,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1258,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1640
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26222",
    "bcr_drug_uuid": "b3f798db-b752-4079-b430-8d7d3cea945c",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1620
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26226",
    "bcr_drug_uuid": "f6f38be5-a3cf-4506-8aff-4ba14246fdc2",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "AMITOSTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 509,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 614,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7220
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26232",
    "bcr_drug_uuid": "7b14e46a-8a83-4fc5-b3ca-f941f72a255a",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "ETOPSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 757,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 901,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4650
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26227",
    "bcr_drug_uuid": "38a5fbe9-e640-4d56-b32b-034b72d65f5f",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 509,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 614,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1730
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26230",
    "bcr_drug_uuid": "a5d8710d-3672-4dda-b17b-f73e9e9c6238",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 635,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 726,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26225",
    "bcr_drug_uuid": "519de3c8-57e8-4eff-b384-e6009fef6629",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 398,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 481,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 48
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26228",
    "bcr_drug_uuid": "187361ca-a5d7-4c06-9f76-a4e679d45120",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 509,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 614,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3100
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26231",
    "bcr_drug_uuid": "bfb5f291-5d88-41ff-b188-cd65f7d75f9d",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 757,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 901,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "OTHER",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2875
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26223",
    "bcr_drug_uuid": "6a13deac-102e-4729-9d5d-1f596ff8ddbd",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4620
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26233",
    "bcr_drug_uuid": "eaaa368c-902a-4b74-8d3a-8f1c52f88526",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 931,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1015,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 210000
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26234",
    "bcr_drug_uuid": "4cc322ae-a086-4db1-9219-ea8fd592c0b2",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1043,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1189,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2730
  },
  {
    "bcr_patient_uuid": "afd92922-b8dc-48bd-a9c0-bc8d95855eb7",
    "patient_ID": "TCGA.24.1560",
    "bcr_drug_barcode": "TCGA-24-1560-D26224",
    "bcr_drug_uuid": "c4244ff8-464e-4aca-994a-e9ba64291b6b",
    "form_completion_date": "2009-7-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 398,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 481,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 48
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26241",
    "bcr_drug_uuid": "983f19e8-c170-4e8c-a957-2fd3136788b3",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 848,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26242",
    "bcr_drug_uuid": "ee1fa917-d739-42c0-a6a9-ed708dfb432d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 848,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26246",
    "bcr_drug_uuid": "9953bd31-98a7-4304-9edc-fd8d0a59cea7",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1157,
    "drug_cycles": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26243",
    "bcr_drug_uuid": "4b34bcc3-f52f-492f-9ba7-1937763104e1",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 531,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 642,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 375
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26239",
    "bcr_drug_uuid": "0334ce07-bbcf-45f3-bfca-861ce3612e89",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26244",
    "bcr_drug_uuid": "bdfeb5b7-63f2-4a09-ac87-33fa567a3c19",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 677,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26245",
    "bcr_drug_uuid": "b7064ebb-533d-4713-9120-c9eb84ab6ce2",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 677,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26238",
    "bcr_drug_uuid": "a426f399-4902-40c8-b6d3-f24a234dac4e",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4c18d9cf-4af4-4a86-8b1c-f78795fbbd7e",
    "patient_ID": "TCGA.24.1562",
    "bcr_drug_barcode": "TCGA-24-1562-D26240",
    "bcr_drug_uuid": "108a7baa-7cfc-4e5f-b5a3-fd69f3093a19",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 257,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 405,
    "drug_cycles": 8,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26256",
    "bcr_drug_uuid": "0a7b61df-19a5-490f-be5a-3ce579d751d4",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1183,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1239,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 24.7
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26257",
    "bcr_drug_uuid": "610a8295-344d-4fd1-9716-df116525edf1",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1402,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1402,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 459
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26251",
    "bcr_drug_uuid": "dd492ae2-573e-41f7-b671-4cc2cec89e5c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 408,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 676,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26254",
    "bcr_drug_uuid": "268270d4-d717-41f2-9c43-964163522ded",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 812,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 181
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26252",
    "bcr_drug_uuid": "95408fd7-f755-419a-8146-2263478e1c30",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 728,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 805,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26249",
    "bcr_drug_uuid": "d33a7059-08ca-4bb1-b763-fcaade80c979",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3450
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26255",
    "bcr_drug_uuid": "f65e8c56-e88c-4759-8cb6-66183229fcd6",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 889,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1061,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3310
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26258",
    "bcr_drug_uuid": "1e096777-3bc5-41f1-94f2-87440512f7e0",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1087,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1182,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26253",
    "bcr_drug_uuid": "06e2c625-c9ad-454e-bc58-427688825aeb",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 812,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2820
  },
  {
    "bcr_patient_uuid": "52386f66-2877-4c75-894e-5c1dc03e6ef4",
    "patient_ID": "TCGA.24.1563",
    "bcr_drug_barcode": "TCGA-24-1563-D26250",
    "bcr_drug_uuid": "bc788a60-417a-421c-8fb6-073e20697b4d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1910
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26262",
    "bcr_drug_uuid": "4274b50b-6f29-4a5b-8db4-d3a6bf59e040",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1396
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26265",
    "bcr_drug_uuid": "57fa40c2-e908-4f10-b4a6-d694ac8a1cbd",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "AMITOSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5080
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26267",
    "bcr_drug_uuid": "5ee39715-291f-406e-84f2-8e4b5ba1beab",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 435,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 463,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 136
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26271",
    "bcr_drug_uuid": "505397d8-457f-4ff7-8a80-079b34298244",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 736,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26261",
    "bcr_drug_uuid": "f3a01cf8-d968-4223-82cc-bd63aa6e9e04",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 779
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26269",
    "bcr_drug_uuid": "885692fc-e283-4f72-9e5a-3fe4b23f90df",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "VP16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 589,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 624,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26268",
    "bcr_drug_uuid": "2179241a-2d85-45a8-ba4f-489c7af8a09b",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 499,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 568,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1496
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26263",
    "bcr_drug_uuid": "51e43b92-611a-4890-9826-27aff4d67584",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26264",
    "bcr_drug_uuid": "69a543c6-6550-4db1-a0a8-b9826d22017c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5080
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26270",
    "bcr_drug_uuid": "a5908269-249e-4154-b6c3-3255d80efacf",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEZMAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 589,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 624,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2462
  },
  {
    "bcr_patient_uuid": "d77ef9cf-f8e6-4ee9-8d4f-1106885f6b06",
    "patient_ID": "TCGA.24.1564",
    "bcr_drug_barcode": "TCGA-24-1564-D26266",
    "bcr_drug_uuid": "550d7621-efda-4cae-917c-292e022877ba",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 333,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 32.5
  },
  {
    "bcr_patient_uuid": "cf1e86ec-4bcb-403c-831b-d67bddef14eb",
    "patient_ID": "TCGA.24.1565",
    "bcr_drug_barcode": "TCGA-24-1565-D26277",
    "bcr_drug_uuid": "43054d58-b335-4d70-a5db-42959006cfc5",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 178,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cf1e86ec-4bcb-403c-831b-d67bddef14eb",
    "patient_ID": "TCGA.24.1565",
    "bcr_drug_barcode": "TCGA-24-1565-D26275",
    "bcr_drug_uuid": "f520e210-c6e9-48c9-bbff-f257cb97ba74",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1389
  },
  {
    "bcr_patient_uuid": "cf1e86ec-4bcb-403c-831b-d67bddef14eb",
    "patient_ID": "TCGA.24.1565",
    "bcr_drug_barcode": "TCGA-24-1565-D26276",
    "bcr_drug_uuid": "00f13539-fd47-4c29-96ff-381d74b856a4",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 774
  },
  {
    "bcr_patient_uuid": "2cb50c2d-e749-4172-b101-d975507435c5",
    "patient_ID": "TCGA.24.1567",
    "bcr_drug_barcode": "TCGA-24-1567-D26282",
    "bcr_drug_uuid": "31ebe1d0-b99f-4a7e-8abb-aa91ab2aec48",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "TOPECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2cb50c2d-e749-4172-b101-d975507435c5",
    "patient_ID": "TCGA.24.1567",
    "bcr_drug_barcode": "TCGA-24-1567-D26281",
    "bcr_drug_uuid": "f43d1ffa-d988-4cc3-acfd-7e4947d8ced1",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2cb50c2d-e749-4172-b101-d975507435c5",
    "patient_ID": "TCGA.24.1567",
    "bcr_drug_barcode": "TCGA-24-1567-D26280",
    "bcr_drug_uuid": "37c78ac7-dfc0-49fd-903a-05a2a8300aef",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26295",
    "bcr_drug_uuid": "38ef06ab-1145-47bd-b309-658243311e65",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2234,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2448,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26294",
    "bcr_drug_uuid": "040db0b8-aff7-4a23-91e1-26379fb0e44c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2022,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2203,
    "drug_cycles": 28,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26287",
    "bcr_drug_uuid": "faecc8ec-f46c-4ea3-a013-3370d0692293",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1181,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26292",
    "bcr_drug_uuid": "087cc90f-f414-4d12-b7a8-7c94798e1b4c",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1899,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1991,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26285",
    "bcr_drug_uuid": "29019868-73c5-442e-93bb-8e83ea1504ae",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26290",
    "bcr_drug_uuid": "931b22e6-c6ab-4846-b1a4-4a22273d74c1",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1356,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1516,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26288",
    "bcr_drug_uuid": "5d9979f4-99a7-405a-93ed-dabecce5eacd",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1107,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1181,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26296",
    "bcr_drug_uuid": "d4130ac0-ad5f-40f4-bc29-77b8a859e40b",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2568,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2629,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26289",
    "bcr_drug_uuid": "6d56fba5-bc5f-4161-b73f-5a4fa8ee9809",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1356,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1516,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26291",
    "bcr_drug_uuid": "f52b3576-79f5-4a6e-917a-2e7962393f43",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1853,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26286",
    "bcr_drug_uuid": "3dcddc28-0f92-48c0-81ee-683913402b4d",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26297",
    "bcr_drug_uuid": "8f14e722-33d5-4063-9ffc-83a6ed940314",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2629,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2629,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "19427350-619b-4b9c-a3ba-37f667bb2843",
    "patient_ID": "TCGA.24.1603",
    "bcr_drug_barcode": "TCGA-24-1603-D26293",
    "bcr_drug_uuid": "8366500b-f54e-499d-98e4-e46780890b36",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1899,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1991,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "65435f50-a35d-49e3-a36e-b95d9e274ca0",
    "patient_ID": "TCGA.24.1604",
    "bcr_drug_barcode": "TCGA-24-1604-D26301",
    "bcr_drug_uuid": "bed4ffb4-9a55-4d58-b397-da646f96aa74",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "65435f50-a35d-49e3-a36e-b95d9e274ca0",
    "patient_ID": "TCGA.24.1604",
    "bcr_drug_barcode": "TCGA-24-1604-D26302",
    "bcr_drug_uuid": "85fca390-b524-4247-a5db-7f6c3f76196e",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "65435f50-a35d-49e3-a36e-b95d9e274ca0",
    "patient_ID": "TCGA.24.1604",
    "bcr_drug_barcode": "TCGA-24-1604-D26303",
    "bcr_drug_uuid": "b92fd08e-07a3-48f6-8490-99db36a1e4ff",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "65435f50-a35d-49e3-a36e-b95d9e274ca0",
    "patient_ID": "TCGA.24.1604",
    "bcr_drug_barcode": "TCGA-24-1604-D26300",
    "bcr_drug_uuid": "6f7f507e-ed71-4327-97f9-50366d7aae44",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26309",
    "bcr_drug_uuid": "c1b63ae7-ab4d-4099-9c0e-258e497592cb",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 644,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 888,
    "drug_cycles": 11,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26311",
    "bcr_drug_uuid": "3d68a968-d13b-4ac5-bf8d-30f04aec9604",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1010,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1133,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26307",
    "bcr_drug_uuid": "cfb807b3-6f3b-4d81-ba3b-b873bc99e8de",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26310",
    "bcr_drug_uuid": "d4a208fe-06b7-4a31-929e-0f583e7fb3d7",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 644,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 888,
    "drug_cycles": 11,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26312",
    "bcr_drug_uuid": "fa6b707e-13d5-41cc-baf3-af81fce80495",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1010,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1133,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26308",
    "bcr_drug_uuid": "182d6037-89ec-4b51-9376-02ae5255ef66",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d3164236-c14a-4230-b527-ecd1a3992f02",
    "patient_ID": "TCGA.24.1614",
    "bcr_drug_barcode": "TCGA-24-1614-D26313",
    "bcr_drug_uuid": "9e5ef115-0bd9-4e75-b594-70ec7010fc98",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1284,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1443,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26319",
    "bcr_drug_uuid": "92f77834-4053-4145-a116-5dcec0326efd",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26323",
    "bcr_drug_uuid": "b2d785f8-6f1a-4971-8ce9-822f6d1f7270",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26318",
    "bcr_drug_uuid": "2346b95a-8b34-41a1-9489-cea42c9c5fd2",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26316",
    "bcr_drug_uuid": "0c8429b0-fc35-4b1c-80fb-413423b37379",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26317",
    "bcr_drug_uuid": "0800291c-aa44-4757-aa71-a9006dfb1af0",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26322",
    "bcr_drug_uuid": "b0f49dab-9394-4ad9-b5f8-091f90596108",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26321",
    "bcr_drug_uuid": "668a90a6-760c-44f1-b6b0-791749668e43",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d7027f5-60a0-47ab-a79d-667c9acc0e54",
    "patient_ID": "TCGA.24.1616",
    "bcr_drug_barcode": "TCGA-24-1616-D26320",
    "bcr_drug_uuid": "6e2e7642-c775-4c35-9930-1c443468a918",
    "form_completion_date": "2009-5-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "09c77947-a333-4392-b18d-a6c1f08764a1",
    "patient_ID": "TCGA.24.1842",
    "bcr_drug_barcode": "TCGA-24-1842-D26328",
    "bcr_drug_uuid": "df6ea24c-564d-43a8-adf8-78174c16894c",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMIAB/ VERSUS PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14331
  },
  {
    "bcr_patient_uuid": "09c77947-a333-4392-b18d-a6c1f08764a1",
    "patient_ID": "TCGA.24.1842",
    "bcr_drug_barcode": "TCGA-24-1842-D26327",
    "bcr_drug_uuid": "740a180c-a931-483e-be25-7580f2c5f4e9",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2043
  },
  {
    "bcr_patient_uuid": "09c77947-a333-4392-b18d-a6c1f08764a1",
    "patient_ID": "TCGA.24.1842",
    "bcr_drug_barcode": "TCGA-24-1842-D26326",
    "bcr_drug_uuid": "7171dab9-2b07-41ce-92ac-dda733de4616",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4355
  },
  {
    "bcr_patient_uuid": "9ec86cbd-8c74-4697-90da-529ab91ab835",
    "patient_ID": "TCGA.24.1843",
    "bcr_drug_barcode": "TCGA-24-1843-D26331",
    "bcr_drug_uuid": "e6b12e88-599d-4d24-8628-c3d561b959f1",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 373
  },
  {
    "bcr_patient_uuid": "9ec86cbd-8c74-4697-90da-529ab91ab835",
    "patient_ID": "TCGA.24.1843",
    "bcr_drug_barcode": "TCGA-24-1843-D26333",
    "bcr_drug_uuid": "56bb4b8e-25cd-4200-8444-4be7bf4dbc66",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2957
  },
  {
    "bcr_patient_uuid": "9ec86cbd-8c74-4697-90da-529ab91ab835",
    "patient_ID": "TCGA.24.1843",
    "bcr_drug_barcode": "TCGA-24-1843-D26332",
    "bcr_drug_uuid": "eb2bc7df-1c3d-4cb5-8759-e3e1f218165b",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 582
  },
  {
    "bcr_patient_uuid": "a36a4440-15ef-4837-904b-380a964d16f1",
    "patient_ID": "TCGA.24.1844",
    "bcr_drug_barcode": "TCGA-24-1844-D26337",
    "bcr_drug_uuid": "0a33fed2-263a-493b-9cdd-9f88ce31ef9b",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1285
  },
  {
    "bcr_patient_uuid": "a36a4440-15ef-4837-904b-380a964d16f1",
    "patient_ID": "TCGA.24.1844",
    "bcr_drug_barcode": "TCGA-24-1844-D26338",
    "bcr_drug_uuid": "0839f9cf-d618-4e02-b47c-6400449516f1",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2660
  },
  {
    "bcr_patient_uuid": "a36a4440-15ef-4837-904b-380a964d16f1",
    "patient_ID": "TCGA.24.1844",
    "bcr_drug_barcode": "TCGA-24-1844-D26336",
    "bcr_drug_uuid": "a38574db-890c-452c-abb7-3c28b26d82af",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 405
  },
  {
    "bcr_patient_uuid": "a782352e-c4bb-4c3e-ba82-456a47c3689a",
    "patient_ID": "TCGA.24.1845",
    "bcr_drug_barcode": "TCGA-24-1845-D26341",
    "bcr_drug_uuid": "648e66f9-bb04-47e6-b0b3-5924e9d57a16",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1169
  },
  {
    "bcr_patient_uuid": "a782352e-c4bb-4c3e-ba82-456a47c3689a",
    "patient_ID": "TCGA.24.1845",
    "bcr_drug_barcode": "TCGA-24-1845-D26343",
    "bcr_drug_uuid": "83aed886-8165-445f-9927-bd928274d9fe",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 469
  },
  {
    "bcr_patient_uuid": "a782352e-c4bb-4c3e-ba82-456a47c3689a",
    "patient_ID": "TCGA.24.1845",
    "bcr_drug_barcode": "TCGA-24-1845-D26344",
    "bcr_drug_uuid": "3eb57026-ad81-47df-b3f8-c4a97364c200",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "PACLIATXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 118
  },
  {
    "bcr_patient_uuid": "a782352e-c4bb-4c3e-ba82-456a47c3689a",
    "patient_ID": "TCGA.24.1845",
    "bcr_drug_barcode": "TCGA-24-1845-D26342",
    "bcr_drug_uuid": "bd50326e-286b-406c-93da-ac4a34f33bb0",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "DOXETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 603
  },
  {
    "bcr_patient_uuid": "67f526f1-def5-43b4-bc89-154baae190fc",
    "patient_ID": "TCGA.24.1846",
    "bcr_drug_barcode": "TCGA-24-1846-D26347",
    "bcr_drug_uuid": "b64016e1-72c8-4a3b-8f11-3dc2a09dd64b",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3800
  },
  {
    "bcr_patient_uuid": "67f526f1-def5-43b4-bc89-154baae190fc",
    "patient_ID": "TCGA.24.1846",
    "bcr_drug_barcode": "TCGA-24-1846-D26348",
    "bcr_drug_uuid": "f815ee22-1cf2-484f-a4bf-7ee83a32679e",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1173
  },
  {
    "bcr_patient_uuid": "21966708-4e66-4211-add0-f1515b09e362",
    "patient_ID": "TCGA.24.1847",
    "bcr_drug_barcode": "TCGA-24-1847-D26353",
    "bcr_drug_uuid": "c4a831bf-4848-4384-ba02-f802c9f681c4",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 687
  },
  {
    "bcr_patient_uuid": "21966708-4e66-4211-add0-f1515b09e362",
    "patient_ID": "TCGA.24.1847",
    "bcr_drug_barcode": "TCGA-24-1847-D26351",
    "bcr_drug_uuid": "1b6a9f6f-1592-436b-800f-4e4d1a19ba98",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 733
  },
  {
    "bcr_patient_uuid": "21966708-4e66-4211-add0-f1515b09e362",
    "patient_ID": "TCGA.24.1847",
    "bcr_drug_barcode": "TCGA-24-1847-D26352",
    "bcr_drug_uuid": "d01c128c-796e-4aa3-9939-631fc9179bbc",
    "form_completion_date": "2009-7-24",
    "pharmaceutical_therapy_drug_name": "CIPLASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 862
  },
  {
    "bcr_patient_uuid": "94efd4f9-69b0-4efa-8a0c-61106e898fdd",
    "patient_ID": "TCGA.24.1849",
    "bcr_drug_barcode": "TCGA-24-1849-D26357",
    "bcr_drug_uuid": "400d2f6c-3fea-402d-95b7-44939bd2741c",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 696
  },
  {
    "bcr_patient_uuid": "94efd4f9-69b0-4efa-8a0c-61106e898fdd",
    "patient_ID": "TCGA.24.1849",
    "bcr_drug_barcode": "TCGA-24-1849-D26356",
    "bcr_drug_uuid": "0521934a-f71f-4439-9f05-99c3eb435b47",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3306
  },
  {
    "bcr_patient_uuid": "b6b607cd-67b8-4c04-a212-a4e8c0743f05",
    "patient_ID": "TCGA.24.1850",
    "bcr_drug_barcode": "TCGA-24-1850-D26360",
    "bcr_drug_uuid": "f7c53c2b-1b5d-48ce-9a74-26affe5d69ee",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3138
  },
  {
    "bcr_patient_uuid": "b6b607cd-67b8-4c04-a212-a4e8c0743f05",
    "patient_ID": "TCGA.24.1850",
    "bcr_drug_barcode": "TCGA-24-1850-D26361",
    "bcr_drug_uuid": "2be1a502-15f0-4f43-b7ec-c94679b5e0d4",
    "form_completion_date": "2009-8-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 706
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26370",
    "bcr_drug_uuid": "e7eb9218-249e-49ad-b914-a39276408ee6",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1709,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26367",
    "bcr_drug_uuid": "df90f7fb-b62b-48db-af5d-7c531637e2c2",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1071,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1255,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26365",
    "bcr_drug_uuid": "55c0ae4e-b446-4d4c-b6f0-4e29ecf218c0",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26368",
    "bcr_drug_uuid": "2daf9300-1112-4263-8c24-998de2e397b3",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1071,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1255,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26364",
    "bcr_drug_uuid": "4fbaa045-8c1a-4562-8a14-027c36c47dc8",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26369",
    "bcr_drug_uuid": "416cb486-e33c-42e3-a36f-a9a39252ecd5",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1497,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1558,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26366",
    "bcr_drug_uuid": "41abc427-0a0a-417c-bdac-62964cd28fc6",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1010,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1040,
    "drug_cycles": 2,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d48fff14-9413-40a7-a09c-41f12bbe0aa9",
    "patient_ID": "TCGA.24.1852",
    "bcr_drug_barcode": "TCGA-24-1852-D26371",
    "bcr_drug_uuid": "f16113a4-2994-442f-a585-2f7a08d53101",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1709,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "97efb80d-4f46-4aef-b95e-20d260de01b2",
    "patient_ID": "TCGA.24.1920",
    "bcr_drug_barcode": "TCGA-24-1920-D26376",
    "bcr_drug_uuid": "60e3adc8-609a-4ba5-823a-c75a423ac0b5",
    "form_completion_date": "2010-2-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 224
  },
  {
    "bcr_patient_uuid": "97efb80d-4f46-4aef-b95e-20d260de01b2",
    "patient_ID": "TCGA.24.1920",
    "bcr_drug_barcode": "TCGA-24-1920-D26374",
    "bcr_drug_uuid": "d93c627d-3367-4275-af6c-0f3fb99702c6",
    "form_completion_date": "2010-2-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "97efb80d-4f46-4aef-b95e-20d260de01b2",
    "patient_ID": "TCGA.24.1920",
    "bcr_drug_barcode": "TCGA-24-1920-D26377",
    "bcr_drug_uuid": "7df933df-bf58-41f3-81b9-772e4f0b5960",
    "form_completion_date": "2010-2-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 593
  },
  {
    "bcr_patient_uuid": "97efb80d-4f46-4aef-b95e-20d260de01b2",
    "patient_ID": "TCGA.24.1920",
    "bcr_drug_barcode": "TCGA-24-1920-D26375",
    "bcr_drug_uuid": "dbe3b69a-5471-42c9-b8e2-7f0a3447efca",
    "form_completion_date": "2010-2-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 354
  },
  {
    "bcr_patient_uuid": "8449955f-42d9-46f6-919a-5cc5d59e6284",
    "patient_ID": "TCGA.24.1923",
    "bcr_drug_barcode": "TCGA-24-1923-D26383",
    "bcr_drug_uuid": "dd656b25-2f04-4167-937f-f3d8b4434a9c",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 383,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "8449955f-42d9-46f6-919a-5cc5d59e6284",
    "patient_ID": "TCGA.24.1923",
    "bcr_drug_barcode": "TCGA-24-1923-D26381",
    "bcr_drug_uuid": "ea59cc77-d039-49f3-9ebc-8a903228c266",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8449955f-42d9-46f6-919a-5cc5d59e6284",
    "patient_ID": "TCGA.24.1923",
    "bcr_drug_barcode": "TCGA-24-1923-D26380",
    "bcr_drug_uuid": "6472b85a-ce8f-4dd6-b255-8d215538af3f",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8449955f-42d9-46f6-919a-5cc5d59e6284",
    "patient_ID": "TCGA.24.1923",
    "bcr_drug_barcode": "TCGA-24-1923-D26382",
    "bcr_drug_uuid": "8c315697-557b-4e11-9d30-223d743a4782",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8449955f-42d9-46f6-919a-5cc5d59e6284",
    "patient_ID": "TCGA.24.1923",
    "bcr_drug_barcode": "TCGA-24-1923-D26384",
    "bcr_drug_uuid": "aa10be72-fe56-4ef3-9a71-3abf202da29c",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "GOG182",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26393",
    "bcr_drug_uuid": "e36c9e00-fc2f-4c5e-b431-98eba3c2118a",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 681,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7914
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26387",
    "bcr_drug_uuid": "c723aeb5-e5fe-484c-99f6-21e20b245735",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2595
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26391",
    "bcr_drug_uuid": "5f75fd73-f687-48f7-9cc1-f4a8ec07679b",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 583,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 184
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26392",
    "bcr_drug_uuid": "ad26b9f3-a159-4558-87f5-8659e0f24ca6",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 681,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 441
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26388",
    "bcr_drug_uuid": "56f40dff-03e0-4832-bcad-78ced0f5ca2a",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1621
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26390",
    "bcr_drug_uuid": "6afe2675-ab28-4150-b5ab-93fa07fdbd99",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 583,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 18.4
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26394",
    "bcr_drug_uuid": "b0797198-ab1c-487a-8587-9d4b65e76dd1",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 706,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 743,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12600
  },
  {
    "bcr_patient_uuid": "26558703-a659-43f2-86cb-0695989bc14e",
    "patient_ID": "TCGA.24.1924",
    "bcr_drug_barcode": "TCGA-24-1924-D26389",
    "bcr_drug_uuid": "e22e432e-4877-404e-b67c-452eaeef5a91",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 329,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 525,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 576
  },
  {
    "bcr_patient_uuid": "8c47ae58-91c7-4247-b420-50f31f5eb00d",
    "patient_ID": "TCGA.24.1927",
    "bcr_drug_barcode": "TCGA-24-1927-D26397",
    "bcr_drug_uuid": "86eca33e-cb34-4166-9875-5c1d0a83466b",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1587
  },
  {
    "bcr_patient_uuid": "8c47ae58-91c7-4247-b420-50f31f5eb00d",
    "patient_ID": "TCGA.24.1927",
    "bcr_drug_barcode": "TCGA-24-1927-D26401",
    "bcr_drug_uuid": "ad8c1787-5794-4bc3-95ed-0ed4f4b84efa",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "SCH 58500",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "8c47ae58-91c7-4247-b420-50f31f5eb00d",
    "patient_ID": "TCGA.24.1927",
    "bcr_drug_barcode": "TCGA-24-1927-D26399",
    "bcr_drug_uuid": "a191ec4f-2b7b-4766-8c5b-1bad03dbc5d3",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "GAMINOCAMPTOTHECIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 293,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 328,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3750
  },
  {
    "bcr_patient_uuid": "8c47ae58-91c7-4247-b420-50f31f5eb00d",
    "patient_ID": "TCGA.24.1927",
    "bcr_drug_barcode": "TCGA-24-1927-D26398",
    "bcr_drug_uuid": "d7b1885b-3bef-4eb1-996e-229cbcd78c8d",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3947
  },
  {
    "bcr_patient_uuid": "8c47ae58-91c7-4247-b420-50f31f5eb00d",
    "patient_ID": "TCGA.24.1927",
    "bcr_drug_barcode": "TCGA-24-1927-D26400",
    "bcr_drug_uuid": "2ecf64b7-e849-4d43-bf62-b9e2074a9a34",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "AMINOPTERIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 372,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8100
  },
  {
    "bcr_patient_uuid": "b45c543a-40d9-423a-a7fa-98e4b325b487",
    "patient_ID": "TCGA.24.1928",
    "bcr_drug_barcode": "TCGA-24-1928-D26404",
    "bcr_drug_uuid": "84aa9ced-7dc3-4ffe-88f5-66e7f23074ad",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1130
  },
  {
    "bcr_patient_uuid": "b45c543a-40d9-423a-a7fa-98e4b325b487",
    "patient_ID": "TCGA.24.1928",
    "bcr_drug_barcode": "TCGA-24-1928-D26406",
    "bcr_drug_uuid": "bd6a4fde-5afb-48cc-a6cd-6538eb9a0726",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 226,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "b45c543a-40d9-423a-a7fa-98e4b325b487",
    "patient_ID": "TCGA.24.1928",
    "bcr_drug_barcode": "TCGA-24-1928-D26408",
    "bcr_drug_uuid": "f968a12b-04f3-4647-a29c-b5af2d7f610a",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "b45c543a-40d9-423a-a7fa-98e4b325b487",
    "patient_ID": "TCGA.24.1928",
    "bcr_drug_barcode": "TCGA-24-1928-D26405",
    "bcr_drug_uuid": "e3a4fc7d-f026-495c-ba6e-a47f284cbba8",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 537
  },
  {
    "bcr_patient_uuid": "b45c543a-40d9-423a-a7fa-98e4b325b487",
    "patient_ID": "TCGA.24.1928",
    "bcr_drug_barcode": "TCGA-24-1928-D26407",
    "bcr_drug_uuid": "c759afb6-7464-4e2e-ba2c-560abc41b8d8",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 254,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 282,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 138
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26413",
    "bcr_drug_uuid": "42a297e9-ec61-4400-8745-73b1640c5461",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 518
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26418",
    "bcr_drug_uuid": "9086fde0-9ee3-4bd6-b4a4-5d839da5a442",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1112,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 305
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26426",
    "bcr_drug_uuid": "49444753-00db-4017-92ca-a382d843fd92",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2325,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 896
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26420",
    "bcr_drug_uuid": "02605ba7-d542-46e5-bcfe-98776bd33895",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1331,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1389,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 218
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26417",
    "bcr_drug_uuid": "a301ab51-acb4-43f8-aa33-f545f90b0e05",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1112,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1112,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26412",
    "bcr_drug_uuid": "ca6822ec-a578-4121-b321-ab2c95e1258f",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4020
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26424",
    "bcr_drug_uuid": "463db060-351c-40c4-879a-df2335f578fb",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2052,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2144,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 448
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26414",
    "bcr_drug_uuid": "e547bd75-7dc8-4f1b-842e-a0194ce97a1a",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "AMITOSTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1960
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26421",
    "bcr_drug_uuid": "dc04c370-83b2-43a7-9056-046e157157ab",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1422,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1475,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 11435
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26415",
    "bcr_drug_uuid": "a9a826f0-b068-4db5-8615-3b2a585578f0",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "OVAREX/PLACEBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 547,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 631,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26411",
    "bcr_drug_uuid": "cb1b0037-5317-42e9-aa49-71ed0d133007",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2286
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26416",
    "bcr_drug_uuid": "204bad86-3701-46aa-87bf-b90605370054",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 726,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1083,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 95.4
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26419",
    "bcr_drug_uuid": "1c7de380-a8bf-42e1-bcc3-74884e150e50",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1275,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3170
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26423",
    "bcr_drug_uuid": "95d84403-e2dd-44a7-8788-27ee16d4f0a1",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2052,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2144,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 44.8
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26425",
    "bcr_drug_uuid": "6363893c-0be6-4cef-8d0f-77cddb3d53fc",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2164,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2325,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 23008
  },
  {
    "bcr_patient_uuid": "62efb5ae-43dc-4a4c-a898-6cd9c6dba027",
    "patient_ID": "TCGA.24.1930",
    "bcr_drug_barcode": "TCGA-24-1930-D26422",
    "bcr_drug_uuid": "72bb79de-05db-4399-a015-de42d19cbb55",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "HEXAMETHYMELAMINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1492,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1684,
    "drug_cycles": 7,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 49
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26439",
    "bcr_drug_uuid": "19d878df-30b8-4dd0-8ac9-22b938ca4021",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2235,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2298,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1225
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26440",
    "bcr_drug_uuid": "940f4776-0977-4739-bfab-c2d2ea68f56f",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2593,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2757,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26436",
    "bcr_drug_uuid": "aa45d459-df46-4429-a1eb-c4b7b073ebfd",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 745,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 940,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3024
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26434",
    "bcr_drug_uuid": "7aa60143-74ad-4409-a132-ccd6e17d4473",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 414,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2013
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26433",
    "bcr_drug_uuid": "329ca615-a2d4-49ba-bb76-8766d1c58663",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 414,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1836
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26432",
    "bcr_drug_uuid": "af49fe20-8feb-40e3-bd7f-02304f1d85f4",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1032
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26437",
    "bcr_drug_uuid": "da54104e-edf3-496d-9bb4-0a3e21627587",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1381,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1555,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 77
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26438",
    "bcr_drug_uuid": "16ff8ab0-dc3b-4e6e-83fe-68792b53fed2",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1905,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2085,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 504
  },
  {
    "bcr_patient_uuid": "e20ea417-7296-4da8-9fdb-71cd1f45153a",
    "patient_ID": "TCGA.24.2020",
    "bcr_drug_barcode": "TCGA-24-2020-D26435",
    "bcr_drug_uuid": "4a4c8d77-7b48-4d12-91cd-d84d72ab935a",
    "form_completion_date": "2010-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 745,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 940,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2496
  },
  {
    "bcr_patient_uuid": "5201ee13-2aed-4641-9169-4d5ee07a23da",
    "patient_ID": "TCGA.24.2023",
    "bcr_drug_barcode": "TCGA-24-2023-D26443",
    "bcr_drug_uuid": "e6e1767b-c704-4c4c-a6fa-108c9024c4a7",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5775
  },
  {
    "bcr_patient_uuid": "5201ee13-2aed-4641-9169-4d5ee07a23da",
    "patient_ID": "TCGA.24.2023",
    "bcr_drug_barcode": "TCGA-24-2023-D26445",
    "bcr_drug_uuid": "e8d6fbd5-5369-4e58-8efe-8b2f82ce54d6",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 502,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "5201ee13-2aed-4641-9169-4d5ee07a23da",
    "patient_ID": "TCGA.24.2023",
    "bcr_drug_barcode": "TCGA-24-2023-D26447",
    "bcr_drug_uuid": "b78b10cb-7049-4c3c-b560-95defbc79e0a",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1245,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "5201ee13-2aed-4641-9169-4d5ee07a23da",
    "patient_ID": "TCGA.24.2023",
    "bcr_drug_barcode": "TCGA-24-2023-D26444",
    "bcr_drug_uuid": "723fff60-9a4d-4926-9ddc-5c109565804f",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2151
  },
  {
    "bcr_patient_uuid": "5201ee13-2aed-4641-9169-4d5ee07a23da",
    "patient_ID": "TCGA.24.2023",
    "bcr_drug_barcode": "TCGA-24-2023-D26446",
    "bcr_drug_uuid": "16528892-89f9-4770-a7b5-a9fa9bde5046",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 273,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 502,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "5201ee13-2aed-4641-9169-4d5ee07a23da",
    "patient_ID": "TCGA.24.2023",
    "bcr_drug_barcode": "TCGA-24-2023-D26448",
    "bcr_drug_uuid": "6037de33-2474-48a3-bb85-c4f84c3f0f75",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1126,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1245,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2740
  },
  {
    "bcr_patient_uuid": "0a48873a-092a-4b25-822b-b0b3c18c08a8",
    "patient_ID": "TCGA.24.2024",
    "bcr_drug_barcode": "TCGA-24-2024-D26453",
    "bcr_drug_uuid": "38b75d0f-1ca9-4064-b1e6-b5137f0d86bf",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 456,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 568,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3533
  },
  {
    "bcr_patient_uuid": "0a48873a-092a-4b25-822b-b0b3c18c08a8",
    "patient_ID": "TCGA.24.2024",
    "bcr_drug_barcode": "TCGA-24-2024-D26454",
    "bcr_drug_uuid": "b6880a72-50bd-41c7-b4b8-360e632eb75c",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 456,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 568,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2444
  },
  {
    "bcr_patient_uuid": "0a48873a-092a-4b25-822b-b0b3c18c08a8",
    "patient_ID": "TCGA.24.2024",
    "bcr_drug_barcode": "TCGA-24-2024-D26452",
    "bcr_drug_uuid": "a14ae0bf-eabb-413b-8ff0-8caa2797bc01",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3348
  },
  {
    "bcr_patient_uuid": "0a48873a-092a-4b25-822b-b0b3c18c08a8",
    "patient_ID": "TCGA.24.2024",
    "bcr_drug_barcode": "TCGA-24-2024-D26451",
    "bcr_drug_uuid": "0b41e156-a9cb-47a8-9417-eade393e92ee",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1573
  },
  {
    "bcr_patient_uuid": "2517ca7a-6057-4c19-b7e1-f6d078e9881a",
    "patient_ID": "TCGA.24.2026",
    "bcr_drug_barcode": "TCGA-24-2026-D26458",
    "bcr_drug_uuid": "ea8accae-d7ca-4fd7-ad89-da2f1cc2e415",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2517ca7a-6057-4c19-b7e1-f6d078e9881a",
    "patient_ID": "TCGA.24.2026",
    "bcr_drug_barcode": "TCGA-24-2026-D26457",
    "bcr_drug_uuid": "f88ee7b6-f4e7-481c-9ef4-5fd54df656e6",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26467",
    "bcr_drug_uuid": "2d2b4a81-4f1d-47a5-a5b0-372469ed0d16",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2048,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2216,
    "drug_cycles": 20,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1747
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26465",
    "bcr_drug_uuid": "54208a6d-19e0-4665-a518-330bd875c85b",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 624,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 88
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26468",
    "bcr_drug_uuid": "39b52851-9ea8-4dcb-b413-aa58da9233b1",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2540,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26461",
    "bcr_drug_uuid": "2d43a2fe-8c73-4fc0-b6df-5bdf7e245f96",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3724
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26472",
    "bcr_drug_uuid": "7a0c196f-7579-4417-8df7-250b3790b44e",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2759,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2951,
    "drug_cycles": 18,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1108
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26464",
    "bcr_drug_uuid": "67b0bdd5-4fb4-45ad-9910-b53124852ebb",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 624,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1860
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26462",
    "bcr_drug_uuid": "a3364f64-b01d-4bd7-bc80-7f57e825af8f",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9838
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26466",
    "bcr_drug_uuid": "f2bd2c6e-2dcd-4f31-a184-ca1b3b57f630",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1985,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 151
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26470",
    "bcr_drug_uuid": "4629f733-986c-4921-836a-29f1968e7f2c",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2591,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 83
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26474",
    "bcr_drug_uuid": "f0bcae84-ea4c-4013-ae03-5fcbde163417",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3273,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1052
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26463",
    "bcr_drug_uuid": "e1480191-f1f7-4995-a17e-fda2f9dee553",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 624,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3411
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26469",
    "bcr_drug_uuid": "4e98ff92-93cd-4216-842d-416ba1559929",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2591,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1992
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26471",
    "bcr_drug_uuid": "10a2545f-f218-4b9f-9b3d-a0efb8844d26",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2602,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2745,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 311
  },
  {
    "bcr_patient_uuid": "219f54ef-4235-482d-b799-f2fa9930105c",
    "patient_ID": "TCGA.24.2027",
    "bcr_drug_barcode": "TCGA-24-2027-D26473",
    "bcr_drug_uuid": "abff2c37-622f-462a-9cfd-3f9b51bf3440",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2982,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3154,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 67.05
  },
  {
    "bcr_patient_uuid": "bbbf1184-1e19-479a-b31f-daa692d52e02",
    "patient_ID": "TCGA.24.2029",
    "bcr_drug_barcode": "TCGA-24-2029-D26477",
    "bcr_drug_uuid": "541eb0c1-a2d4-464c-bdf3-8324f4bbff54",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1946
  },
  {
    "bcr_patient_uuid": "bbbf1184-1e19-479a-b31f-daa692d52e02",
    "patient_ID": "TCGA.24.2029",
    "bcr_drug_barcode": "TCGA-24-2029-D26478",
    "bcr_drug_uuid": "52b83717-b8f7-4848-add1-2b37c6de9dcb",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3773
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26481",
    "bcr_drug_uuid": "86e9993c-2161-4fd6-8e3b-d782e8d7b07c",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1064
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26485",
    "bcr_drug_uuid": "5e971953-a98a-4612-bf01-e5f656e45ff8",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 864,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 994,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 48
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26487",
    "bcr_drug_uuid": "983be44f-bafd-4148-897e-f00814c3f649",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1176,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1253,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26486",
    "bcr_drug_uuid": "f3d03ec6-706d-44d0-a89b-d662bc0bb9ea",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1028,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1028,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26483",
    "bcr_drug_uuid": "70169bdf-9305-4494-a6f9-4d83f54bdc26",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 657,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 790,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1380
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26488",
    "bcr_drug_uuid": "b3ffba76-89e3-409b-8ffa-d79a8440d978",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1365,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1420
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26484",
    "bcr_drug_uuid": "d7b6b9ee-28f5-434d-9f33-4f7733e9670b",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 657,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 790,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1778
  },
  {
    "bcr_patient_uuid": "d2ccefea-c1d6-465f-97b1-e51e29c5f1f8",
    "patient_ID": "TCGA.24.2030",
    "bcr_drug_barcode": "TCGA-24-2030-D26482",
    "bcr_drug_uuid": "29f56a89-c0a3-487d-8cde-7998973ac418",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2334
  },
  {
    "bcr_patient_uuid": "872d2922-7292-4681-adb7-d3b267eccbe7",
    "patient_ID": "TCGA.24.2033",
    "bcr_drug_barcode": "TCGA-24-2033-D26494",
    "bcr_drug_uuid": "c32ae140-edf1-44da-b2ae-3eee3ef19553",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 471,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "872d2922-7292-4681-adb7-d3b267eccbe7",
    "patient_ID": "TCGA.24.2033",
    "bcr_drug_barcode": "TCGA-24-2033-D26492",
    "bcr_drug_uuid": "cf9d8857-7237-4caf-99e5-a79b8fd29421",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2940
  },
  {
    "bcr_patient_uuid": "872d2922-7292-4681-adb7-d3b267eccbe7",
    "patient_ID": "TCGA.24.2033",
    "bcr_drug_barcode": "TCGA-24-2033-D26491",
    "bcr_drug_uuid": "ef87003d-e997-422d-84af-6d400d8d9cc9",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN 6TH",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3020
  },
  {
    "bcr_patient_uuid": "872d2922-7292-4681-adb7-d3b267eccbe7",
    "patient_ID": "TCGA.24.2033",
    "bcr_drug_barcode": "TCGA-24-2033-D26493",
    "bcr_drug_uuid": "3b90cc85-3ff1-4f51-abf7-8d2c3554bda3",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 358,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 400,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26501",
    "bcr_drug_uuid": "1d759db4-e008-4860-82be-d4e68759c228",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 679,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26499",
    "bcr_drug_uuid": "8b07cdb1-fd20-4693-a570-d3d9a65a391d",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26502",
    "bcr_drug_uuid": "66b642e8-83f9-47bc-871f-e6156f363161",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "VP16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 688,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26497",
    "bcr_drug_uuid": "7ec23e69-94f3-444b-b7c0-69dec024718f",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26503",
    "bcr_drug_uuid": "9b196005-4792-4e49-a9b9-fd9018c4606a",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "IFOSTAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 688,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26500",
    "bcr_drug_uuid": "ed9654da-c2f1-4280-ac44-e22812dd52ef",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "PSC833",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "062982f8-9f49-425a-99e9-008af5ed9040",
    "patient_ID": "TCGA.24.2035",
    "bcr_drug_barcode": "TCGA-24-2035-D26498",
    "bcr_drug_uuid": "baefbf0e-5174-4efb-90d2-283e5f1c4c4c",
    "form_completion_date": "2010-3-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26509",
    "bcr_drug_uuid": "bc14658b-86a2-4a1f-870a-341bd741fbb8",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 592,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26507",
    "bcr_drug_uuid": "ee86ed68-4a7a-4351-91fd-30b88a37e9e1",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26511",
    "bcr_drug_uuid": "14225659-0bd5-4f58-a64d-dc0ea9287d74",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26512",
    "bcr_drug_uuid": "c4ede41b-9b04-4c0d-a118-e94eb903797c",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1430,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26513",
    "bcr_drug_uuid": "b4e39ce6-689b-42ed-8318-45fc53d4696b",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "MITOMYCIN C",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26510",
    "bcr_drug_uuid": "52ed5c3b-9463-4989-be52-0f43c0a1647d",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1156,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26506",
    "bcr_drug_uuid": "9ad91411-5ada-42b1-8c1b-3cecf1c8b3b4",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26514",
    "bcr_drug_uuid": "c7f4e305-74e3-4c1b-9f9c-c33e1ff66512",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1855,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26515",
    "bcr_drug_uuid": "0d178a19-0839-48c5-92bb-9d47ac316742",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1064,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "c9226204-cb61-40b8-8a94-a7e71c14ea3a",
    "patient_ID": "TCGA.24.2036",
    "bcr_drug_barcode": "TCGA-24-2036-D26508",
    "bcr_drug_uuid": "11db3802-3c6e-43cf-9b7f-6b6c52a8fa85",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 592,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "17181157-c9e2-4bd6-8653-f5dce56f9053",
    "patient_ID": "TCGA.24.2038",
    "bcr_drug_barcode": "TCGA-24-2038-D26519",
    "bcr_drug_uuid": "d15be7f1-44d9-45a2-aebb-c743ee12a8fe",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1212,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1254,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 35.2
  },
  {
    "bcr_patient_uuid": "17181157-c9e2-4bd6-8653-f5dce56f9053",
    "patient_ID": "TCGA.24.2038",
    "bcr_drug_barcode": "TCGA-24-2038-D26521",
    "bcr_drug_uuid": "58c875e5-4f1d-46f3-bc72-100d4df55821",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1352,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2345
  },
  {
    "bcr_patient_uuid": "17181157-c9e2-4bd6-8653-f5dce56f9053",
    "patient_ID": "TCGA.24.2038",
    "bcr_drug_barcode": "TCGA-24-2038-D26520",
    "bcr_drug_uuid": "a072c4d8-69e2-471b-8007-4a211bafee54",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1352,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1407
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26530",
    "bcr_drug_uuid": "384a517f-ad06-41c1-80f4-3469584c01cf",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 984,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1112,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4630
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26528",
    "bcr_drug_uuid": "f2497656-b837-4017-8ab0-97d93059374a",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 718,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2765
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26526",
    "bcr_drug_uuid": "0362e136-d6c8-4db8-93b0-f02785a3ccee",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26529",
    "bcr_drug_uuid": "82cbc27a-6761-4f89-b883-f8421831e315",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 984,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1112,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 16000
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26524",
    "bcr_drug_uuid": "ef5ca1b9-d193-4a6f-bce0-d480174dd9c7",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2717
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26527",
    "bcr_drug_uuid": "2bf84b24-19c6-4b84-8e8e-c27da4acf2db",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 718,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "9af2248a-d86a-4277-93b4-8eba5a39bd3c",
    "patient_ID": "TCGA.24.2254",
    "bcr_drug_barcode": "TCGA-24-2254-D26525",
    "bcr_drug_uuid": "a12fb8d1-7f50-472a-800a-53b1adcdb84d",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 165,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 233
  },
  {
    "bcr_patient_uuid": "f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b",
    "patient_ID": "TCGA.24.2260",
    "bcr_drug_barcode": "TCGA-24-2260-D26536",
    "bcr_drug_uuid": "be9c03cb-0688-422d-bbba-c3b8ad80547d",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 682,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 849,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5810
  },
  {
    "bcr_patient_uuid": "f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b",
    "patient_ID": "TCGA.24.2260",
    "bcr_drug_barcode": "TCGA-24-2260-D26534",
    "bcr_drug_uuid": "486ab8c1-e67a-4f02-84fc-9d4463840857",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 727
  },
  {
    "bcr_patient_uuid": "f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b",
    "patient_ID": "TCGA.24.2260",
    "bcr_drug_barcode": "TCGA-24-2260-D26535",
    "bcr_drug_uuid": "e69ef23b-4fcd-426c-9680-aba7c3773664",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 682,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 849,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2905
  },
  {
    "bcr_patient_uuid": "f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b",
    "patient_ID": "TCGA.24.2260",
    "bcr_drug_barcode": "TCGA-24-2260-D26538",
    "bcr_drug_uuid": "ca2ff536-892b-4233-b660-b424a07d9133",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CHLORAMBUCIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1011,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1081,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b",
    "patient_ID": "TCGA.24.2260",
    "bcr_drug_barcode": "TCGA-24-2260-D26533",
    "bcr_drug_uuid": "0d57b63c-7817-41f7-ac60-a2bdb86ca7e3",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1110
  },
  {
    "bcr_patient_uuid": "f2ce00e4-0d4f-4faa-bee1-ddf1b306e97b",
    "patient_ID": "TCGA.24.2260",
    "bcr_drug_barcode": "TCGA-24-2260-D26537",
    "bcr_drug_uuid": "68704d25-051a-471c-a28e-460d3f9e5802",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 876,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1009,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26548",
    "bcr_drug_uuid": "be3d0294-80f9-4963-a9e2-1cb9cd844483",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 793,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 836
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26553",
    "bcr_drug_uuid": "e6f21e39-f7e8-4d1b-bd85-610ce88ab7e9",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN #1",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1332,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 375
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26549",
    "bcr_drug_uuid": "ee87030e-ab29-41cc-ab1f-578c59409e73",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 827,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 946,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26545",
    "bcr_drug_uuid": "2f85a28c-7869-4a5d-b332-7968861c41ca",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 219,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5570
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26547",
    "bcr_drug_uuid": "04311818-c59d-4fb2-8a48-9c6e708a25de",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 793,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2524
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26555",
    "bcr_drug_uuid": "a457bccc-0352-40de-8b76-62e657783707",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1347,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1381,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4560
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26546",
    "bcr_drug_uuid": "e1443b92-f117-4894-90a5-9dce2d137e05",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 219,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7740
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26552",
    "bcr_drug_uuid": "5ac265d1-a02c-4322-b595-e41e47f869dc",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1332,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2302
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26551",
    "bcr_drug_uuid": "ac6e2596-885c-4402-bd72-a60cd1a76c62",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1011,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1011,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2.4
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26550",
    "bcr_drug_uuid": "299c0ea3-e684-4499-8259-f831fced1a2f",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 983,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 997,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 145
  },
  {
    "bcr_patient_uuid": "99a61986-7b23-46b5-99a4-efba6bad3766",
    "patient_ID": "TCGA.24.2267",
    "bcr_drug_barcode": "TCGA-24-2267-D26554",
    "bcr_drug_uuid": "6bb395af-f4f7-4d4d-9e89-b91f4208e217",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN #2-7",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1172,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1332,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 375
  },
  {
    "bcr_patient_uuid": "a8c4a333-6b67-44c8-9000-516f8ccea788",
    "patient_ID": "TCGA.24.2271",
    "bcr_drug_barcode": "TCGA-24-2271-D26559",
    "bcr_drug_uuid": "6efd5855-3b58-4628-9e62-c993e2ad5554",
    "form_completion_date": "2010-6-25",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a8c4a333-6b67-44c8-9000-516f8ccea788",
    "patient_ID": "TCGA.24.2271",
    "bcr_drug_barcode": "TCGA-24-2271-D26558",
    "bcr_drug_uuid": "9cc98084-f3e0-467d-aac7-d99952fa1fc1",
    "form_completion_date": "2010-6-25",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26567",
    "bcr_drug_uuid": "d4c1aa33-8106-4504-b217-27a2fb6accfc",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2882
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26563",
    "bcr_drug_uuid": "2b16b758-e19d-49e6-9459-6aff9e5f60c5",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4240
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26566",
    "bcr_drug_uuid": "ea7b837d-bd0d-492e-a86c-465e4bf2be80",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 599
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26562",
    "bcr_drug_uuid": "9c3be379-ed37-4783-be42-e672ea742981",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2248
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26568",
    "bcr_drug_uuid": "d053512b-b2e1-474b-8f28-2aca5360d223",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1025,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 57.5
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26564",
    "bcr_drug_uuid": "56d3c465-44f3-4e81-8160-e949e0ad7d63",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 192
  },
  {
    "bcr_patient_uuid": "97ad0360-3be4-401a-a94c-7f2800a1b519",
    "patient_ID": "TCGA.24.2280",
    "bcr_drug_barcode": "TCGA-24-2280-D26565",
    "bcr_drug_uuid": "4f041d9d-20ed-4b8c-b24e-f02931809265",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 538,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 766,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 478
  },
  {
    "bcr_patient_uuid": "59b3fbfe-0b7c-41e5-b756-ee7e23730df5",
    "patient_ID": "TCGA.24.2281",
    "bcr_drug_barcode": "TCGA-24-2281-D26572",
    "bcr_drug_uuid": "15f30f01-7272-4617-84a1-8e94f86f6372",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "59b3fbfe-0b7c-41e5-b756-ee7e23730df5",
    "patient_ID": "TCGA.24.2281",
    "bcr_drug_barcode": "TCGA-24-2281-D26571",
    "bcr_drug_uuid": "c3bc6bfa-aeaf-48c8-9afb-72f424b38730",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf",
    "patient_ID": "TCGA.24.2288",
    "bcr_drug_barcode": "TCGA-24-2288-D26576",
    "bcr_drug_uuid": "f9e65bb5-d987-4920-ba32-65526fa41a72",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 21,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "28ed2d42-5b4c-4bca-b2b2-6b2a6d3c42cf",
    "patient_ID": "TCGA.24.2288",
    "bcr_drug_barcode": "TCGA-24-2288-D26575",
    "bcr_drug_uuid": "a60ba99a-bb6f-4c5d-a38b-cb3218c5aeed",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 21,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "b867e933-e3e3-4491-9bb6-b18c48d6f173",
    "patient_ID": "TCGA.24.2289",
    "bcr_drug_barcode": "TCGA-24-2289-D26580",
    "bcr_drug_uuid": "586feb5d-42b7-4242-945c-dfdd16f8647e",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 645
  },
  {
    "bcr_patient_uuid": "b867e933-e3e3-4491-9bb6-b18c48d6f173",
    "patient_ID": "TCGA.24.2289",
    "bcr_drug_barcode": "TCGA-24-2289-D26579",
    "bcr_drug_uuid": "e30043ad-c281-46eb-9aa1-a49e87ab0647",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 4,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1735
  },
  {
    "bcr_patient_uuid": "b867e933-e3e3-4491-9bb6-b18c48d6f173",
    "patient_ID": "TCGA.24.2289",
    "bcr_drug_barcode": "TCGA-24-2289-D26581",
    "bcr_drug_uuid": "09917dd3-3ce9-4899-8d93-69466b71bdb0",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 598,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 708,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 957
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26584",
    "bcr_drug_uuid": "53051e26-96ea-4381-935b-d86d4e464e6e",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4620
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26587",
    "bcr_drug_uuid": "d5c6eadd-a0ce-4465-b7c7-7e3097a30df4",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26591",
    "bcr_drug_uuid": "7019634d-a409-44df-8bad-84a1aca17ae3",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 663,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 705,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 780
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26586",
    "bcr_drug_uuid": "7d77c5da-5552-44b1-8c6c-576ffdeebe86",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 349,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 412,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1270
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26588",
    "bcr_drug_uuid": "1a112873-89ab-4529-bc98-8ed1d92e82f2",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 439,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 550,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 707
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26589",
    "bcr_drug_uuid": "457c381a-169a-40b2-8c7d-830abe8195e0",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 578,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 599,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26590",
    "bcr_drug_uuid": "6e13ad8f-bd41-4fa0-85b0-746ed6cc06d4",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 607,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 614,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7060
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26593",
    "bcr_drug_uuid": "9886b603-9d94-4810-9353-3667147b2718",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 727,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 823,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26595",
    "bcr_drug_uuid": "8176d176-b9b6-4830-a395-f70cdbb3a561",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26585",
    "bcr_drug_uuid": "76e08919-c8aa-463f-94ef-39dd7a978a2f",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26596",
    "bcr_drug_uuid": "347a3fb1-1fa2-4ba3-963c-15dc7ba75973",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1005,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1055,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26592",
    "bcr_drug_uuid": "9820826f-3bc0-4f1d-a77a-c94f988b7243",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 663,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 705,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 279
  },
  {
    "bcr_patient_uuid": "2b14123b-8fcd-402c-9399-4e7c47f20252",
    "patient_ID": "TCGA.24.2290",
    "bcr_drug_barcode": "TCGA-24-2290-D26594",
    "bcr_drug_uuid": "ee1d8054-d6cb-4ac4-a322-4504c3bdf623",
    "form_completion_date": "2010-2-19",
    "pharmaceutical_therapy_drug_name": "VAMYDEX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 855,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 939,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2250
  },
  {
    "bcr_patient_uuid": "bdd792e7-d75f-4aa3-b38e-f0708e112075",
    "patient_ID": "TCGA.24.2293",
    "bcr_drug_barcode": "TCGA-24-2293-D26602",
    "bcr_drug_uuid": "c370ef42-66a2-4812-a7b2-c1a6cfdf941d",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bdd792e7-d75f-4aa3-b38e-f0708e112075",
    "patient_ID": "TCGA.24.2293",
    "bcr_drug_barcode": "TCGA-24-2293-D26600",
    "bcr_drug_uuid": "478b2750-e834-4ab0-9745-79e4791c52ea",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bdd792e7-d75f-4aa3-b38e-f0708e112075",
    "patient_ID": "TCGA.24.2293",
    "bcr_drug_barcode": "TCGA-24-2293-D26603",
    "bcr_drug_uuid": "a3d3ee41-2df1-443f-afc8-12b8d71bb04f",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bdd792e7-d75f-4aa3-b38e-f0708e112075",
    "patient_ID": "TCGA.24.2293",
    "bcr_drug_barcode": "TCGA-24-2293-D26601",
    "bcr_drug_uuid": "8050a129-6bfa-4037-8fe8-a5b254002a76",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "MELPHALAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bdd792e7-d75f-4aa3-b38e-f0708e112075",
    "patient_ID": "TCGA.24.2293",
    "bcr_drug_barcode": "TCGA-24-2293-D26599",
    "bcr_drug_uuid": "259222b7-aa56-4b27-b5c1-a167efcc5a05",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1",
    "patient_ID": "TCGA.24.2295",
    "bcr_drug_barcode": "TCGA-24-2295-D26609",
    "bcr_drug_uuid": "fa744431-dc45-47a0-aeef-bfff1ee692fc",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2874
  },
  {
    "bcr_patient_uuid": "7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1",
    "patient_ID": "TCGA.24.2295",
    "bcr_drug_barcode": "TCGA-24-2295-D26606",
    "bcr_drug_uuid": "4b24ec33-656b-4372-8c85-24b7baf3e849",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1591
  },
  {
    "bcr_patient_uuid": "7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1",
    "patient_ID": "TCGA.24.2295",
    "bcr_drug_barcode": "TCGA-24-2295-D26607",
    "bcr_drug_uuid": "def7542e-56d7-45d4-ab76-bbf9b8045491",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3737
  },
  {
    "bcr_patient_uuid": "7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1",
    "patient_ID": "TCGA.24.2295",
    "bcr_drug_barcode": "TCGA-24-2295-D26608",
    "bcr_drug_uuid": "f6b1b0fe-2b75-479a-a270-6363001de556",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7bd1851f-7e2e-4dbc-9f0e-7cb2863371e1",
    "patient_ID": "TCGA.24.2295",
    "bcr_drug_barcode": "TCGA-24-2295-D26610",
    "bcr_drug_uuid": "b5f3da82-9a24-4265-b713-fc348932d319",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 895,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2ab32e11-80d6-4ed0-a42e-da612219bbdd",
    "patient_ID": "TCGA.24.2297",
    "bcr_drug_barcode": "TCGA-24-2297-D26614",
    "bcr_drug_uuid": "bade886c-5107-470b-a559-711bc8169b7c",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5530
  },
  {
    "bcr_patient_uuid": "2ab32e11-80d6-4ed0-a42e-da612219bbdd",
    "patient_ID": "TCGA.24.2297",
    "bcr_drug_barcode": "TCGA-24-2297-D26613",
    "bcr_drug_uuid": "e6ac7e27-9cfb-4e5a-9db9-eeac915c3e23",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3981
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26617",
    "bcr_drug_uuid": "4027e5e5-c127-453d-b1cd-fed38de4e230",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3605
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26621",
    "bcr_drug_uuid": "0d6bb242-0d31-4085-9602-963c9791488c",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 762,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 817,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 27.7
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26624",
    "bcr_drug_uuid": "364cb2f7-17b3-4ba1-9c59-a3d286407790",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1568,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 308
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26618",
    "bcr_drug_uuid": "fe77059f-2f22-47c8-9eaa-bf0724926c0f",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 218,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5830
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26622",
    "bcr_drug_uuid": "14a42edb-bca3-40f7-aeb5-d55e4146512a",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 986,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1328,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 424
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26619",
    "bcr_drug_uuid": "213e17eb-ff72-482a-b2f0-1bd215af56c4",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 726,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2477
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26623",
    "bcr_drug_uuid": "f2aedc57-777a-4a52-a35c-d6cb5de91ee1",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 986,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1328,
    "drug_cycles": 13,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 731
  },
  {
    "bcr_patient_uuid": "7e4e7914-ec23-4c55-98d6-3c5eecffa8e4",
    "patient_ID": "TCGA.24.2298",
    "bcr_drug_barcode": "TCGA-24-2298-D26620",
    "bcr_drug_uuid": "66801fd9-77b5-4227-aed6-30f08f29ad7f",
    "form_completion_date": "2010-3-16",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1984
  },
  {
    "bcr_patient_uuid": "d73a0a33-e4e8-44bd-9580-2038ab06583a",
    "patient_ID": "TCGA.25.1313",
    "bcr_drug_barcode": "TCGA-25-1313-D26631",
    "bcr_drug_uuid": "64b80a98-0e23-47cf-bcb1-77881ca35bf0",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 394,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 547,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "d73a0a33-e4e8-44bd-9580-2038ab06583a",
    "patient_ID": "TCGA.25.1313",
    "bcr_drug_barcode": "TCGA-25-1313-D26630",
    "bcr_drug_uuid": "4f66c38b-6088-4295-adf1-a6dfc5e09598",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d73a0a33-e4e8-44bd-9580-2038ab06583a",
    "patient_ID": "TCGA.25.1313",
    "bcr_drug_barcode": "TCGA-25-1313-D26629",
    "bcr_drug_uuid": "9a05fe1c-906f-4d7a-9f6e-1d0ff03b187b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0b2ea4b7-98bb-4190-b682-2c75b447c90a",
    "patient_ID": "TCGA.25.1314",
    "bcr_drug_barcode": "TCGA-25-1314-D26634",
    "bcr_drug_uuid": "2bc86970-b813-419d-8821-e2a618a9af3d",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0b2ea4b7-98bb-4190-b682-2c75b447c90a",
    "patient_ID": "TCGA.25.1314",
    "bcr_drug_barcode": "TCGA-25-1314-D26636",
    "bcr_drug_uuid": "579ce73b-269e-4c24-894b-9066edf721fb",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 425,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0b2ea4b7-98bb-4190-b682-2c75b447c90a",
    "patient_ID": "TCGA.25.1314",
    "bcr_drug_barcode": "TCGA-25-1314-D26635",
    "bcr_drug_uuid": "547d8656-df9f-4efe-b7be-f94cd726c8b9",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0b2ea4b7-98bb-4190-b682-2c75b447c90a",
    "patient_ID": "TCGA.25.1314",
    "bcr_drug_barcode": "TCGA-25-1314-D26637",
    "bcr_drug_uuid": "56d387be-95f9-4b53-ae0c-c4b479c8a965",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "635f5335-b008-428e-b005-615776a6643f",
    "patient_ID": "TCGA.25.1315",
    "bcr_drug_barcode": "TCGA-25-1315-D26642",
    "bcr_drug_uuid": "d4f35481-a6a4-428f-a818-6234b6ced3c3",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "635f5335-b008-428e-b005-615776a6643f",
    "patient_ID": "TCGA.25.1315",
    "bcr_drug_barcode": "TCGA-25-1315-D26641",
    "bcr_drug_uuid": "c395c2f1-e27d-4a82-81f6-4762e3f4988d",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 334,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "635f5335-b008-428e-b005-615776a6643f",
    "patient_ID": "TCGA.25.1315",
    "bcr_drug_barcode": "TCGA-25-1315-D26640",
    "bcr_drug_uuid": "38092d51-5b3f-48c2-a4e2-05502242355f",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "635f5335-b008-428e-b005-615776a6643f",
    "patient_ID": "TCGA.25.1315",
    "bcr_drug_barcode": "TCGA-25-1315-D26643",
    "bcr_drug_uuid": "b8fab70f-4e15-47c4-8b5e-ab9d6db13556",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "days_to_drug_end": 334,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "635f5335-b008-428e-b005-615776a6643f",
    "patient_ID": "TCGA.25.1315",
    "bcr_drug_barcode": "TCGA-25-1315-D26644",
    "bcr_drug_uuid": "c50db350-ba19-4e40-b7b1-7487af0619b7",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "58427bce-6b81-4083-aeda-25f59e292bbc",
    "patient_ID": "TCGA.25.1316",
    "bcr_drug_barcode": "TCGA-25-1316-D26648",
    "bcr_drug_uuid": "367c6a85-9774-4f94-a158-d267423a02ae",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 276,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "58427bce-6b81-4083-aeda-25f59e292bbc",
    "patient_ID": "TCGA.25.1316",
    "bcr_drug_barcode": "TCGA-25-1316-D26647",
    "bcr_drug_uuid": "937633f3-8ac6-4073-b96b-b491f465f7f6",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "58427bce-6b81-4083-aeda-25f59e292bbc",
    "patient_ID": "TCGA.25.1316",
    "bcr_drug_barcode": "TCGA-25-1316-D26649",
    "bcr_drug_uuid": "8c815216-6c85-454c-b0ae-2f590d0c8aef",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "78777a80-cc6c-46c9-a14a-837ac7943719",
    "patient_ID": "TCGA.25.1317",
    "bcr_drug_barcode": "TCGA-25-1317-D26652",
    "bcr_drug_uuid": "4415066a-d41d-4847-b874-98a231029cf3",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "78777a80-cc6c-46c9-a14a-837ac7943719",
    "patient_ID": "TCGA.25.1317",
    "bcr_drug_barcode": "TCGA-25-1317-D26653",
    "bcr_drug_uuid": "0b21e1d6-b7d7-4509-84fd-30a3a6f2ba0c",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 31,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13319c20-02f6-4b5f-b24f-3d8f4084094c",
    "patient_ID": "TCGA.25.1318",
    "bcr_drug_barcode": "TCGA-25-1318-D26656",
    "bcr_drug_uuid": "9f44ee55-e19b-4469-a2ca-6ca3de3dea19",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13319c20-02f6-4b5f-b24f-3d8f4084094c",
    "patient_ID": "TCGA.25.1318",
    "bcr_drug_barcode": "TCGA-25-1318-D26658",
    "bcr_drug_uuid": "e9dbb616-a754-4560-91d3-70c2166bff27",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPETECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 212,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 273,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "13319c20-02f6-4b5f-b24f-3d8f4084094c",
    "patient_ID": "TCGA.25.1318",
    "bcr_drug_barcode": "TCGA-25-1318-D26657",
    "bcr_drug_uuid": "34a3d4ed-3134-4055-807f-d263f12fbe00",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "914d8613-3c25-4a10-be50-28b42f4d3a5d",
    "patient_ID": "TCGA.25.1319",
    "bcr_drug_barcode": "TCGA-25-1319-D26661",
    "bcr_drug_uuid": "c61612c2-a456-4253-97b0-a3354dfbd96a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "914d8613-3c25-4a10-be50-28b42f4d3a5d",
    "patient_ID": "TCGA.25.1319",
    "bcr_drug_barcode": "TCGA-25-1319-D26662",
    "bcr_drug_uuid": "994fc650-88ad-49bc-83d0-b2f707ef5859",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46395c3d-5e51-477f-946e-e58b87cc7baa",
    "patient_ID": "TCGA.25.1320",
    "bcr_drug_barcode": "TCGA-25-1320-D26667",
    "bcr_drug_uuid": "5c3d0e22-0362-45b8-9daf-27c853cebc0f",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 181,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46395c3d-5e51-477f-946e-e58b87cc7baa",
    "patient_ID": "TCGA.25.1320",
    "bcr_drug_barcode": "TCGA-25-1320-D26665",
    "bcr_drug_uuid": "ace5ad75-8cc5-441f-80ff-875333731b1c",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46395c3d-5e51-477f-946e-e58b87cc7baa",
    "patient_ID": "TCGA.25.1320",
    "bcr_drug_barcode": "TCGA-25-1320-D26666",
    "bcr_drug_uuid": "32ce5448-ce5a-4626-ae66-c2f43005976b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "days_to_drug_end": 181,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "46395c3d-5e51-477f-946e-e58b87cc7baa",
    "patient_ID": "TCGA.25.1320",
    "bcr_drug_barcode": "TCGA-25-1320-D26668",
    "bcr_drug_uuid": "4494b225-32ae-457c-add4-f6ee7654acec",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 607,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d",
    "patient_ID": "TCGA.25.1321",
    "bcr_drug_barcode": "TCGA-25-1321-D26671",
    "bcr_drug_uuid": "b6642ab9-ddb0-47d9-847b-edf5d7ad4a7a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d",
    "patient_ID": "TCGA.25.1321",
    "bcr_drug_barcode": "TCGA-25-1321-D26674",
    "bcr_drug_uuid": "0a92e43c-03a4-49b0-8988-d565ab0f53b8",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 498,
    "drug_cycles": 2,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d",
    "patient_ID": "TCGA.25.1321",
    "bcr_drug_barcode": "TCGA-25-1321-D26672",
    "bcr_drug_uuid": "fbb96ad3-036d-4338-b798-0b952467b432",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "6ad8bc89-d8e9-48c2-bc25-c8e51f972b4d",
    "patient_ID": "TCGA.25.1321",
    "bcr_drug_barcode": "TCGA-25-1321-D26673",
    "bcr_drug_uuid": "00fdffad-a9ac-447b-b494-d4c6acc9a1e4",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b520aae5-65a6-4b27-bc2a-10b02c7b1aeb",
    "patient_ID": "TCGA.25.1322",
    "bcr_drug_barcode": "TCGA-25-1322-D26678",
    "bcr_drug_uuid": "1a388ff5-ebda-4497-83dc-d0d6d3229810",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "days_to_drug_end": 91,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b520aae5-65a6-4b27-bc2a-10b02c7b1aeb",
    "patient_ID": "TCGA.25.1322",
    "bcr_drug_barcode": "TCGA-25-1322-D26677",
    "bcr_drug_uuid": "739c8ffc-668b-4118-a7a3-5e7bf16ec133",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2ee36d9d-128b-4761-aa1a-a637da106f3d",
    "patient_ID": "TCGA.25.1323",
    "bcr_drug_barcode": "TCGA-25-1323-D26681",
    "bcr_drug_uuid": "5457762b-8086-46df-b0f1-b18019f572b8",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 365,
    "days_to_drug_end": 365,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2ee36d9d-128b-4761-aa1a-a637da106f3d",
    "patient_ID": "TCGA.25.1323",
    "bcr_drug_barcode": "TCGA-25-1323-D26683",
    "bcr_drug_uuid": "8f1e9ed6-2060-4f4b-a9db-76db4190ce6a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2ee36d9d-128b-4761-aa1a-a637da106f3d",
    "patient_ID": "TCGA.25.1323",
    "bcr_drug_barcode": "TCGA-25-1323-D26682",
    "bcr_drug_uuid": "bfd7343e-9a15-493c-9b9d-0895f18fde09",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c73244fd-d486-439f-a94f-fb0bd4e9ac8f",
    "patient_ID": "TCGA.25.1324",
    "bcr_drug_barcode": "TCGA-25-1324-D26687",
    "bcr_drug_uuid": "db95bdbb-40b6-444b-b6c7-f8cfd3d260d7",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c73244fd-d486-439f-a94f-fb0bd4e9ac8f",
    "patient_ID": "TCGA.25.1324",
    "bcr_drug_barcode": "TCGA-25-1324-D26686",
    "bcr_drug_uuid": "1f668234-3cb1-44c3-b63d-ddd8accfe042",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "07a859fc-6f78-4905-9035-90e2403dbe8d",
    "patient_ID": "TCGA.25.1326",
    "bcr_drug_barcode": "TCGA-25-1326-D26692",
    "bcr_drug_uuid": "135291be-0cf9-4eff-a32f-e251268a5f6b",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPETECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "07a859fc-6f78-4905-9035-90e2403dbe8d",
    "patient_ID": "TCGA.25.1326",
    "bcr_drug_barcode": "TCGA-25-1326-D26696",
    "bcr_drug_uuid": "e9376983-d8c4-4462-94bd-b2bdfe55ab02",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 396,
    "days_to_drug_end": 518,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "07a859fc-6f78-4905-9035-90e2403dbe8d",
    "patient_ID": "TCGA.25.1326",
    "bcr_drug_barcode": "TCGA-25-1326-D26694",
    "bcr_drug_uuid": "58e93434-8106-4fde-8237-8f06debfac04",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "days_to_drug_end": 153,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "07a859fc-6f78-4905-9035-90e2403dbe8d",
    "patient_ID": "TCGA.25.1326",
    "bcr_drug_barcode": "TCGA-25-1326-D26693",
    "bcr_drug_uuid": "793c8970-8384-4df9-a64a-7f0044bb4524",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "days_to_drug_end": 153,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "07a859fc-6f78-4905-9035-90e2403dbe8d",
    "patient_ID": "TCGA.25.1326",
    "bcr_drug_barcode": "TCGA-25-1326-D26695",
    "bcr_drug_uuid": "c162c533-1b7a-47a4-9eef-32d33fbd1c44",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "days_to_drug_end": 153,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79fd602b-3e8e-4353-aa78-4f5f170b607d",
    "patient_ID": "TCGA.25.1328",
    "bcr_drug_barcode": "TCGA-25-1328-D26700",
    "bcr_drug_uuid": "7cf22dc8-eab8-40af-919b-502e16d6da2a",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 275,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 395,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "79fd602b-3e8e-4353-aa78-4f5f170b607d",
    "patient_ID": "TCGA.25.1328",
    "bcr_drug_barcode": "TCGA-25-1328-D26703",
    "bcr_drug_uuid": "2bf527ee-a751-4f97-ae92-5d1509de4d83",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79fd602b-3e8e-4353-aa78-4f5f170b607d",
    "patient_ID": "TCGA.25.1328",
    "bcr_drug_barcode": "TCGA-25-1328-D26699",
    "bcr_drug_uuid": "35af06d0-1470-4bcc-b7de-b72f7bf5a4e4",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 275,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 395,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "79fd602b-3e8e-4353-aa78-4f5f170b607d",
    "patient_ID": "TCGA.25.1328",
    "bcr_drug_barcode": "TCGA-25-1328-D26702",
    "bcr_drug_uuid": "c713fc4f-e804-4cde-9a55-e2302007534c",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 214,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "79fd602b-3e8e-4353-aa78-4f5f170b607d",
    "patient_ID": "TCGA.25.1328",
    "bcr_drug_barcode": "TCGA-25-1328-D26701",
    "bcr_drug_uuid": "74b4f735-4e91-4cc1-b586-2b6debf758be",
    "form_completion_date": "2009-3-27",
    "pharmaceutical_therapy_drug_name": "CARBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 275,
    "days_to_drug_end": 395,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "808eb134-9c7d-43bb-b86c-2f3259193954",
    "patient_ID": "TCGA.25.1623",
    "bcr_drug_barcode": "TCGA-25-1623-D26708",
    "bcr_drug_uuid": "d9439bd7-877e-492d-85c7-8c04fff9154d",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "A202171 PROTOCOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "808eb134-9c7d-43bb-b86c-2f3259193954",
    "patient_ID": "TCGA.25.1623",
    "bcr_drug_barcode": "TCGA-25-1623-D26709",
    "bcr_drug_uuid": "8a30a7a1-bdd1-481a-bde2-e96b6f7d9ab0",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "808eb134-9c7d-43bb-b86c-2f3259193954",
    "patient_ID": "TCGA.25.1623",
    "bcr_drug_barcode": "TCGA-25-1623-D26710",
    "bcr_drug_uuid": "f38d9a87-50ec-4e63-9295-238f9c127577",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "88d61634-913c-435a-8d25-e019c8dab7da",
    "patient_ID": "TCGA.25.1625",
    "bcr_drug_barcode": "TCGA-25-1625-D26714",
    "bcr_drug_uuid": "3eac29d8-a7d5-4c20-be59-87f846c18e02",
    "form_completion_date": "2009-6-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "88d61634-913c-435a-8d25-e019c8dab7da",
    "patient_ID": "TCGA.25.1625",
    "bcr_drug_barcode": "TCGA-25-1625-D26713",
    "bcr_drug_uuid": "cf67ac82-70f1-4f1e-bff1-f4e1f59f7bc0",
    "form_completion_date": "2009-6-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "662d77d1-1a43-427a-813b-e11edd30868e",
    "patient_ID": "TCGA.25.1626",
    "bcr_drug_barcode": "TCGA-25-1626-D26718",
    "bcr_drug_uuid": "e35ee48a-e2ed-46c0-bc8d-99b1952ba6c4",
    "form_completion_date": "2009-6-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "662d77d1-1a43-427a-813b-e11edd30868e",
    "patient_ID": "TCGA.25.1626",
    "bcr_drug_barcode": "TCGA-25-1626-D26719",
    "bcr_drug_uuid": "be7f9a79-ee48-4e2c-a58a-f9c54237084e",
    "form_completion_date": "2009-6-15",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "662d77d1-1a43-427a-813b-e11edd30868e",
    "patient_ID": "TCGA.25.1626",
    "bcr_drug_barcode": "TCGA-25-1626-D26720",
    "bcr_drug_uuid": "65255dd7-ebe5-4226-aa16-7268117cf88c",
    "form_completion_date": "2009-6-15",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 319,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 319,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "662d77d1-1a43-427a-813b-e11edd30868e",
    "patient_ID": "TCGA.25.1626",
    "bcr_drug_barcode": "TCGA-25-1626-D26717",
    "bcr_drug_uuid": "41ec1a22-9d13-48f6-a366-98d7ba9b6812",
    "form_completion_date": "2009-6-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "drug_cycles": 7,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3f917550-89a6-404b-94df-938c99121411",
    "patient_ID": "TCGA.25.1628",
    "bcr_drug_barcode": "TCGA-25-1628-D26727",
    "bcr_drug_uuid": "6b515f85-0f51-40e8-a3c8-80ce274d199e",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 299,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 350,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3f917550-89a6-404b-94df-938c99121411",
    "patient_ID": "TCGA.25.1628",
    "bcr_drug_barcode": "TCGA-25-1628-D26725",
    "bcr_drug_uuid": "60320a2a-a599-48c4-ba83-457f94d9c083",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3f917550-89a6-404b-94df-938c99121411",
    "patient_ID": "TCGA.25.1628",
    "bcr_drug_barcode": "TCGA-25-1628-D26726",
    "bcr_drug_uuid": "3ec7e384-43ab-4947-a08c-80b115ff8ef0",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "263e85e2-7b6f-453f-8fd0-e5ea1409fece",
    "patient_ID": "TCGA.25.1630",
    "bcr_drug_barcode": "TCGA-25-1630-D26730",
    "bcr_drug_uuid": "94a3ddc3-9d4a-47a5-a36a-de3736298c44",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "263e85e2-7b6f-453f-8fd0-e5ea1409fece",
    "patient_ID": "TCGA.25.1630",
    "bcr_drug_barcode": "TCGA-25-1630-D26731",
    "bcr_drug_uuid": "9c32d4f7-8cc1-4b59-b283-5ddc42545296",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c435627c-159d-4a6d-a819-30abac24bf4d",
    "patient_ID": "TCGA.25.1632",
    "bcr_drug_barcode": "TCGA-25-1632-D26739",
    "bcr_drug_uuid": "4fe0a3f6-7b53-4115-8a2a-7e3d948ed169",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 566,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 719,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c435627c-159d-4a6d-a819-30abac24bf4d",
    "patient_ID": "TCGA.25.1632",
    "bcr_drug_barcode": "TCGA-25-1632-D26740",
    "bcr_drug_uuid": "da7c4e92-7f80-4302-aed3-833dc33e5ee6",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 566,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 719,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c435627c-159d-4a6d-a819-30abac24bf4d",
    "patient_ID": "TCGA.25.1632",
    "bcr_drug_barcode": "TCGA-25-1632-D26738",
    "bcr_drug_uuid": "c6464d1a-44a2-400e-b1bb-9d4bf8921c3a",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c435627c-159d-4a6d-a819-30abac24bf4d",
    "patient_ID": "TCGA.25.1632",
    "bcr_drug_barcode": "TCGA-25-1632-D26737",
    "bcr_drug_uuid": "48dd2827-21eb-4711-ac76-adb1caa6884d",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c435627c-159d-4a6d-a819-30abac24bf4d",
    "patient_ID": "TCGA.25.1632",
    "bcr_drug_barcode": "TCGA-25-1632-D26736",
    "bcr_drug_uuid": "434bcedc-1d40-4be8-8da0-4c711ac644db",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20336269-5a5b-4ba7-8fe8-665a1f9af738",
    "patient_ID": "TCGA.25.1633",
    "bcr_drug_barcode": "TCGA-25-1633-D26743",
    "bcr_drug_uuid": "926932a0-85d9-4736-b465-0f4c56b8a5af",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20336269-5a5b-4ba7-8fe8-665a1f9af738",
    "patient_ID": "TCGA.25.1633",
    "bcr_drug_barcode": "TCGA-25-1633-D26747",
    "bcr_drug_uuid": "427c83f1-26f0-4fe8-9a55-0084402a72e5",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 617,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 740,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "20336269-5a5b-4ba7-8fe8-665a1f9af738",
    "patient_ID": "TCGA.25.1633",
    "bcr_drug_barcode": "TCGA-25-1633-D26744",
    "bcr_drug_uuid": "5d315761-84c9-49cf-8c15-eaa878daade1",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20336269-5a5b-4ba7-8fe8-665a1f9af738",
    "patient_ID": "TCGA.25.1633",
    "bcr_drug_barcode": "TCGA-25-1633-D26745",
    "bcr_drug_uuid": "2974ff47-ecb9-4eb0-9fb1-64a7abe5887b",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20336269-5a5b-4ba7-8fe8-665a1f9af738",
    "patient_ID": "TCGA.25.1633",
    "bcr_drug_barcode": "TCGA-25-1633-D26746",
    "bcr_drug_uuid": "6fbbf988-5e98-4f81-bf14-b1ab4ee1fe6a",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 617,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 740,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "15556b28-c6bd-455a-87b6-4b7b3e33d0e4",
    "patient_ID": "TCGA.25.1634",
    "bcr_drug_barcode": "TCGA-25-1634-D26750",
    "bcr_drug_uuid": "77f0fa9e-4f0e-4ad7-9b9c-164793954696",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15556b28-c6bd-455a-87b6-4b7b3e33d0e4",
    "patient_ID": "TCGA.25.1634",
    "bcr_drug_barcode": "TCGA-25-1634-D26753",
    "bcr_drug_uuid": "8e382f61-b38a-43a3-9947-df69a2c74a5b",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 380,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 843,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "15556b28-c6bd-455a-87b6-4b7b3e33d0e4",
    "patient_ID": "TCGA.25.1634",
    "bcr_drug_barcode": "TCGA-25-1634-D26752",
    "bcr_drug_uuid": "677bee05-2917-4607-845e-3e4a39387f0f",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15556b28-c6bd-455a-87b6-4b7b3e33d0e4",
    "patient_ID": "TCGA.25.1634",
    "bcr_drug_barcode": "TCGA-25-1634-D26751",
    "bcr_drug_uuid": "9a6ce675-728d-4759-b42a-6c3646dcff73",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 206,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bc2591b0-65d7-48c3-a5cc-783f67b65869",
    "patient_ID": "TCGA.25.1635",
    "bcr_drug_barcode": "TCGA-25-1635-D26757",
    "bcr_drug_uuid": "f2c02abe-3a05-4bc0-914c-48f367820dfa",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bc2591b0-65d7-48c3-a5cc-783f67b65869",
    "patient_ID": "TCGA.25.1635",
    "bcr_drug_barcode": "TCGA-25-1635-D26758",
    "bcr_drug_uuid": "6c145dd3-1953-43e8-8e9d-9837ebbe110c",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bc2591b0-65d7-48c3-a5cc-783f67b65869",
    "patient_ID": "TCGA.25.1635",
    "bcr_drug_barcode": "TCGA-25-1635-D26759",
    "bcr_drug_uuid": "cedc0d74-6848-4ad4-b8b1-73046c2b6d83",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 233,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "bc2591b0-65d7-48c3-a5cc-783f67b65869",
    "patient_ID": "TCGA.25.1635",
    "bcr_drug_barcode": "TCGA-25-1635-D26761",
    "bcr_drug_uuid": "71ad95f2-916c-4bfe-8f65-738b7c70f090",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 741,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "bc2591b0-65d7-48c3-a5cc-783f67b65869",
    "patient_ID": "TCGA.25.1635",
    "bcr_drug_barcode": "TCGA-25-1635-D26760",
    "bcr_drug_uuid": "c428925d-3fb6-46e7-87a4-90747d2e33b9",
    "form_completion_date": "2009-6-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 741,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "15f1a992-0724-4d76-a71a-702ac7753a41",
    "patient_ID": "TCGA.25.1870",
    "bcr_drug_barcode": "TCGA-25-1870-D26765",
    "bcr_drug_uuid": "4bc62a25-6c3d-4d78-954d-188ffcb588d9",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15f1a992-0724-4d76-a71a-702ac7753a41",
    "patient_ID": "TCGA.25.1870",
    "bcr_drug_barcode": "TCGA-25-1870-D26767",
    "bcr_drug_uuid": "b2a59205-5185-49f2-86a8-2afc4d4ccf2b",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "15f1a992-0724-4d76-a71a-702ac7753a41",
    "patient_ID": "TCGA.25.1870",
    "bcr_drug_barcode": "TCGA-25-1870-D26764",
    "bcr_drug_uuid": "0b248d06-5a2e-4a14-9ab0-886deac002cc",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15f1a992-0724-4d76-a71a-702ac7753a41",
    "patient_ID": "TCGA.25.1870",
    "bcr_drug_barcode": "TCGA-25-1870-D26766",
    "bcr_drug_uuid": "f889655c-9daa-433c-a1a9-86d2e757677e",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 151,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ff844242-7559-4b07-b09e-69ea40e5ac6b",
    "patient_ID": "TCGA.25.1871",
    "bcr_drug_barcode": "TCGA-25-1871-D26771",
    "bcr_drug_uuid": "924836ed-90a7-4364-a68e-5ab77f2c0e5f",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ff844242-7559-4b07-b09e-69ea40e5ac6b",
    "patient_ID": "TCGA.25.1871",
    "bcr_drug_barcode": "TCGA-25-1871-D26772",
    "bcr_drug_uuid": "c52ffe62-beb4-4e65-8800-9ad2f5d6ddc3",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ff844242-7559-4b07-b09e-69ea40e5ac6b",
    "patient_ID": "TCGA.25.1871",
    "bcr_drug_barcode": "TCGA-25-1871-D26770",
    "bcr_drug_uuid": "d92a92dd-9124-458e-bc3c-4809ba6811c5",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "077079c3-6877-467b-b9cc-5c650aae4f07",
    "patient_ID": "TCGA.25.1877",
    "bcr_drug_barcode": "TCGA-25-1877-D26776",
    "bcr_drug_uuid": "cd38b202-c4a0-40bb-87e0-14323d353670",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "077079c3-6877-467b-b9cc-5c650aae4f07",
    "patient_ID": "TCGA.25.1877",
    "bcr_drug_barcode": "TCGA-25-1877-D26777",
    "bcr_drug_uuid": "aa853d2b-f944-48a8-acdb-816b629fa09c",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "077079c3-6877-467b-b9cc-5c650aae4f07",
    "patient_ID": "TCGA.25.1877",
    "bcr_drug_barcode": "TCGA-25-1877-D26775",
    "bcr_drug_uuid": "1db2e824-9247-48e7-8fde-e1f15f8e6b2b",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "9bdbaccf-b43b-4ec3-8b9b-dff65215eb00",
    "patient_ID": "TCGA.25.1878",
    "bcr_drug_barcode": "TCGA-25-1878-D26783",
    "bcr_drug_uuid": "48a35437-9288-49cd-ae24-3a823d6bcb0f",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 976,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "9bdbaccf-b43b-4ec3-8b9b-dff65215eb00",
    "patient_ID": "TCGA.25.1878",
    "bcr_drug_barcode": "TCGA-25-1878-D26782",
    "bcr_drug_uuid": "48b9c418-a412-48f8-a53d-e838216fdb8d",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9bdbaccf-b43b-4ec3-8b9b-dff65215eb00",
    "patient_ID": "TCGA.25.1878",
    "bcr_drug_barcode": "TCGA-25-1878-D26781",
    "bcr_drug_uuid": "0a18dede-dff1-44eb-a51c-a1d4c4e62aee",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9bdbaccf-b43b-4ec3-8b9b-dff65215eb00",
    "patient_ID": "TCGA.25.1878",
    "bcr_drug_barcode": "TCGA-25-1878-D26780",
    "bcr_drug_uuid": "0ead63ed-b358-4809-b61d-f26d2ce59642",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 976,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26790",
    "bcr_drug_uuid": "d2120dac-c367-4e8b-bf47-4defae73d882",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26792",
    "bcr_drug_uuid": "3d6dee1b-1b8e-4505-8aeb-21d50754c68c",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26786",
    "bcr_drug_uuid": "404a7c2b-b98b-4746-8fd4-d6a9b2082d7c",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26789",
    "bcr_drug_uuid": "944d91a1-d9d3-42ea-839c-7bfac4d6e1bf",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26793",
    "bcr_drug_uuid": "5312bdff-a94c-42e6-9730-0eac4f016934",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26788",
    "bcr_drug_uuid": "f51efcd0-d4f8-4952-8ded-9510e58c4648",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26791",
    "bcr_drug_uuid": "21269f23-6d86-4696-9758-640be84884d1",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "818dc159-aba4-46bc-a4ed-68ee0f8c4461",
    "patient_ID": "TCGA.25.2042",
    "bcr_drug_barcode": "TCGA-25-2042-D26787",
    "bcr_drug_uuid": "36818245-ce52-4b65-a391-aaf7cdc2f464",
    "form_completion_date": "2009-11-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f5033d52-ec36-4e67-88d8-b6d898b81b2f",
    "patient_ID": "TCGA.25.2391",
    "bcr_drug_barcode": "TCGA-25-2391-D26798",
    "bcr_drug_uuid": "80def7b0-0486-484f-b014-381d703f1ff1",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "days_to_drug_end": 153,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f5033d52-ec36-4e67-88d8-b6d898b81b2f",
    "patient_ID": "TCGA.25.2391",
    "bcr_drug_barcode": "TCGA-25-2391-D26797",
    "bcr_drug_uuid": "416777aa-730e-4ecb-9f3e-193f5095066c",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f5033d52-ec36-4e67-88d8-b6d898b81b2f",
    "patient_ID": "TCGA.25.2391",
    "bcr_drug_barcode": "TCGA-25-2391-D26799",
    "bcr_drug_uuid": "c57fb4b0-6cdc-4067-95a8-0f82c14e07ac",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4b49027-7815-4813-9769-a3fe3a26a37a",
    "patient_ID": "TCGA.25.2393",
    "bcr_drug_barcode": "TCGA-25-2393-D26804",
    "bcr_drug_uuid": "f9f70865-c436-451d-b7cb-66c175893433",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4b49027-7815-4813-9769-a3fe3a26a37a",
    "patient_ID": "TCGA.25.2393",
    "bcr_drug_barcode": "TCGA-25-2393-D26806",
    "bcr_drug_uuid": "9208f692-32d6-4340-b523-c6d8ae520f26",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 305,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 517,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b4b49027-7815-4813-9769-a3fe3a26a37a",
    "patient_ID": "TCGA.25.2393",
    "bcr_drug_barcode": "TCGA-25-2393-D26805",
    "bcr_drug_uuid": "74515577-69c9-4221-9daf-8dd8bca545c2",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fd4740db-76a8-4362-be71-7b609479bb67",
    "patient_ID": "TCGA.25.2398",
    "bcr_drug_barcode": "TCGA-25-2398-D26815",
    "bcr_drug_uuid": "3e6a6ff7-6b15-4b7b-b636-374a1ff5b5c4",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "fd4740db-76a8-4362-be71-7b609479bb67",
    "patient_ID": "TCGA.25.2398",
    "bcr_drug_barcode": "TCGA-25-2398-D26814",
    "bcr_drug_uuid": "41fdf2d1-c9cc-49c5-83c4-a444f3bb2ce0",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fd4740db-76a8-4362-be71-7b609479bb67",
    "patient_ID": "TCGA.25.2398",
    "bcr_drug_barcode": "TCGA-25-2398-D26813",
    "bcr_drug_uuid": "36111e26-366f-4d5d-a6d5-42950816aaaf",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fd4740db-76a8-4362-be71-7b609479bb67",
    "patient_ID": "TCGA.25.2398",
    "bcr_drug_barcode": "TCGA-25-2398-D26816",
    "bcr_drug_uuid": "f6a05e71-bcad-4194-9d40-47255dd4cb92",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 603,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "ad2b1a0a-153f-483d-b228-5763eba3f6cc",
    "patient_ID": "TCGA.25.2399",
    "bcr_drug_barcode": "TCGA-25-2399-D26821",
    "bcr_drug_uuid": "9ca6cc56-eeb0-4463-8fad-adb07d1f9dae",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "ad2b1a0a-153f-483d-b228-5763eba3f6cc",
    "patient_ID": "TCGA.25.2399",
    "bcr_drug_barcode": "TCGA-25-2399-D26819",
    "bcr_drug_uuid": "f67bbe0c-7be0-4fd0-9911-bdf622d7f6d3",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad2b1a0a-153f-483d-b228-5763eba3f6cc",
    "patient_ID": "TCGA.25.2399",
    "bcr_drug_barcode": "TCGA-25-2399-D26820",
    "bcr_drug_uuid": "2bdcf36c-2cf7-4179-8ba3-4fef5c34ce65",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c127332-5ca0-45f1-a5ac-4876ad94e491",
    "patient_ID": "TCGA.25.2400",
    "bcr_drug_barcode": "TCGA-25-2400-D26826",
    "bcr_drug_uuid": "b2c304b8-84cc-401b-96cf-efb9ef1818ac",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 669,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5c127332-5ca0-45f1-a5ac-4876ad94e491",
    "patient_ID": "TCGA.25.2400",
    "bcr_drug_barcode": "TCGA-25-2400-D26825",
    "bcr_drug_uuid": "ca0c6a83-308f-49c2-8e37-8b1f9a7132ec",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c127332-5ca0-45f1-a5ac-4876ad94e491",
    "patient_ID": "TCGA.25.2400",
    "bcr_drug_barcode": "TCGA-25-2400-D26824",
    "bcr_drug_uuid": "6e054b23-144e-4321-9b35-9402bf36de69",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5c127332-5ca0-45f1-a5ac-4876ad94e491",
    "patient_ID": "TCGA.25.2400",
    "bcr_drug_barcode": "TCGA-25-2400-D26827",
    "bcr_drug_uuid": "bbae9713-7efb-4282-ae16-6d2982fdbce5",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 669,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "22178c3c-6b04-46d8-8041-dc83fa195029",
    "patient_ID": "TCGA.25.2404",
    "bcr_drug_barcode": "TCGA-25-2404-D26834",
    "bcr_drug_uuid": "4123b5ea-9752-4c53-b3c4-a2caeb17b133",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 306,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "22178c3c-6b04-46d8-8041-dc83fa195029",
    "patient_ID": "TCGA.25.2404",
    "bcr_drug_barcode": "TCGA-25-2404-D26832",
    "bcr_drug_uuid": "ee45824f-b834-4398-9099-e4d8084dda45",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "22178c3c-6b04-46d8-8041-dc83fa195029",
    "patient_ID": "TCGA.25.2404",
    "bcr_drug_barcode": "TCGA-25-2404-D26835",
    "bcr_drug_uuid": "0e941bf3-b016-4c1b-950e-b8376803e7df",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 306,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "22178c3c-6b04-46d8-8041-dc83fa195029",
    "patient_ID": "TCGA.25.2404",
    "bcr_drug_barcode": "TCGA-25-2404-D26833",
    "bcr_drug_uuid": "1b5f7082-be2b-44dd-a5b6-9dc5903110fc",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fdd4adb8-9295-480a-9352-305b5eb51187",
    "patient_ID": "TCGA.25.2408",
    "bcr_drug_barcode": "TCGA-25-2408-D26839",
    "bcr_drug_uuid": "39386c00-8aa3-4ae3-9a10-8f09e244de14",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fdd4adb8-9295-480a-9352-305b5eb51187",
    "patient_ID": "TCGA.25.2408",
    "bcr_drug_barcode": "TCGA-25-2408-D26838",
    "bcr_drug_uuid": "d85bbcd3-e90c-46cb-ac16-f0e6fb8ce699",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dce71741-ccbe-40b7-a0b8-2048d07187a4",
    "patient_ID": "TCGA.25.2409",
    "bcr_drug_barcode": "TCGA-25-2409-D26843",
    "bcr_drug_uuid": "f9e622c7-2103-4813-979c-461082e72b52",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dce71741-ccbe-40b7-a0b8-2048d07187a4",
    "patient_ID": "TCGA.25.2409",
    "bcr_drug_barcode": "TCGA-25-2409-D26844",
    "bcr_drug_uuid": "e4044ad0-3ce1-44b3-9b0a-9b22bab4fe96",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "dce71741-ccbe-40b7-a0b8-2048d07187a4",
    "patient_ID": "TCGA.25.2409",
    "bcr_drug_barcode": "TCGA-25-2409-D26842",
    "bcr_drug_uuid": "6e085dc2-54ad-4fd4-b583-556c47e0fceb",
    "form_completion_date": "2010-1-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27125",
    "bcr_drug_uuid": "7f10efbe-1ac7-4b34-8a8f-d2018c500d2a",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27126",
    "bcr_drug_uuid": "f7096fd1-a75b-40ad-908c-dcdb17d5cd01",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27133",
    "bcr_drug_uuid": "2ff9881a-ae13-4df7-acf6-5ec75660419f",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27135",
    "bcr_drug_uuid": "8b78391e-9f51-426d-91ab-a34a0f7efd4a",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27129",
    "bcr_drug_uuid": "82e60918-c339-44fc-a5e8-d2e1ac77bd14",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 743,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27137",
    "bcr_drug_uuid": "c7d13c51-ca4e-4da5-bf9b-2509804ed7e5",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1900,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27139",
    "bcr_drug_uuid": "51e458fd-2614-41e5-9f4b-779a7d8ebbee",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2395,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27138",
    "bcr_drug_uuid": "79bc99cb-f7b0-44ea-9611-2552e156242c",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2395,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27127",
    "bcr_drug_uuid": "553498e9-4fe2-45d7-9580-0ced2aa9ffba",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27131",
    "bcr_drug_uuid": "568adf68-a27f-4f9c-944c-b128bdc775b2",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "ORAL ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27134",
    "bcr_drug_uuid": "a72dc90d-76a7-464f-a6b5-1e6e5248cb0e",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1719,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27132",
    "bcr_drug_uuid": "a3c745b9-c5ed-42e9-bac6-15d75ede0e8e",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27130",
    "bcr_drug_uuid": "c7147c57-ad18-4e46-91b1-41247eacbe8a",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 743,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27136",
    "bcr_drug_uuid": "f168b196-edb1-49f3-9196-eb9e7332f9ab",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1900,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "05019013-7ea5-4905-ac79-901146ba2ee2",
    "patient_ID": "TCGA.29.1688",
    "bcr_drug_barcode": "TCGA-29-1688-D27128",
    "bcr_drug_uuid": "62430697-e553-49a9-a8fe-953be4c87a64",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6b06281b-d3a9-440e-a86c-ee7db003352a",
    "patient_ID": "TCGA.29.1690",
    "bcr_drug_barcode": "TCGA-29-1690-D27144",
    "bcr_drug_uuid": "27a85986-1d9f-457a-b3ca-613d2b8873ee",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "6b06281b-d3a9-440e-a86c-ee7db003352a",
    "patient_ID": "TCGA.29.1690",
    "bcr_drug_barcode": "TCGA-29-1690-D27143",
    "bcr_drug_uuid": "0d7fdf72-7232-4393-8010-1726ecc18ae0",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "6b06281b-d3a9-440e-a86c-ee7db003352a",
    "patient_ID": "TCGA.29.1690",
    "bcr_drug_barcode": "TCGA-29-1690-D27146",
    "bcr_drug_uuid": "9ffc6761-7c68-4a4c-ac9d-2cd3fe1748e7",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "6b06281b-d3a9-440e-a86c-ee7db003352a",
    "patient_ID": "TCGA.29.1690",
    "bcr_drug_barcode": "TCGA-29-1690-D27145",
    "bcr_drug_uuid": "12b9fc4e-5a0b-44cd-98a4-73f1ff3cbff9",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27150",
    "bcr_drug_uuid": "af52351f-2a65-4bab-8bf4-573d7d8c7298",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27149",
    "bcr_drug_uuid": "5981636e-0c5c-47af-832a-7eb7e79b6129",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27153",
    "bcr_drug_uuid": "3cf322bf-45f6-4d30-896a-5a44d2a27e15",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 868,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27152",
    "bcr_drug_uuid": "75e41a0f-d235-4fb2-bf9f-34dc7fff8807",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 654,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27157",
    "bcr_drug_uuid": "56c9442e-1bb2-4585-8583-da00a67982b0",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "MEGACE (ORAL)",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 988,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27155",
    "bcr_drug_uuid": "877c785c-7487-4730-b800-ec7ca6a067f5",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1353,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27151",
    "bcr_drug_uuid": "3c9233cf-e2f4-4c15-835e-c8f00dafb4a7",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 654,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 868,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27154",
    "bcr_drug_uuid": "a5cf93f1-4cc5-4e17-bfaf-4fa8c64efbb5",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 988,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b4225c44-b9b6-46c5-aabf-7b0d9a9fe20b",
    "patient_ID": "TCGA.29.1691",
    "bcr_drug_barcode": "TCGA-29-1691-D27156",
    "bcr_drug_uuid": "af8df55a-1129-4a08-ac99-6b6e6328d6ed",
    "form_completion_date": "2010-2-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1353,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27161",
    "bcr_drug_uuid": "685c255e-2242-435e-b5d3-229453699a04",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27164",
    "bcr_drug_uuid": "2917d0e8-ad7f-4643-8b76-7d5a97ff304d",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 694,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27162",
    "bcr_drug_uuid": "9c687c7a-133d-404f-917c-d69210cd5624",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 544,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27166",
    "bcr_drug_uuid": "2438d130-a7cc-471c-8770-e9cab1a2f523",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2247,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27172",
    "bcr_drug_uuid": "0ab57961-2afb-4492-b67e-51bdc6130ea7",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1793,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2125,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27165",
    "bcr_drug_uuid": "6a477a8e-e65c-467e-a25d-caae5486b693",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1548,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27167",
    "bcr_drug_uuid": "fd9a3712-96c8-4b72-92fe-5432b346c056",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2247,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27169",
    "bcr_drug_uuid": "92bc26a1-5bab-4fd2-858c-6f31f45e04e2",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2556,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2577,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 289
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27160",
    "bcr_drug_uuid": "5949a274-8f5b-4410-89b4-3d629590e929",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27168",
    "bcr_drug_uuid": "f32e96f4-6144-4ed9-be21-ae2a8f6c0b8a",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2278,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2521,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27163",
    "bcr_drug_uuid": "90600159-513c-457a-9f29-036530819aea",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 544,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27171",
    "bcr_drug_uuid": "5190da4a-540d-4dd0-bf50-a58711ff9aea",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2616,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2785,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 45
  },
  {
    "bcr_patient_uuid": "92960f76-0242-4a1c-bf7d-014c2f720219",
    "patient_ID": "TCGA.29.1692",
    "bcr_drug_barcode": "TCGA-29-1692-D27170",
    "bcr_drug_uuid": "642fd6be-d54d-4093-bfe4-f2a4bf2f939c",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2616,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2785,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1250
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27176",
    "bcr_drug_uuid": "fb8da9b0-00a9-430c-a45e-3800eb539f96",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2240
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27175",
    "bcr_drug_uuid": "0757d278-2318-4b45-9678-47eb8fcd786e",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3430
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27186",
    "bcr_drug_uuid": "2b068aab-26e8-4d5a-a660-39db26909fe9",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2788,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3018,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27188",
    "bcr_drug_uuid": "7b31538c-cb7a-49f2-b298-883d0d7265ad",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 3124,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27189",
    "bcr_drug_uuid": "edd1f6b0-04b0-4e5e-9c38-9e06e27bd456",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1668,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1724,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 740
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27180",
    "bcr_drug_uuid": "09f2c506-a8de-433b-8463-52ecb7d8023b",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1300,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 345
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27183",
    "bcr_drug_uuid": "e4783d5b-4f80-410d-8ebf-7cbc99d4bb3e",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2027,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2058,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27182",
    "bcr_drug_uuid": "0db74b13-ee6a-4798-8578-305ae89eded5",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1780,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1892,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27185",
    "bcr_drug_uuid": "7c9b327c-69b8-4fed-86a2-711957766a83",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2627,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2669,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27187",
    "bcr_drug_uuid": "c12cf4bd-c639-48b1-805a-bb3f7fd66ebc",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3124,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27177",
    "bcr_drug_uuid": "911cfe1e-c684-4c8b-a1de-9819fbfb1f3a",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 717,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 814,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27184",
    "bcr_drug_uuid": "914a0b3d-a2b8-4daf-878e-bb64c869e520",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2239,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27181",
    "bcr_drug_uuid": "48ad0517-e616-4bc4-a5c8-66eb467f5e18",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1668,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1724,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1375
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27178",
    "bcr_drug_uuid": "4489659a-4376-4edb-b06d-0f34644d7822",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 717,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 814,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "6fb71a0c-bc50-48c8-acfa-db94be1e151a",
    "patient_ID": "TCGA.29.1693",
    "bcr_drug_barcode": "TCGA-29-1693-D27179",
    "bcr_drug_uuid": "42a47a83-7947-4c60-bd0b-68bc8f373b71",
    "form_completion_date": "2010-3-24",
    "pharmaceutical_therapy_drug_name": "XYOTAX",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1069,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1157,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27200",
    "bcr_drug_uuid": "b5f367a1-a738-4e22-a8a7-2955c3f77f89",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1108,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27196",
    "bcr_drug_uuid": "e0acd0c1-67c5-4fec-9a4e-5fa66cabb881",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CT2103 TAXANE ANALOG",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 658,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 719,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 243
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27195",
    "bcr_drug_uuid": "ade1f387-8cb7-4e4d-8868-333460058f40",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 241,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 485,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27199",
    "bcr_drug_uuid": "81ddb67a-43e6-4641-8513-cf5f881a7693",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1057,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1071,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27198",
    "bcr_drug_uuid": "07cd68f0-122d-49b4-b143-3c7b65ac8a72",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 969,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1071,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27201",
    "bcr_drug_uuid": "3808c300-3209-4949-9587-1d31449fa233",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 658,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27193",
    "bcr_drug_uuid": "537110ed-8116-4d74-99e4-41d8b322fe29",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27197",
    "bcr_drug_uuid": "3a3e5828-1122-4499-bc15-0ce8f44feeb3",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL LIPOSOMAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 750,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 928,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 56
  },
  {
    "bcr_patient_uuid": "1db60f09-7f5a-4f21-8003-06a6abc781db",
    "patient_ID": "TCGA.29.1694",
    "bcr_drug_barcode": "TCGA-29-1694-D27194",
    "bcr_drug_uuid": "cc3697a1-5e61-408e-bd54-3f001f19f4c8",
    "form_completion_date": "2010-4-5",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27207",
    "bcr_drug_uuid": "5a0a45c1-c2b7-49f9-a424-cd55b46658ac",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2550
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27208",
    "bcr_drug_uuid": "935ba94e-17b1-42bb-bfcb-777d7af0b574",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5472
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27209",
    "bcr_drug_uuid": "9b52668c-3ac3-46d0-824a-5e670e09207e",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 357,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 479,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27213",
    "bcr_drug_uuid": "a99ed1d2-8b6d-4027-869a-87359a36904f",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 948,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 997,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1305
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27211",
    "bcr_drug_uuid": "74cef5fc-3be7-47ae-9823-b91fc4246b28",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 598,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 791,
    "drug_cycles": 10,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27214",
    "bcr_drug_uuid": "2391893d-dd51-43c2-b966-532867973538",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 633,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 997,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27212",
    "bcr_drug_uuid": "02efd7a1-75d6-4e57-b6e6-9146747f5cc3",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 864,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 934,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 140
  },
  {
    "bcr_patient_uuid": "8a98a6e6-b763-4824-858b-fd2738e6c9a3",
    "patient_ID": "TCGA.29.1696",
    "bcr_drug_barcode": "TCGA-29-1696-D27210",
    "bcr_drug_uuid": "46c5e2a6-3891-4521-9859-437c416d0ad3",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 507,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 573,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 8321
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27218",
    "bcr_drug_uuid": "d5003891-7fb6-49cf-a9d9-e8c42ce205f6",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11184
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27217",
    "bcr_drug_uuid": "2defdb44-07c7-4c6f-989c-522e938522e5",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4512
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27219",
    "bcr_drug_uuid": "08e36e3c-04d0-4eb9-82d4-db345de17ba7",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 182,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1246
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27220",
    "bcr_drug_uuid": "cc1a9ed1-7a73-4ac6-af71-62aaef17faab",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 510,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 535,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 54
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27221",
    "bcr_drug_uuid": "b1d90209-3eef-4785-bbe2-df492af098b4",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 552,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 664,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 574
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27223",
    "bcr_drug_uuid": "71741cc7-cf5c-4722-83bf-365852338e29",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 878,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 899,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 574
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27224",
    "bcr_drug_uuid": "54c4ffc2-7da7-44bc-b3f3-c4ec287b03d4",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 927,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 934,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5.2
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27222",
    "bcr_drug_uuid": "0454b893-307a-4c01-8b81-3973f8a22e54",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 780,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 843,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "42ebd30b-175e-4ece-a806-e55cb7e40e96",
    "patient_ID": "TCGA.29.1697",
    "bcr_drug_barcode": "TCGA-29-1697-D27225",
    "bcr_drug_uuid": "4bbdb89d-adc9-4248-a03d-a57515745d82",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 927,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 927,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 650
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27229",
    "bcr_drug_uuid": "b9c29270-ee60-4e30-a093-5f075678c76a",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2603
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27228",
    "bcr_drug_uuid": "d19d3315-e66f-4c1a-ac23-98bece9f387a",
    "form_completion_date": "2009-12-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 237,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5600
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27239",
    "bcr_drug_uuid": "f5e6d97b-a6dc-4699-8440-cfe1999a7c59",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1419,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27235",
    "bcr_drug_uuid": "9c5d0db2-99d5-41ba-b046-73bcf1606509",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1615,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1783,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 68
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27232",
    "bcr_drug_uuid": "61b62b7a-751e-47c8-952b-ae69e732b57f",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1321,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1566,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27236",
    "bcr_drug_uuid": "a7599369-16cc-498d-a785-820ab146b2f3",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1811,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1972,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27234",
    "bcr_drug_uuid": "9879c952-a90b-4770-80e8-145d5b666e53",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1580,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1587,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27237",
    "bcr_drug_uuid": "649ad6e9-fc1e-4d4b-a6f7-c658c687eaf9",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1986,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2028,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27238",
    "bcr_drug_uuid": "2ebf8390-c1f5-4b22-ae80-22ec2332c195",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2051,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2245,
    "drug_cycles": 8,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27233",
    "bcr_drug_uuid": "4515594c-0c88-4d51-80b8-5b339a8c5f5f",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1321,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1349,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 510
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27240",
    "bcr_drug_uuid": "ac7e4095-4661-4ea2-bd92-532cd8fe44c8",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "AVASTIN (BEVACIZUMAB)",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1524,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1580,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27230",
    "bcr_drug_uuid": "6ad63dbf-f942-4b8a-bf8f-e7dd53d68606",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 909,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 570
  },
  {
    "bcr_patient_uuid": "18d21132-a795-4551-83ba-66483de423a2",
    "patient_ID": "TCGA.29.1698",
    "bcr_drug_barcode": "TCGA-29-1698-D27231",
    "bcr_drug_uuid": "67b7d4d3-f5ae-4f94-854b-bd9759d9535e",
    "form_completion_date": "2010-4-9",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 853,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 53
  },
  {
    "bcr_patient_uuid": "86b513ba-df09-485d-92d4-fb9e888f7350",
    "patient_ID": "TCGA.29.1701",
    "bcr_drug_barcode": "TCGA-29-1701-D27245",
    "bcr_drug_uuid": "8a9dbe36-b51f-41ec-a7f0-2cd48435ff0e",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4505
  },
  {
    "bcr_patient_uuid": "86b513ba-df09-485d-92d4-fb9e888f7350",
    "patient_ID": "TCGA.29.1701",
    "bcr_drug_barcode": "TCGA-29-1701-D27244",
    "bcr_drug_uuid": "3afc4585-7d77-43be-9d92-ae8b9b0b2bbf",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1280
  },
  {
    "bcr_patient_uuid": "86b513ba-df09-485d-92d4-fb9e888f7350",
    "patient_ID": "TCGA.29.1701",
    "bcr_drug_barcode": "TCGA-29-1701-D27246",
    "bcr_drug_uuid": "80f36875-2327-4911-af6e-4d9c45dbafc4",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 318,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 381,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "86b513ba-df09-485d-92d4-fb9e888f7350",
    "patient_ID": "TCGA.29.1701",
    "bcr_drug_barcode": "TCGA-29-1701-D27247",
    "bcr_drug_uuid": "2cc1b601-8961-400e-906f-a8d1ec418ba8",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 409,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 472,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0e1598d8-cbe5-4113-95f1-4bcda061239b",
    "patient_ID": "TCGA.29.1702",
    "bcr_drug_barcode": "TCGA-29-1702-D27250",
    "bcr_drug_uuid": "9cbffc31-fc40-4166-b1b8-601d6f9fa089",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "0e1598d8-cbe5-4113-95f1-4bcda061239b",
    "patient_ID": "TCGA.29.1702",
    "bcr_drug_barcode": "TCGA-29-1702-D27251",
    "bcr_drug_uuid": "8929ea04-1247-4be3-aecc-300064ec7a3b",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0e1598d8-cbe5-4113-95f1-4bcda061239b",
    "patient_ID": "TCGA.29.1702",
    "bcr_drug_barcode": "TCGA-29-1702-D27252",
    "bcr_drug_uuid": "0722dd17-afea-443f-a0cb-14c6334919b9",
    "form_completion_date": "2010-4-20",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 376,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0e1598d8-cbe5-4113-95f1-4bcda061239b",
    "patient_ID": "TCGA.29.1702",
    "bcr_drug_barcode": "TCGA-29-1702-D27253",
    "bcr_drug_uuid": "475e241e-06ea-4bd8-a562-92e47214f991",
    "form_completion_date": "2010-4-20",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 466,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27256",
    "bcr_drug_uuid": "14913535-e3ee-4b29-8485-5ef50b7c1123",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1595
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27257",
    "bcr_drug_uuid": "299385fc-3e5b-4fd2-a656-6fdb78daa069",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4081
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27258",
    "bcr_drug_uuid": "8cb8447c-f35a-435e-9fb1-d51d74f152d2",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 478,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 651,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 773
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27263",
    "bcr_drug_uuid": "4d5bfe23-dd0f-43f5-8880-c91953ddc025",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1720,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1720,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27266",
    "bcr_drug_uuid": "5a22c5fc-1192-4db9-86cb-84768e401698",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 743,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 946,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27259",
    "bcr_drug_uuid": "7f6adfa1-73ce-46ec-b9ae-fdec4acedd2f",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 478,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 651,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 55
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27262",
    "bcr_drug_uuid": "98b7f1cd-615d-4d0f-8e2d-ac2ababfc43d",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1577,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1667,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1370
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27261",
    "bcr_drug_uuid": "4c4f2cec-35a9-462b-bc94-0fb8506d93aa",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL LIPOSOMAL -DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1317,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1457,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27264",
    "bcr_drug_uuid": "53f8a8a1-9b2e-4469-9d98-66f1234ca04d",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1746,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1753,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27260",
    "bcr_drug_uuid": "48f028c2-6e0e-4b9a-a457-ab27cc986d53",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 743,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 946,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27265",
    "bcr_drug_uuid": "7f78908a-4b31-41ff-9268-b209ed2e6c93",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 337,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 470,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "b3511675-fd68-4745-8020-e290ca0fd115",
    "patient_ID": "TCGA.29.1703",
    "bcr_drug_barcode": "TCGA-29-1703-D27267",
    "bcr_drug_uuid": "e56227e6-4d59-43d0-b3a9-8d0ba62a4731",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "AMGEN 706",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1030,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1314,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27275",
    "bcr_drug_uuid": "6e65321e-a2c2-438b-bdff-716ffd3b90ac",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1566,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1587,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27270",
    "bcr_drug_uuid": "4a020b5d-1ba8-4996-a204-5c0b373e2693",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27272",
    "bcr_drug_uuid": "68023b00-a088-44b2-8aed-3c723e70c172",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 642,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 775,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 485
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27273",
    "bcr_drug_uuid": "1225fcb2-265b-417c-9401-e86d350027a4",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 642,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 775,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 230
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27276",
    "bcr_drug_uuid": "21531b27-b04c-4716-b054-832e9646f84e",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1566,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 1587,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27271",
    "bcr_drug_uuid": "05c70827-4563-4f78-b419-5a8d88b695fe",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "8e7f1c74-7cb3-43c0-b07c-bf69b780053f",
    "patient_ID": "TCGA.29.1704",
    "bcr_drug_barcode": "TCGA-29-1704-D27274",
    "bcr_drug_uuid": "3a06f6c4-c0c7-4806-a597-21b86570feb4",
    "form_completion_date": "2010-3-3",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1188,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1300,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27282",
    "bcr_drug_uuid": "05836639-1a84-47c3-89c5-694b2a5435b3",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 450
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27281",
    "bcr_drug_uuid": "615621a7-8290-4dca-b679-0976af6b59a0",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 55,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27280",
    "bcr_drug_uuid": "12ace512-a8b1-4ed4-816f-77013d68ef1f",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4905
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27284",
    "bcr_drug_uuid": "4aeb20a4-d869-46cd-8c57-04ed761d6fb4",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 416,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27283",
    "bcr_drug_uuid": "5ed39f48-80a2-4a76-94a0-313bd99a7df8",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 356,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27285",
    "bcr_drug_uuid": "539804dc-173d-426d-b2ec-e4a1b4cdb703",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 524,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 524,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 725
  },
  {
    "bcr_patient_uuid": "f9c835db-2ab6-4bf5-826f-48723493c0ec",
    "patient_ID": "TCGA.29.1705",
    "bcr_drug_barcode": "TCGA-29-1705-D27286",
    "bcr_drug_uuid": "eb8131b7-b5ed-4fb3-b08f-f744072602e0",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 356,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 990
  },
  {
    "bcr_patient_uuid": "7fd6ab8a-201e-431d-a886-6ab553b6ca36",
    "patient_ID": "TCGA.29.1707",
    "bcr_drug_barcode": "TCGA-29-1707-D27290",
    "bcr_drug_uuid": "fc8868bb-2ed5-4725-a212-cd48bbf7c30f",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1789
  },
  {
    "bcr_patient_uuid": "7fd6ab8a-201e-431d-a886-6ab553b6ca36",
    "patient_ID": "TCGA.29.1707",
    "bcr_drug_barcode": "TCGA-29-1707-D27289",
    "bcr_drug_uuid": "e28df67d-25f3-4d16-9603-b74cb561c0df",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3840
  },
  {
    "bcr_patient_uuid": "7fd6ab8a-201e-431d-a886-6ab553b6ca36",
    "patient_ID": "TCGA.29.1707",
    "bcr_drug_barcode": "TCGA-29-1707-D27292",
    "bcr_drug_uuid": "708f4379-a553-4e68-bf82-a4c4c10480b1",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1375,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 570
  },
  {
    "bcr_patient_uuid": "7fd6ab8a-201e-431d-a886-6ab553b6ca36",
    "patient_ID": "TCGA.29.1707",
    "bcr_drug_barcode": "TCGA-29-1707-D27291",
    "bcr_drug_uuid": "07440f16-26f4-408f-bed7-79da5f4f959b",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1326,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27296",
    "bcr_drug_uuid": "cb4c7e37-e52e-4fb8-8fa2-b06c4fbe488f",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27298",
    "bcr_drug_uuid": "1870b77f-b3fb-4d51-96e7-40c68e3af351",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27304",
    "bcr_drug_uuid": "84cb2e2e-ce41-4f1d-a1cd-a6d742fb2eab",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1870
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27295",
    "bcr_drug_uuid": "8d6988ea-2c98-4eee-8af3-1f1b8f6e91dd",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2790
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27297",
    "bcr_drug_uuid": "2f49fa88-c076-48ba-94c2-fa4d9a572e80",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 52,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27301",
    "bcr_drug_uuid": "5b6525f0-9d61-446a-83e7-b1a19eff710c",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 556,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 580,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27302",
    "bcr_drug_uuid": "a00ec514-4300-45f1-801d-4a792374bdf9",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 682,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 766,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 310
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27299",
    "bcr_drug_uuid": "6303ae09-5316-4b1f-9a64-00d5aad22cb6",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "DOXORUBINCIN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 322,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 437,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27300",
    "bcr_drug_uuid": "c217baa5-64ae-4d44-9f6c-3f18651504b7",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 468,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1410
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27303",
    "bcr_drug_uuid": "d6f9fb02-9165-45de-bb0e-4af029666a8c",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 780,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 853,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 7
  },
  {
    "bcr_patient_uuid": "4261267c-7042-4c6e-83ed-12fb401003fc",
    "patient_ID": "TCGA.29.1710",
    "bcr_drug_barcode": "TCGA-29-1710-D27305",
    "bcr_drug_uuid": "e024dbec-28ae-40c1-9e8f-79c02f82ff18",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CEP 11981",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 619,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 653,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "f58e49fc-9641-4b46-be4c-766445ec70a3",
    "patient_ID": "TCGA.29.1711",
    "bcr_drug_barcode": "TCGA-29-1711-D27309",
    "bcr_drug_uuid": "c10283d7-f31a-4930-b91d-e81e88307348",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 170
  },
  {
    "bcr_patient_uuid": "f58e49fc-9641-4b46-be4c-766445ec70a3",
    "patient_ID": "TCGA.29.1711",
    "bcr_drug_barcode": "TCGA-29-1711-D27310",
    "bcr_drug_uuid": "5006a879-35cd-40f4-959a-d7c4ac2e9da4",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 234,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1863
  },
  {
    "bcr_patient_uuid": "f58e49fc-9641-4b46-be4c-766445ec70a3",
    "patient_ID": "TCGA.29.1711",
    "bcr_drug_barcode": "TCGA-29-1711-D27308",
    "bcr_drug_uuid": "403d3536-f161-4d82-81c6-8c42ccda444c",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "374ea8df-ecc4-44b0-b519-33efa5078018",
    "patient_ID": "TCGA.29.1761",
    "bcr_drug_barcode": "TCGA-29-1761-D27313",
    "bcr_drug_uuid": "fe321eac-53ee-44e1-a7b6-8047473fcbf2",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "374ea8df-ecc4-44b0-b519-33efa5078018",
    "patient_ID": "TCGA.29.1761",
    "bcr_drug_barcode": "TCGA-29-1761-D27314",
    "bcr_drug_uuid": "c8045157-0494-4ff3-81f0-5ad85149afb6",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27323",
    "bcr_drug_uuid": "cd162e63-987c-4f2a-ae65-454519e42da0",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2509,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2555,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 150
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27322",
    "bcr_drug_uuid": "718474fa-5bd1-47e2-b4f3-1e1d8862e5b6",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2439,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2488,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27320",
    "bcr_drug_uuid": "0217767c-919b-42cc-9e93-cc15c80a7898",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCI LIIPOSOMAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2167,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2229,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27319",
    "bcr_drug_uuid": "62ebbf79-daf4-4030-8213-1c06279ced96",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1387,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1513,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27321",
    "bcr_drug_uuid": "70b6d9af-391e-4fec-a670-83101d90add9",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2255,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2418,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27317",
    "bcr_drug_uuid": "41be6bf3-dcfb-4d18-8360-f08247ea6ab4",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5495b18a-10ec-427b-83b8-03ef4b587b13",
    "patient_ID": "TCGA.29.1762",
    "bcr_drug_barcode": "TCGA-29-1762-D27318",
    "bcr_drug_uuid": "fc15c1dd-7e5f-443e-a5a5-e8bd13e582ee",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27327",
    "bcr_drug_uuid": "09bda96f-0f13-49ee-acb6-2d6f13f554c5",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1645
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27326",
    "bcr_drug_uuid": "cb9f2119-7302-400b-83e8-3f5ad57235a0",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3175
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27332",
    "bcr_drug_uuid": "feb62c19-c331-439f-937c-9067cac1f748",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1727,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1839,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27328",
    "bcr_drug_uuid": "0edd2650-9330-4381-8830-33e36ca5e4a2",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 450,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 579,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 675
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27334",
    "bcr_drug_uuid": "413c6676-1d15-45d6-9312-3ef011666f04",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2189,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 2252,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27330",
    "bcr_drug_uuid": "f931a981-978e-4332-8125-5f615bb61706",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1367,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 435
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27335",
    "bcr_drug_uuid": "0fddbda9-cca7-4024-8e3a-f946b424ef6d",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 2049,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2161,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27333",
    "bcr_drug_uuid": "8b5415a7-cf18-4683-aff5-dab81c1097a6",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2049,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2126,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27331",
    "bcr_drug_uuid": "14e4248a-479b-4a23-9689-768e0c095441",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1376,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "242da7d0-8c6a-4395-9a0d-aa36e7c25ce6",
    "patient_ID": "TCGA.29.1763",
    "bcr_drug_barcode": "TCGA-29-1763-D27329",
    "bcr_drug_uuid": "643648fe-7469-4eba-8a99-020867cbdb1a",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1283,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1325,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27340",
    "bcr_drug_uuid": "669fa902-94cd-4761-a34a-ea52ea36e477",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12000
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27341",
    "bcr_drug_uuid": "83c24fb9-19f6-410f-aaaf-62de9ce57d42",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4581
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27339",
    "bcr_drug_uuid": "85cefe8c-1946-4726-86f9-76af29868908",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1050
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27343",
    "bcr_drug_uuid": "2ed46035-c347-455e-9929-04ea06ea6a27",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 822,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 968,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 590
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27346",
    "bcr_drug_uuid": "6ec309e5-10b4-426d-b870-50ae85cfacdf",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1785,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1785,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27348",
    "bcr_drug_uuid": "3b9a01d6-eba5-46dd-9f01-cca971cfa936",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1973,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1100
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27342",
    "bcr_drug_uuid": "43f88f80-cf14-4b7a-aeaf-28fc5909aab4",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 797,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 818,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 60
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27345",
    "bcr_drug_uuid": "990413d8-d086-4927-80af-1ad44a3a2002",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1366,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1515,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27344",
    "bcr_drug_uuid": "0f5f3466-2df4-4ffd-ace9-bbcf4c0edd98",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1301,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1343,
    "drug_cycles": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c70228cc-79c0-4c00-8926-6671c1474701",
    "patient_ID": "TCGA.29.1764",
    "bcr_drug_barcode": "TCGA-29-1764-D27347",
    "bcr_drug_uuid": "4c572c40-ea4e-48bd-9a55-2181e2a7a827",
    "form_completion_date": "2010-4-21",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1973,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "01ea6354-137b-47f3-9021-a01a382b1147",
    "patient_ID": "TCGA.29.1766",
    "bcr_drug_barcode": "TCGA-29-1766-D27351",
    "bcr_drug_uuid": "ef80a8af-4328-4fe3-8e92-d75f92c1b8f2",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 39,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 196,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 19590
  },
  {
    "bcr_patient_uuid": "01ea6354-137b-47f3-9021-a01a382b1147",
    "patient_ID": "TCGA.29.1766",
    "bcr_drug_barcode": "TCGA-29-1766-D27352",
    "bcr_drug_uuid": "85e08cba-87ad-4cd9-a99a-e7e8ebce3b30",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 98,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1580
  },
  {
    "bcr_patient_uuid": "01ea6354-137b-47f3-9021-a01a382b1147",
    "patient_ID": "TCGA.29.1766",
    "bcr_drug_barcode": "TCGA-29-1766-D27353",
    "bcr_drug_uuid": "28d919af-cf13-4344-82b0-4b3bf6086ddb",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 224,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 320
  },
  {
    "bcr_patient_uuid": "01ea6354-137b-47f3-9021-a01a382b1147",
    "patient_ID": "TCGA.29.1766",
    "bcr_drug_barcode": "TCGA-29-1766-D27356",
    "bcr_drug_uuid": "af7205f0-a192-41e7-b706-5f49b22dc251",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1084,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1112,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5.4
  },
  {
    "bcr_patient_uuid": "01ea6354-137b-47f3-9021-a01a382b1147",
    "patient_ID": "TCGA.29.1766",
    "bcr_drug_barcode": "TCGA-29-1766-D27355",
    "bcr_drug_uuid": "bbd623cf-b7e5-418b-92c9-bf283a3e5baa",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 825,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 909,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "01ea6354-137b-47f3-9021-a01a382b1147",
    "patient_ID": "TCGA.29.1766",
    "bcr_drug_barcode": "TCGA-29-1766-D27354",
    "bcr_drug_uuid": "0abcc6b0-9996-4a86-8660-099bc0af0f02",
    "form_completion_date": "2010-4-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 685,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 727,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "838693d5-1ae0-4d75-834b-e1b89b96b0ed",
    "patient_ID": "TCGA.29.1768",
    "bcr_drug_barcode": "TCGA-29-1768-D27360",
    "bcr_drug_uuid": "2c0ce251-f345-4a8a-aa00-e298dbc2b8c5",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 348
  },
  {
    "bcr_patient_uuid": "838693d5-1ae0-4d75-834b-e1b89b96b0ed",
    "patient_ID": "TCGA.29.1768",
    "bcr_drug_barcode": "TCGA-29-1768-D27363",
    "bcr_drug_uuid": "ed65a20a-8958-4fff-ba00-02ed6343c835",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 827,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 915,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "838693d5-1ae0-4d75-834b-e1b89b96b0ed",
    "patient_ID": "TCGA.29.1768",
    "bcr_drug_barcode": "TCGA-29-1768-D27361",
    "bcr_drug_uuid": "76216199-6c74-4f8b-8259-3693f0df3818",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 551,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 719,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 675
  },
  {
    "bcr_patient_uuid": "838693d5-1ae0-4d75-834b-e1b89b96b0ed",
    "patient_ID": "TCGA.29.1768",
    "bcr_drug_barcode": "TCGA-29-1768-D27364",
    "bcr_drug_uuid": "7b41d12a-5d40-47dc-95e1-2e6fe9230598",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB OR PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 252,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1493
  },
  {
    "bcr_patient_uuid": "838693d5-1ae0-4d75-834b-e1b89b96b0ed",
    "patient_ID": "TCGA.29.1768",
    "bcr_drug_barcode": "TCGA-29-1768-D27359",
    "bcr_drug_uuid": "46ff17c1-0870-4b53-8e92-fcd7ccef6c0e",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 103,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 816
  },
  {
    "bcr_patient_uuid": "838693d5-1ae0-4d75-834b-e1b89b96b0ed",
    "patient_ID": "TCGA.29.1768",
    "bcr_drug_barcode": "TCGA-29-1768-D27362",
    "bcr_drug_uuid": "b4a10dad-0fcb-4aa0-a4a8-d8eb58d7cc56",
    "form_completion_date": "2009-11-13",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 551,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 719,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "94769f2c-b6fd-48ec-af34-b41165340b7c",
    "patient_ID": "TCGA.29.1769",
    "bcr_drug_barcode": "TCGA-29-1769-D27367",
    "bcr_drug_uuid": "8825618c-518a-4baf-b858-9aab04f99db2",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 20,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 318
  },
  {
    "bcr_patient_uuid": "94769f2c-b6fd-48ec-af34-b41165340b7c",
    "patient_ID": "TCGA.29.1769",
    "bcr_drug_barcode": "TCGA-29-1769-D27368",
    "bcr_drug_uuid": "44526a07-f299-45c9-bcb9-c9ffd10801e6",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 20,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 870
  },
  {
    "bcr_patient_uuid": "94769f2c-b6fd-48ec-af34-b41165340b7c",
    "patient_ID": "TCGA.29.1769",
    "bcr_drug_barcode": "TCGA-29-1769-D27371",
    "bcr_drug_uuid": "2fb6d93d-b53e-4aa6-aff1-90ff331b09d6",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "ABAGOVOMAB VS PLACEBO",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 206,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "94769f2c-b6fd-48ec-af34-b41165340b7c",
    "patient_ID": "TCGA.29.1769",
    "bcr_drug_barcode": "TCGA-29-1769-D27370",
    "bcr_drug_uuid": "5d098ad8-d2fa-4557-9751-80e53c5f41c5",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 130
  },
  {
    "bcr_patient_uuid": "94769f2c-b6fd-48ec-af34-b41165340b7c",
    "patient_ID": "TCGA.29.1769",
    "bcr_drug_barcode": "TCGA-29-1769-D27369",
    "bcr_drug_uuid": "f005e844-c120-4a8d-9084-4363e2a321d1",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 150,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27381",
    "bcr_drug_uuid": "ca385d1c-e8cd-4c8d-b8b6-e3f6342b9b43",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 762,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27379",
    "bcr_drug_uuid": "4fc81e28-e99d-4465-a5a8-ea8769a382d4",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 546,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 650
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27376",
    "bcr_drug_uuid": "1d5ec102-18ba-4f80-9f5a-75392abd2a11",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 741,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 762,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27378",
    "bcr_drug_uuid": "9f9ea9ab-d749-4426-8eca-5a68cfc3c54c",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 690
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27377",
    "bcr_drug_uuid": "68258d53-863a-4fea-910f-39d19e435491",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27375",
    "bcr_drug_uuid": "1e51f5fb-e363-496b-ae43-0a814f064d15",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 630
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27380",
    "bcr_drug_uuid": "7ad46917-dc48-46d5-9e93-4f4dab7ff79d",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 546,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1370
  },
  {
    "bcr_patient_uuid": "5abb6d80-fc39-49a4-8db5-3db24543feb6",
    "patient_ID": "TCGA.29.1770",
    "bcr_drug_barcode": "TCGA-29-1770-D27374",
    "bcr_drug_uuid": "86b9066d-36b2-4f36-b460-71f470c4e95a",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "7b042fb2-8f53-4fb1-8a44-40cd2128b279",
    "patient_ID": "TCGA.29.1771",
    "bcr_drug_barcode": "TCGA-29-1771-D27387",
    "bcr_drug_uuid": "80543e63-933d-4f44-b5c2-c3062cc2448e",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "7b042fb2-8f53-4fb1-8a44-40cd2128b279",
    "patient_ID": "TCGA.29.1771",
    "bcr_drug_barcode": "TCGA-29-1771-D27386",
    "bcr_drug_uuid": "03cb09e7-1cf9-421c-a6b1-1647d5106a8b",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 345
  },
  {
    "bcr_patient_uuid": "7b042fb2-8f53-4fb1-8a44-40cd2128b279",
    "patient_ID": "TCGA.29.1771",
    "bcr_drug_barcode": "TCGA-29-1771-D27389",
    "bcr_drug_uuid": "d1e90be4-8811-4a8f-a1c5-b914364b9454",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 602,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 728,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 695
  },
  {
    "bcr_patient_uuid": "7b042fb2-8f53-4fb1-8a44-40cd2128b279",
    "patient_ID": "TCGA.29.1771",
    "bcr_drug_barcode": "TCGA-29-1771-D27384",
    "bcr_drug_uuid": "359e1584-0379-4f8d-a2a5-25b007e48c08",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 602,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 728,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 319
  },
  {
    "bcr_patient_uuid": "7b042fb2-8f53-4fb1-8a44-40cd2128b279",
    "patient_ID": "TCGA.29.1771",
    "bcr_drug_barcode": "TCGA-29-1771-D27388",
    "bcr_drug_uuid": "16adb117-4d4b-4234-b6bb-d2c6435b6e4d",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "ABAGOVOMAG VS PLACEBO",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 595,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2
  },
  {
    "bcr_patient_uuid": "7b042fb2-8f53-4fb1-8a44-40cd2128b279",
    "patient_ID": "TCGA.29.1771",
    "bcr_drug_barcode": "TCGA-29-1771-D27385",
    "bcr_drug_uuid": "2c7306f8-d949-46b9-93fc-b192664a6e89",
    "form_completion_date": "2009-11-18",
    "pharmaceutical_therapy_drug_name": "PACILATXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 602,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 728,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 245
  },
  {
    "bcr_patient_uuid": "d3dd5e69-9752-4b50-9b1f-814afbc2c3dd",
    "patient_ID": "TCGA.29.1774",
    "bcr_drug_barcode": "TCGA-29-1774-D27393",
    "bcr_drug_uuid": "8f0d525a-84cc-4376-80b4-468b67a8058f",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 14,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "d3dd5e69-9752-4b50-9b1f-814afbc2c3dd",
    "patient_ID": "TCGA.29.1774",
    "bcr_drug_barcode": "TCGA-29-1774-D27392",
    "bcr_drug_uuid": "c9297a2b-c8a3-47df-a05f-0986a27f2382",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 247,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 380,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1425
  },
  {
    "bcr_patient_uuid": "d3dd5e69-9752-4b50-9b1f-814afbc2c3dd",
    "patient_ID": "TCGA.29.1774",
    "bcr_drug_barcode": "TCGA-29-1774-D27394",
    "bcr_drug_uuid": "a01ca2d5-3332-453a-b76e-75339728fa1f",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 37,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 410
  },
  {
    "bcr_patient_uuid": "d3dd5e69-9752-4b50-9b1f-814afbc2c3dd",
    "patient_ID": "TCGA.29.1774",
    "bcr_drug_barcode": "TCGA-29-1774-D27395",
    "bcr_drug_uuid": "a3f71688-b40d-4551-91df-ad954d163bcc",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 86,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1075
  },
  {
    "bcr_patient_uuid": "d3dd5e69-9752-4b50-9b1f-814afbc2c3dd",
    "patient_ID": "TCGA.29.1774",
    "bcr_drug_barcode": "TCGA-29-1774-D27396",
    "bcr_drug_uuid": "8c33e373-811e-4dbf-8c56-ea8a94342b13",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27401",
    "bcr_drug_uuid": "d81cc8d4-ee3e-44c2-9775-1336cc2c23a5",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB VS PLACEBO",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 114,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 320,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 11694
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27400",
    "bcr_drug_uuid": "3d88301d-c73c-4314-b25e-8d6c5c85050d",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4290
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27399",
    "bcr_drug_uuid": "39863e9b-48dc-497d-bc6f-7ddaf6d74979",
    "form_completion_date": "2009-12-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2040
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27402",
    "bcr_drug_uuid": "ac4fe03f-ca40-4a24-96fe-592c7547f834",
    "form_completion_date": "2010-5-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 432,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 100
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27405",
    "bcr_drug_uuid": "fa8fc828-6c75-47d5-927d-86af2fa3cfb2",
    "form_completion_date": "2010-5-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 397,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 467,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27404",
    "bcr_drug_uuid": "4e0514c2-918e-49ce-b00d-fda19f334ef1",
    "form_completion_date": "2010-5-10",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 377,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27407",
    "bcr_drug_uuid": "0754f353-8c2d-477a-aa6c-ebb7d3191088",
    "form_completion_date": "2010-5-10",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 530,
    "days_to_drug_end": 576,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27403",
    "bcr_drug_uuid": "a1f3b59c-bbe7-4421-a1b4-a70684037a52",
    "form_completion_date": "2010-5-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 355,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 355,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a4a3fca9-723a-47f5-a49d-b3acb71c04a7",
    "patient_ID": "TCGA.29.1775",
    "bcr_drug_barcode": "TCGA-29-1775-D27406",
    "bcr_drug_uuid": "2eb3063c-17a4-467e-8041-172da15d04d5",
    "form_completion_date": "2010-5-10",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 576,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 604,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "7472b3ba-9b15-4d97-8708-a2dd82ca0f45",
    "patient_ID": "TCGA.29.1776",
    "bcr_drug_barcode": "TCGA-29-1776-D27413",
    "bcr_drug_uuid": "ab1add4a-31c8-482e-a205-0e9c8a61be8b",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 522,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 592,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2184
  },
  {
    "bcr_patient_uuid": "7472b3ba-9b15-4d97-8708-a2dd82ca0f45",
    "patient_ID": "TCGA.29.1776",
    "bcr_drug_barcode": "TCGA-29-1776-D27412",
    "bcr_drug_uuid": "a9e8a531-b7c7-4ded-a8d8-72c12e8cf1b2",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 522,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 592,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 88
  },
  {
    "bcr_patient_uuid": "7472b3ba-9b15-4d97-8708-a2dd82ca0f45",
    "patient_ID": "TCGA.29.1776",
    "bcr_drug_barcode": "TCGA-29-1776-D27411",
    "bcr_drug_uuid": "383ee8a0-b591-49b5-91f3-fe0b14dbf094",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "7472b3ba-9b15-4d97-8708-a2dd82ca0f45",
    "patient_ID": "TCGA.29.1776",
    "bcr_drug_barcode": "TCGA-29-1776-D27410",
    "bcr_drug_uuid": "dc28acfe-77b0-4f61-b4d1-2cefb76d2598",
    "form_completion_date": "2010-4-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5",
    "patient_ID": "TCGA.29.1777",
    "bcr_drug_barcode": "TCGA-29-1777-D27417",
    "bcr_drug_uuid": "b75caa77-a905-4a32-b84b-da1b1c8917a5",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 325,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5",
    "patient_ID": "TCGA.29.1777",
    "bcr_drug_barcode": "TCGA-29-1777-D27416",
    "bcr_drug_uuid": "2d46646d-aff6-454e-b00e-294b99ca71f9",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 303,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 740
  },
  {
    "bcr_patient_uuid": "5ced5b58-fab4-4bcd-b706-d6e49ce0cfc5",
    "patient_ID": "TCGA.29.1777",
    "bcr_drug_barcode": "TCGA-29-1777-D27418",
    "bcr_drug_uuid": "c821d43b-cc39-4e8d-baef-20905b8795e5",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 346,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "44e840c9-ea54-4dba-9b2a-264ef1f2c304",
    "patient_ID": "TCGA.29.1778",
    "bcr_drug_barcode": "TCGA-29-1778-D27423",
    "bcr_drug_uuid": "af76c927-da93-45aa-a1f7-96a6182eaa7a",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 325
  },
  {
    "bcr_patient_uuid": "44e840c9-ea54-4dba-9b2a-264ef1f2c304",
    "patient_ID": "TCGA.29.1778",
    "bcr_drug_barcode": "TCGA-29-1778-D27422",
    "bcr_drug_uuid": "7b208018-f74b-4c65-ae60-865ca874ba40",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 410
  },
  {
    "bcr_patient_uuid": "44e840c9-ea54-4dba-9b2a-264ef1f2c304",
    "patient_ID": "TCGA.29.1778",
    "bcr_drug_barcode": "TCGA-29-1778-D27425",
    "bcr_drug_uuid": "fef2287b-ade4-4f49-808f-23aac02719c6",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "44e840c9-ea54-4dba-9b2a-264ef1f2c304",
    "patient_ID": "TCGA.29.1778",
    "bcr_drug_barcode": "TCGA-29-1778-D27421",
    "bcr_drug_uuid": "76ba3141-d32e-463c-a900-bae906b194f2",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 101,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "44e840c9-ea54-4dba-9b2a-264ef1f2c304",
    "patient_ID": "TCGA.29.1778",
    "bcr_drug_barcode": "TCGA-29-1778-D27424",
    "bcr_drug_uuid": "1622a274-30ac-42b7-b84f-9a475d6681f6",
    "form_completion_date": "2009-10-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 325
  },
  {
    "bcr_patient_uuid": "f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6",
    "patient_ID": "TCGA.29.1781",
    "bcr_drug_barcode": "TCGA-29-1781-D27429",
    "bcr_drug_uuid": "ca447e99-c2a8-46bb-a4db-19480aae1034",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 255,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2322
  },
  {
    "bcr_patient_uuid": "f6ebf3a7-31c6-4f4c-9a0b-74cf35bfedf6",
    "patient_ID": "TCGA.29.1781",
    "bcr_drug_barcode": "TCGA-29-1781-D27428",
    "bcr_drug_uuid": "cf2a312b-1bea-47bb-8927-fec695033234",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 255,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2970
  },
  {
    "bcr_patient_uuid": "460616ec-f66f-483b-88c1-757edd86261d",
    "patient_ID": "TCGA.29.1783",
    "bcr_drug_barcode": "TCGA-29-1783-D27433",
    "bcr_drug_uuid": "896921c8-ee1c-44b6-93d4-67af63d3a66a",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1623
  },
  {
    "bcr_patient_uuid": "460616ec-f66f-483b-88c1-757edd86261d",
    "patient_ID": "TCGA.29.1783",
    "bcr_drug_barcode": "TCGA-29-1783-D27434",
    "bcr_drug_uuid": "282d262f-4bb3-40a5-81c7-dc51c8aa8886",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 430,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 9750
  },
  {
    "bcr_patient_uuid": "460616ec-f66f-483b-88c1-757edd86261d",
    "patient_ID": "TCGA.29.1783",
    "bcr_drug_barcode": "TCGA-29-1783-D27432",
    "bcr_drug_uuid": "c784772b-4edc-4349-9d95-598ee3dd7271",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4536
  },
  {
    "bcr_patient_uuid": "23d32627-9fd2-4312-bcda-ee7409e3983f",
    "patient_ID": "TCGA.29.1784",
    "bcr_drug_barcode": "TCGA-29-1784-D27437",
    "bcr_drug_uuid": "a7ddfd0e-e8fd-4f46-898d-db041e8123b7",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3330
  },
  {
    "bcr_patient_uuid": "23d32627-9fd2-4312-bcda-ee7409e3983f",
    "patient_ID": "TCGA.29.1784",
    "bcr_drug_barcode": "TCGA-29-1784-D27438",
    "bcr_drug_uuid": "14115b3c-a38c-47f2-84e9-b36340c5c238",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 17,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 270
  },
  {
    "bcr_patient_uuid": "23d32627-9fd2-4312-bcda-ee7409e3983f",
    "patient_ID": "TCGA.29.1784",
    "bcr_drug_barcode": "TCGA-29-1784-D27440",
    "bcr_drug_uuid": "f607cd30-cc09-4356-b447-bf0f45cbb16c",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE HCI",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 24,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2480
  },
  {
    "bcr_patient_uuid": "23d32627-9fd2-4312-bcda-ee7409e3983f",
    "patient_ID": "TCGA.29.1784",
    "bcr_drug_barcode": "TCGA-29-1784-D27439",
    "bcr_drug_uuid": "ca6a7ec0-5ee5-4be8-a942-9b86ff67a8b2",
    "form_completion_date": "2009-12-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL; ALBUMIN-BOUNT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 59,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27447",
    "bcr_drug_uuid": "f00119e6-143f-459d-8b3a-d340fd6169a6",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 496,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 330
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27445",
    "bcr_drug_uuid": "331fce9e-ac3e-4a38-99a9-35704d71d5e4",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27448",
    "bcr_drug_uuid": "2004f10c-78e9-4a30-aaeb-be371007890c",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 612,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 610
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27444",
    "bcr_drug_uuid": "ec9873e2-600a-4805-bc39-ff9d81e7fef3",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 610
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27443",
    "bcr_drug_uuid": "698a373b-5699-474a-b8d6-fdd85307ffa6",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 51,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 610
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27449",
    "bcr_drug_uuid": "8111da34-a2c8-4258-aff6-c9d64b6c2e16",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 612,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 110
  },
  {
    "bcr_patient_uuid": "1aea3c25-d2bc-4ff5-bc27-32e939944e9d",
    "patient_ID": "TCGA.29.1785",
    "bcr_drug_barcode": "TCGA-29-1785-D27446",
    "bcr_drug_uuid": "c431ed1c-ba8d-41fc-b6a4-f5e5a1fbc579",
    "form_completion_date": "2009-11-2",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 496,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 496,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27452",
    "bcr_drug_uuid": "132a139a-586a-4d1a-af97-fa14a99ca34a",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2042,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2151,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27453",
    "bcr_drug_uuid": "1bb30d93-19c1-43d9-aff6-31304c0e1cab",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2256,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2287,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27455",
    "bcr_drug_uuid": "625a1bad-817a-495e-bbe8-b1b729a59ddc",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27454",
    "bcr_drug_uuid": "d3474bc8-4f86-4d81-95e2-3bc02d4caeaf",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2315,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2424,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27456",
    "bcr_drug_uuid": "f1b37728-c715-49d5-8f09-f3ccd3f67332",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27458",
    "bcr_drug_uuid": "317f4820-8ca1-4a04-914d-ed26beb2ab02",
    "form_completion_date": "2010-3-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 996,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1171,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27457",
    "bcr_drug_uuid": "b3519929-e195-4d53-a529-432c75296acc",
    "form_completion_date": "2010-3-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 996,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1171,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a2319490-b85d-4219-a1b0-fa1ec432d5c8",
    "patient_ID": "TCGA.29.2414",
    "bcr_drug_barcode": "TCGA-29-2414-D27459",
    "bcr_drug_uuid": "d4828223-bc26-41cd-87bd-0dc1451bb931",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 996,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1171,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "40635bf3-d8ba-4833-b623-547e55e5d07e",
    "patient_ID": "TCGA.29.2425",
    "bcr_drug_barcode": "TCGA-29-2425-D27465",
    "bcr_drug_uuid": "bb6485f6-0925-462b-b098-086512a78e90",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "40635bf3-d8ba-4833-b623-547e55e5d07e",
    "patient_ID": "TCGA.29.2425",
    "bcr_drug_barcode": "TCGA-29-2425-D27467",
    "bcr_drug_uuid": "b173f7f4-e6ed-49dc-bf99-a3d7a213801b",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "40635bf3-d8ba-4833-b623-547e55e5d07e",
    "patient_ID": "TCGA.29.2425",
    "bcr_drug_barcode": "TCGA-29-2425-D27468",
    "bcr_drug_uuid": "a11754f7-bc64-44fb-b4ba-049a4f6f9766",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1584,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1696,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "40635bf3-d8ba-4833-b623-547e55e5d07e",
    "patient_ID": "TCGA.29.2425",
    "bcr_drug_barcode": "TCGA-29-2425-D27463",
    "bcr_drug_uuid": "68120a6b-d428-4644-a08d-39d0d8635aa4",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1584,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1696,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "40635bf3-d8ba-4833-b623-547e55e5d07e",
    "patient_ID": "TCGA.29.2425",
    "bcr_drug_barcode": "TCGA-29-2425-D27466",
    "bcr_drug_uuid": "b1c41005-66fb-4b61-bb72-9a2dde69f06d",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 97,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "40635bf3-d8ba-4833-b623-547e55e5d07e",
    "patient_ID": "TCGA.29.2425",
    "bcr_drug_barcode": "TCGA-29-2425-D27464",
    "bcr_drug_uuid": "7db78a21-3be4-499a-a7bc-fff049921c40",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1584,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1696,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "6f25001a-f890-4fd0-a994-e62a9ea5c6f3",
    "patient_ID": "TCGA.29.2427",
    "bcr_drug_barcode": "TCGA-29-2427-D27471",
    "bcr_drug_uuid": "5f00d7f8-73b2-4db4-ba11-5a41234d2ca1",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 3,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "6f25001a-f890-4fd0-a994-e62a9ea5c6f3",
    "patient_ID": "TCGA.29.2427",
    "bcr_drug_barcode": "TCGA-29-2427-D27474",
    "bcr_drug_uuid": "3d7a84c3-cc88-4b27-84a0-697e76c7cbc7",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "ABRAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1816,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1900,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 510
  },
  {
    "bcr_patient_uuid": "6f25001a-f890-4fd0-a994-e62a9ea5c6f3",
    "patient_ID": "TCGA.29.2427",
    "bcr_drug_barcode": "TCGA-29-2427-D27473",
    "bcr_drug_uuid": "ee7023c9-49e0-48c5-8781-e28ef2609827",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1584,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1690,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "6f25001a-f890-4fd0-a994-e62a9ea5c6f3",
    "patient_ID": "TCGA.29.2427",
    "bcr_drug_barcode": "TCGA-29-2427-D27472",
    "bcr_drug_uuid": "47d4b680-8d55-4cf4-868b-ae44e3ae1436",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "drug_cycles": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 0
  },
  {
    "bcr_patient_uuid": "6f25001a-f890-4fd0-a994-e62a9ea5c6f3",
    "patient_ID": "TCGA.29.2427",
    "bcr_drug_barcode": "TCGA-29-2427-D27476",
    "bcr_drug_uuid": "8b87346f-baaf-46c2-9c7d-07ad0af96ad2",
    "form_completion_date": "2011-10-20",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 940,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5640
  },
  {
    "bcr_patient_uuid": "6f25001a-f890-4fd0-a994-e62a9ea5c6f3",
    "patient_ID": "TCGA.29.2427",
    "bcr_drug_barcode": "TCGA-29-2427-D27475",
    "bcr_drug_uuid": "ee835a1c-74f7-4113-a155-edb8c347a4b2",
    "form_completion_date": "2011-10-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "b0585c7a-7205-4dac-9d54-6da89674accb",
    "patient_ID": "TCGA.29.2428",
    "bcr_drug_barcode": "TCGA-29-2428-D27479",
    "bcr_drug_uuid": "0f7b6d8e-68b1-42e2-8242-af4bf9964970",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 670
  },
  {
    "bcr_patient_uuid": "b0585c7a-7205-4dac-9d54-6da89674accb",
    "patient_ID": "TCGA.29.2428",
    "bcr_drug_barcode": "TCGA-29-2428-D27480",
    "bcr_drug_uuid": "a0dae621-3815-4b2a-8364-e19198be75ac",
    "form_completion_date": "2010-2-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "4309ca23-1cf9-40a2-a01c-ccee90f958b2",
    "patient_ID": "TCGA.29.2429",
    "bcr_drug_barcode": "TCGA-29-2429-D27483",
    "bcr_drug_uuid": "e4df2fd2-1dc4-424a-b456-c3e415c37ace",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4309ca23-1cf9-40a2-a01c-ccee90f958b2",
    "patient_ID": "TCGA.29.2429",
    "bcr_drug_barcode": "TCGA-29-2429-D27482",
    "bcr_drug_uuid": "c75fad2f-73f0-4fa6-8870-e9a28e7ae23a",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "996313ef-11e7-459d-ba5f-ac1a4d0de513",
    "patient_ID": "TCGA.29.2431",
    "bcr_drug_barcode": "TCGA-29-2431-D27488",
    "bcr_drug_uuid": "c63c5158-3a3d-4f97-92f7-c6cba8fdb995",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 977,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1145,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 335,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "996313ef-11e7-459d-ba5f-ac1a4d0de513",
    "patient_ID": "TCGA.29.2431",
    "bcr_drug_barcode": "TCGA-29-2431-D27487",
    "bcr_drug_uuid": "02256292-b3b7-427a-9157-5147ef0ba72c",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "996313ef-11e7-459d-ba5f-ac1a4d0de513",
    "patient_ID": "TCGA.29.2431",
    "bcr_drug_barcode": "TCGA-29-2431-D27490",
    "bcr_drug_uuid": "4697eff4-cb13-4836-8a81-0e4382d5b5fe",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 390,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1120,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "996313ef-11e7-459d-ba5f-ac1a4d0de513",
    "patient_ID": "TCGA.29.2431",
    "bcr_drug_barcode": "TCGA-29-2431-D27489",
    "bcr_drug_uuid": "90ddaf81-71b9-42e3-b499-498c241002c3",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 977,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1145,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 530,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "996313ef-11e7-459d-ba5f-ac1a4d0de513",
    "patient_ID": "TCGA.29.2431",
    "bcr_drug_barcode": "TCGA-29-2431-D27486",
    "bcr_drug_uuid": "e8857415-3e93-4361-930e-4ccb6671e0c1",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0e6c9433-289c-4744-a0c1-47ec67774047",
    "patient_ID": "TCGA.29.2432",
    "bcr_drug_barcode": "TCGA-29-2432-D27493",
    "bcr_drug_uuid": "d5720bb9-fbde-4f8d-a0b5-7bb82df87ce2",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 540,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3150
  },
  {
    "bcr_patient_uuid": "0e6c9433-289c-4744-a0c1-47ec67774047",
    "patient_ID": "TCGA.29.2432",
    "bcr_drug_barcode": "TCGA-29-2432-D27495",
    "bcr_drug_uuid": "cebea2c3-9245-4c77-b299-33df263ad6d7",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "BEVACIZUMAB",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1010,
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0e6c9433-289c-4744-a0c1-47ec67774047",
    "patient_ID": "TCGA.29.2432",
    "bcr_drug_barcode": "TCGA-29-2432-D27494",
    "bcr_drug_uuid": "ec863682-01e3-4e42-b640-495a71b085bc",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 303,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1809
  },
  {
    "bcr_patient_uuid": "fd806e1d-b5ea-4556-9b12-5254fd9f00a2",
    "patient_ID": "TCGA.29.2433",
    "bcr_drug_barcode": "TCGA-29-2433-D27501",
    "bcr_drug_uuid": "02db8301-db04-448c-8746-b7444a422db3",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 175,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "fd806e1d-b5ea-4556-9b12-5254fd9f00a2",
    "patient_ID": "TCGA.29.2433",
    "bcr_drug_barcode": "TCGA-29-2433-D27499",
    "bcr_drug_uuid": "fd6d33a9-4c41-4913-8419-21223bb1d0fd",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 14,
    "drug_cycles": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fd806e1d-b5ea-4556-9b12-5254fd9f00a2",
    "patient_ID": "TCGA.29.2433",
    "bcr_drug_barcode": "TCGA-29-2433-D27502",
    "bcr_drug_uuid": "e13efaba-05ce-4654-aeba-b4a2ec4de5f9",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "fd806e1d-b5ea-4556-9b12-5254fd9f00a2",
    "patient_ID": "TCGA.29.2433",
    "bcr_drug_barcode": "TCGA-29-2433-D27498",
    "bcr_drug_uuid": "2e115b5c-8485-45e4-8df9-75e36bafe736",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 14,
    "drug_cycles": 1,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "fd806e1d-b5ea-4556-9b12-5254fd9f00a2",
    "patient_ID": "TCGA.29.2433",
    "bcr_drug_barcode": "TCGA-29-2433-D27500",
    "bcr_drug_uuid": "6c774a12-0b32-4828-af0e-0361420497ac",
    "form_completion_date": "2010-6-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 540,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1040
  },
  {
    "bcr_patient_uuid": "fd806e1d-b5ea-4556-9b12-5254fd9f00a2",
    "patient_ID": "TCGA.29.2433",
    "bcr_drug_barcode": "TCGA-29-2433-D27503",
    "bcr_drug_uuid": "d4f86338-7a09-4c77-a277-30cd5198568f",
    "form_completion_date": "2010-6-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 450,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1350
  },
  {
    "bcr_patient_uuid": "cb090048-9af1-489d-9ebe-7efaa3dc4e85",
    "patient_ID": "TCGA.29.2434",
    "bcr_drug_barcode": "TCGA-29-2434-D27506",
    "bcr_drug_uuid": "269dc635-745c-4959-aef6-d92e348c7080",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb090048-9af1-489d-9ebe-7efaa3dc4e85",
    "patient_ID": "TCGA.29.2434",
    "bcr_drug_barcode": "TCGA-29-2434-D27507",
    "bcr_drug_uuid": "052789d2-36ee-41a4-8bc3-b6bfa7a2f87b",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_dose": 100,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cb090048-9af1-489d-9ebe-7efaa3dc4e85",
    "patient_ID": "TCGA.29.2434",
    "bcr_drug_barcode": "TCGA-29-2434-D27508",
    "bcr_drug_uuid": "266546a4-d823-480b-9c84-a8b4ae413205",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 100,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8fa35df3-f544-4c47-bdd1-e4d6fc6662be",
    "patient_ID": "TCGA.29.2435",
    "bcr_drug_barcode": "TCGA-29-2435-D27511",
    "bcr_drug_uuid": "4b060dcb-322a-4357-b030-8cbe7307bc71",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8fa35df3-f544-4c47-bdd1-e4d6fc6662be",
    "patient_ID": "TCGA.29.2435",
    "bcr_drug_barcode": "TCGA-29-2435-D27512",
    "bcr_drug_uuid": "9d87155a-3587-4120-8dd9-6703aa7a39c4",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "295231ab-477b-4077-a368-db34f867102c",
    "patient_ID": "TCGA.29.2436",
    "bcr_drug_barcode": "TCGA-29-2436-D27515",
    "bcr_drug_uuid": "5061e9ad-2cf6-4dd3-970c-57ce41b37689",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 275,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1406
  },
  {
    "bcr_patient_uuid": "295231ab-477b-4077-a368-db34f867102c",
    "patient_ID": "TCGA.29.2436",
    "bcr_drug_barcode": "TCGA-29-2436-D27516",
    "bcr_drug_uuid": "906d31f6-1d9e-4baf-a9b5-2cb038fe599e",
    "form_completion_date": "2010-6-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 191,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 870,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5220
  },
  {
    "bcr_patient_uuid": "F1CB3D48-1415-408D-89D1-DFDCC5924963",
    "patient_ID": "TCGA.29.A5NZ",
    "bcr_drug_barcode": "TCGA-29-A5NZ-D59533",
    "bcr_drug_uuid": "061ED9E3-C6F0-4348-9A32-9FAAD64DC411",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F1CB3D48-1415-408D-89D1-DFDCC5924963",
    "patient_ID": "TCGA.29.A5NZ",
    "bcr_drug_barcode": "TCGA-29-A5NZ-D59534",
    "bcr_drug_uuid": "2ABD0BB8-6960-48F8-B08D-28AB17CF9FE6",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "days_to_drug_start": 396,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 543,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F1CB3D48-1415-408D-89D1-DFDCC5924963",
    "patient_ID": "TCGA.29.A5NZ",
    "bcr_drug_barcode": "TCGA-29-A5NZ-D59535",
    "bcr_drug_uuid": "55F4F735-7B13-4FA5-8105-4B4D8480A870",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "days_to_drug_start": 396,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 543,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F1CB3D48-1415-408D-89D1-DFDCC5924963",
    "patient_ID": "TCGA.29.A5NZ",
    "bcr_drug_barcode": "TCGA-29-A5NZ-D59537",
    "bcr_drug_uuid": "F3B64637-8466-489E-AAE7-0CB2CD1E80C6",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "days_to_drug_start": 893,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F1CB3D48-1415-408D-89D1-DFDCC5924963",
    "patient_ID": "TCGA.29.A5NZ",
    "bcr_drug_barcode": "TCGA-29-A5NZ-D59532",
    "bcr_drug_uuid": "B8A9B895-3774-4B7A-8E4E-601BAEEB0C3B",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "F1CB3D48-1415-408D-89D1-DFDCC5924963",
    "patient_ID": "TCGA.29.A5NZ",
    "bcr_drug_barcode": "TCGA-29-A5NZ-D59536",
    "bcr_drug_uuid": "F16C6D42-2092-4457-B4B5-D5F1169B78FD",
    "form_completion_date": "2014-5-14",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "days_to_drug_start": 686,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 817,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27529",
    "bcr_drug_uuid": "484b8f0c-dfc0-4609-8b68-bcb68ba7cfb0",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1002,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1075,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 343
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27528",
    "bcr_drug_uuid": "e1b0dbd2-3f76-4035-bd5a-4d21fb2d5ead",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 973,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 990,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27522",
    "bcr_drug_uuid": "5dcaa7ee-b212-4231-a324-aa6ce4fbc112",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 424,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 521,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27527",
    "bcr_drug_uuid": "042e666e-6398-41eb-b4a7-a7c8f827113c",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 955,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27521",
    "bcr_drug_uuid": "cef80948-64c3-4608-b830-fc9ffb5114e7",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 314,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27524",
    "bcr_drug_uuid": "c9389674-3b88-4809-aa7a-cba33bed3d60",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 555,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27519",
    "bcr_drug_uuid": "0dfd75da-44eb-4094-886c-ea2ef1f0d39d",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27530",
    "bcr_drug_uuid": "994c0e08-62d3-4f19-b713-c74fad7d2a4f",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1002,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1081,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27520",
    "bcr_drug_uuid": "3b0d4be7-ecbf-4ea1-ad60-3f6e3b6fccad",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27525",
    "bcr_drug_uuid": "d02262bf-8e14-4818-a03b-da6d5cc93714",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 555,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 278
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27523",
    "bcr_drug_uuid": "96e20ade-957d-4325-bf8a-52bcf4a52c4a",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 555,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 700,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 343
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27526",
    "bcr_drug_uuid": "229d1033-3c45-40c6-a9ff-3ac9a8dfcd07",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 906,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 955,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "09820a33-80b1-42d0-8366-a0ddaf94b122",
    "patient_ID": "TCGA.30.1714",
    "bcr_drug_barcode": "TCGA-30-1714-D27531",
    "bcr_drug_uuid": "ac3a5434-1fed-435f-8b81-48141e149b33",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "ARMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 283,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "ad2939e6-b8b8-475a-90e2-6a369c3d3167",
    "patient_ID": "TCGA.30.1718",
    "bcr_drug_barcode": "TCGA-30-1718-D27535",
    "bcr_drug_uuid": "05090990-3b2e-4695-8640-d685a8dd5e38",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "HEXALIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad2939e6-b8b8-475a-90e2-6a369c3d3167",
    "patient_ID": "TCGA.30.1718",
    "bcr_drug_barcode": "TCGA-30-1718-D27537",
    "bcr_drug_uuid": "ca71da11-843d-4468-988f-8a5f48ffbfb5",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 206,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 492,
    "drug_cycles": 11,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad2939e6-b8b8-475a-90e2-6a369c3d3167",
    "patient_ID": "TCGA.30.1718",
    "bcr_drug_barcode": "TCGA-30-1718-D27536",
    "bcr_drug_uuid": "49cdeed1-76cc-4608-aea3-af439a26c1e5",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad2939e6-b8b8-475a-90e2-6a369c3d3167",
    "patient_ID": "TCGA.30.1718",
    "bcr_drug_barcode": "TCGA-30-1718-D27540",
    "bcr_drug_uuid": "abea4d31-e57d-4f0f-b821-23a5d05123ec",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 865,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 896,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad2939e6-b8b8-475a-90e2-6a369c3d3167",
    "patient_ID": "TCGA.30.1718",
    "bcr_drug_barcode": "TCGA-30-1718-D27538",
    "bcr_drug_uuid": "c2fa4a73-8690-49e7-a1b7-cc0ec4f5d70e",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ad2939e6-b8b8-475a-90e2-6a369c3d3167",
    "patient_ID": "TCGA.30.1718",
    "bcr_drug_barcode": "TCGA-30-1718-D27539",
    "bcr_drug_uuid": "0a8e0ead-87c1-40cb-a0a2-d7af833547a1",
    "form_completion_date": "2009-12-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d603bba-62e6-48fb-b8fc-401109abcaee",
    "patient_ID": "TCGA.30.1853",
    "bcr_drug_barcode": "TCGA-30-1853-D27548",
    "bcr_drug_uuid": "87eb4360-2370-42e4-9920-32b4be6791ba",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 950,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1011,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "5d603bba-62e6-48fb-b8fc-401109abcaee",
    "patient_ID": "TCGA.30.1853",
    "bcr_drug_barcode": "TCGA-30-1853-D27544",
    "bcr_drug_uuid": "02e54e5c-6ffc-4742-92ba-1de798919bf9",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "5d603bba-62e6-48fb-b8fc-401109abcaee",
    "patient_ID": "TCGA.30.1853",
    "bcr_drug_barcode": "TCGA-30-1853-D27546",
    "bcr_drug_uuid": "d1cdcf9f-1d4f-495b-9ca3-3f1820988c17",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 669,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 778,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "5d603bba-62e6-48fb-b8fc-401109abcaee",
    "patient_ID": "TCGA.30.1853",
    "bcr_drug_barcode": "TCGA-30-1853-D27547",
    "bcr_drug_uuid": "aee7c046-3c2e-4a58-80b4-4b642c08a7e9",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TRABECTEDIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 886,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 932,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 580
  },
  {
    "bcr_patient_uuid": "5d603bba-62e6-48fb-b8fc-401109abcaee",
    "patient_ID": "TCGA.30.1853",
    "bcr_drug_barcode": "TCGA-30-1853-D27543",
    "bcr_drug_uuid": "8a8fea1c-af3d-4d12-abe1-1732158991df",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 669,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 778,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "5d603bba-62e6-48fb-b8fc-401109abcaee",
    "patient_ID": "TCGA.30.1853",
    "bcr_drug_barcode": "TCGA-30-1853-D27545",
    "bcr_drug_uuid": "23159ed1-9189-4f06-bf1f-100d10cfbf8b",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27556",
    "bcr_drug_uuid": "17d3f156-81fa-443c-9bcd-8c5a72174dbb",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27559",
    "bcr_drug_uuid": "c66732af-f355-40df-a6b3-4993bb55a8f7",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27560",
    "bcr_drug_uuid": "c580c4e7-0a42-4ca4-b24f-43a2ca827d00",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27562",
    "bcr_drug_uuid": "4f34558c-9912-4486-8df5-f0a6fcc95fb1",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 230,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27553",
    "bcr_drug_uuid": "06847472-6031-4f11-a05b-a66e4c119973",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27557",
    "bcr_drug_uuid": "7f66f918-6c82-4943-a08a-9ce8dee928ec",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27555",
    "bcr_drug_uuid": "1df9a4b7-edff-4838-abd5-cb77b22ee5a5",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27558",
    "bcr_drug_uuid": "9d9e6ff1-26ab-4620-9423-bc250e900e29",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 272,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 300,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27561",
    "bcr_drug_uuid": "76cc12ec-df1b-4744-aea9-228dca5926e0",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CPT 11",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 339,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 462,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "91a6f311-c758-4e40-9abb-cc0f6584b9c9",
    "patient_ID": "TCGA.30.1856",
    "bcr_drug_barcode": "TCGA-30-1856-D27554",
    "bcr_drug_uuid": "8b99703a-2b37-485b-9c5b-9fd8cf793f2a",
    "form_completion_date": "2009-9-23",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 195,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27570",
    "bcr_drug_uuid": "1c7d824c-50bd-44c9-8d9b-885a9264aaf6",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27569",
    "bcr_drug_uuid": "d9e87488-f292-4809-82e9-b9d72576d084",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 9,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27572",
    "bcr_drug_uuid": "adb0eafc-52e6-4a08-9a54-550b06ff59ef",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TRABECTEDIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 369,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 593,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27567",
    "bcr_drug_uuid": "2994f82f-4e05-4b8d-b9ca-755057a83d52",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27575",
    "bcr_drug_uuid": "93b2bc44-d1e0-47f3-9e5b-acbef8b3a702",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1214,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1376,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27571",
    "bcr_drug_uuid": "afacbc4a-1d91-481a-9356-4e49172e7a00",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1.25
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27576",
    "bcr_drug_uuid": "bb4f183e-5f3e-46f4-9694-2a4f046344e2",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1334,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1379,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27568",
    "bcr_drug_uuid": "39b99982-93f4-4457-a0fe-8336aafbe6dd",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 199,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27574",
    "bcr_drug_uuid": "2fe73c42-528a-49b7-8ace-300e3463ab5b",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1197,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27573",
    "bcr_drug_uuid": "c6e94b43-b6ed-43ef-b8bb-65ed70ca8fb9",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 982,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1103,
    "drug_cycles": 5,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27577",
    "bcr_drug_uuid": "d9868c5b-53d0-4d6b-8ac2-95b76c3a77b4",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "ARMIDEX",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1166,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "dac8d825-dd47-47ed-a426-0ee75feb76f3",
    "patient_ID": "TCGA.30.1859",
    "bcr_drug_barcode": "TCGA-30-1859-D27578",
    "bcr_drug_uuid": "4f6ba9dd-c995-4de2-8e41-6f52823d25d7",
    "form_completion_date": "2010-1-27",
    "pharmaceutical_therapy_drug_name": "SARGRAMOSTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1131,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27585",
    "bcr_drug_uuid": "2b258497-1982-434d-8908-7f2d70f63de5",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 744,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 915,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27581",
    "bcr_drug_uuid": "3329995b-440d-44b0-bae0-188b798ee53c",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 413,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27586",
    "bcr_drug_uuid": "3abc00eb-e2d3-4427-8aa4-b023be30b7dd",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 915,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 957,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27583",
    "bcr_drug_uuid": "2b1e50e4-2b3e-4287-9fb3-c53cce0cb15f",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27584",
    "bcr_drug_uuid": "d3ce4085-ca82-4143-ad0b-ec81ff9f2ea9",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 744,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 915,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27587",
    "bcr_drug_uuid": "cf6521d0-a099-4672-b87c-60626cb8ac54",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 994,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1069,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27588",
    "bcr_drug_uuid": "6f7e67db-f301-47f1-a6f6-e0f3af86bd09",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1246,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27582",
    "bcr_drug_uuid": "0f428947-8a45-4e60-a43e-7772159e8841",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 207,
    "drug_cycles": 7,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "563853a2-9ac2-48be-adf3-1e547ee2b274",
    "patient_ID": "TCGA.30.1860",
    "bcr_drug_barcode": "TCGA-30-1860-D27589",
    "bcr_drug_uuid": "078a36dd-f808-4f61-bea3-655803dd03ab",
    "form_completion_date": "2010-1-8",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1246,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27597",
    "bcr_drug_uuid": "42b5deb5-1f12-40c6-b3c9-532ec204c50a",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27601",
    "bcr_drug_uuid": "e9f71e7a-9032-4e6d-8906-57b4fa5f37b8",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27599",
    "bcr_drug_uuid": "c64a880a-85be-42d3-8378-642a1f1dce7f",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27598",
    "bcr_drug_uuid": "6b21b434-6af0-431c-90dd-0fc0118ede26",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27600",
    "bcr_drug_uuid": "41f27513-1242-4061-a85b-c2884f60a85c",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27602",
    "bcr_drug_uuid": "70f90115-e87d-47e9-bf4f-7456761ae58e",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27596",
    "bcr_drug_uuid": "898a6998-0b59-4803-ba74-26e008181c0e",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 265,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "cbc7f427-5f7b-4267-ad56-055d8880a4cc",
    "patient_ID": "TCGA.30.1866",
    "bcr_drug_barcode": "TCGA-30-1866-D27603",
    "bcr_drug_uuid": "e1c6ebe7-8c5c-4199-a06f-ab66088a058b",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27608",
    "bcr_drug_uuid": "65d2783e-d0d4-43f0-b528-fa7114edf7cd",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27609",
    "bcr_drug_uuid": "d9cac678-a898-49d5-b2a4-66e0b4a3f093",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27611",
    "bcr_drug_uuid": "2e966536-4070-4988-b610-3209fb63fbd4",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "ALIMTA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 767,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 943,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27616",
    "bcr_drug_uuid": "baf2c401-c86f-49bf-a41e-7796a1bdab3e",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1398,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1489,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27612",
    "bcr_drug_uuid": "99f53275-3d20-47d8-b7a2-9abc8e23d5ec",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 767,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 943,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27617",
    "bcr_drug_uuid": "140f7ef0-28fe-4f59-83ca-87f440debd96",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1510,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1534,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27614",
    "bcr_drug_uuid": "f1585f4b-3343-44d0-a65c-ea6a32f8f8f9",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "SNS 595",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1279,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1331,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 48
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27610",
    "bcr_drug_uuid": "3e6d063a-3c03-4260-a94a-c80bf3c5d04a",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 179,
    "drug_cycles": 9,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27613",
    "bcr_drug_uuid": "b19d902f-e78b-4c03-8c6d-10e286a434f3",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1184,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1211,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27615",
    "bcr_drug_uuid": "2a21156d-6a16-4035-bcbe-3876506d6d74",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1398,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1489,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "84f5876d-82b0-45ff-8f3d-a10653683454",
    "patient_ID": "TCGA.30.1869",
    "bcr_drug_barcode": "TCGA-30-1869-D27618",
    "bcr_drug_uuid": "9c9e5af4-0f8a-426b-8a5a-445a5fcbc1d1",
    "form_completion_date": "2010-1-27",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1175,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27627",
    "bcr_drug_uuid": "85360ccf-2a0a-47ee-83db-5975230aeea8",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1610,
    "drug_cycles": 9,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27622",
    "bcr_drug_uuid": "38844241-56d0-4348-bad6-cea1c8676542",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27625",
    "bcr_drug_uuid": "cd005c2a-a2f0-4edc-80ae-1a99c144c424",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 718,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 823,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27630",
    "bcr_drug_uuid": "c3c91988-c02c-4a0a-a97d-2a9642af6acd",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1660,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_cycles": 8,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 20
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27629",
    "bcr_drug_uuid": "13b6227e-71f3-470b-9004-61740ce4ae73",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CBP501",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1642,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1656,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3.6
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27624",
    "bcr_drug_uuid": "4f399194-c399-49e7-8a36-5be1a8c99795",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 718,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 823,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27623",
    "bcr_drug_uuid": "9ac2fa30-2499-46b0-a7fb-bcfb674103ca",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27626",
    "bcr_drug_uuid": "b598f971-0c3c-459c-bbc9-82ee2b755e69",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1228,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27628",
    "bcr_drug_uuid": "06ef436c-e8d9-4b26-94f4-70f29686f536",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1610,
    "drug_cycles": 9,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27621",
    "bcr_drug_uuid": "628b3fcc-ca45-466b-98fc-54ef1c3a8bea",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 357,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 497,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "bc873b2a-35b7-4365-a2cc-e6a83063556e",
    "patient_ID": "TCGA.30.1880",
    "bcr_drug_barcode": "TCGA-30-1880-D27631",
    "bcr_drug_uuid": "8eafb3d9-4869-4af0-9a1f-cf55767563cd",
    "form_completion_date": "2010-1-8",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 1660,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1722,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "f7e01929-733b-420a-ab2b-051dd4a992e5",
    "patient_ID": "TCGA.30.1887",
    "bcr_drug_barcode": "TCGA-30-1887-D27635",
    "bcr_drug_uuid": "18d7a1d8-66b8-4c1c-ad1c-13862bf6263b",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "f7e01929-733b-420a-ab2b-051dd4a992e5",
    "patient_ID": "TCGA.30.1887",
    "bcr_drug_barcode": "TCGA-30-1887-D27634",
    "bcr_drug_uuid": "e96002ef-d950-4ede-b623-c6ca3cdff2f2",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 433,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "f7e01929-733b-420a-ab2b-051dd4a992e5",
    "patient_ID": "TCGA.30.1887",
    "bcr_drug_barcode": "TCGA-30-1887-D27637",
    "bcr_drug_uuid": "867b6ed3-96ff-40dc-a6e7-722a047a5b95",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "drug_cycles": 3,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "f7e01929-733b-420a-ab2b-051dd4a992e5",
    "patient_ID": "TCGA.30.1887",
    "bcr_drug_barcode": "TCGA-30-1887-D27638",
    "bcr_drug_uuid": "f0f317a4-a2de-4a8f-8fff-54f488ba5642",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 503,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 671,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 64
  },
  {
    "bcr_patient_uuid": "f7e01929-733b-420a-ab2b-051dd4a992e5",
    "patient_ID": "TCGA.30.1887",
    "bcr_drug_barcode": "TCGA-30-1887-D27636",
    "bcr_drug_uuid": "d1a4e7ac-6745-47f8-8a98-0b3be8413eca",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27647",
    "bcr_drug_uuid": "ef980ca7-1da5-42fc-85e7-525fe996afd6",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 460,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 526,
    "drug_cycles": 4,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27650",
    "bcr_drug_uuid": "cd524283-81d7-4569-8af9-8bae2aa59655",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 701,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 890,
    "drug_cycles": 12,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27642",
    "bcr_drug_uuid": "cbedad2d-cf2a-4f75-b280-dfa270d0b918",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 7,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27641",
    "bcr_drug_uuid": "99ab0f66-db33-4c20-9813-a34ce14f25d6",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 330,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 40
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27645",
    "bcr_drug_uuid": "fd0a5766-c375-4546-8acd-af9b0cb09e93",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 453,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27651",
    "bcr_drug_uuid": "c5a7f0b8-9eba-4728-9684-dfe16a36d94a",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "NAVELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 855,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 890,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 25
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27643",
    "bcr_drug_uuid": "2c926101-6d5b-42b0-8452-bd5074d5c811",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 7,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27646",
    "bcr_drug_uuid": "d5f3bf0d-8d21-4914-88a2-107de938f057",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 460,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 526,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 700
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27649",
    "bcr_drug_uuid": "f3619476-e2c4-4284-9f6a-0ac66cec5f6c",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 666,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 694,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 80
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27644",
    "bcr_drug_uuid": "ebea0ddd-3575-40ef-843f-5007f3fde1d6",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 358,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 386,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27648",
    "bcr_drug_uuid": "a2090fb3-e9be-4240-9b2a-17011087a3de",
    "form_completion_date": "2009-12-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 554,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 638,
    "drug_cycles": 5,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "4a2ca7b8-729d-4fab-a6f3-a5d1e5d1f4f3",
    "patient_ID": "TCGA.30.1891",
    "bcr_drug_barcode": "TCGA-30-1891-D27652",
    "bcr_drug_uuid": "9ada3d87-0c7b-450a-8c0e-0577b7ea4a49",
    "form_completion_date": "2010-1-27",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 358,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 386,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27655",
    "bcr_drug_uuid": "8613c854-9f6d-47d0-82ed-0e350279b555",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 419,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27659",
    "bcr_drug_uuid": "4ac6ea86-5442-489f-b149-c59fd9bf4337",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 754,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27663",
    "bcr_drug_uuid": "19c74bf7-d4e0-4ed9-bb80-9ae383b30f63",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1258,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27660",
    "bcr_drug_uuid": "a87f93b1-bdb0-4f71-8935-83676e4ed831",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27664",
    "bcr_drug_uuid": "7a5870a1-c1e0-40f5-bbd4-40f24bf5b58c",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1265,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1384,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27665",
    "bcr_drug_uuid": "ac5780c2-338d-43f3-bba7-da96287273e4",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CATUMAXUMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1428,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1449,
    "drug_cycles": 4,
    "drug_units": "UG",
    "drug_tota_dose_units": "UG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27661",
    "bcr_drug_uuid": "86024c3e-d6d1-4070-b455-2802e60f49cb",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "ALTIMA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 862,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27656",
    "bcr_drug_uuid": "2ac4a1ea-4121-4873-8a86-65f2bbcc6841",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27657",
    "bcr_drug_uuid": "15b4f156-d559-4a4c-a41e-4f580ece69c1",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27658",
    "bcr_drug_uuid": "06790c50-25b2-4844-acd8-09bc85d7380d",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 428,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 573,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27662",
    "bcr_drug_uuid": "bca6db49-eba4-482d-b1b7-38025d302b3a",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "CYTOXIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1197,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 50
  },
  {
    "bcr_patient_uuid": "a09f0626-002a-48fd-8b2d-c66b8285cf23",
    "patient_ID": "TCGA.30.1892",
    "bcr_drug_barcode": "TCGA-30-1892-D27666",
    "bcr_drug_uuid": "ef88b090-ede2-43bf-b637-d824c853ef5c",
    "form_completion_date": "2009-12-28",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1134,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1197,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 15
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27676",
    "bcr_drug_uuid": "23580769-8adf-40ec-b355-47fff6d32793",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "AZD 2281",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1032,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27672",
    "bcr_drug_uuid": "fc93f3e4-6ccb-4337-9034-702229893171",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 835
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27674",
    "bcr_drug_uuid": "1808b6be-23eb-4458-a360-341875a10491",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 841,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27671",
    "bcr_drug_uuid": "1d97e4b9-be4e-4cee-a355-0b45ddc151f3",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 153,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 223,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 345
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27677",
    "bcr_drug_uuid": "e2d31a97-b9d2-412e-b26f-0484d481e4c5",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 479,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 944,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 9140
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27669",
    "bcr_drug_uuid": "fd7a3513-ddff-4504-a30a-3788779f9e79",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4200
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27670",
    "bcr_drug_uuid": "9abcadac-29d0-4872-bf15-828eb4d2e730",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 7,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1650
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27675",
    "bcr_drug_uuid": "39eb5ea5-4df1-41c4-b4e9-3369be3f31fd",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 944,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1099,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "SWITCHED FROM TAMOZIFEN"
  },
  {
    "bcr_patient_uuid": "6fee41dc-b8a9-4347-8085-b7e05f813ad0",
    "patient_ID": "TCGA.31.1944",
    "bcr_drug_barcode": "TCGA-31-1944-D27673",
    "bcr_drug_uuid": "d9a922f5-a0b8-49a9-b586-fd2fcc484996",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 841,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3300
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27682",
    "bcr_drug_uuid": "56f9a0bb-a46c-40eb-95a8-194c7567a88b",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 12000
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27685",
    "bcr_drug_uuid": "87e7d1d3-165b-4969-bce1-1a00f13eec10",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 687,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 743,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 180
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27681",
    "bcr_drug_uuid": "1686102f-3307-402f-ba68-dfff1343b060",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 43,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27680",
    "bcr_drug_uuid": "67422b5d-9481-47cc-850b-68769f0c75d5",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 43,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1400
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27684",
    "bcr_drug_uuid": "67ffe7ae-da38-4393-8271-545d0259f6ff",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "LIOSOMAL DOCORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 687,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 743,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 144
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27683",
    "bcr_drug_uuid": "6a769fec-2edb-4b44-910d-e1d49d42c7ce",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2200
  },
  {
    "bcr_patient_uuid": "da274941-3edd-420b-9262-bbd959923c67",
    "patient_ID": "TCGA.31.1946",
    "bcr_drug_barcode": "TCGA-31-1946-D27686",
    "bcr_drug_uuid": "870e5a5d-f290-492a-b282-4171aac9f5d4",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 771,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 828,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "UNABLE TO TOLERATE LIPOSOMAL DOXOROBICIN",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1",
    "patient_ID": "TCGA.31.1950",
    "bcr_drug_barcode": "TCGA-31-1950-D27689",
    "bcr_drug_uuid": "15db6c90-507f-4efe-82aa-9cb243720c1e",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 33,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3300
  },
  {
    "bcr_patient_uuid": "4ca9c0e8-75a7-4665-9d88-6dd2bb44b1e1",
    "patient_ID": "TCGA.31.1950",
    "bcr_drug_barcode": "TCGA-31-1950-D27690",
    "bcr_drug_uuid": "4979d025-1341-4190-b965-c7dc0349b252",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 431,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 571,
    "drug_cycles": 18,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "b0839f46-8c82-4619-be3d-c857a1759463",
    "patient_ID": "TCGA.31.1951",
    "bcr_drug_barcode": "TCGA-31-1951-D27693",
    "bcr_drug_uuid": "c56143b7-c7a5-4bbd-86fc-83ffbd920fc5",
    "form_completion_date": "2010-1-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "b0839f46-8c82-4619-be3d-c857a1759463",
    "patient_ID": "TCGA.31.1951",
    "bcr_drug_barcode": "TCGA-31-1951-D27696",
    "bcr_drug_uuid": "bf9312cc-d8a3-4719-b7bf-b516ea90cadd",
    "form_completion_date": "2010-1-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1260
  },
  {
    "bcr_patient_uuid": "b0839f46-8c82-4619-be3d-c857a1759463",
    "patient_ID": "TCGA.31.1951",
    "bcr_drug_barcode": "TCGA-31-1951-D27694",
    "bcr_drug_uuid": "657dd0b8-f79b-44b4-9847-db5ac8eed2ea",
    "form_completion_date": "2010-1-4",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 328,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 482,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 240
  },
  {
    "bcr_patient_uuid": "b0839f46-8c82-4619-be3d-c857a1759463",
    "patient_ID": "TCGA.31.1951",
    "bcr_drug_barcode": "TCGA-31-1951-D27695",
    "bcr_drug_uuid": "5334b5e4-7145-488e-a753-00c01b6c049d",
    "form_completion_date": "2010-1-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "61feee94-3ac9-42fe-aaa3-dc6a3efe563c",
    "patient_ID": "TCGA.31.1953",
    "bcr_drug_barcode": "TCGA-31-1953-D27699",
    "bcr_drug_uuid": "87f2114d-3ed1-418a-b563-c4a1efdd6c0f",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1350
  },
  {
    "bcr_patient_uuid": "61feee94-3ac9-42fe-aaa3-dc6a3efe563c",
    "patient_ID": "TCGA.31.1953",
    "bcr_drug_barcode": "TCGA-31-1953-D27702",
    "bcr_drug_uuid": "eb1db586-968a-445e-87e4-81609c8cc5e2",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "PACILTAXLE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "61feee94-3ac9-42fe-aaa3-dc6a3efe563c",
    "patient_ID": "TCGA.31.1953",
    "bcr_drug_barcode": "TCGA-31-1953-D27701",
    "bcr_drug_uuid": "c46dae01-314c-4890-b522-e1446a0f2223",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 100,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "61feee94-3ac9-42fe-aaa3-dc6a3efe563c",
    "patient_ID": "TCGA.31.1953",
    "bcr_drug_barcode": "TCGA-31-1953-D27700",
    "bcr_drug_uuid": "ece15379-890e-4d24-8c23-a9bd4dcd8e46",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 840
  },
  {
    "bcr_patient_uuid": "cce34351-1700-405b-818f-a598f63a33e8",
    "patient_ID": "TCGA.31.1955",
    "bcr_drug_barcode": "TCGA-31-1955-D27707",
    "bcr_drug_uuid": "757d2b76-c7e5-4149-b65c-a27c6ad1cd5d",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1189,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "cce34351-1700-405b-818f-a598f63a33e8",
    "patient_ID": "TCGA.31.1955",
    "bcr_drug_barcode": "TCGA-31-1955-D27706",
    "bcr_drug_uuid": "8a4bfe3d-6d89-4c2c-81c6-56515d7caf3d",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "cce34351-1700-405b-818f-a598f63a33e8",
    "patient_ID": "TCGA.31.1955",
    "bcr_drug_barcode": "TCGA-31-1955-D27705",
    "bcr_drug_uuid": "a8c5e460-08d8-4949-8b43-c0ef7c599020",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "cce34351-1700-405b-818f-a598f63a33e8",
    "patient_ID": "TCGA.31.1955",
    "bcr_drug_barcode": "TCGA-31-1955-D27708",
    "bcr_drug_uuid": "0b6c3e47-9f51-45cd-8472-8b584f993367",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACILTAXLE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1189,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "e1158102-06f2-47bb-9fe0-49b57f070755",
    "patient_ID": "TCGA.31.1956",
    "bcr_drug_barcode": "TCGA-31-1956-D27712",
    "bcr_drug_uuid": "d3e74b41-1369-48f8-a1ad-767692bd830f",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5150
  },
  {
    "bcr_patient_uuid": "e1158102-06f2-47bb-9fe0-49b57f070755",
    "patient_ID": "TCGA.31.1956",
    "bcr_drug_barcode": "TCGA-31-1956-D27713",
    "bcr_drug_uuid": "5cc90a67-38af-4ca7-a5cf-9c7676f0cb0b",
    "form_completion_date": "2009-10-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1590
  },
  {
    "bcr_patient_uuid": "186d40cd-624c-4016-a497-b30c892d393c",
    "patient_ID": "TCGA.31.1959",
    "bcr_drug_barcode": "TCGA-31-1959-D27717",
    "bcr_drug_uuid": "47c2d5b6-061b-4fb7-be57-74717e442a52",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "PACILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "186d40cd-624c-4016-a497-b30c892d393c",
    "patient_ID": "TCGA.31.1959",
    "bcr_drug_barcode": "TCGA-31-1959-D27716",
    "bcr_drug_uuid": "5b3d6d1e-fcaa-435b-b73d-24586385e15c",
    "form_completion_date": "2009-10-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "de548bdd-14ca-486b-bd16-a6fbdd5b50d2",
    "patient_ID": "TCGA.36.1568",
    "bcr_drug_barcode": "TCGA-36-1568-D27852",
    "bcr_drug_uuid": "9d38e2ae-a6be-479e-9c79-8865a90a7eb5",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2610
  },
  {
    "bcr_patient_uuid": "de548bdd-14ca-486b-bd16-a6fbdd5b50d2",
    "patient_ID": "TCGA.36.1568",
    "bcr_drug_barcode": "TCGA-36-1568-D27853",
    "bcr_drug_uuid": "178044bb-7b27-4a53-b3d0-6e8a5a9352c3",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 123,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1257
  },
  {
    "bcr_patient_uuid": "de548bdd-14ca-486b-bd16-a6fbdd5b50d2",
    "patient_ID": "TCGA.36.1568",
    "bcr_drug_barcode": "TCGA-36-1568-D27851",
    "bcr_drug_uuid": "2a3f80b3-6a80-4ee7-9c35-29309d21d631",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 624,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 737,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 286
  },
  {
    "bcr_patient_uuid": "0f530b3e-5b6d-4892-9ebd-9138d76fdca7",
    "patient_ID": "TCGA.36.1570",
    "bcr_drug_barcode": "TCGA-36-1570-D27859",
    "bcr_drug_uuid": "630cd072-7436-4d96-9eeb-af8fcd0dcd9b",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1330
  },
  {
    "bcr_patient_uuid": "0f530b3e-5b6d-4892-9ebd-9138d76fdca7",
    "patient_ID": "TCGA.36.1570",
    "bcr_drug_barcode": "TCGA-36-1570-D27858",
    "bcr_drug_uuid": "1ab5a040-88b7-41b1-a6ee-4bbb809a9b42",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2808
  },
  {
    "bcr_patient_uuid": "0f530b3e-5b6d-4892-9ebd-9138d76fdca7",
    "patient_ID": "TCGA.36.1570",
    "bcr_drug_barcode": "TCGA-36-1570-D27860",
    "bcr_drug_uuid": "90a5225e-1532-4db6-aef6-b5596c72151e",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 432,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 432,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "12581634-eebb-4841-8498-71dc9d78c546",
    "patient_ID": "TCGA.36.1571",
    "bcr_drug_barcode": "TCGA-36-1571-D27864",
    "bcr_drug_uuid": "1478fbc5-996d-422f-b992-85c1bdc1d14d",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2100
  },
  {
    "bcr_patient_uuid": "12581634-eebb-4841-8498-71dc9d78c546",
    "patient_ID": "TCGA.36.1571",
    "bcr_drug_barcode": "TCGA-36-1571-D27865",
    "bcr_drug_uuid": "6c4703e2-a040-46b1-8900-b41aa4c1e515",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 531,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4920
  },
  {
    "bcr_patient_uuid": "12581634-eebb-4841-8498-71dc9d78c546",
    "patient_ID": "TCGA.36.1571",
    "bcr_drug_barcode": "TCGA-36-1571-D27863",
    "bcr_drug_uuid": "5e7ee568-9720-4fc7-aa9a-93f967ae30bc",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 173,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5130
  },
  {
    "bcr_patient_uuid": "12581634-eebb-4841-8498-71dc9d78c546",
    "patient_ID": "TCGA.36.1571",
    "bcr_drug_barcode": "TCGA-36-1571-D27866",
    "bcr_drug_uuid": "6ad7f24d-3255-4eb0-abb2-2de5df56d30e",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 531,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 26752
  },
  {
    "bcr_patient_uuid": "eeb9d147-608d-4692-8adf-2f601d23a8ff",
    "patient_ID": "TCGA.36.1574",
    "bcr_drug_barcode": "TCGA-36-1574-D27870",
    "bcr_drug_uuid": "b60340a0-dad8-46b3-93d0-e6f6518416c5",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eeb9d147-608d-4692-8adf-2f601d23a8ff",
    "patient_ID": "TCGA.36.1574",
    "bcr_drug_barcode": "TCGA-36-1574-D27869",
    "bcr_drug_uuid": "6eb02c37-b4e7-4e56-9f69-931e6671a4bb",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 8,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3445c524-5a37-40b6-8614-956d76eed939",
    "patient_ID": "TCGA.36.1576",
    "bcr_drug_barcode": "TCGA-36-1576-D27875",
    "bcr_drug_uuid": "80ba7cc4-fcbf-4b2d-9604-42e785b2d9ec",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3648
  },
  {
    "bcr_patient_uuid": "3445c524-5a37-40b6-8614-956d76eed939",
    "patient_ID": "TCGA.36.1576",
    "bcr_drug_barcode": "TCGA-36-1576-D27876",
    "bcr_drug_uuid": "0dad68a9-7536-434e-9a5c-be93632dbd1b",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 222,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2528
  },
  {
    "bcr_patient_uuid": "e294b940-2828-499c-be24-47ef6c2e9035",
    "patient_ID": "TCGA.36.1577",
    "bcr_drug_barcode": "TCGA-36-1577-D27880",
    "bcr_drug_uuid": "1cf4b2f0-97fd-4253-9c7c-3486f0010871",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 248,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 744
  },
  {
    "bcr_patient_uuid": "e294b940-2828-499c-be24-47ef6c2e9035",
    "patient_ID": "TCGA.36.1577",
    "bcr_drug_barcode": "TCGA-36-1577-D27879",
    "bcr_drug_uuid": "983593fc-3f1f-42ad-b8ae-4c4868fc29b6",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 611,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1833
  },
  {
    "bcr_patient_uuid": "f65f2e78-c001-4ef3-ae88-3e4f83c7aceb",
    "patient_ID": "TCGA.36.1578",
    "bcr_drug_barcode": "TCGA-36-1578-D27886",
    "bcr_drug_uuid": "f8bb0861-fe1f-4810-b9ca-bbfb06383418",
    "form_completion_date": "2010-2-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2013
  },
  {
    "bcr_patient_uuid": "f65f2e78-c001-4ef3-ae88-3e4f83c7aceb",
    "patient_ID": "TCGA.36.1578",
    "bcr_drug_barcode": "TCGA-36-1578-D27885",
    "bcr_drug_uuid": "72c7d40a-c4da-405a-8c98-02ff8c7b4036",
    "form_completion_date": "2010-2-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4830
  },
  {
    "bcr_patient_uuid": "f65f2e78-c001-4ef3-ae88-3e4f83c7aceb",
    "patient_ID": "TCGA.36.1578",
    "bcr_drug_barcode": "TCGA-36-1578-D27887",
    "bcr_drug_uuid": "67ff741a-20f6-473c-93bf-60dc4e5ef139",
    "form_completion_date": "2010-2-17",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 321,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 345,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 136
  },
  {
    "bcr_patient_uuid": "533f5ff9-466c-4cdb-9c46-b841c2626775",
    "patient_ID": "TCGA.36.1580",
    "bcr_drug_barcode": "TCGA-36-1580-D27891",
    "bcr_drug_uuid": "e781ca54-c93a-4270-99d5-4d97f278b1f6",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4796
  },
  {
    "bcr_patient_uuid": "533f5ff9-466c-4cdb-9c46-b841c2626775",
    "patient_ID": "TCGA.36.1580",
    "bcr_drug_barcode": "TCGA-36-1580-D27890",
    "bcr_drug_uuid": "9fd38eaf-a33b-4dc5-9d51-7f07a8c2f098",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 454,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 553,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 222
  },
  {
    "bcr_patient_uuid": "ef5e85cf-2d82-4d52-a02c-fed5c76e4cec",
    "patient_ID": "TCGA.36.1581",
    "bcr_drug_barcode": "TCGA-36-1581-D27895",
    "bcr_drug_uuid": "56016835-05a9-40f2-92ca-42c4583f66c4",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2313
  },
  {
    "bcr_patient_uuid": "ef5e85cf-2d82-4d52-a02c-fed5c76e4cec",
    "patient_ID": "TCGA.36.1581",
    "bcr_drug_barcode": "TCGA-36-1581-D27894",
    "bcr_drug_uuid": "ea9b943e-fd52-4668-bfd9-333776986799",
    "form_completion_date": "2010-1-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4639
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27899",
    "bcr_drug_uuid": "f97ac4b2-d650-4e0b-82ef-023ec4a9925c",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 276,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1656
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27903",
    "bcr_drug_uuid": "eff0b655-1129-4e38-9a79-2aa737b79883",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 962,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 990,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 64,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 128
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27904",
    "bcr_drug_uuid": "83421639-814a-411d-92dd-307c3db6c2a0",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1026,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 238,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 714
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27898",
    "bcr_drug_uuid": "5b9c44a0-5967-43a8-a397-f66f878463e7",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 484,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2904
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27901",
    "bcr_drug_uuid": "7982e596-7543-4260-943d-63f1887475e5",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 591,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 738,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 296,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1776
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27902",
    "bcr_drug_uuid": "bca15819-c1b5-4032-b2f1-f535ccbcddb3",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 830,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 925,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 465,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1860
  },
  {
    "bcr_patient_uuid": "20ac688c-04c1-45a6-823a-6b523002ce92",
    "patient_ID": "TCGA.36.2529",
    "bcr_drug_barcode": "TCGA-36-2529-D27900",
    "bcr_drug_uuid": "96151d8e-dc0a-4199-ae71-fdf09fd5aaa6",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 591,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 738,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 454,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2724
  },
  {
    "bcr_patient_uuid": "92a1a8f3-54f2-4983-bb14-dcb73658d897",
    "patient_ID": "TCGA.36.2530",
    "bcr_drug_barcode": "TCGA-36-2530-D27910",
    "bcr_drug_uuid": "215057f5-f69e-4580-ae14-b0022e318d6a",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 763,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 179,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1196
  },
  {
    "bcr_patient_uuid": "92a1a8f3-54f2-4983-bb14-dcb73658d897",
    "patient_ID": "TCGA.36.2530",
    "bcr_drug_barcode": "TCGA-36-2530-D27907",
    "bcr_drug_uuid": "1de2a511-cd83-4b35-8503-f3f0dc13bb5b",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 660,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "92a1a8f3-54f2-4983-bb14-dcb73658d897",
    "patient_ID": "TCGA.36.2530",
    "bcr_drug_barcode": "TCGA-36-2530-D27909",
    "bcr_drug_uuid": "4444d108-727d-4d9d-a952-8bbcb1dbb4f9",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 763,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 560,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3808
  },
  {
    "bcr_patient_uuid": "92a1a8f3-54f2-4983-bb14-dcb73658d897",
    "patient_ID": "TCGA.36.2530",
    "bcr_drug_barcode": "TCGA-36-2530-D27908",
    "bcr_drug_uuid": "4e54a205-21a1-4976-8efb-8bf32ebc5abf",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 78,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1836
  },
  {
    "bcr_patient_uuid": "92a1a8f3-54f2-4983-bb14-dcb73658d897",
    "patient_ID": "TCGA.36.2530",
    "bcr_drug_barcode": "TCGA-36-2530-D27911",
    "bcr_drug_uuid": "25e8b24b-f738-482a-9dfc-14cda1f2e880",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CEDIRANIB PLACEBO",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 639,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 982,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 15,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "04abcf51-c52a-4e74-a5f4-4bc4fb444902",
    "patient_ID": "TCGA.36.2532",
    "bcr_drug_barcode": "TCGA-36-2532-D27915",
    "bcr_drug_uuid": "11a22433-ac29-46a9-ad76-efd5fe41bfce",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 93,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2201.2
  },
  {
    "bcr_patient_uuid": "04abcf51-c52a-4e74-a5f4-4bc4fb444902",
    "patient_ID": "TCGA.36.2532",
    "bcr_drug_barcode": "TCGA-36-2532-D27914",
    "bcr_drug_uuid": "cbd4dd5a-2acc-4498-bc13-dd61c64eaa82",
    "form_completion_date": "2010-8-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 564,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "e08a619d-8a55-435d-8c41-a77a112ed889",
    "patient_ID": "TCGA.36.2534",
    "bcr_drug_barcode": "TCGA-36-2534-D27921",
    "bcr_drug_uuid": "25f3327a-f99f-435e-b0c9-374a05c7adac",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 544,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 685,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3720
  },
  {
    "bcr_patient_uuid": "e08a619d-8a55-435d-8c41-a77a112ed889",
    "patient_ID": "TCGA.36.2534",
    "bcr_drug_barcode": "TCGA-36-2534-D27919",
    "bcr_drug_uuid": "13620b52-e2ce-4432-a515-5fa70c731e9f",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 470,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3735
  },
  {
    "bcr_patient_uuid": "e08a619d-8a55-435d-8c41-a77a112ed889",
    "patient_ID": "TCGA.36.2534",
    "bcr_drug_barcode": "TCGA-36-2534-D27920",
    "bcr_drug_uuid": "6a4a8078-bc7d-4d80-a77b-932a4360fe9a",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 949
  },
  {
    "bcr_patient_uuid": "5075cdc1-1b7c-4e25-98ea-fb568bd35f2d",
    "patient_ID": "TCGA.36.2537",
    "bcr_drug_barcode": "TCGA-36-2537-D27924",
    "bcr_drug_uuid": "95758800-a6d0-45e1-8d9a-5752cd7fc5a6",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 893,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5358
  },
  {
    "bcr_patient_uuid": "5075cdc1-1b7c-4e25-98ea-fb568bd35f2d",
    "patient_ID": "TCGA.36.2537",
    "bcr_drug_barcode": "TCGA-36-2537-D27925",
    "bcr_drug_uuid": "c3174758-216c-4fc8-8a98-36a43e572c20",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 125,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 301,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1806
  },
  {
    "bcr_patient_uuid": "5075cdc1-1b7c-4e25-98ea-fb568bd35f2d",
    "patient_ID": "TCGA.36.2537",
    "bcr_drug_barcode": "TCGA-36-2537-D27926",
    "bcr_drug_uuid": "13bac041-aab1-4e77-b1bf-d66aab5c449c",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 614,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 850,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5100
  },
  {
    "bcr_patient_uuid": "5075cdc1-1b7c-4e25-98ea-fb568bd35f2d",
    "patient_ID": "TCGA.36.2537",
    "bcr_drug_barcode": "TCGA-36-2537-D27927",
    "bcr_drug_uuid": "f86a3fa0-169d-4c38-b7ae-1895cedf7055",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 614,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 55,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 330
  },
  {
    "bcr_patient_uuid": "5075cdc1-1b7c-4e25-98ea-fb568bd35f2d",
    "patient_ID": "TCGA.36.2537",
    "bcr_drug_barcode": "TCGA-36-2537-D27928",
    "bcr_drug_uuid": "ef10bbf8-5e83-430a-ab10-ddebd51a9219",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 721,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 763,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1512,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 9072
  },
  {
    "bcr_patient_uuid": "3ea880f4-7a78-4cb7-bfe4-54b3c30a812e",
    "patient_ID": "TCGA.36.2538",
    "bcr_drug_barcode": "TCGA-36-2538-D27933",
    "bcr_drug_uuid": "705a490a-ccbc-41a1-809c-d3f33a0265f2",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 542,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 682,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 680,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4080
  },
  {
    "bcr_patient_uuid": "3ea880f4-7a78-4cb7-bfe4-54b3c30a812e",
    "patient_ID": "TCGA.36.2538",
    "bcr_drug_barcode": "TCGA-36-2538-D27932",
    "bcr_drug_uuid": "21626185-0374-4efb-867e-ac1a9976bdd6",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 270,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1620
  },
  {
    "bcr_patient_uuid": "3ea880f4-7a78-4cb7-bfe4-54b3c30a812e",
    "patient_ID": "TCGA.36.2538",
    "bcr_drug_barcode": "TCGA-36-2538-D27931",
    "bcr_drug_uuid": "387a8a6f-3cad-4e2f-b5ac-9faf5418cfe4",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 690,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4140
  },
  {
    "bcr_patient_uuid": "3ea880f4-7a78-4cb7-bfe4-54b3c30a812e",
    "patient_ID": "TCGA.36.2538",
    "bcr_drug_barcode": "TCGA-36-2538-D27934",
    "bcr_drug_uuid": "5c21d21c-6cbb-45e6-89d4-afdc7839cae1",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 542,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 682,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 38,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 238
  },
  {
    "bcr_patient_uuid": "30c7efdd-5a86-4418-a33c-a5d27fe56e42",
    "patient_ID": "TCGA.36.2540",
    "bcr_drug_barcode": "TCGA-36-2540-D27938",
    "bcr_drug_uuid": "eb3e8ac7-0199-40aa-b642-d77d932a1478",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 370,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2220
  },
  {
    "bcr_patient_uuid": "30c7efdd-5a86-4418-a33c-a5d27fe56e42",
    "patient_ID": "TCGA.36.2540",
    "bcr_drug_barcode": "TCGA-36-2540-D27940",
    "bcr_drug_uuid": "e4be68cd-4638-4590-b0f3-6f83e64f48b0",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 726,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "30c7efdd-5a86-4418-a33c-a5d27fe56e42",
    "patient_ID": "TCGA.36.2540",
    "bcr_drug_barcode": "TCGA-36-2540-D27937",
    "bcr_drug_uuid": "ae88c1fa-9bf0-4d92-8b5b-786a2cdb17ca",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1280,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7680
  },
  {
    "bcr_patient_uuid": "30c7efdd-5a86-4418-a33c-a5d27fe56e42",
    "patient_ID": "TCGA.36.2540",
    "bcr_drug_barcode": "TCGA-36-2540-D27939",
    "bcr_drug_uuid": "d8bff8c2-883d-4027-bb84-1ed49eb546f2",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 726,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 940,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7aadc24b-3de2-478f-b9e5-aca44424f514",
    "patient_ID": "TCGA.36.2542",
    "bcr_drug_barcode": "TCGA-36-2542-D27944",
    "bcr_drug_uuid": "fb87fce9-8378-400b-913d-98bf43261971",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 77,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1345
  },
  {
    "bcr_patient_uuid": "7aadc24b-3de2-478f-b9e5-aca44424f514",
    "patient_ID": "TCGA.36.2542",
    "bcr_drug_barcode": "TCGA-36-2542-D27943",
    "bcr_drug_uuid": "c15888a5-ada4-4d21-bda0-cac3f969bd25",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 540,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3240
  },
  {
    "bcr_patient_uuid": "da56dfbe-35ae-4bd7-9a11-d9bbb02b1833",
    "patient_ID": "TCGA.36.2544",
    "bcr_drug_barcode": "TCGA-36-2544-D27950",
    "bcr_drug_uuid": "f7dd65b4-7325-4b8e-a966-a1d861d1b258",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 247,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1542
  },
  {
    "bcr_patient_uuid": "da56dfbe-35ae-4bd7-9a11-d9bbb02b1833",
    "patient_ID": "TCGA.36.2544",
    "bcr_drug_barcode": "TCGA-36-2544-D27949",
    "bcr_drug_uuid": "d7582250-4e83-4f98-9c7e-db0b477604b2",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 546,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3276
  },
  {
    "bcr_patient_uuid": "da56dfbe-35ae-4bd7-9a11-d9bbb02b1833",
    "patient_ID": "TCGA.36.2544",
    "bcr_drug_barcode": "TCGA-36-2544-D27951",
    "bcr_drug_uuid": "1aab2bea-e290-440c-af43-f14733a32813",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 343,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 605,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 605
  },
  {
    "bcr_patient_uuid": "da56dfbe-35ae-4bd7-9a11-d9bbb02b1833",
    "patient_ID": "TCGA.36.2544",
    "bcr_drug_barcode": "TCGA-36-2544-D27952",
    "bcr_drug_uuid": "cf3913cd-287d-4a0c-a040-c13ae4ef276f",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 343,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 260,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 260
  },
  {
    "bcr_patient_uuid": "f3cd0ca3-8e5d-481b-b28c-619a4123dcd0",
    "patient_ID": "TCGA.36.2545",
    "bcr_drug_barcode": "TCGA-36-2545-D27956",
    "bcr_drug_uuid": "f704b1b9-e697-44d8-9ce9-bd83bccb7ab4",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 90,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2364
  },
  {
    "bcr_patient_uuid": "f3cd0ca3-8e5d-481b-b28c-619a4123dcd0",
    "patient_ID": "TCGA.36.2545",
    "bcr_drug_barcode": "TCGA-36-2545-D27955",
    "bcr_drug_uuid": "f6ca9e7b-80f0-47bd-9a94-dad045441d16",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 750,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5450
  },
  {
    "bcr_patient_uuid": "5e447cbc-9bc9-4e1a-9b43-06cf619e5aa9",
    "patient_ID": "TCGA.36.2547",
    "bcr_drug_barcode": "TCGA-36-2547-D27959",
    "bcr_drug_uuid": "2d0f8024-f78a-4818-b9a7-2f78a52624a2",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5e447cbc-9bc9-4e1a-9b43-06cf619e5aa9",
    "patient_ID": "TCGA.36.2547",
    "bcr_drug_barcode": "TCGA-36-2547-D27960",
    "bcr_drug_uuid": "88a8157c-ca8d-494c-ab8d-de85bb90d7c1",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLILTAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3250e604-d12a-4922-aaca-6f0cae095842",
    "patient_ID": "TCGA.36.2548",
    "bcr_drug_barcode": "TCGA-36-2548-D27964",
    "bcr_drug_uuid": "c61c0ee3-7792-4556-a74e-0f4ce2ceb27b",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3250e604-d12a-4922-aaca-6f0cae095842",
    "patient_ID": "TCGA.36.2548",
    "bcr_drug_barcode": "TCGA-36-2548-D27963",
    "bcr_drug_uuid": "7905da51-efd8-42a9-9ef7-e165f09bb674",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 267,
    "drug_cycles": 9,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "9815ab87-454d-4dfc-8b3d-4b35af32d764",
    "patient_ID": "TCGA.36.2549",
    "bcr_drug_barcode": "TCGA-36-2549-D27968",
    "bcr_drug_uuid": "5a6c332e-d031-47ff-8289-63c802a63356",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 309,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1854
  },
  {
    "bcr_patient_uuid": "9815ab87-454d-4dfc-8b3d-4b35af32d764",
    "patient_ID": "TCGA.36.2549",
    "bcr_drug_barcode": "TCGA-36-2549-D27967",
    "bcr_drug_uuid": "45c7c8d0-307f-4398-800e-680320d860a1",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 710,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4400
  },
  {
    "bcr_patient_uuid": "9f096022-e3ec-4f63-8c52-03ef24c018f3",
    "patient_ID": "TCGA.36.2551",
    "bcr_drug_barcode": "TCGA-36-2551-D27973",
    "bcr_drug_uuid": "c5bf7b9a-ad76-474f-9a4c-47d768c31c8c",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 555,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "9f096022-e3ec-4f63-8c52-03ef24c018f3",
    "patient_ID": "TCGA.36.2551",
    "bcr_drug_barcode": "TCGA-36-2551-D27974",
    "bcr_drug_uuid": "0ca9fe75-fd2c-420d-9ba2-b0f3b63798df",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "LIPOSOMAL DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 346,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 55,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "9f096022-e3ec-4f63-8c52-03ef24c018f3",
    "patient_ID": "TCGA.36.2551",
    "bcr_drug_barcode": "TCGA-36-2551-D27972",
    "bcr_drug_uuid": "d1503daa-5943-43ab-bce9-9e6c09b8eab5",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 243,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1602
  },
  {
    "bcr_patient_uuid": "9f096022-e3ec-4f63-8c52-03ef24c018f3",
    "patient_ID": "TCGA.36.2551",
    "bcr_drug_barcode": "TCGA-36-2551-D27971",
    "bcr_drug_uuid": "21e402db-38f5-420a-be93-d6c90b1b5f97",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 198,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 650,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6340
  },
  {
    "bcr_patient_uuid": "2d8b42fb-b12c-454e-a5a5-22c91913386f",
    "patient_ID": "TCGA.36.2552",
    "bcr_drug_barcode": "TCGA-36-2552-D27978",
    "bcr_drug_uuid": "8a05a1cd-08bc-4e8a-b376-7580f51e54b5",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 241,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1449.5
  },
  {
    "bcr_patient_uuid": "2d8b42fb-b12c-454e-a5a5-22c91913386f",
    "patient_ID": "TCGA.36.2552",
    "bcr_drug_barcode": "TCGA-36-2552-D27977",
    "bcr_drug_uuid": "9d94ac77-895f-4af1-9a46-8a1f6ca3fb17",
    "form_completion_date": "2010-8-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 454,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2724
  },
  {
    "bcr_patient_uuid": "E35B2813-427E-4E83-95F6-4F0281F42A59",
    "patient_ID": "TCGA.3P.A9WA",
    "bcr_drug_barcode": "TCGA-3P-A9WA-D60123",
    "bcr_drug_uuid": "CBB9DB6A-C8A4-465E-8180-0CE8BB362721",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E35B2813-427E-4E83-95F6-4F0281F42A59",
    "patient_ID": "TCGA.3P.A9WA",
    "bcr_drug_barcode": "TCGA-3P-A9WA-D60124",
    "bcr_drug_uuid": "ADC8FFC1-7FE3-4DBB-A041-FC4CD4F35B60",
    "form_completion_date": "2014-5-29",
    "pharmaceutical_therapy_drug_name": "PARAPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D28028",
    "bcr_drug_uuid": "55f15f39-17c5-4aa3-9a39-bab6794e69f5",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 184,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 135,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 945
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D28031",
    "bcr_drug_uuid": "dfdd0a09-cbbb-4dcb-9cc5-cefebd224b34",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 36,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 325,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 325
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D28030",
    "bcr_drug_uuid": "c19b14c4-4aae-4c87-bf43-e31418a4506b",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 185,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1260
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D28029",
    "bcr_drug_uuid": "cb3e3212-e23f-4b37-9f42-93c5ee99a980",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 240,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D28819",
    "bcr_drug_uuid": "f7f05050-c2e8-4fa4-8768-ce2a34d3835e",
    "form_completion_date": "2011-5-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 640,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 682,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 180,
    "regimen_number": 3,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 540
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D28818",
    "bcr_drug_uuid": "495ec0d8-ca4e-4ef2-af6c-2f5ee7b212fc",
    "form_completion_date": "2011-5-18",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 232,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 560,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 242,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1453
  },
  {
    "bcr_patient_uuid": "7922df77-f09a-488c-a1be-58646ceb9b3e",
    "patient_ID": "TCGA.42.2582",
    "bcr_drug_barcode": "TCGA-42-2582-D31446",
    "bcr_drug_uuid": "44CFCC79-0825-468C-84A0-5E1288307CF4",
    "form_completion_date": "2012-5-2",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 800,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 955,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28037",
    "bcr_drug_uuid": "32127c37-e882-42f0-ab66-04c4714e1a54",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 515,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2575
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28035",
    "bcr_drug_uuid": "b35f1439-dc93-4cce-84ce-54954bd7c017",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 395,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1183
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28034",
    "bcr_drug_uuid": "1e1bb656-c424-468b-bd66-cb465f9f5eae",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 94,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 160,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1018
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28036",
    "bcr_drug_uuid": "ffec8b1d-1d6c-4050-b6c3-f453bbffc47e",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 150,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 119,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1507
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28799",
    "bcr_drug_uuid": "6b469b25-b567-4107-b82e-efe85e137b95",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "CLINICAL TRIAL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 326,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 605,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 267,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "MAINTENANCE",
    "drug_total_dose": 2694
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28798",
    "bcr_drug_uuid": "f8ec148f-6eed-4601-8312-6fe0888b92b3",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 276,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "drug_cycles": 5,
    "regimen_number": 2,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eef62876-7d17-496a-8971-2c7008d77014",
    "patient_ID": "TCGA.42.2587",
    "bcr_drug_barcode": "TCGA-42-2587-D28796",
    "bcr_drug_uuid": "61a1c2b5-2d22-4594-b3a4-46f029c4a77c",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 283,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 290,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 117,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 234
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28042",
    "bcr_drug_uuid": "b4616f91-0148-4e23-8b9d-ab3fd76760d7",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 97,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1146
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28043",
    "bcr_drug_uuid": "2c83e6ca-240b-4be5-b796-006d114d3975",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 258,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 590,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2360
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28041",
    "bcr_drug_uuid": "ad0e141f-2887-4cee-9a89-8172ebda8ce7",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 558,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2169
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28040",
    "bcr_drug_uuid": "06643023-c853-4442-ba1b-5cd6259c1b6b",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 137,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 948
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28834",
    "bcr_drug_uuid": "dedd22e6-28a2-4020-8f6d-c266b1f48fe7",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 744,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 819,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1203
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28824",
    "bcr_drug_uuid": "30c139f2-e12d-4ed8-a1b3-31fc9eb5bb59",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "TARGETED MOLECULAR THERAPY",
    "days_to_drug_start": 343,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 399,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 747,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 2323
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28822",
    "bcr_drug_uuid": "1d0588af-256c-45d7-b974-d57254093ea4",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 315,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 399,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 248
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28831",
    "bcr_drug_uuid": "b29f6f17-e86e-411b-a740-fec10c2f256b",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "FEMARA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 687,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 2.5,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 245
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28826",
    "bcr_drug_uuid": "c56b5635-c884-4eba-be7b-af5898e3ce77",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 455,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 595,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 266,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1862
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28937",
    "bcr_drug_uuid": "74BDD96A-B5A2-41A7-926D-5F07411E36B7",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "MEGESTROL ACETATE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 687,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 784,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 5,
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 39200
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28825",
    "bcr_drug_uuid": "800d12e7-9f55-4e4a-80b4-0d6d58cca353",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 427,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 72,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 72
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28827",
    "bcr_drug_uuid": "575215c3-b906-40ca-a891-4f6663e92d32",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 427,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 602,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 621,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10302
  },
  {
    "bcr_patient_uuid": "654d02ab-05b4-4863-99d9-04d087ff91b4",
    "patient_ID": "TCGA.42.2588",
    "bcr_drug_barcode": "TCGA-42-2588-D28833",
    "bcr_drug_uuid": "d04a7679-dc92-4c44-8f30-ad96ecf65f2c",
    "form_completion_date": "2012-1-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 735,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 819,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 675,
    "regimen_number": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 4881
  },
  {
    "bcr_patient_uuid": "dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb",
    "patient_ID": "TCGA.42.2589",
    "bcr_drug_barcode": "TCGA-42-2589-D28046",
    "bcr_drug_uuid": "811bc53a-f05b-4779-a676-128d0da2822a",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 308,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2046
  },
  {
    "bcr_patient_uuid": "dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb",
    "patient_ID": "TCGA.42.2589",
    "bcr_drug_barcode": "TCGA-42-2589-D28048",
    "bcr_drug_uuid": "6a1466ac-1f06-4617-a34e-604e6945dac0",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 126,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 140,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 545
  },
  {
    "bcr_patient_uuid": "dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb",
    "patient_ID": "TCGA.42.2589",
    "bcr_drug_barcode": "TCGA-42-2589-D28047",
    "bcr_drug_uuid": "1a6c0376-6bc1-4d52-ad00-2a5d128b8232",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 41,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 696,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1392
  },
  {
    "bcr_patient_uuid": "dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb",
    "patient_ID": "TCGA.42.2589",
    "bcr_drug_barcode": "TCGA-42-2589-D28802",
    "bcr_drug_uuid": "F4DC11FC-B77B-4047-A7F3-0C9AC3E36A26",
    "form_completion_date": "2011-5-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 504,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 475,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2375
  },
  {
    "bcr_patient_uuid": "dfb7dc5d-92f4-4a3a-9667-db38efcc9fdb",
    "patient_ID": "TCGA.42.2589",
    "bcr_drug_barcode": "TCGA-42-2589-D28805",
    "bcr_drug_uuid": "180D0212-9DF5-42F7-928C-EB0455BB8FAE",
    "form_completion_date": "2011-6-9",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 377,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 644,
    "drug_cycles": 11,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 21398
  },
  {
    "bcr_patient_uuid": "2724109f-7d5a-402c-a915-741e43c6f7f9",
    "patient_ID": "TCGA.42.2590",
    "bcr_drug_barcode": "TCGA-42-2590-D28051",
    "bcr_drug_uuid": "6706e8b9-0a34-469c-a95f-9bb26531c61e",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 640,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2470
  },
  {
    "bcr_patient_uuid": "2724109f-7d5a-402c-a915-741e43c6f7f9",
    "patient_ID": "TCGA.42.2590",
    "bcr_drug_barcode": "TCGA-42-2590-D28052",
    "bcr_drug_uuid": "b71ee922-d388-4f5d-b45a-25f2f102aada",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 31,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1600,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12100
  },
  {
    "bcr_patient_uuid": "2724109f-7d5a-402c-a915-741e43c6f7f9",
    "patient_ID": "TCGA.42.2590",
    "bcr_drug_barcode": "TCGA-42-2590-D28811",
    "bcr_drug_uuid": "ab3bd573-dcf1-44c5-8518-8d44a22e4b93",
    "form_completion_date": "2011-5-18",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 249,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 269,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 110,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 235
  },
  {
    "bcr_patient_uuid": "0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa",
    "patient_ID": "TCGA.42.2591",
    "bcr_drug_barcode": "TCGA-42-2591-D28055",
    "bcr_drug_uuid": "72d60219-e3a7-4bcb-9264-f882a37c8488",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 120,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2747
  },
  {
    "bcr_patient_uuid": "0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa",
    "patient_ID": "TCGA.42.2591",
    "bcr_drug_barcode": "TCGA-42-2591-D28056",
    "bcr_drug_uuid": "72191190-2d62-46d3-ae53-fc701676bbb8",
    "form_completion_date": "2010-6-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 715,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5720
  },
  {
    "bcr_patient_uuid": "0750ebcc-348a-4ea9-9dd2-6274d5e6eeaa",
    "patient_ID": "TCGA.42.2591",
    "bcr_drug_barcode": "TCGA-42-2591-D28794",
    "bcr_drug_uuid": "5782a341-5e6f-45a5-bd62-6a5e998694fc",
    "form_completion_date": "2011-8-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 253,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 561,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 270,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "MAINTENANCE",
    "drug_total_dose": 3240
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28065",
    "bcr_drug_uuid": "52fe6e4b-e0f3-45ac-a637-1646983fa465",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 718,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28062",
    "bcr_drug_uuid": "465a4575-5435-43fd-83d8-e1e1e3f854a2",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "PATUPILONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 260,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28060",
    "bcr_drug_uuid": "4476f55a-92b6-41f6-86a8-d943b07880fc",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28061",
    "bcr_drug_uuid": "6e3807f9-6043-4aec-aa04-b7e7feab6f77",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28066",
    "bcr_drug_uuid": "64899839-fe30-4966-ad41-a6039e479566",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 597,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 718,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28063",
    "bcr_drug_uuid": "cf142304-ee75-49b0-9661-d6a7f35b0e5f",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 444,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 505,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "4ea50685-3b63-440a-b037-597ef2529e7d",
    "patient_ID": "TCGA.57.1582",
    "bcr_drug_barcode": "TCGA-57-1582-D28064",
    "bcr_drug_uuid": "9041086b-05e4-47fa-a97e-8a2434ee502f",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 505,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 597,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8",
    "patient_ID": "TCGA.57.1583",
    "bcr_drug_barcode": "TCGA-57-1583-D28070",
    "bcr_drug_uuid": "434279a5-98f5-4980-865b-49ce6f7f5e16",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "76cc2d21-eebc-4f09-9bc7-dbf7af0aafa8",
    "patient_ID": "TCGA.57.1583",
    "bcr_drug_barcode": "TCGA-57-1583-D28069",
    "bcr_drug_uuid": "fcaf527f-ac45-49ba-b12e-0898f26aa9fe",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "ed21615c-0de3-421c-9e8d-8996026c4431",
    "patient_ID": "TCGA.57.1584",
    "bcr_drug_barcode": "TCGA-57-1584-D28074",
    "bcr_drug_uuid": "ebf8762c-60c4-480c-b622-f381bd0c690b",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 573,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "ed21615c-0de3-421c-9e8d-8996026c4431",
    "patient_ID": "TCGA.57.1584",
    "bcr_drug_barcode": "TCGA-57-1584-D28073",
    "bcr_drug_uuid": "0c8bcfba-47b8-4021-9897-453225bb8218",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 573,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "5ed14506-f69a-4da8-9965-72d3270b9f72",
    "patient_ID": "TCGA.57.1585",
    "bcr_drug_barcode": "TCGA-57-1585-D28077",
    "bcr_drug_uuid": "81bf2efd-8318-47a1-9950-fbc7a075cf68",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5ed14506-f69a-4da8-9965-72d3270b9f72",
    "patient_ID": "TCGA.57.1585",
    "bcr_drug_barcode": "TCGA-57-1585-D28078",
    "bcr_drug_uuid": "e291cd52-9ae7-45f5-a0bd-fc522f30f01b",
    "form_completion_date": "2009-7-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28085",
    "bcr_drug_uuid": "154aa145-3583-4eae-b349-106673305fb4",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 323,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 406,
    "drug_cycles": 3,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28084",
    "bcr_drug_uuid": "5948359f-b509-4b5a-ba6a-be19c611bbce",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 259,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28081",
    "bcr_drug_uuid": "bbf33820-9f76-4cfb-afe0-79a5c0eb3edb",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 8,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28083",
    "bcr_drug_uuid": "d67969e3-a53c-49a7-9e9d-e199f334de35",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 259,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 4,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28086",
    "bcr_drug_uuid": "f5064788-37a0-4453-8e48-7afd74568b5a",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 433,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 542,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28088",
    "bcr_drug_uuid": "c50fed41-30b0-467a-9fce-96067cfa97d2",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28082",
    "bcr_drug_uuid": "39d706ee-04ea-4d4b-b740-faa6cc534736",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 8,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "48e66676-dbed-48a4-9a7f-a6d247b15c17",
    "patient_ID": "TCGA.57.1586",
    "bcr_drug_barcode": "TCGA-57-1586-D28087",
    "bcr_drug_uuid": "ded42d21-aa2e-4520-a82a-0e2c905d3c55",
    "form_completion_date": "2009-9-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 553,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 1,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "15fc17cd-d073-4f81-a4a2-2db3cb9d7069",
    "patient_ID": "TCGA.57.1993",
    "bcr_drug_barcode": "TCGA-57-1993-D28093",
    "bcr_drug_uuid": "b07a8455-73a1-4571-bd1b-3e468ec2f2f8",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "15fc17cd-d073-4f81-a4a2-2db3cb9d7069",
    "patient_ID": "TCGA.57.1993",
    "bcr_drug_barcode": "TCGA-57-1993-D28094",
    "bcr_drug_uuid": "6953096a-c7ed-4c25-b134-8dca8f12f670",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d7925dfc-18ce-46ab-a47b-9d06eacc96d0",
    "patient_ID": "TCGA.59.2354",
    "bcr_drug_barcode": "TCGA-59-2354-D28108",
    "bcr_drug_uuid": "efd422e2-ed42-4926-ac5f-947cb1a6f888",
    "form_completion_date": "2010-3-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "d7925dfc-18ce-46ab-a47b-9d06eacc96d0",
    "patient_ID": "TCGA.59.2354",
    "bcr_drug_barcode": "TCGA-59-2354-D28109",
    "bcr_drug_uuid": "a31debf1-cc26-497d-8434-113fc8930b99",
    "form_completion_date": "2010-3-31",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "708eec28-2348-4e15-b98c-8c6f9d057b1e",
    "patient_ID": "TCGA.59.2355",
    "bcr_drug_barcode": "TCGA-59-2355-D28113",
    "bcr_drug_uuid": "90eccdfc-050e-473d-854a-6bd75e253a13",
    "form_completion_date": "2010-3-31",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "708eec28-2348-4e15-b98c-8c6f9d057b1e",
    "patient_ID": "TCGA.59.2355",
    "bcr_drug_barcode": "TCGA-59-2355-D28112",
    "bcr_drug_uuid": "a484b2da-a6d7-403b-b76e-17312504bdbc",
    "form_completion_date": "2010-3-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f4d95c8e-fb84-46ca-acc0-827015cc9d0a",
    "patient_ID": "TCGA.59.2363",
    "bcr_drug_barcode": "TCGA-59-2363-D28116",
    "bcr_drug_uuid": "370376ef-e337-4f4a-99e9-1946fb317d53",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPALTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f4d95c8e-fb84-46ca-acc0-827015cc9d0a",
    "patient_ID": "TCGA.59.2363",
    "bcr_drug_barcode": "TCGA-59-2363-D28117",
    "bcr_drug_uuid": "3947e570-c2af-4b0d-8d63-fb7eb1a976ca",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d8abed4-62b3-4e17-a8ce-9f6028e97103",
    "patient_ID": "TCGA.59.2372",
    "bcr_drug_barcode": "TCGA-59-2372-D28120",
    "bcr_drug_uuid": "791be596-c56b-401b-8e73-0067dcd7484f",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d8abed4-62b3-4e17-a8ce-9f6028e97103",
    "patient_ID": "TCGA.59.2372",
    "bcr_drug_barcode": "TCGA-59-2372-D28121",
    "bcr_drug_uuid": "ae86c082-8c04-4078-bd1e-b303705819cd",
    "form_completion_date": "2010-3-15",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "drug_cycles": 4,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "BC84C5C5-1785-4EDD-B732-8987F862063E",
    "patient_ID": "TCGA.5X.AA5U",
    "bcr_drug_barcode": "TCGA-5X-AA5U-D68523",
    "bcr_drug_uuid": "BCE4C9F7-2318-4C8B-8545-9F0283051595",
    "form_completion_date": "2014-11-24",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC84C5C5-1785-4EDD-B732-8987F862063E",
    "patient_ID": "TCGA.5X.AA5U",
    "bcr_drug_barcode": "TCGA-5X-AA5U-D69109",
    "bcr_drug_uuid": "22AB155E-AD49-40BF-BE96-92E5512C3A5C",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BC84C5C5-1785-4EDD-B732-8987F862063E",
    "patient_ID": "TCGA.5X.AA5U",
    "bcr_drug_barcode": "TCGA-5X-AA5U-D69110",
    "bcr_drug_uuid": "75E7835F-DABB-414B-939A-450620B2352C",
    "form_completion_date": "2014-12-29",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1c0318d9-0472-4840-add4-46bb9f914a30",
    "patient_ID": "TCGA.61.1721",
    "bcr_drug_barcode": "TCGA-61-1721-D28125",
    "bcr_drug_uuid": "be53f54f-26ff-45ce-8475-53ab28702ead",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEOADJUVANT",
    "drug_total_dose": 1782
  },
  {
    "bcr_patient_uuid": "1c0318d9-0472-4840-add4-46bb9f914a30",
    "patient_ID": "TCGA.61.1721",
    "bcr_drug_barcode": "TCGA-61-1721-D28126",
    "bcr_drug_uuid": "88f75546-60dd-4748-83ef-3e287dfec167",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "NEOADJUVANT",
    "drug_total_dose": 3960
  },
  {
    "bcr_patient_uuid": "1c0318d9-0472-4840-add4-46bb9f914a30",
    "patient_ID": "TCGA.61.1721",
    "bcr_drug_barcode": "TCGA-61-1721-D28124",
    "bcr_drug_uuid": "0b65dd59-5982-4c6e-bd9a-705298dcb9bd",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 317,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 528
  },
  {
    "bcr_patient_uuid": "1c0318d9-0472-4840-add4-46bb9f914a30",
    "patient_ID": "TCGA.61.1721",
    "bcr_drug_barcode": "TCGA-61-1721-D28127",
    "bcr_drug_uuid": "d4666102-4b7e-48ee-80ae-e210b59c5590",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 317,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 786
  },
  {
    "bcr_patient_uuid": "47feba88-1ec9-4904-b0e2-3718f294badb",
    "patient_ID": "TCGA.61.1722",
    "bcr_drug_barcode": "TCGA-61-1722-D28130",
    "bcr_drug_uuid": "08dcb240-abe5-4cd2-8b81-b865b8e57bf9",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "47feba88-1ec9-4904-b0e2-3718f294badb",
    "patient_ID": "TCGA.61.1722",
    "bcr_drug_barcode": "TCGA-61-1722-D28132",
    "bcr_drug_uuid": "1ebe6dcf-919d-439f-ad65-eca304b64bc0",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "47feba88-1ec9-4904-b0e2-3718f294badb",
    "patient_ID": "TCGA.61.1722",
    "bcr_drug_barcode": "TCGA-61-1722-D28131",
    "bcr_drug_uuid": "905dc122-807e-446f-80c3-408de2511c9f",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "MITOXANTRONE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 171,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 29
  },
  {
    "bcr_patient_uuid": "47feba88-1ec9-4904-b0e2-3718f294badb",
    "patient_ID": "TCGA.61.1722",
    "bcr_drug_barcode": "TCGA-61-1722-D28133",
    "bcr_drug_uuid": "594842d6-0c7e-4151-b277-bf6fbd04c4ab",
    "form_completion_date": "2010-3-12",
    "pharmaceutical_therapy_drug_name": "DECODRON",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 174,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 30
  },
  {
    "bcr_patient_uuid": "2ae65a06-df0f-4de1-a536-537cae0cc260",
    "patient_ID": "TCGA.61.1724",
    "bcr_drug_barcode": "TCGA-61-1724-D28139",
    "bcr_drug_uuid": "10ae53d3-cf86-4d27-acc9-b14b417c38e9",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 368,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2ae65a06-df0f-4de1-a536-537cae0cc260",
    "patient_ID": "TCGA.61.1724",
    "bcr_drug_barcode": "TCGA-61-1724-D28141",
    "bcr_drug_uuid": "01418efe-a192-41b4-b329-40e650144015",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 608,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2ae65a06-df0f-4de1-a536-537cae0cc260",
    "patient_ID": "TCGA.61.1724",
    "bcr_drug_barcode": "TCGA-61-1724-D28138",
    "bcr_drug_uuid": "5a48d2d4-f2f1-4169-aa5f-c07f1a4897e3",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2ae65a06-df0f-4de1-a536-537cae0cc260",
    "patient_ID": "TCGA.61.1724",
    "bcr_drug_barcode": "TCGA-61-1724-D28137",
    "bcr_drug_uuid": "17389b1d-4f26-4ea4-9e25-44de0d1f6504",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "2ae65a06-df0f-4de1-a536-537cae0cc260",
    "patient_ID": "TCGA.61.1724",
    "bcr_drug_barcode": "TCGA-61-1724-D28136",
    "bcr_drug_uuid": "6af00c2d-d0db-4f4b-8bcf-05807748460e",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2ae65a06-df0f-4de1-a536-537cae0cc260",
    "patient_ID": "TCGA.61.1724",
    "bcr_drug_barcode": "TCGA-61-1724-D28140",
    "bcr_drug_uuid": "cd8e9c06-c812-47cd-be39-6f65386c41ef",
    "form_completion_date": "2009-12-1",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 514,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28148",
    "bcr_drug_uuid": "ae6635ba-24c7-4ef6-9109-fcb345f40100",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 908,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8550
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28147",
    "bcr_drug_uuid": "be9ce53c-8440-43ce-9790-f43f463a4749",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 235,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 577,
    "drug_cycles": 12,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3204
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28144",
    "bcr_drug_uuid": "ff470391-4fb2-4ee9-b99a-db1ca43e94df",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1548
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28146",
    "bcr_drug_uuid": "f8dca13c-4cb2-443d-852d-5f8c0ef3f597",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 456
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28149",
    "bcr_drug_uuid": "e3c3aa0d-b3cf-4832-a3b3-7edb59254a73",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 908,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4368
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28145",
    "bcr_drug_uuid": "de6d03ff-d938-406d-934b-3b682ca22abc",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 585
  },
  {
    "bcr_patient_uuid": "a6eb0cd0-fe57-41b0-8593-776208684293",
    "patient_ID": "TCGA.61.1725",
    "bcr_drug_barcode": "TCGA-61-1725-D28150",
    "bcr_drug_uuid": "0b003971-e65d-4cad-886b-054a4cb03a53",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "GAMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 908,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "99407c1d-40b5-4ded-ba29-1e40dfd65be4",
    "patient_ID": "TCGA.61.1727",
    "bcr_drug_barcode": "TCGA-61-1727-D28153",
    "bcr_drug_uuid": "5b0e1651-62e8-40b8-8bd2-0b31b786ad3d",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 600
  },
  {
    "bcr_patient_uuid": "99407c1d-40b5-4ded-ba29-1e40dfd65be4",
    "patient_ID": "TCGA.61.1727",
    "bcr_drug_barcode": "TCGA-61-1727-D28154",
    "bcr_drug_uuid": "131ac56b-194e-470a-b9b1-98791766dc47",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2250
  },
  {
    "bcr_patient_uuid": "07fbdb3c-8337-4319-8255-f2363f8a031e",
    "patient_ID": "TCGA.61.1728",
    "bcr_drug_barcode": "TCGA-61-1728-D28158",
    "bcr_drug_uuid": "f040590a-48e8-4891-9aff-f2534f18ff54",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5280
  },
  {
    "bcr_patient_uuid": "07fbdb3c-8337-4319-8255-f2363f8a031e",
    "patient_ID": "TCGA.61.1728",
    "bcr_drug_barcode": "TCGA-61-1728-D28157",
    "bcr_drug_uuid": "f38cdfc3-7031-4308-ad4e-4dc2ee43c0d7",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "SNS 595",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 246,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 848,
    "drug_cycles": 20,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1920
  },
  {
    "bcr_patient_uuid": "07fbdb3c-8337-4319-8255-f2363f8a031e",
    "patient_ID": "TCGA.61.1728",
    "bcr_drug_barcode": "TCGA-61-1728-D28159",
    "bcr_drug_uuid": "c225c5ce-5c01-4ae5-b74f-a6e2034824bf",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2000
  },
  {
    "bcr_patient_uuid": "04ecaf38-0232-4dcd-9242-308a22cc1331",
    "patient_ID": "TCGA.61.1733",
    "bcr_drug_barcode": "TCGA-61-1733-D28164",
    "bcr_drug_uuid": "c5f1a4ae-9989-4347-8a0a-d1afa03088c0",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3924
  },
  {
    "bcr_patient_uuid": "04ecaf38-0232-4dcd-9242-308a22cc1331",
    "patient_ID": "TCGA.61.1733",
    "bcr_drug_barcode": "TCGA-61-1733-D28167",
    "bcr_drug_uuid": "9cb8b2cf-4118-4be9-bfb9-b27a645a9d44",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 484,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 625,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "04ecaf38-0232-4dcd-9242-308a22cc1331",
    "patient_ID": "TCGA.61.1733",
    "bcr_drug_barcode": "TCGA-61-1733-D28166",
    "bcr_drug_uuid": "3d4bc96f-852a-4613-af54-9a451e00749f",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 231,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 372,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 482
  },
  {
    "bcr_patient_uuid": "04ecaf38-0232-4dcd-9242-308a22cc1331",
    "patient_ID": "TCGA.61.1733",
    "bcr_drug_barcode": "TCGA-61-1733-D28169",
    "bcr_drug_uuid": "54936660-8150-4378-bb3a-200680460618",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 484,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 625,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 582
  },
  {
    "bcr_patient_uuid": "04ecaf38-0232-4dcd-9242-308a22cc1331",
    "patient_ID": "TCGA.61.1733",
    "bcr_drug_barcode": "TCGA-61-1733-D28168",
    "bcr_drug_uuid": "62907e81-bc0a-4302-9897-8d0b0a0fa75e",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 484,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 625,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "04ecaf38-0232-4dcd-9242-308a22cc1331",
    "patient_ID": "TCGA.61.1733",
    "bcr_drug_barcode": "TCGA-61-1733-D28165",
    "bcr_drug_uuid": "b774d231-1124-433a-818f-ba0a853908d0",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 638
  },
  {
    "bcr_patient_uuid": "b5e64bdb-24f1-400d-aaf7-8fda8ab6fd3c",
    "patient_ID": "TCGA.61.1734",
    "bcr_drug_barcode": "TCGA-61-1734-D28172",
    "bcr_drug_uuid": "199c76a7-19fe-4f8a-90f0-0064008b434b",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b5e64bdb-24f1-400d-aaf7-8fda8ab6fd3c",
    "patient_ID": "TCGA.61.1734",
    "bcr_drug_barcode": "TCGA-61-1734-D28173",
    "bcr_drug_uuid": "14804ed4-485f-4cb9-b2be-ce15222dcfc1",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 158,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a2d29de-869a-4dc8-ad11-6ee0d0a3a895",
    "patient_ID": "TCGA.61.1736",
    "bcr_drug_barcode": "TCGA-61-1736-D28177",
    "bcr_drug_uuid": "0dd45cff-9b04-43bc-862b-62ac6b70880a",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a2d29de-869a-4dc8-ad11-6ee0d0a3a895",
    "patient_ID": "TCGA.61.1736",
    "bcr_drug_barcode": "TCGA-61-1736-D28178",
    "bcr_drug_uuid": "57649c27-8fde-4924-bb6a-36f78d3d965e",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0a2d29de-869a-4dc8-ad11-6ee0d0a3a895",
    "patient_ID": "TCGA.61.1736",
    "bcr_drug_barcode": "TCGA-61-1736-D28176",
    "bcr_drug_uuid": "f0714214-07d4-4c41-9e61-b6470308eea9",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0a2d29de-869a-4dc8-ad11-6ee0d0a3a895",
    "patient_ID": "TCGA.61.1736",
    "bcr_drug_barcode": "TCGA-61-1736-D28179",
    "bcr_drug_uuid": "4be9230a-4d81-4cd4-a1ba-3f24ad91f5cc",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "0a2d29de-869a-4dc8-ad11-6ee0d0a3a895",
    "patient_ID": "TCGA.61.1736",
    "bcr_drug_barcode": "TCGA-61-1736-D28180",
    "bcr_drug_uuid": "6b95b794-0927-46c0-8786-6e66ec7050fc",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 946,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "0aa020cb-69d2-4235-a609-c279a133d8bb",
    "patient_ID": "TCGA.61.1737",
    "bcr_drug_barcode": "TCGA-61-1737-D28184",
    "bcr_drug_uuid": "bde9b500-2bbc-4635-9b62-37438f743031",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2600
  },
  {
    "bcr_patient_uuid": "0aa020cb-69d2-4235-a609-c279a133d8bb",
    "patient_ID": "TCGA.61.1737",
    "bcr_drug_barcode": "TCGA-61-1737-D28183",
    "bcr_drug_uuid": "36e353f0-bed3-40a3-affc-66fbe869646f",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 480
  },
  {
    "bcr_patient_uuid": "0aa020cb-69d2-4235-a609-c279a133d8bb",
    "patient_ID": "TCGA.61.1737",
    "bcr_drug_barcode": "TCGA-61-1737-D28186",
    "bcr_drug_uuid": "593c4bb6-7022-48d5-a8df-50583f549c87",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 372
  },
  {
    "bcr_patient_uuid": "0aa020cb-69d2-4235-a609-c279a133d8bb",
    "patient_ID": "TCGA.61.1737",
    "bcr_drug_barcode": "TCGA-61-1737-D28187",
    "bcr_drug_uuid": "567b59df-038a-4301-84af-f74ac4ccfccd",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 198
  },
  {
    "bcr_patient_uuid": "0aa020cb-69d2-4235-a609-c279a133d8bb",
    "patient_ID": "TCGA.61.1737",
    "bcr_drug_barcode": "TCGA-61-1737-D28185",
    "bcr_drug_uuid": "9a678242-a8a6-4502-b315-c6433876552a",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 176,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 270
  },
  {
    "bcr_patient_uuid": "0aa020cb-69d2-4235-a609-c279a133d8bb",
    "patient_ID": "TCGA.61.1737",
    "bcr_drug_barcode": "TCGA-61-1737-D28188",
    "bcr_drug_uuid": "83835e07-7625-4324-9530-b58a5533f592",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 582,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 19000
  },
  {
    "bcr_patient_uuid": "72c40fba-f502-489b-ad87-843f52655894",
    "patient_ID": "TCGA.61.1738",
    "bcr_drug_barcode": "TCGA-61-1738-D28195",
    "bcr_drug_uuid": "5cae6b69-090f-47c8-8713-2eaa5c448e60",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 422,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 658,
    "drug_cycles": 29,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 191.4
  },
  {
    "bcr_patient_uuid": "72c40fba-f502-489b-ad87-843f52655894",
    "patient_ID": "TCGA.61.1738",
    "bcr_drug_barcode": "TCGA-61-1738-D28196",
    "bcr_drug_uuid": "265b0571-09c1-4944-b6d1-b8f6b8c01b1c",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 709,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 843,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 6200
  },
  {
    "bcr_patient_uuid": "72c40fba-f502-489b-ad87-843f52655894",
    "patient_ID": "TCGA.61.1738",
    "bcr_drug_barcode": "TCGA-61-1738-D28194",
    "bcr_drug_uuid": "0008d328-4bb3-4d4a-b5d0-28d09f97d2c3",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 287,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 338,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 210
  },
  {
    "bcr_patient_uuid": "72c40fba-f502-489b-ad87-843f52655894",
    "patient_ID": "TCGA.61.1738",
    "bcr_drug_barcode": "TCGA-61-1738-D28192",
    "bcr_drug_uuid": "f55cc532-8bdd-4cad-ad7b-e462a95f6c05",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "72c40fba-f502-489b-ad87-843f52655894",
    "patient_ID": "TCGA.61.1738",
    "bcr_drug_barcode": "TCGA-61-1738-D28193",
    "bcr_drug_uuid": "b26e2e7f-9a62-4f34-90d4-d3463baaab74",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 276,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 364
  },
  {
    "bcr_patient_uuid": "72c40fba-f502-489b-ad87-843f52655894",
    "patient_ID": "TCGA.61.1738",
    "bcr_drug_barcode": "TCGA-61-1738-D28191",
    "bcr_drug_uuid": "b8292746-a108-4445-8ef5-59cea4a9b2b0",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 135,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2376
  },
  {
    "bcr_patient_uuid": "005a6517-2e5a-4ea3-ab36-531522723607",
    "patient_ID": "TCGA.61.1740",
    "bcr_drug_barcode": "TCGA-61-1740-D28199",
    "bcr_drug_uuid": "bc6d55fe-44ed-4ff5-92ae-80281edfcb66",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1020
  },
  {
    "bcr_patient_uuid": "16ced1b8-64d5-4498-82df-4d37bfe5b310",
    "patient_ID": "TCGA.61.1741",
    "bcr_drug_barcode": "TCGA-61-1741-D28205",
    "bcr_drug_uuid": "5aea964c-d67f-417c-94a3-3c4307475905",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 522,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 605,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1750
  },
  {
    "bcr_patient_uuid": "16ced1b8-64d5-4498-82df-4d37bfe5b310",
    "patient_ID": "TCGA.61.1741",
    "bcr_drug_barcode": "TCGA-61-1741-D28202",
    "bcr_drug_uuid": "ce5d7a64-d023-4d01-946f-515257c9017a",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3799
  },
  {
    "bcr_patient_uuid": "16ced1b8-64d5-4498-82df-4d37bfe5b310",
    "patient_ID": "TCGA.61.1741",
    "bcr_drug_barcode": "TCGA-61-1741-D28204",
    "bcr_drug_uuid": "846166d2-712d-44eb-9155-a202bd1f1136",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 522,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 605,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 838
  },
  {
    "bcr_patient_uuid": "16ced1b8-64d5-4498-82df-4d37bfe5b310",
    "patient_ID": "TCGA.61.1741",
    "bcr_drug_barcode": "TCGA-61-1741-D28203",
    "bcr_drug_uuid": "de49cd91-151a-46e9-a204-106b50968a1f",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 12,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2240
  },
  {
    "bcr_patient_uuid": "16ced1b8-64d5-4498-82df-4d37bfe5b310",
    "patient_ID": "TCGA.61.1741",
    "bcr_drug_barcode": "TCGA-61-1741-D28206",
    "bcr_drug_uuid": "286c1a59-9223-4a69-b1f8-b72959043137",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "ORAL",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "a3e26259-732b-49fb-bc95-2f0ec7a0494e",
    "patient_ID": "TCGA.61.1743",
    "bcr_drug_barcode": "TCGA-61-1743-D28210",
    "bcr_drug_uuid": "030502fa-6d42-4a5a-a3af-eedba0383040",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a3e26259-732b-49fb-bc95-2f0ec7a0494e",
    "patient_ID": "TCGA.61.1743",
    "bcr_drug_barcode": "TCGA-61-1743-D28211",
    "bcr_drug_uuid": "90ea70e1-cefe-4bee-b0bb-c04b6269d3a3",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 40,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 172,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "0dd95368-0713-45f0-84f4-c91af9cbba74",
    "patient_ID": "TCGA.61.1895",
    "bcr_drug_barcode": "TCGA-61-1895-D28214",
    "bcr_drug_uuid": "509215c0-2874-4032-a07f-fe9216ced5a7",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3780
  },
  {
    "bcr_patient_uuid": "0dd95368-0713-45f0-84f4-c91af9cbba74",
    "patient_ID": "TCGA.61.1895",
    "bcr_drug_barcode": "TCGA-61-1895-D28215",
    "bcr_drug_uuid": "8ef7db20-0617-45f6-90ae-fe393e156f93",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 44,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "35b1bb47-b32b-4acd-8e5e-fe6bd56c0289",
    "patient_ID": "TCGA.61.1899",
    "bcr_drug_barcode": "TCGA-61-1899-D28219",
    "bcr_drug_uuid": "e0d17430-bc63-44d6-894d-4b001467cc7a",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1104
  },
  {
    "bcr_patient_uuid": "35b1bb47-b32b-4acd-8e5e-fe6bd56c0289",
    "patient_ID": "TCGA.61.1899",
    "bcr_drug_barcode": "TCGA-61-1899-D28218",
    "bcr_drug_uuid": "6194d641-aa69-41e2-8f81-acbf267cc1df",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 159,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2220
  },
  {
    "bcr_patient_uuid": "ef653772-e5d2-46ec-8610-f81d75d7353c",
    "patient_ID": "TCGA.61.1900",
    "bcr_drug_barcode": "TCGA-61-1900-D28224",
    "bcr_drug_uuid": "ee2b9e79-59a9-465a-bef5-7c013a3693c7",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 75
  },
  {
    "bcr_patient_uuid": "ef653772-e5d2-46ec-8610-f81d75d7353c",
    "patient_ID": "TCGA.61.1900",
    "bcr_drug_barcode": "TCGA-61-1900-D28223",
    "bcr_drug_uuid": "ab4e8e00-7f0c-4de9-96bb-e60b0987d787",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 135
  },
  {
    "bcr_patient_uuid": "ef653772-e5d2-46ec-8610-f81d75d7353c",
    "patient_ID": "TCGA.61.1900",
    "bcr_drug_barcode": "TCGA-61-1900-D28222",
    "bcr_drug_uuid": "abc2cd6c-fb56-402d-b274-676c502e0ea5",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 250
  },
  {
    "bcr_patient_uuid": "7a75d318-b301-4f77-a97f-4d6784d27216",
    "patient_ID": "TCGA.61.1901",
    "bcr_drug_barcode": "TCGA-61-1901-D28228",
    "bcr_drug_uuid": "4b2e65d9-beef-462d-9820-6aa8c06bf8c1",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3941
  },
  {
    "bcr_patient_uuid": "7a75d318-b301-4f77-a97f-4d6784d27216",
    "patient_ID": "TCGA.61.1901",
    "bcr_drug_barcode": "TCGA-61-1901-D28227",
    "bcr_drug_uuid": "f89a19a1-eb39-4031-9043-3ea9fd7fe6cf",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 294,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2098
  },
  {
    "bcr_patient_uuid": "b3df9c0a-420c-4cc2-a3e0-56df1ed7e997",
    "patient_ID": "TCGA.61.1903",
    "bcr_drug_barcode": "TCGA-61-1903-D28234",
    "bcr_drug_uuid": "438d748a-9cd1-4c10-8e86-c856d91b1b2b",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 412
  },
  {
    "bcr_patient_uuid": "b3df9c0a-420c-4cc2-a3e0-56df1ed7e997",
    "patient_ID": "TCGA.61.1903",
    "bcr_drug_barcode": "TCGA-61-1903-D28232",
    "bcr_drug_uuid": "a528c65e-1612-4b37-ae33-ae6ecab7b7e1",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 560
  },
  {
    "bcr_patient_uuid": "b3df9c0a-420c-4cc2-a3e0-56df1ed7e997",
    "patient_ID": "TCGA.61.1903",
    "bcr_drug_barcode": "TCGA-61-1903-D28233",
    "bcr_drug_uuid": "d44ae97c-2ba5-4224-bb8e-a2b0df6b511a",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "2cdd5154-ee5c-4d67-b2eb-947dfaa56be2",
    "patient_ID": "TCGA.61.1904",
    "bcr_drug_barcode": "TCGA-61-1904-D28237",
    "bcr_drug_uuid": "849f17c4-a3e6-4980-83f5-dd6cfc965087",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "2cdd5154-ee5c-4d67-b2eb-947dfaa56be2",
    "patient_ID": "TCGA.61.1904",
    "bcr_drug_barcode": "TCGA-61-1904-D28238",
    "bcr_drug_uuid": "9631e833-0db2-4797-ad8d-eebda0dea026",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2600
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28247",
    "bcr_drug_uuid": "256a66da-facb-406a-b470-479d7de669f4",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 489,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1038,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28248",
    "bcr_drug_uuid": "08069844-2b07-4cb9-ba89-13dc8ef3efcc",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 489,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1038,
    "drug_cycles": 10,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28241",
    "bcr_drug_uuid": "ad137f25-8a5c-497a-a23c-cc32c105dbf9",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28246",
    "bcr_drug_uuid": "10f0eb71-7ac1-4247-ac2f-0c1943154b96",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 484,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1000
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28242",
    "bcr_drug_uuid": "3df3ef68-bd63-40f3-8aac-cda81634d52e",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2076
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28243",
    "bcr_drug_uuid": "bc864245-d830-48e2-b862-7ee8c983f05d",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 279,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 7.8
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28244",
    "bcr_drug_uuid": "f5a0e7fc-c6ea-43b4-89f5-f51891c4f550",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 335,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 391,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 234
  },
  {
    "bcr_patient_uuid": "f553e953-6464-421f-8933-26ca82cb79d3",
    "patient_ID": "TCGA.61.1906",
    "bcr_drug_barcode": "TCGA-61-1906-D28245",
    "bcr_drug_uuid": "d096b01e-2201-4d76-8e34-adaf4f8cd7f9",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 484,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1600
  },
  {
    "bcr_patient_uuid": "7ab3765f-910a-41c9-86cc-08534d2a4e4b",
    "patient_ID": "TCGA.61.1907",
    "bcr_drug_barcode": "TCGA-61-1907-D28252",
    "bcr_drug_uuid": "81f78f66-be55-4b92-8c94-7e94311bbce0",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 678
  },
  {
    "bcr_patient_uuid": "7ab3765f-910a-41c9-86cc-08534d2a4e4b",
    "patient_ID": "TCGA.61.1907",
    "bcr_drug_barcode": "TCGA-61-1907-D28251",
    "bcr_drug_uuid": "ad0cedb8-9cfe-4c7d-a378-44814f214092",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 163,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 768
  },
  {
    "bcr_patient_uuid": "7ab3765f-910a-41c9-86cc-08534d2a4e4b",
    "patient_ID": "TCGA.61.1907",
    "bcr_drug_barcode": "TCGA-61-1907-D28254",
    "bcr_drug_uuid": "46b1d80a-bd2f-47c1-b54e-9840ed2f9d2f",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 774,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 927,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "7ab3765f-910a-41c9-86cc-08534d2a4e4b",
    "patient_ID": "TCGA.61.1907",
    "bcr_drug_barcode": "TCGA-61-1907-D28253",
    "bcr_drug_uuid": "b7771071-32ea-49c0-95ce-797ccca2d8b5",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 357,
    "drug_cycles": 17,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 14280
  },
  {
    "bcr_patient_uuid": "75f2d97a-b96c-403f-8055-5c5c8083e856",
    "patient_ID": "TCGA.61.1910",
    "bcr_drug_barcode": "TCGA-61-1910-D28258",
    "bcr_drug_uuid": "4a16e1dc-aba9-48c9-b387-2f5461cbc49b",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 756
  },
  {
    "bcr_patient_uuid": "75f2d97a-b96c-403f-8055-5c5c8083e856",
    "patient_ID": "TCGA.61.1910",
    "bcr_drug_barcode": "TCGA-61-1910-D28257",
    "bcr_drug_uuid": "1156e454-75aa-4807-9098-9c0c7f48c158",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4550
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28263",
    "bcr_drug_uuid": "0cdd8ba8-eb65-46bb-aed4-903e1f8e4311",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 893,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 998,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 8400
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28265",
    "bcr_drug_uuid": "d1f8adbb-656c-4ba2-897a-f44078508729",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1306,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1432,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 9800
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28264",
    "bcr_drug_uuid": "57b42526-f8f9-4174-9f48-ef76fc389e56",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 893,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 998,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3000
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28267",
    "bcr_drug_uuid": "35c6a1ab-a350-42c4-adc4-1f8a13363ab3",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1306,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1432,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5700
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28261",
    "bcr_drug_uuid": "07995a31-b89c-4dcf-a2ac-8df6206991d6",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4650
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28266",
    "bcr_drug_uuid": "d66c5aa9-31ea-436a-b0f6-83a2a727862c",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1306,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1432,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 500
  },
  {
    "bcr_patient_uuid": "93095c36-2263-438f-a619-a4a4d6ae13c7",
    "patient_ID": "TCGA.61.1911",
    "bcr_drug_barcode": "TCGA-61-1911-D28262",
    "bcr_drug_uuid": "50d13255-fa36-4270-9b48-bf97f80061db",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1710
  },
  {
    "bcr_patient_uuid": "8516d4f2-0b98-4847-99c6-4d7269fa4af2",
    "patient_ID": "TCGA.61.1913",
    "bcr_drug_barcode": "TCGA-61-1913-D28271",
    "bcr_drug_uuid": "490e164d-620b-44b0-bb79-d767b6bd4d4c",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3930
  },
  {
    "bcr_patient_uuid": "8516d4f2-0b98-4847-99c6-4d7269fa4af2",
    "patient_ID": "TCGA.61.1913",
    "bcr_drug_barcode": "TCGA-61-1913-D28270",
    "bcr_drug_uuid": "a567da40-6f3c-49d1-b3f8-ce39c43506a2",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 127,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "8e1b8811-1eb2-4337-852c-c19eaa0ee418",
    "patient_ID": "TCGA.61.1914",
    "bcr_drug_barcode": "TCGA-61-1914-D28275",
    "bcr_drug_uuid": "40a2d81b-7bf7-4f8e-a283-d44999b5d6ce",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3360
  },
  {
    "bcr_patient_uuid": "8e1b8811-1eb2-4337-852c-c19eaa0ee418",
    "patient_ID": "TCGA.61.1914",
    "bcr_drug_barcode": "TCGA-61-1914-D28274",
    "bcr_drug_uuid": "6f5663c3-61f6-4e8c-b0d0-f89618d07922",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 22,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 193,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2400
  },
  {
    "bcr_patient_uuid": "8e1b8811-1eb2-4337-852c-c19eaa0ee418",
    "patient_ID": "TCGA.61.1914",
    "bcr_drug_barcode": "TCGA-61-1914-D28276",
    "bcr_drug_uuid": "6ffd14a7-cd33-4aa5-af00-b98302635493",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1753,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1871,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1890
  },
  {
    "bcr_patient_uuid": "8e1b8811-1eb2-4337-852c-c19eaa0ee418",
    "patient_ID": "TCGA.61.1914",
    "bcr_drug_barcode": "TCGA-61-1914-D28278",
    "bcr_drug_uuid": "6d844227-9edb-4c02-bd47-494f8080a17f",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 1155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1673,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1030
  },
  {
    "bcr_patient_uuid": "8e1b8811-1eb2-4337-852c-c19eaa0ee418",
    "patient_ID": "TCGA.61.1914",
    "bcr_drug_barcode": "TCGA-61-1914-D28277",
    "bcr_drug_uuid": "b2513645-c71d-4268-bb2e-b6543d55e1b3",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1753,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1871,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2580
  },
  {
    "bcr_patient_uuid": "0adadf17-c4b6-48b0-a326-21450de3e144",
    "patient_ID": "TCGA.61.1915",
    "bcr_drug_barcode": "TCGA-61-1915-D28281",
    "bcr_drug_uuid": "4bd27c43-6a47-4962-a865-7fbad514b6d9",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1560
  },
  {
    "bcr_patient_uuid": "0adadf17-c4b6-48b0-a326-21450de3e144",
    "patient_ID": "TCGA.61.1915",
    "bcr_drug_barcode": "TCGA-61-1915-D28282",
    "bcr_drug_uuid": "04be4ceb-917f-4055-b536-a529442dfbcf",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3300
  },
  {
    "bcr_patient_uuid": "b25b3379-df8f-4900-9bce-0f8df50f549b",
    "patient_ID": "TCGA.61.1916",
    "bcr_drug_barcode": "TCGA-61-1916-D28288",
    "bcr_drug_uuid": "5e8b3d4e-c2e0-42c2-b5e8-a398b22b2443",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b25b3379-df8f-4900-9bce-0f8df50f549b",
    "patient_ID": "TCGA.61.1916",
    "bcr_drug_barcode": "TCGA-61-1916-D28287",
    "bcr_drug_uuid": "598ec300-0689-445d-8bf0-36cb29f5a1b8",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b25b3379-df8f-4900-9bce-0f8df50f549b",
    "patient_ID": "TCGA.61.1916",
    "bcr_drug_barcode": "TCGA-61-1916-D28285",
    "bcr_drug_uuid": "24ff60f6-90b7-445c-ad89-3ccb0e5e15ba",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b25b3379-df8f-4900-9bce-0f8df50f549b",
    "patient_ID": "TCGA.61.1916",
    "bcr_drug_barcode": "TCGA-61-1916-D28286",
    "bcr_drug_uuid": "e5b625fa-134d-465f-b7c8-424ba5a72067",
    "form_completion_date": "2010-2-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4",
    "patient_ID": "TCGA.61.1917",
    "bcr_drug_barcode": "TCGA-61-1917-D28291",
    "bcr_drug_uuid": "77081d9f-b721-4405-931e-35b61c21871b",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4",
    "patient_ID": "TCGA.61.1917",
    "bcr_drug_barcode": "TCGA-61-1917-D28292",
    "bcr_drug_uuid": "e7226494-66f0-4f59-8453-395e4e996045",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "87cdf9a8-0579-4d3e-b4df-0f8eef63d7f4",
    "patient_ID": "TCGA.61.1917",
    "bcr_drug_barcode": "TCGA-61-1917-D28293",
    "bcr_drug_uuid": "8bc7ad9c-d6f6-4863-863b-8d9a79d97ca5",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 19,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3491d67a-4f83-4f67-8085-bbb9fe942be5",
    "patient_ID": "TCGA.61.1918",
    "bcr_drug_barcode": "TCGA-61-1918-D28297",
    "bcr_drug_uuid": "a042ee9d-a58b-4d21-9b66-936fdf07b954",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2179
  },
  {
    "bcr_patient_uuid": "3491d67a-4f83-4f67-8085-bbb9fe942be5",
    "patient_ID": "TCGA.61.1918",
    "bcr_drug_barcode": "TCGA-61-1918-D28296",
    "bcr_drug_uuid": "c63c99b6-fa3c-4a93-9fd6-6e95ef6aad5c",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": true,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4686
  },
  {
    "bcr_patient_uuid": "3491d67a-4f83-4f67-8085-bbb9fe942be5",
    "patient_ID": "TCGA.61.1918",
    "bcr_drug_barcode": "TCGA-61-1918-D28298",
    "bcr_drug_uuid": "9c8afc14-2d7e-4c8e-a376-8e012320308d",
    "form_completion_date": "2009-11-30",
    "pharmaceutical_therapy_drug_name": "GEMCITIBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 15616
  },
  {
    "bcr_patient_uuid": "931738a7-4b5b-46dc-b69f-72600862d8af",
    "patient_ID": "TCGA.61.1995",
    "bcr_drug_barcode": "TCGA-61-1995-D28303",
    "bcr_drug_uuid": "154a83f9-1655-45ff-9961-44cd5d6992a7",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3202
  },
  {
    "bcr_patient_uuid": "931738a7-4b5b-46dc-b69f-72600862d8af",
    "patient_ID": "TCGA.61.1995",
    "bcr_drug_barcode": "TCGA-61-1995-D28304",
    "bcr_drug_uuid": "5b457183-3195-43d4-8c3e-f244c641648d",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 132,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1311
  },
  {
    "bcr_patient_uuid": "565d06a1-3640-4274-8fb3-8cad7e578876",
    "patient_ID": "TCGA.61.1998",
    "bcr_drug_barcode": "TCGA-61-1998-D28309",
    "bcr_drug_uuid": "d1901164-9c69-4aa7-bfc2-bf9a93581e24",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 175
  },
  {
    "bcr_patient_uuid": "565d06a1-3640-4274-8fb3-8cad7e578876",
    "patient_ID": "TCGA.61.1998",
    "bcr_drug_barcode": "TCGA-61-1998-D28308",
    "bcr_drug_uuid": "32b34fbe-8dba-4a98-8abb-fdabf73ff607",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": true,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "AUC",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 6
  },
  {
    "bcr_patient_uuid": "565d06a1-3640-4274-8fb3-8cad7e578876",
    "patient_ID": "TCGA.61.1998",
    "bcr_drug_barcode": "TCGA-61-1998-D28307",
    "bcr_drug_uuid": "bf3290fb-d43f-40f0-b67f-584975a56c14",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 10,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "drug_cycles": 2,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 188
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28312",
    "bcr_drug_uuid": "01c66404-139e-49b4-880f-f7fc97c53c34",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1905
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28318",
    "bcr_drug_uuid": "b473a7f5-5323-4b38-b6ec-4f105fe01e5c",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 588,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3780
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28319",
    "bcr_drug_uuid": "c8caf399-a8ff-4dc9-8b74-2708050e41c0",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 525,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 588,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 855
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28313",
    "bcr_drug_uuid": "f41bfb1f-715c-488a-8c23-0547b7a39613",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 9,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2130
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28316",
    "bcr_drug_uuid": "f43225b8-2247-4397-90fb-8ac91e6a7806",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 420,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 491,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 508
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28314",
    "bcr_drug_uuid": "de3a38db-115b-4578-b4ca-1a70e152bc86",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CCDP",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 720
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28317",
    "bcr_drug_uuid": "a7437859-e26f-4182-a68e-d71bb725f774",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 420,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 491,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 367
  },
  {
    "bcr_patient_uuid": "29949b65-2913-4c86-bbd7-b85c5df6f15e",
    "patient_ID": "TCGA.61.2000",
    "bcr_drug_barcode": "TCGA-61-2000-D28315",
    "bcr_drug_uuid": "d8595da8-5331-4069-8b2c-8ce6f92b1d33",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 28,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 231,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 390
  },
  {
    "bcr_patient_uuid": "85bb4987-51e7-40fe-ad59-2aa56754eca9",
    "patient_ID": "TCGA.61.2002",
    "bcr_drug_barcode": "TCGA-61-2002-D28324",
    "bcr_drug_uuid": "eb420498-8627-4216-ab0a-82de0025a5ca",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 157,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 563,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 924
  },
  {
    "bcr_patient_uuid": "85bb4987-51e7-40fe-ad59-2aa56754eca9",
    "patient_ID": "TCGA.61.2002",
    "bcr_drug_barcode": "TCGA-61-2002-D28325",
    "bcr_drug_uuid": "258ebe71-34ac-4e7a-8daa-c688b3a646d9",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 400,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 558,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 6600
  },
  {
    "bcr_patient_uuid": "85bb4987-51e7-40fe-ad59-2aa56754eca9",
    "patient_ID": "TCGA.61.2002",
    "bcr_drug_barcode": "TCGA-61-2002-D28322",
    "bcr_drug_uuid": "d6e3f98a-0305-4a2c-8bea-29b7e39775c5",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1668
  },
  {
    "bcr_patient_uuid": "85bb4987-51e7-40fe-ad59-2aa56754eca9",
    "patient_ID": "TCGA.61.2002",
    "bcr_drug_barcode": "TCGA-61-2002-D28323",
    "bcr_drug_uuid": "400a7f22-69a2-4b72-84ef-540194cb48b8",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 129,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4800
  },
  {
    "bcr_patient_uuid": "33dc48d8-2e01-482b-944c-ac10da727ec9",
    "patient_ID": "TCGA.61.2003",
    "bcr_drug_barcode": "TCGA-61-2003-D28329",
    "bcr_drug_uuid": "1de90898-a17b-4157-9573-4a8049004b10",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "33dc48d8-2e01-482b-944c-ac10da727ec9",
    "patient_ID": "TCGA.61.2003",
    "bcr_drug_barcode": "TCGA-61-2003-D28331",
    "bcr_drug_uuid": "c055893d-8966-4aca-8d83-54c687fa097f",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "33dc48d8-2e01-482b-944c-ac10da727ec9",
    "patient_ID": "TCGA.61.2003",
    "bcr_drug_barcode": "TCGA-61-2003-D28330",
    "bcr_drug_uuid": "08a1b811-658b-474d-8e5c-6b15e313b88e",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "33dc48d8-2e01-482b-944c-ac10da727ec9",
    "patient_ID": "TCGA.61.2003",
    "bcr_drug_barcode": "TCGA-61-2003-D28328",
    "bcr_drug_uuid": "548a0b5e-a665-40db-864c-7a990f366c0d",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 121,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "33dc48d8-2e01-482b-944c-ac10da727ec9",
    "patient_ID": "TCGA.61.2003",
    "bcr_drug_barcode": "TCGA-61-2003-D28332",
    "bcr_drug_uuid": "682e5459-eee9-47d4-aa3f-b5543a57a9c5",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 122,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "3ac45a71-c463-4f0f-b030-58c475a34418",
    "patient_ID": "TCGA.61.2008",
    "bcr_drug_barcode": "TCGA-61-2008-D28336",
    "bcr_drug_uuid": "d05da628-44eb-4405-8981-f0723b085b60",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 690
  },
  {
    "bcr_patient_uuid": "3ac45a71-c463-4f0f-b030-58c475a34418",
    "patient_ID": "TCGA.61.2008",
    "bcr_drug_barcode": "TCGA-61-2008-D28339",
    "bcr_drug_uuid": "f5583f7b-a50c-4bf5-a9c9-11a8333d4781",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 979,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 372
  },
  {
    "bcr_patient_uuid": "3ac45a71-c463-4f0f-b030-58c475a34418",
    "patient_ID": "TCGA.61.2008",
    "bcr_drug_barcode": "TCGA-61-2008-D28338",
    "bcr_drug_uuid": "5258713d-41d6-476f-9869-3f98a9284455",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 979,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 702
  },
  {
    "bcr_patient_uuid": "3ac45a71-c463-4f0f-b030-58c475a34418",
    "patient_ID": "TCGA.61.2008",
    "bcr_drug_barcode": "TCGA-61-2008-D28337",
    "bcr_drug_uuid": "e3ffc3a5-5a6b-4053-a5c4-3a61628c98ce",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 861,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 979,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1260
  },
  {
    "bcr_patient_uuid": "3ac45a71-c463-4f0f-b030-58c475a34418",
    "patient_ID": "TCGA.61.2008",
    "bcr_drug_barcode": "TCGA-61-2008-D28335",
    "bcr_drug_uuid": "aae34ce1-d57d-4c05-924f-9c8a7cbc4f8f",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28342",
    "bcr_drug_uuid": "fd4307f9-d370-43de-9bb1-aa5a096b8295",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 778
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28343",
    "bcr_drug_uuid": "d23924cf-bfbe-491c-857d-ee0725112933",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1545
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28346",
    "bcr_drug_uuid": "fb931ec9-877c-411a-b75f-07a07fd3afd4",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 490
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28348",
    "bcr_drug_uuid": "ef2747cc-31fe-4893-8aab-d084a7b528c2",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 839,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1003,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 658
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28347",
    "bcr_drug_uuid": "a6d772c2-aeae-48ee-9e3e-c9357345c653",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 839,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1003,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 987
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28350",
    "bcr_drug_uuid": "9d9b6e91-c5ec-4d50-b8fc-c27068ee4470",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 658,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28344",
    "bcr_drug_uuid": "6d2c40c5-e1e8-4083-a77d-24b61b62bef7",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28345",
    "bcr_drug_uuid": "3ff0898b-635f-4c55-b7d9-beb06c6248c8",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 295,
    "drug_cycles": 7,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 635
  },
  {
    "bcr_patient_uuid": "ae914f23-87b9-4169-a7f7-a3483078c902",
    "patient_ID": "TCGA.61.2009",
    "bcr_drug_barcode": "TCGA-61-2009-D28349",
    "bcr_drug_uuid": "60906890-5f6c-494d-8601-e9967fafa145",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1100,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1126,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 304
  },
  {
    "bcr_patient_uuid": "20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c",
    "patient_ID": "TCGA.61.2012",
    "bcr_drug_barcode": "TCGA-61-2012-D28354",
    "bcr_drug_uuid": "03ea578a-6288-48d0-aac8-a043b050c091",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "20c6be4d-7baf-4ea0-93e2-a5212f2e9b9c",
    "patient_ID": "TCGA.61.2012",
    "bcr_drug_barcode": "TCGA-61-2012-D28353",
    "bcr_drug_uuid": "d10ed0e0-e577-49c9-8ed4-ad2fb0a269bd",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f0ca8205-0754-4bd8-a6a8-31901040c5e7",
    "patient_ID": "TCGA.61.2017",
    "bcr_drug_barcode": "TCGA-61-2017-D28363",
    "bcr_drug_uuid": "7c13d883-2763-4805-b918-f5c98710e43d",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1053,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1186,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 456
  },
  {
    "bcr_patient_uuid": "f0ca8205-0754-4bd8-a6a8-31901040c5e7",
    "patient_ID": "TCGA.61.2017",
    "bcr_drug_barcode": "TCGA-61-2017-D28362",
    "bcr_drug_uuid": "d69aaa81-29d1-4b99-baa8-5b5f7db327bb",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1053,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1186,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 618
  },
  {
    "bcr_patient_uuid": "f0ca8205-0754-4bd8-a6a8-31901040c5e7",
    "patient_ID": "TCGA.61.2017",
    "bcr_drug_barcode": "TCGA-61-2017-D28364",
    "bcr_drug_uuid": "d8e6f6d0-11e5-4857-9176-65b9fd0c367b",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1053,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1186,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1206
  },
  {
    "bcr_patient_uuid": "f0ca8205-0754-4bd8-a6a8-31901040c5e7",
    "patient_ID": "TCGA.61.2017",
    "bcr_drug_barcode": "TCGA-61-2017-D28360",
    "bcr_drug_uuid": "61c43bff-0d72-4d2c-922c-9694670bfceb",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f0ca8205-0754-4bd8-a6a8-31901040c5e7",
    "patient_ID": "TCGA.61.2017",
    "bcr_drug_barcode": "TCGA-61-2017-D28361",
    "bcr_drug_uuid": "90f7abab-7512-4fca-acad-6e58dec64576",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "13d6c31a-6899-4119-a5c2-90adcb5bd20c",
    "patient_ID": "TCGA.61.2018",
    "bcr_drug_barcode": "TCGA-61-2018-D28370",
    "bcr_drug_uuid": "4af20208-1f14-49df-8e50-22ee1f341ab5",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1920
  },
  {
    "bcr_patient_uuid": "13d6c31a-6899-4119-a5c2-90adcb5bd20c",
    "patient_ID": "TCGA.61.2018",
    "bcr_drug_barcode": "TCGA-61-2018-D28367",
    "bcr_drug_uuid": "77d725e0-430c-4c12-8d5e-4cae274cdd50",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2010
  },
  {
    "bcr_patient_uuid": "13d6c31a-6899-4119-a5c2-90adcb5bd20c",
    "patient_ID": "TCGA.61.2018",
    "bcr_drug_barcode": "TCGA-61-2018-D28369",
    "bcr_drug_uuid": "c38fd237-8010-48ed-8dc4-1bae13e77bb3",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 460
  },
  {
    "bcr_patient_uuid": "13d6c31a-6899-4119-a5c2-90adcb5bd20c",
    "patient_ID": "TCGA.61.2018",
    "bcr_drug_barcode": "TCGA-61-2018-D28368",
    "bcr_drug_uuid": "b98b71fc-711e-4226-b130-12e02b9eb2e1",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 60,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 639
  },
  {
    "bcr_patient_uuid": "be03bfec-5bb6-4cab-9dd2-bee590bd45f1",
    "patient_ID": "TCGA.61.2087",
    "bcr_drug_barcode": "TCGA-61-2087-D28373",
    "bcr_drug_uuid": "ff89b35b-775d-4c23-a18c-aa0cfcd3e92e",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "be03bfec-5bb6-4cab-9dd2-bee590bd45f1",
    "patient_ID": "TCGA.61.2087",
    "bcr_drug_barcode": "TCGA-61-2087-D28374",
    "bcr_drug_uuid": "4ae5fbbf-121c-45a8-8164-fb222d5e5605",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "be03bfec-5bb6-4cab-9dd2-bee590bd45f1",
    "patient_ID": "TCGA.61.2087",
    "bcr_drug_barcode": "TCGA-61-2087-D28375",
    "bcr_drug_uuid": "e7f46eb7-164e-4af4-821e-a810016df63b",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "242943fe-1fa0-4a12-8f7e-9c6c4af1194d",
    "patient_ID": "TCGA.61.2088",
    "bcr_drug_barcode": "TCGA-61-2088-D28379",
    "bcr_drug_uuid": "3b8a8370-edc0-494d-8215-80aaae8e9888",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 900
  },
  {
    "bcr_patient_uuid": "242943fe-1fa0-4a12-8f7e-9c6c4af1194d",
    "patient_ID": "TCGA.61.2088",
    "bcr_drug_barcode": "TCGA-61-2088-D28378",
    "bcr_drug_uuid": "f85675b8-465d-493f-b708-2e8f9ca175a4",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3900
  },
  {
    "bcr_patient_uuid": "c183d3fb-2eee-44f8-890e-b9bf907141e6",
    "patient_ID": "TCGA.61.2092",
    "bcr_drug_barcode": "TCGA-61-2092-D28382",
    "bcr_drug_uuid": "1690eed1-9060-4323-bdef-31b6bfdd2e65",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c183d3fb-2eee-44f8-890e-b9bf907141e6",
    "patient_ID": "TCGA.61.2092",
    "bcr_drug_barcode": "TCGA-61-2092-D28383",
    "bcr_drug_uuid": "310d2d4f-8dad-40ae-b4e9-74aad0299ebd",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b31d85cc-d2e2-4bd1-9986-d6bbe30e657f",
    "patient_ID": "TCGA.61.2094",
    "bcr_drug_barcode": "TCGA-61-2094-D28387",
    "bcr_drug_uuid": "8ca7bbee-0d63-40d2-b769-73f7e9411a50",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b31d85cc-d2e2-4bd1-9986-d6bbe30e657f",
    "patient_ID": "TCGA.61.2094",
    "bcr_drug_barcode": "TCGA-61-2094-D28386",
    "bcr_drug_uuid": "384a2e6a-6501-479e-b41c-10713af19c13",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "drug_cycles": 6,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28391",
    "bcr_drug_uuid": "954df6b0-eb97-48ef-8420-fc927a9cd581",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 602,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28396",
    "bcr_drug_uuid": "e6c07ec3-5875-407b-a937-5379bdc53ed6",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "OVAREX MA6 B43.13",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 447,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 12
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28393",
    "bcr_drug_uuid": "579b6224-4d67-44a5-b5fa-72d19bcd0692",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1193,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1264,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28390",
    "bcr_drug_uuid": "6a0849e1-a42b-4ac6-a5f9-7a36be83542d",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 59,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 602,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28394",
    "bcr_drug_uuid": "e9c95270-88d0-44f3-972d-75a8bfd8447e",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1360,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1389,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 468
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28392",
    "bcr_drug_uuid": "78845da3-7582-496a-a208-b129f7fb4348",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 783,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1188,
    "drug_cycles": 12,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "778ce436-a825-4689-81c1-b7c965404163",
    "patient_ID": "TCGA.61.2095",
    "bcr_drug_barcode": "TCGA-61-2095-D28395",
    "bcr_drug_uuid": "40f7e2ed-0250-4c2b-9f7c-bcfa87bce830",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28404",
    "bcr_drug_uuid": "0194e725-95cb-4433-a529-83ed2c8d8982",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1059,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1156,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1876
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28403",
    "bcr_drug_uuid": "6d4dc7be-241f-4118-bcfc-23669a4aa990",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 916,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 988,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1230
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28406",
    "bcr_drug_uuid": "32b36471-32ff-40be-8198-66ce4f3ce473",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1372,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1430
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28400",
    "bcr_drug_uuid": "747e5765-384f-47e1-b3e6-cb03b2421b71",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 645
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28399",
    "bcr_drug_uuid": "7d5010dc-37d5-47a1-a188-bb9fc40715d6",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1440
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28408",
    "bcr_drug_uuid": "4c55795f-5c4d-4e31-8f40-261d3e5b4ebd",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1723,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2010,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 5320
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28402",
    "bcr_drug_uuid": "9421779f-251f-47b0-b58b-f6a909449e5b",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 544,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1296
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28405",
    "bcr_drug_uuid": "bddc4142-e4c3-4aca-a2af-b3fd121af417",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1191,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1372,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 9450
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28401",
    "bcr_drug_uuid": "0ce482e8-1b48-4a3b-aba4-5e06a663f25c",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 474,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 544,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 2200
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28407",
    "bcr_drug_uuid": "3d15ee97-366f-4c71-9465-e207cf22ffdc",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1723,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2010,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 43.2
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28410",
    "bcr_drug_uuid": "70f500bc-f3f6-4f06-83c6-f6a96bfed24c",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "MELPHALON",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 642,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28411",
    "bcr_drug_uuid": "105b962c-185f-43a2-a308-d39d139bae04",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 642,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "6beaa1cb-a9f1-4127-898c-7aff2273788e",
    "patient_ID": "TCGA.61.2096",
    "bcr_drug_barcode": "TCGA-61-2096-D28409",
    "bcr_drug_uuid": "9e834075-0f48-4e0a-a791-c91c65803a6d",
    "form_completion_date": "2010-2-9",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 642,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "47681e4b-01e8-4779-b966-ce57aff4b712",
    "patient_ID": "TCGA.61.2097",
    "bcr_drug_barcode": "TCGA-61-2097-D28416",
    "bcr_drug_uuid": "ae9a2672-4912-4212-8eba-36c96d2e1d6f",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "INTERFERON GAMMA",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 48,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "47681e4b-01e8-4779-b966-ce57aff4b712",
    "patient_ID": "TCGA.61.2097",
    "bcr_drug_barcode": "TCGA-61-2097-D28415",
    "bcr_drug_uuid": "12fc9951-d8e0-437b-8f44-647e2e6662d1",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1814
  },
  {
    "bcr_patient_uuid": "47681e4b-01e8-4779-b966-ce57aff4b712",
    "patient_ID": "TCGA.61.2097",
    "bcr_drug_barcode": "TCGA-61-2097-D28414",
    "bcr_drug_uuid": "070e6cd1-5dac-4a4d-b01c-582c4b2e1bc9",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 167,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3060
  },
  {
    "bcr_patient_uuid": "eb7c3b35-7a5e-4621-b31f-9775c51f9a23",
    "patient_ID": "TCGA.61.2098",
    "bcr_drug_barcode": "TCGA-61-2098-D28419",
    "bcr_drug_uuid": "e844b70b-eaae-45a1-98eb-911c6c63e56c",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eb7c3b35-7a5e-4621-b31f-9775c51f9a23",
    "patient_ID": "TCGA.61.2098",
    "bcr_drug_barcode": "TCGA-61-2098-D28420",
    "bcr_drug_uuid": "e06ba706-69b6-4c0a-a1d8-73d71b53a692",
    "form_completion_date": "2009-12-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "drug_cycles": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28426",
    "bcr_drug_uuid": "395d5771-ffed-491a-baa5-f715fb8fbd06",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3050
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28434",
    "bcr_drug_uuid": "e2b74437-6a3e-4db1-ba77-7c66df176fc0",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "IL 12",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 1129,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/KG",
    "drug_tota_dose_units": "MG/KG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 300
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28430",
    "bcr_drug_uuid": "a0365ba7-19d8-4ea4-9b7a-ce9c9cf90d23",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "HEXALEN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1159,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28428",
    "bcr_drug_uuid": "22a24cee-77c5-423e-b0fa-2fadedc64e6d",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "HEXALIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 733,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 800
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28432",
    "bcr_drug_uuid": "bb3e3e24-b6db-4a5c-ae01-b27ab1c1628c",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1220,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28429",
    "bcr_drug_uuid": "f557ab9d-8841-415f-a81a-2986f12eb545",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1103,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28433",
    "bcr_drug_uuid": "b3ae2276-2ab9-4b82-bc5e-83f7143af1ea",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "VP 16",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1251,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28423",
    "bcr_drug_uuid": "48ba6dc6-f632-4dce-b86d-ff727f1251b3",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1800
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28425",
    "bcr_drug_uuid": "a9ae8b0a-2427-4bb0-82c6-ee9668363f5f",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 221,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28431",
    "bcr_drug_uuid": "ad0029f1-24b5-490c-b5e2-56e03495b8a3",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1190,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28424",
    "bcr_drug_uuid": "a17b6920-5a05-4657-a3ee-1dafc0f723e7",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 117,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 762
  },
  {
    "bcr_patient_uuid": "5d1a54fe-e0df-4c17-b623-b649a136dc82",
    "patient_ID": "TCGA.61.2101",
    "bcr_drug_barcode": "TCGA-61-2101-D28427",
    "bcr_drug_uuid": "119e9ed1-a261-483a-a7bf-34bcece33123",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 733,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1420
  },
  {
    "bcr_patient_uuid": "7a08efd0-f984-430e-a8eb-1881047214b6",
    "patient_ID": "TCGA.61.2102",
    "bcr_drug_barcode": "TCGA-61-2102-D28439",
    "bcr_drug_uuid": "43d7605a-1774-4181-a4da-677d897ac471",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "7a08efd0-f984-430e-a8eb-1881047214b6",
    "patient_ID": "TCGA.61.2102",
    "bcr_drug_barcode": "TCGA-61-2102-D28440",
    "bcr_drug_uuid": "9c357105-fe4d-4ec2-93e3-529f563fd5d8",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05263959-c4f5-4540-b6d2-d8c8a128861f",
    "patient_ID": "TCGA.61.2104",
    "bcr_drug_barcode": "TCGA-61-2104-D28445",
    "bcr_drug_uuid": "bc697473-6eba-4dfb-8a1c-4a4b60daa0d1",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05263959-c4f5-4540-b6d2-d8c8a128861f",
    "patient_ID": "TCGA.61.2104",
    "bcr_drug_barcode": "TCGA-61-2104-D28447",
    "bcr_drug_uuid": "172b7324-19f1-4c6a-9b48-f25584cfe417",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1680,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1681,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "05263959-c4f5-4540-b6d2-d8c8a128861f",
    "patient_ID": "TCGA.61.2104",
    "bcr_drug_barcode": "TCGA-61-2104-D28444",
    "bcr_drug_uuid": "6d9216c8-daf8-4211-927c-874a245d8a96",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05263959-c4f5-4540-b6d2-d8c8a128861f",
    "patient_ID": "TCGA.61.2104",
    "bcr_drug_barcode": "TCGA-61-2104-D28448",
    "bcr_drug_uuid": "a1b6da11-0c8e-4f50-bdd0-5590dcf6b817",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXANE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1838,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2338,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "05263959-c4f5-4540-b6d2-d8c8a128861f",
    "patient_ID": "TCGA.61.2104",
    "bcr_drug_barcode": "TCGA-61-2104-D28446",
    "bcr_drug_uuid": "32cf4d72-b8d4-4a25-99aa-7918878ab0d8",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "05263959-c4f5-4540-b6d2-d8c8a128861f",
    "patient_ID": "TCGA.61.2104",
    "bcr_drug_barcode": "TCGA-61-2104-D28443",
    "bcr_drug_uuid": "16e277f4-06cf-4d80-8c70-a07667591497",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5",
    "patient_ID": "TCGA.61.2109",
    "bcr_drug_barcode": "TCGA-61-2109-D28453",
    "bcr_drug_uuid": "2ea9b28a-6af9-4fcd-aa66-d49a600f60ac",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 486,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 9060
  },
  {
    "bcr_patient_uuid": "dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5",
    "patient_ID": "TCGA.61.2109",
    "bcr_drug_barcode": "TCGA-61-2109-D28454",
    "bcr_drug_uuid": "fd722d54-c930-4c8a-b35d-106c76576754",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 486,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 601,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 325
  },
  {
    "bcr_patient_uuid": "dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5",
    "patient_ID": "TCGA.61.2109",
    "bcr_drug_barcode": "TCGA-61-2109-D28452",
    "bcr_drug_uuid": "8e1688ad-53a1-4989-98a4-ba00ccbb8717",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 8910
  },
  {
    "bcr_patient_uuid": "dc5a6ce7-01e5-408d-812e-e3e0ddc1cde5",
    "patient_ID": "TCGA.61.2109",
    "bcr_drug_barcode": "TCGA-61-2109-D28451",
    "bcr_drug_uuid": "c0bde517-fee3-47fb-8d5f-e06a0012720c",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 14,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 253,
    "drug_cycles": 10,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3125
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28459",
    "bcr_drug_uuid": "cf284d67-59f2-44d4-ac77-0aaaa1a593e9",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 661,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 770,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 28
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28458",
    "bcr_drug_uuid": "2b91b2c6-dd7b-4b55-a31e-a5d0b54914e4",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1620
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28457",
    "bcr_drug_uuid": "e104ed61-6ac7-4c6c-ad84-389d00289ed8",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 161,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 2970
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28462",
    "bcr_drug_uuid": "83713042-6ff6-4fb5-af9f-d052de0e9ef4",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1089,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1239,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 12640
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28460",
    "bcr_drug_uuid": "b7c2bc59-6246-44da-afb4-445792bf317e",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "CARBPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 774,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 930,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3900
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28461",
    "bcr_drug_uuid": "106ff996-b75a-4830-a231-a7812b2ba5bc",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 979,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1089,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 315
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28464",
    "bcr_drug_uuid": "22c34e90-e390-42af-afe8-975c0b18cac9",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "IL 2",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 244,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 356,
    "drug_route": "INTRA-PERITONEAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 16
  },
  {
    "bcr_patient_uuid": "88180134-710f-46ea-9b06-5e5d860d6d9f",
    "patient_ID": "TCGA.61.2110",
    "bcr_drug_barcode": "TCGA-61-2110-D28463",
    "bcr_drug_uuid": "59347194-a069-4b01-830f-b2a17362f69d",
    "form_completion_date": "2009-12-4",
    "pharmaceutical_therapy_drug_name": "TAMOXIFEN",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 459,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1354,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "ORAL",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 10
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28471",
    "bcr_drug_uuid": "92211853-fa2a-4218-a96b-db3d1db39268",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2373,
    "drug_cycles": 6,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28470",
    "bcr_drug_uuid": "ab138666-d4a6-45cd-bb67-a74d0a8c97dd",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2268,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2373,
    "drug_cycles": 6,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28468",
    "bcr_drug_uuid": "5cf77f39-17b0-4d14-8ea3-ea290c63b199",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 3400
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28473",
    "bcr_drug_uuid": "6cda5c22-d228-450b-8486-fb10316b9cf7",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3079,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3165,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 4000
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28476",
    "bcr_drug_uuid": "a363d2df-0d8e-45e5-8faa-c9bbfb618a20",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "MEGACE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28469",
    "bcr_drug_uuid": "acfa69b3-3faa-4a7d-9a8d-b719408b3bf9",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28474",
    "bcr_drug_uuid": "15db7502-ada4-472f-9061-ef9ea6087a00",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CYTOXAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3808,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/DAY",
    "drug_tota_dose_units": "MG/DAY",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28472",
    "bcr_drug_uuid": "1f0c6548-7a9f-44a1-ac71-91c393f297a4",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3079,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 3165,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 512
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28475",
    "bcr_drug_uuid": "bb037fb1-3dfc-476d-a329-f46e33afc260",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 3808,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_units": "MG/M2/WK",
    "drug_tota_dose_units": "MG/M2/WK",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "91a17d40-c8cb-4cce-b306-966382a8fe4a",
    "patient_ID": "TCGA.61.2111",
    "bcr_drug_barcode": "TCGA-61-2111-D28477",
    "bcr_drug_uuid": "82428555-0922-4f7b-a9ca-780dd852553d",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "PROVERA",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "71faa2c1-0d5b-4dcc-bdf9-f2405f29907c",
    "patient_ID": "TCGA.61.2113",
    "bcr_drug_barcode": "TCGA-61-2113-D28482",
    "bcr_drug_uuid": "235aa36e-7dcb-4f30-bc39-310e5bca1a66",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 336,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 392,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 418
  },
  {
    "bcr_patient_uuid": "71faa2c1-0d5b-4dcc-bdf9-f2405f29907c",
    "patient_ID": "TCGA.61.2113",
    "bcr_drug_barcode": "TCGA-61-2113-D28480",
    "bcr_drug_uuid": "d22d635b-1e7e-4114-9e2d-0d2b6db38ded",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG/M2",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 1480
  },
  {
    "bcr_patient_uuid": "71faa2c1-0d5b-4dcc-bdf9-f2405f29907c",
    "patient_ID": "TCGA.61.2113",
    "bcr_drug_barcode": "TCGA-61-2113-D28481",
    "bcr_drug_uuid": "d4d534c2-01be-4eff-bfb2-369ee917dcf2",
    "form_completion_date": "2009-12-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 4026
  },
  {
    "bcr_patient_uuid": "1098441d-fb10-4590-a302-0a7cc2332798",
    "patient_ID": "TCGA.61.2610",
    "bcr_drug_barcode": "TCGA-61-2610-D28488",
    "bcr_drug_uuid": "efec5670-4d2b-42da-9e6f-aff946b9e90c",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "DOXIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 591,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1130,
    "drug_cycles": 12,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "1098441d-fb10-4590-a302-0a7cc2332798",
    "patient_ID": "TCGA.61.2610",
    "bcr_drug_barcode": "TCGA-61-2610-D28487",
    "bcr_drug_uuid": "4974f4a7-8f86-480b-a922-48a07a10417c",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 357,
    "drug_cycles": 12,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1098441d-fb10-4590-a302-0a7cc2332798",
    "patient_ID": "TCGA.61.2610",
    "bcr_drug_barcode": "TCGA-61-2610-D28486",
    "bcr_drug_uuid": "741fb562-5cf2-415d-a54f-11bcb861ea9a",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 357,
    "drug_cycles": 12,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "1098441d-fb10-4590-a302-0a7cc2332798",
    "patient_ID": "TCGA.61.2610",
    "bcr_drug_barcode": "TCGA-61-2610-D28485",
    "bcr_drug_uuid": "d0b1651f-f3cd-4ccb-b9f5-cd3b5e34a0b5",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "TOPTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 439,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 530,
    "drug_cycles": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "499645bd-e33e-4f89-8526-50460e8bb884",
    "patient_ID": "TCGA.61.2611",
    "bcr_drug_barcode": "TCGA-61-2611-D28494",
    "bcr_drug_uuid": "b44534f8-de06-4bb5-9592-2d22bb4537a9",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 316,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 265,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "499645bd-e33e-4f89-8526-50460e8bb884",
    "patient_ID": "TCGA.61.2611",
    "bcr_drug_barcode": "TCGA-61-2611-D28492",
    "bcr_drug_uuid": "34666b3b-f332-478f-9e6c-b0f883bb1244",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN HCI LIPSOME",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 402,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 402,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 10,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "499645bd-e33e-4f89-8526-50460e8bb884",
    "patient_ID": "TCGA.61.2611",
    "bcr_drug_barcode": "TCGA-61-2611-D28493",
    "bcr_drug_uuid": "7bd1c9d0-0ad8-486c-9554-76f86e0b5519",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 316,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c040df8a-9d6d-43bd-911a-17a7b4e1ec74",
    "patient_ID": "TCGA.61.2612",
    "bcr_drug_barcode": "TCGA-61-2612-D28498",
    "bcr_drug_uuid": "ac6ec127-0170-49d5-9779-1f00c29d2825",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c040df8a-9d6d-43bd-911a-17a7b4e1ec74",
    "patient_ID": "TCGA.61.2612",
    "bcr_drug_barcode": "TCGA-61-2612-D28497",
    "bcr_drug_uuid": "e6638335-cf6e-49bd-bf75-5b476c5ad5d5",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c88502e9-0bc6-47c3-adc4-d98b63c7797b",
    "patient_ID": "TCGA.61.2613",
    "bcr_drug_barcode": "TCGA-61-2613-D28503",
    "bcr_drug_uuid": "65037e9d-ec78-4979-b499-010777f95ff1",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 86,
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "c88502e9-0bc6-47c3-adc4-d98b63c7797b",
    "patient_ID": "TCGA.61.2613",
    "bcr_drug_barcode": "TCGA-61-2613-D28501",
    "bcr_drug_uuid": "98cb83b6-f0a2-4cb6-8613-c44af0665952",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 235,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "c88502e9-0bc6-47c3-adc4-d98b63c7797b",
    "patient_ID": "TCGA.61.2613",
    "bcr_drug_barcode": "TCGA-61-2613-D28502",
    "bcr_drug_uuid": "17da5326-4465-4984-b2f9-5ce7c262d9ca",
    "form_completion_date": "2010-9-7",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 384,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 265,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "260723BF-9620-450D-BF31-F3A45543F9DB",
    "patient_ID": "TCGA.OY.A56P",
    "bcr_drug_barcode": "TCGA-OY-A56P-D40751",
    "bcr_drug_uuid": "4C69AC4B-5520-421E-ADEF-0F12EB0C0911",
    "form_completion_date": "2013-2-27",
    "pharmaceutical_therapy_drug_name": "TAXOTERE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "260723BF-9620-450D-BF31-F3A45543F9DB",
    "patient_ID": "TCGA.OY.A56P",
    "bcr_drug_barcode": "TCGA-OY-A56P-D40752",
    "bcr_drug_uuid": "002D674C-302E-4EEE-9324-3C912254F7DC",
    "form_completion_date": "2013-2-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 160,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C7CF6755-8856-435B-A443-174B22A25B07",
    "patient_ID": "TCGA.OY.A56Q",
    "bcr_drug_barcode": "TCGA-OY-A56Q-D40756",
    "bcr_drug_uuid": "E86F10BA-0449-406C-ABBE-AF17416539F6",
    "form_completion_date": "2013-2-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C7CF6755-8856-435B-A443-174B22A25B07",
    "patient_ID": "TCGA.OY.A56Q",
    "bcr_drug_barcode": "TCGA-OY-A56Q-D40757",
    "bcr_drug_uuid": "4E265E98-8861-485E-A5C5-21CEDE8B7F99",
    "form_completion_date": "2013-2-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 23,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 128,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8628F1B2-3763-4BA9-A375-083874BB18F2",
    "patient_ID": "TCGA.VG.A8LO",
    "bcr_drug_barcode": "TCGA-VG-A8LO-D60809",
    "bcr_drug_uuid": "FC9C6E78-2625-4BFD-879D-1E1FFFD56E85",
    "form_completion_date": "2014-6-26",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 8,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8628F1B2-3763-4BA9-A375-083874BB18F2",
    "patient_ID": "TCGA.VG.A8LO",
    "bcr_drug_barcode": "TCGA-VG-A8LO-D60817",
    "bcr_drug_uuid": "036051C3-A9BB-4A8E-B1F9-DC9174E397E2",
    "form_completion_date": "2014-6-26",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 8,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B8023162-5E82-40E6-AD8C-8ACF81821F01",
    "patient_ID": "TCGA.WR.A838",
    "bcr_drug_barcode": "TCGA-WR-A838-D57160",
    "bcr_drug_uuid": "392FF296-622C-4E06-8938-686004A62D8D",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B8023162-5E82-40E6-AD8C-8ACF81821F01",
    "patient_ID": "TCGA.WR.A838",
    "bcr_drug_barcode": "TCGA-WR-A838-D66186",
    "bcr_drug_uuid": "CCE11CBD-98D9-43FB-99E6-8770D1782337",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
